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Preface 
	This	dissertation	is	the	result	of	my	own	work	and	includes	nothing	which	is	the	outcome	of	work	done	in	collaboration	except	as	declared	in	the	Preface	and	specified	in	the	text. 	
It	 is	not	 substantially	 the	same	as	any	 that	 I	have	submitted,	or,	 is	being	concurrently	submitted	for	a	degree	or	diploma	or	other	qualification	at	the	University	of	Cambridge	or	 any	 other	 University	 or	 similar	 institution	 except	 as	 declared	 in	 the	 Preface	 and	specified	in	the	text.	I	further	state	that	no	substantial	part	of	my	dissertation	has	already	been	submitted,	or,	is	being	concurrently	submitted	for	any	such	degree,	diploma	or	other	qualification	at	the	University	of	Cambridge	or	any	other	University	or	similar	institution	except	as	declared	in	the	Preface	and	specified	in	the	text 	
It	does	not	exceed	 the	prescribed	word	 limit	of	60,000	words,	as	set	by	 the	Biological	Sciences	Degree	Committee.	
	
The	majority	of	the	data	on	the	role	of	E-cadherin	in	leader	cell	migration	and	loser	cell	status	has	been	published	in	(Wagstaff	et	al.	2016).	The	bulk	of	the	data	describing	the	role	 of	 p53	and	p21	 in	 leader	 cell	migration	has	been	 compiled	 into	 a	manuscript	 for	publication	in	late	2018	(Kozyrska	et	al.	2018	–	see	Appendix	1).	
The	cell	tracking	quantifications	in	Figure	V.2I-K	and	Figure	VI.1H-J	were	performed	by	Medhavi	Vishwakarma	in	the	Piddini	lab.	
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Abstract 
	Cell	competition	is	a	form	of	cell-cell	signalling	that	results	in	the	elimination	of	less	fit	cells	from	a	tissue	by	their	fitter	counterparts.	I	take	advantage	of	an	established	in	vitro	model	of	cell	competition	using	Madin-Darby	canine	kidney	(MDCK)	cells	to	shed	insight	into	the	molecular	basis	of	cell	competition	in	epithelial	cells.	In	this	system,	silencing	of	the	tumour	suppressor	scribble	 (scribKD)	results	 in	a	 ‘loser’	phenotype	whereby	scribKD	cells	are	specifically	eliminated	from	the	monolayer	by	surrounding	wild-type	cells.	More	specifically,	scribKD	cells	are	compacted	into	tight	clones	through	activation	of	a	directed,	collective	 migration	 in	 the	 wild-type	 population:	 scribKD	 are	 ‘mechanical	 losers’	 and	delaminate	and	die	due	to	an	intrinsic	hypersensitivity	to	high	cell	density.	Remarkably,	p53	activation	is	both	necessary	and	sufficient	for	this	mechanical	loser	cell	status.	I	 first	 investigate	 the	 role	of	E-,	N-,	 and	P-cadherin	 in	 the	directed	migration	between	
scribKD	 and	 wild-type	 cells	 and	 in	 scribKD	 cell	 loser	 status.	 I	 show	 that	 differential	expression	of	E-cadherin	between	scribKD	 losers	and	wild-type	winners	is	required	but	not	sufficient	for	directed	migration	and	has	no	impact	on	loser	cell	status.	I	also	show	that	 elevation	 of	 neither	 E-cadherin	 nor	 N-cadherin	 is	 sufficient	 to	 induce	 directed	migration	or	loser	status,	but	that	P-cadherin	may	play	a	role	in	both.	I	next	focus	on	translating	findings	about	the	molecular	details	of	competition	from	the	
scribKD	 set-up	 into	 a	 system	 where	 p53	 differences	 alone	 drive	 the	 formation	 and	elimination	of	mechanical	losers.	I	show	that	the	ROCK	–	P-p38	–	p53	pathway	activated	in	response	to	mechanical	compaction	in	scribKD	cells	is	conserved	in	p53-driven	losers.	In	 the	 latter	 part	 of	my	 thesis,	 I	 characterise	 the	 directed	migration	 observed	 during	MDCK	 competition	 by	 drawing	 parallels	 to	 canonical	 leader-follower	 migration.	Canonical	 leader	 cells	 emerge	when	 epithelial	 sheets	 are	wounded	 and,	 by	 becoming	migratory,	drive	collective	cell	migration	of	follower	cells,	which	results	in	wound	closure.	It	was	not	known	what	confers	the	leader	cell	fate.	I	show	that	p53	and	its	effector	p21	(and	potentially	other	cyclin-dependent	kinase	inhibitors)	are	the	key	drivers	of	leader	cell	migration.	I	demonstrate	that	p53-induced	leaders	use	the	same	molecular	pathways	that	have	been	shown	to	drive	leader	cell	migration	during	wound	healing	and,	in	fact,	p53	and	p21	are	also	elevated	in	leaders	generated	by	wounding.	Importantly,	I	establish	that	p53	activity	drives	efficient	wound	closure.	Lastly,	I	show	that	leader	cells	are	often	eliminated	by	cell	competition	in	the	final	stages	of	wound	closure,	as	their	elevated	p53	mediates	their	hypersensitivity	to	density.	The	model	incorporating	these	data	proposes	that	cellular	damage	during	wounding	generates	cells	with	elevated	p53,	which	become	leaders	and	drive	wound	healing,	but	 these	are	 then	cleared	once	 the	wound	 is	 closed	because	their	high	p53	levels	cause	them	to	become	mechanical	losers.	 	
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Chapter I: Introduction 
	
Cell competition 
Cell	 competition	 is	 a	 form	 of	 cell-cell	 communication	 conserved	 from	 arthropods	 to	mammals,	the	result	of	which	is	the	specific	elimination	of	less	fit	cells	from	a	tissue.	Cell	competition	is	triggered	when	two	cell	populations	of	differing	fitness	levels	come	into	contact:	 ‘loser’	 (less	 fit)	 cells	are	 removed	 from	the	 tissue	usually,	but	not	exclusively,	through	induction	of	apoptosis	by	 ‘winner’	(more	fit)	cells	(Figure	I.1)	(reviewed	in	Di	Gregorio	et	al.	2016).	Following	loser	elimination,	tissue	homeostasis	 is	maintained	by	winner	cells	undergoing	compensatory	proliferation	or	hypertrophy	to	replace	the	lost	cells	or	fill	the	space	vacated	by	losers,	respectively	(de	la	Cova	et	al.	2004;	Simpson	&	Morata	 1981;	 Tamori	 &	 Deng	 2013).	 Importantly,	 loser	 populations	 can	 survive	 in	 a	homotypic	situation,	although	they	often	display	slower	proliferation	rates	(reviewed	in	Di	Gregorio	et	al.	2016).	
Elimination	 of	 weak,	 damaged,	 or	 otherwise	 potentially	 harmful	 cells	 from	 a	 tissue	through	 cell	 competition	 allows	 re-population	 by	 healthy,	wild-type	 cells	 both	 during	development	 (Morata	&	Ripoll	 1975)	 and	 in	 adult	 tissue	maintenance	 (Kolahgar	 et	 al.	2015).	It	has	therefore	been	suggested	that	cell	competition	helps	maintain	overall	tissue	health	and	can	have	a	role	in	delaying	the	onset	of	pathologies	and	ageing.	On	the	flipside,	cells	harbouring	 some	 tumour-promoting	mutations	 (e.g.	 high	 levels	of	Myc)	 exhibit	 a	‘super-competitor’	 phenotype	 whereby	 they	 outcompete	 their	 wild-type	 neighbours	(Figure	I.1)	(Moreno	&	Basler	2004;	de	la	Cova	et	al.	2004;	Sancho	et	al.	2013;	Clavería	et	al.	 2013).	 Similar	 observations	 have	 highlighted	 the	 potential	 importance	 of	 cell	competition	in	cancer	and	this	has	recently	been	demonstrated	in	vivo:	tumour	growth	in	the	adult	Drosophila	melanogaster	(Drosophila)	gut	is	accelerated	due	to	elimination	of	wild-type	 tissue	 by	 adenomas	 resulting	 from	mutations	 in	adenomatous	 polyposis	 coli	(APC)	genes	(Suijkerbuijk	et	al.	2016).	
Despite	 the	 discovery	 of	 cell	 competition	 in	 the	 1970s	 (Morata	 &	 Ripoll	 1975),	 its	mechanistic	 basis	 is	 only	 beginning	 to	 be	 understood.	 It	 remains	 unclear	 how	 cells	compare	 fitness	 within	 a	 tissue	 and	 how	 detection	 of	 loser	 cells	 translates	 into	 their	
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elimination.	In	the	following	sections,	I	will	summarise	the	current	knowledge	of	the	field	that	 led	up	 to	my	PhD	project	 and	discuss	 the	 importance	 of	 cell	 competition	 in	 both	physiology	and	pathology.	
	
Minute cell competition 
The	first	report	of	cell	competition	came	from	studies	in	Drosophila	wing	imaginal	discs	(Morata	 &	 Ripoll	 1975).	 The	 authors	 were	 investigating	Minute	 genes,	 which	 encode	ribosomal	proteins:	Minute	mutations	result	in	impaired	translation	and	slower	growth.	While	homozygous	Minute	mutations	are	lethal,	heterozygous	Minute	flies	(Minute+/-)	are	viable,	 if	 slightly	 developmentally	 delayed	 compared	 to	 wild-type	 animals.	 Clones	 of	
Minute+/-	 tissue	 induced	 in	 a	 wild-type	 background	 are	 much	 smaller	 than	 would	 be	predicted	by	the	slower	proliferation	of	Minute+/-	cells	alone.	In	fact,	 it	was	shown	that	
Minute+/-	cells	undergo	apoptosis	and	are	actively	eliminated	when	surrounded	by	wild-type	cells	(Morata	&	Ripoll	1975).	Conversely,	wild-type	clones	in	Minute+/-	wing	discs	can	take	over	the	entire	compartment	at	the	expense	of	Minute+/-	tissue	(Simpson	&	Morata	1981).	Minute+/-	cells	can	therefore	be	classed	as	loser	cells:	while	viable	in	a	homotypic	environment,	they	are	less	fit	and	eliminated	by	the	fitter	winner	cells	(in	this	case,	wild-type	cells)	around	them.	
Minute	 competition	 highlights	 two	 additional	 important	 features	 of	 cell	 competition.	Firstly,	 cellular	 fitness	 is	 relative,	 as	 slower	 growing	 Minute	 mutant	 cells	 can	 be	outcompeted	by	faster	growing	cells	originating	from	a	distinct,	milder	Minute	mutation.	Secondly,	loser	and	winner	cells	must	be	in	close	proximity	for	cell	competition	to	occur,	but	proximity	 itself	 is	not	sufficient	 for	competition,	as	competition	does	not	cross	the	anterior-posterior	compartment	boundary	in	Drosophila	wing	discs	(Simpson	&	Morata	1981).	
Molecularly,	Minute+/-	cells	have	a	reduced	ability	to	transduce	decapentaplegic	(Dpp,	the	
Drosophila	homologue	of	bone	morphogenetic	proteins,	BMPs)	signalling	in	the	presence	of	wild-type	cells,	which	results	in	the	upregulation	of	the	c-Jun	N-terminal	kinase	(JNK)	pathway	 (Moreno	 et	 al.	 2002).	 However,	 it	 was	 later	 shown	 that	 the	 JNK	 pathway	 is		 	
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Figure	I.1:	Schematic	representation	of	cell	competition.	Top	panel:	both	wild-type	cells	(beige)	and	cells	 harbouring	 loser	 mutations	 (blue)	 can	 thrive	 in	 a	 homotypic	 environment.	 Middle	 panel:	 upon	confrontation	with	fitter	wild-type	cells,	less	fit	loser	cells	are	eliminated	through	the	induction	of	apoptosis.	Elimination	 of	 losers	 is	 accompanied	 by	 compensatory	 proliferation/hypertrophy	 of	 winners.	 Bottom	panel:	super-competitor	cells	(green)	are	fitter	than	wild-type	cells	and	induce	elimination	of	the	latter	from	the	tissue.	
Adapted	from	(Di	Gregorio	et	al.	2016).	
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constitutively	active	in	Minute+/-	cells,	even	prior	to	competition	(Tamori	&	Deng	2011;	Kucinski	et	al.	2017).	JNK	upregulation	in	Minute+/-	losers	was	originally	thought	to	simply	provide	a	pro-apoptotic	signal	(Moreno	et	al.	2002),	but	it	has	now	become	apparent	that	JNK	 also	 stunts	 the	 proliferation	 of	 Minute+/-	 cells,	 putting	 them	 at	 a	 further	 growth	disadvantage	 on	 top	 of	 their	 translational	 impairment	 (Kucinski	 et	 al.	 2017).	Simultaneously,	 JNK	activity	drives	secretion	of	Unpaired	ligands,	which	are	sensed	by	surrounding	wild-type	cells	promoting	 their	 compensatory	proliferation.	 Interestingly,	oxidative	stress	has	shown	to	be	the	underlying	cause	of	the	loser	status	of	both	Minute+/-	and	a	functionally	distinct	loser,	mahjong	cells	(Kucinski	et	al.	2017).	
While	Minute	competition	remains	the	archetypal	model	of	cell	competition,	many	more	mutations	have	 since	been	 identified	 to	play	 a	 role	 in	 cell	 competition.	 Pathways	 that	trigger	cell	competition	can	be	broadly	classified	into	metabolic	or	structural	pathways,	although	there	are	also	some	outliers.	It	is	now	becoming	apparent	that	there	are	most	likely	many	mechanisms	of	cell	competition,	which	all	 lead	to	the	common	outcome	of	loser	cell	elimination,	although	this	is	still	somewhat	controversial	in	the	field.	
	
Metabolic cell competition 
Impaired	translation	of	Minute+/-	cells	can	be	classed	as	a	metabolic	defect,	as	mutant	cells	have	lower	anabolic	activity	than	their	neighbours.	 In	fact,	many	mutations	reducing	a	cell’s	anabolic	potential	also	confer	the	loser	status	(reviewed	in	Amoyel	&	Bach	2014).	This	makes	perfect	sense	at	an	organismal	level,	as	cells	with	defective	metabolism	may	be	detrimental	 to	 the	development	or	 function	of	 the	whole	 tissue	or	organ,	and	 their	elimination	 is	 therefore	 beneficial	 to	 promote	 overall	 health.	 Interestingly,	 cells	 with	overactive	 anabolic	 pathways	 often	 become	 super-competitors	 and	 can	 outcompete	surrounding	wild-type	tissue,	suggesting	that	metabolic	potential	is	a	key	determinant	of	cellular	fitness.	
One	important	metabolic	regulator	in	both	flies	and	mammals	is	the	transcriptional	factor	Myc,	which	promotes	 a	 plethora	 of	 processes,	 including	 cell	 growth	 and	proliferation,	ribosome	and	mitochondrial	 biogenesis,	 as	well	 as	 glucose	 and	 glutamine	metabolism	(Dang	2013).	Cells	with	lower	levels	of	Myc	are	outcompeted	by	cells	with	higher	levels		 	
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of	Myc	in	a	similar	way	to	the	interaction	between	Minute+/-	and	wild-type	cells.	Strikingly,	cells	 with	 higher	 but	 non-tumourigenic	 levels	 of	 Myc	 have	 the	 ability	 to	 outcompete	surrounding	wild-type	tissue	in	a	process	known	as	super-competition	(Johnston	et	al.	1999;	de	 la	Cova	et	al.	2004;	Moreno	&	Basler	2004).	 Importantly,	differential	growth	rates	are	not	sufficient	to	trigger	cell	competition,	as	wild-type	cells	juxtaposed	with	cells	overexpressing	growth-promoting	factors	Dp110	or	CDK4/Cyclin	D	are	not	outcompeted	(de	 la	 Cova	 et	 al.	 2004).	 Mosaic	 Myc	 activation	 has	 also	 been	 shown	 to	 induce	 cell	competition	 in	mammalian	models,	 including	 in	 vivo	 during	early	mouse	development	(Clavería	et	al.	2013;	Sancho	et	al.	2013).	
Other	metabolic	pathways	have	been	shown	to	have	cell	competition	phenotypes	similar	to	Myc,	whereby	 their	 inactivation	 creates	 loser	 cells	when	 juxtaposed	with	wild-type	cells,	while	their	over-activation	results	in	a	super-competitor	phenotype	that	eliminates	surrounding	wild-type	tissue.	Some	examples	include	pathways	regulating	proliferation,	growth,	 and	 patterning:	 Janus	 kinase/signal	 transducer	 and	 activator	 of	 transcription	(JAK/STAT);	Ras/Raf/mitogen-activated	protein	kinase	(MAPK);	and	Wnt	(reviewed	in	Amoyel	&	Bach	2014).	
Interestingly,	Myc	activation	lies	downstream	of	many	metabolic	pathways	that	induce	cell	 competition.	 For	 instance,	 while	 ras	 mutant	 clones	 are	 eliminated	 from	 mosaic	
Drosophila	wing	discs,	this	can	be	partially	rescued	by	expression	of	Myc	(Prober	&	Edgar	2000).	Similarly,	cells	with	misregulated	Hippo	pathway	signalling,	which	is	responsible	for	 organ	 size	 control,	 are	 super-competitors	 because	 the	 pathway	 effector	 Yorkie	(Drosophila	 homologue	 of	 YAP/TAZ)	 directly	 upregulates	Myc	 expression	 (Ziosi	 et	 al.	2010;	Neto-Silva	et	al.	2010).	In	contrast,	Wnt	pathway	activation	results	in	lower	Myc	than	 the	 surrounding	 tissue	 and	 yet	 still	 confers	 the	 super-competitor	 phenotype	(Duman-Scheel	 et	 al.	 2004;	 Vincent	 et	 al.	 2011),	 while	 JAK/STAT	 activation	 partially	rescues	Myc	mutant	clone	outcompetition	 (Rodrigues	et	al.	2012).	Wnt	and	 JAK/STAT	pathways	therefore	affect	cell	competition	in	a	Myc-independent	manner.	Taken	together,	these	experiments	suggest	that	there	are	multiple	parallel	pathways	that	define	a	cell’s	fitness	and	drive	competitive	interactions.	
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Structural cell competition 
The	second	major	class	of	factors	involved	in	cell	competition	includes	molecules	involved	in	 the	 determination	 and	 maintenance	 of	 apico-basal	 polarity,	 including	 Lethal	 giant	larvae	(Lgl),	Scribble,	Discs	large	(Dlg),	and	Mahjong.	Lgl,	Scribble,	and	Dlg	are	classed	as	neoplastic	tumour	suppressors	in	Drosophila,	as	their	 loss	results	 in	disorganisation	of	the	 epithelium,	 differentiation	 failure,	 and	 neoplastic	 growth	 (reviewed	 in	 Clavería	 &	Torres	2016).	Juxtaposition	of	lgl,	scribble,	and	dlg	mutant	cells	with	wild-type	tissue	is	sufficient	to	limit	the	growth	and	lead	to	the	elimination	of	the	mutant	cells.	Interestingly,	while	Mahjong	lies	downstream	of	Lgl	and	mahjong	mutant	cells	are	also	losers,	loss	of	Mahjong	does	not	affect	cell	polarity	(Tamori	et	al.	2010).	In	fact,	as	mentioned	earlier,	the	underlying	cause	of	loser	status	of	mahjong	cells	is	oxidative	stress	rather	than	a	loss	of	polarity	(Kucinski	et	al.	2017).	
scribble	 competition	 was	 the	 initial	 focus	 of	 my	 PhD.	 As	 such,	 I	 further	 discuss	 the	molecular	details	of	this	type	of	competition	in	subsequent	sections	in	this	chapter.	
	
p53 in cell competition 
The	 tumour	 suppressor	p53	 coordinates	 cellular	 responses	 to	many	 types	of	 stresses,	including	DNA	damage,	nutrient	deprivation,	and	hypoxia.	The	best	studied	effects	of	p53	activation	are	cell	cycle	arrest,	senescence,	and	apoptosis.	Four	p53	molecules	form	the	active	 p53	 tetramer,	 which	 exerts	 its	 downstream	 effects	 mainly	 by	 modulating	transcription,	although	 it	 is	becoming	 increasing	clear	 that	p53	also	has	 transcription-independent	 roles	 in	 the	 cytoplasm	 and	 mitochondria.	 Because	 of	 its	 widespread	influence,	 p53	 activity	 is	 tightly	 regulated	 through	 multiple	 mechanisms	 e.g.	 post-translational	modifications,	subcellular	localisation,	and	protein	stability.	One	of	the	key	p53	 regulators	 is	 the	 E3	 ubiquitin	 ligase	 mouse	 double	 minute	 2	 (Mdm2),	 which	suppresses	 p53	 activity	 by	 continually	 targeting	 it	 for	 degradation	 in	 the	 absence	 of	cellular	stress	(reviewed	in	Vousden	&	Lane	2007).	
Differences	in	p53	activity	can	trigger	cell	competition	(Figure	I.2).	For	example,	when	a	mixture	of	 sub-lethally	 irradiated	 (90%)	and	non-irradiated	(10%)	bone	marrow	cells		 	
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Figure	 I.2:	Diagram	summarising	 the	 role	of	p53	 in	various	models	of	 cell	 competition.	 (A)	Non-irradiated	(low	p53)	mouse	bone	marrow	cells	can	colonise	more	of	the	tissue	at	the	expense	of	irradiated	cells	with	higher	p53	levels	(Bondar	&	Medzhitiv	2010).	(B)	Irradiation	directly	induces	the	death	of	a	sub-
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population	of	wild-type	(WT)	haematopoietic	cells,	while	simultaneously	conferring	a	selective	advantage	on	cells	lacking	p53	over	the	surviving	wild-type	cells.	This	promotes	the	tissue	colonisation	ability	of	cells	mutant	for	p53	(Marusyk	et	al.	2010).	(C)	Cells	deficient	in	p53	inhibitors	Mdm2	and	Mdm4	have	elevated	p53	 levels	and	are	eliminated	by	wild-type	 tissue	(low	p53)	during	mouse	embryogenesis	 (Zhang	et	al.	2017).	(D)	In	the	presence	of	Mdm2	inhibitor	Nutlin-3,	wild-type	MDCK	cells	activate	p53	while	p53KO	cells	maintain	low	p53.	Over	time,	wild-type	MDCKs	are	eliminated	by	the	surrounding	p53KO	cells	(Wagstaff	et	al.	2016).	
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was	 transplanted	 into	 a	 lethally	 irradiated	 donor	 mouse,	 the	 contribution	 of	 non-irradiated	cells	 to	 the	 tissue	 increased	over	several	weeks	 to	approximately	40%.	The	absolute	 numbers	 of	 bone	 marrow	 cells	 were	 comparable	 between	 experimental	(irradiated/non-irradiated	 mixture)	 and	 control	 (irradiated	 cells	 only)	 conditions,	suggesting	that	the	expansion	of	the	non-irradiated	population	happens	at	the	expense	of	the	irradiated	cells.	The	outcompetition	of	irradiated	cells	is	mediated	by	p53,	as	the	90	:	10	seeding	ratio	of	irradiated	heterozygous	p53	mutant	cells	to	non-irradiated	wild-type	cells	was	still	maintained	at	the	end	of	the	experiment.	Moreover,	genetic	mosaics	of	bone	marrow	cells	with	a	dominant	negative	p53	allele	have	a	competitive	advantage	over	wild-type	cells	following	irradiation	(Bondar	&	Medzhitiv	2010).	Similarly,	irradiation	confers	a	selective	advantage	on	haematopoietic	cells	deficient	in	p53	and	promotes	their	tissue	colonisation	 ability	 (Marusyk	 et	 al.	 2010).	 Unlike	 in	 canonical	models	 of	 competition,	apoptosis	is	not	induced	in	loser	cells	in	the	mouse	bone	marrow	system:	instead,	losers	adopt	 a	 senescence-like	 state	 and	 are	 replaced	 over	 time	 by	 fitter	 cells	 (Bondar	 &	Medzhitiv	 2010).	 Importantly,	 p53-mediated	 competition	 in	 these	 models	 is	 only	triggered	following	an	external	stressor	such	as	irradiation.	
p53-mediated	 competition	 has	 also	 recently	 been	 reported	 in	 the	 developing	 mouse	embryo.	 In	 this	system,	mild	p53	activation	 triggered	by	partial	 loss	of	p53	regulators	Mdm2	and	Mdm4	is	sufficient	 to	confer	a	competitive	disadvantage	on	mutant	cells	 in	mutant/wild-type	mosaic	embryos	(Zhang	et	al.	2017).	Another	study	later	showed	that	elevated	p53	in	mouse	embryos	represses	the	mechanistic	target	of	rapamycin	(mTOR)	pathway,	a	crucial	growth	and	metabolism	regulator.	Loss	of	mTOR	signalling	 in	 loser	cells	 is	 necessary	 and	 sufficient	 for	 their	 elimination.	 Interestingly,	 excessive	 mTOR	activation	results	in	a	super-competitor	phenotype,	suggesting	it	is	a	key	determinant	of	relative	fitness	levels	(Bowling	et	al.	2018).	
Importantly,	the	Piddini	lab	recently	showed	that	p53	activation	is	the	underlying	cause	of	 the	 loser	 status	 of	 MDCK	 cells	 lacking	 scribble.	 In	 fact,	 mild	 p53	 elevation	 itself	 is	sufficient	to	confer	hypersensitivity	to	cell	density	on	otherwise	wild-type	MDCK	cells	and	this	results	in	their	elimination	by	surrounding	cells	with	lower	p53	in	a	process	termed	‘mechanical	cell	competition’	(Wagstaff	et	al.	2016).	I	will	further	discuss	these	findings	in	 subsequent	 sections,	 as	 they	 are	 fundamental	 to	 my	 PhD	work.	 Please	 note	 that	 I	personally	contributed	to	the	(Wagstaff	et	al.	2016)	publication:	the	majority	of	the	data	
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on	the	role	of	E-cadherin	in	leader	cell	migration	and	loser	cell	status	was	generated	by	me	and	is	described	in	this	thesis.	
Interestingly,	 MDCK	 and	 mouse	 intestinal	 epithelial	 cells	 harbouring	 oncogenic	 p53	variants	with	mutations	in	the	DNA-binding	domain	(e.g.	p53	R175H)	are	competitively	eliminated	from	wild-type	epithelia.	Cells	with	mutant	p53	are	basally	extruded	from	the	monolayer	 and	 this	 is	 often	 accompanied	 by	 nuclear	 and	 cell	 body	 fragmentation.	However,	MDCKs	harbouring	p53	mutations	are	not	eliminated	from	RasV12-transformed	epithelia.	 This	 is	 particularly	 striking	 considering	 that	 p53	mutations	 are	 not	 usually	detected	 at	 the	 initial	 stage	 of	 carcinogenesis,	 but	 only	 in	 mid	 to	 late	 stages.	 Cell	competition	may	therefore	play	an	instructive	role	in	the	sequence	of	cancer	progression:	the	order	 in	which	oncogenic	mutations	appear	could	determine	whether	mutant	cells	can	be	cleared	through	cell	competition	or	not	(Watanabe	et	al.	2018).	
While	most	 studies	have	 focussed	on	 the	 role	 of	 p53	 in	 loser	 cells,	 p53	has	 also	been	shown	 to	 play	 a	 vital	 role	 in	 winners.	 As	 discussed	 previously,	 Myc	 overexpression	triggers	a	super-competitor	phenotype	in	Drosophila.	In	a	non-competitive	Drosophila	cell	culture	model,	Myc	overexpressing	cells	 increase	glycolysis	and	concomitantly	activate	p53,	which	acts	to	balance	their	metabolism	and	promote	fitness	by	boosting	the	more	energy-efficient	oxidative	phosphorylation.	When	confronted	with	wild-type	cells,	Myc	super-competitors	 undergo	 additional	 p53-dependent	 changes:	 they	 further	 boost	glycolysis,	 gain	 a	 proliferative	 advantage,	 and	 secrete	 a	 ‘killing	 factor’	 to	 eliminate	surrounding	wild-type	cells.	Crucially,	p53	activity	is	necessary	for	Myc	overexpressing	cells	to	detect	the	change	from	a	homotypic	environment	to	a	competitive	one	(de	la	Cova	et	al.	2014).	
	
Molecular mechanisms of cellular fitness comparison 
Cell	 competition	 can	 be	 divided	 into	 three	 phases:	 a	 trigger	 that	 confers	 a	 fitness	disadvantage	 on	 one	 cell	 population,	 a	 fitness	 comparison	 stage	 that	 leads	 to	 the	recognition	of	losers,	and	an	execution	stage	whereby	losers	are	eliminated	and	winners	undergo	compensatory	proliferation/hypertrophy.	In	previous	sections,	I	have	described	some	of	the	pathways	that	label	cells	as	less	fit	than	their	neighbours,	and	hence	confer	the	 loser	 status.	 Below,	 I	 discuss	 three	models	 of	 cellular	 fitness	 comparison:	 surface	
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contact,	diffusible	signal,	and	mechanical	models	(Figure	I.3).	These	are	not	exhaustive	and	may	also	work	in	combination.	
	
(i) Surface contact model 
In	the	surface	contact	model	for	fitness	comparison,	molecules	on	a	cell’s	surface	report	its	 fitness	 status	 to	 its	 neighbours.	 Evidence	 for	 this	model	 first	 came	 from	 studies	 in	
Drosophila	wing	imaginal	discs.	The	authors	showed	that	all	cells	express	an	isoform	of	Flower	(fweubi),	a	transmembrane	protein	proposed	to	be	a	calcium	ion	channel,	while	loser	 cells	 simultaneously	 express	 two	 further	 isoforms	 (fweLose-A	 and	 fweLose-B).	 The	relative	amounts	of	fweubi	and	the	loser	isoforms	of	Flower	determine	which	population	will	 be	 eliminated.	 Indeed,	 Flower	 is	 required	 for	Minute	 competition	 and	Myc	 super-competition	(Rhiner	et	al.	2010).	
Importantly,	 upregulation	 of	 Flower	 isoforms	 only	 occurs	 following	 confrontation	between	winner	and	 loser	cells:	 it	 is	not	a	pre-existing	difference	prior	 to	competition	onset.	Pre-existing	differences	in	the	surface	proteomes	of	loser	and	winner	cells	have	not	yet	been	demonstrated	to	constitute	a	fitness	comparison	mechanism,	but	this	remains	an	attractive	hypothesis,	 especially	 considering	 cell-cell	 contact	has	been	 shown	 to	be	required	for	 loser	cell	elimination	in	several	models	of	cell	competition	(Clavería	et	al.	2013;	Portela	et	al.	2010;	Wagstaff	et	al.	2016;	Levayer	et	al.	2015;	Li	&	Baker	2007).		That	said,	others	have	shown	that	direct	cell-cell	contact	is	not	required	for	cell	competition	using	both	in	vivo	(de	la	Cova	et	al.	2004)	and	in	vitro	models	(Senoo-Matsuda	&	Johnston	2007;	Sancho	et	al.	2013).	
	
(ii) Diffusible signal model 
In	the	diffusible	signal	model,	a	cell’s	fate	is	determined	by	its	response	to	secreted	factors.	One	example	of	this	is	Spätzle,	a	diffusible	ligand	that	activates	the	Toll-related	receptor	(TRR).	In	Drosophila	wing	discs,	TRR	activation	is	necessary	for	the	elimination	of	Minute	cells	and	those	with	low	Myc	levels.	In	fact,	loser	cells	express	more	TRR	and	are	hence	more	 responsive	 to	 Spätzle,	 which	 leads	 to	 higher	 nuclear	 factor	kappa-light-chain-	
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Figure	 I.3:	 Schematic	 representation	 of	 three	models	 of	 cellular	 fitness	 comparison.	 (A)	 Surface	contact	model.	Example:	differences	in	the	expression	pattern	of	Flower	(fwe)	isoforms	between	winner	cells	 (beige)	 and	 cells	 harbouring	 loser	mutations	 (blue)	 result	 in	 the	 elimination	 of	 the	mutant	 cells.	(B)	Diffusible	signal	model.	Example:	losers	express	more	Toll-related	receptor	(TRR)	and	are	hence	more	responsive	to	Spätzle,	a	diffusible	ligand	that	activates	TRR.	TRR	activation	leads	to	higher	NF-ĸB	activity,	which	results	in	loser	cell	apoptosis.	(C)	Mechanical	model.	Example:	mechanical	compaction	of	cells	lacking	
scribble	leads	to	their	death	and	delamination.	
Adapted	from	(Di	Gregorio	et	al.	2016).	
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enhancer	of	activated	B	cells	(NF-ĸB)	activity.	NF-ĸB	is	a	protein	complex	involved	in	the	cellular	response	to	stress;	in	the	context	of	competition,	NF-ĸB	activity	leads	to	loser	cell	apoptosis	(Meyer	et	al.	2014).	
Similarly,	transwell	experiments	in	Drosophila	cell	culture	demonstrated	that	contact	is	not	required	for	elimination	of	wild-type	cells	by	cells	overexpressing	Myc.	Furthermore,	conditioned	 media	 from	 competing	 cultures,	 but	 not	 homotypic	 cultures	 of	 cells	overexpressing	 Myc,	 is	 sufficient	 to	 induce	 wild-type	 cell	 death	 while	 boosting	 the	proliferation	of	winner	cells.	This	implies	that	the	two	populations	must	sense	each	other	before	 the	 competition	 ‘signal’	 is	 produced:	 loser	 cells	 respond	 to	 it	 by	 undergoing	apoptosis,	while	winners	increase	their	proliferation	(Senoo-Matsuda	&	Johnston	2007).	The	identity	of	this	signal	remains	unknown.	
Others	have	argued	against	the	diffusible	signal	model.	In	the	early	mouse	embryo,	for	example,	conditioned	media	from	cultures	of	competing	Myc-overexpressing	and	wild-type	cells	is	not	sufficient	to	trigger	loser	cell	apoptosis	(Clavería	et	al.	2013).	This	further	demonstrates	that,	depending	on	the	context,	there	are	most	likely	multiple	mechanisms	mediating	cell	competition.	
	
(iii) Mechanical model 
The	 third	aspect	 that	may	determine	cellular	 fitness	 is	a	 cell’s	 response	 to	mechanical	stress.	Epithelia	must	at	all	times	maintain	continuous,	cohesive	sheets,	so	elimination	of	cells	that	disrupt	this	morphology,	such	as	mechanically	weak	or	supernumerary	cells,	is	a	beneficial	strategy.	In	fact,	epithelia	are	capable	of	extruding	live	cells	 in	response	to	overcrowding;	this	has	been	shown	in	a	number	of	different	systems,	including	Drosophila	imaginal	discs,	mammalian	cell	culture,	and	zebrafish	development	(Marinari	et	al.	2012;	Eisenhoffer	et	al.	2012).	 It	remains	unclear	why	some	cells	are	preferentially	extruded	over	others.	One	possibility	could	be	that	cells	with	weaker	attachments	to	the	substrate	are	the	ones	selected	for	extrusion.	
Mechanical	 cell	 competition	was	 recently	demonstrated	 in	MDCK	cells	 (Wagstaff	 et	 al.	2016),	while	mechanical	super-competition	has	been	described	in	the	Drosophila	pupal	
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notum	 (Levayer	 et	 al.	 2016).	 Please	 refer	 to	 the	 “scribble	 competition	 in	MDCK	 cells”	section	in	this	chapter	for	a	closer	description	of	these	findings.	
	
Roles of cell competition: from quality control to cancer 
During	 an	 organism’s	 lifetime,	 each	 of	 its	 constituent	 cells	 is	 subjected	 to	 different	biochemical	and	physical	stresses.	Each	cell	thus	accumulates	a	unique	set	of	insults,	some	of	which	may	be	detrimental	 to	 its	 fitness.	Cell	competition	 leads	to	 the	elimination	of	these	 less	 fit	 cells	 from	 tissues	 and	 can	 therefore	 be	 regarded	 as	 a	 quality	 control	mechanism	 that	 promotes	 the	 overall	 health	 of	 the	 organism.	 In	 Drosophila,	 cell	competition	 has	 been	 implicated	 in	 improving	 tissue	 fitness	 during	 development	 by	removing	 slowly	 proliferating	 cells	 (Moreno	 et	 al.	 2002),	 regulating	 organ	 size	 by	changing	the	cellular	composition	of	a	tissue	without	affecting	its	size	(de	la	Cova	et	al.	2004;	Moreno	&	Basler	2004),	and	in	adult	tissue	homeostasis	to	maintain	tissue	health	and	delay	the	onset	of	ageing	(Kolahgar	et	al.	2015;	Merino	et	al.	2015).	It	has	also	been	proposed	 that	 cell	 competition	may	act	as	a	protective	mechanism	against	aneuploidy	(Sancho	et	al.	2013).	
Cell	 competition	 has	 also	 been	 shown	 to	 play	 a	 role	 in	 tissue	 regeneration	 in	 vivo	 in	mammalian	models	e.g.	in	the	mouse	heart	(Villa	del	Campo	et	al.	2014)	and	the	rat	liver	(Oertel	et	al.	2006).	In	the	latter	study,	for	example,	it	was	shown	that	rapidly	proliferating	foetal	liver	cells	transplanted	into	an	adult	animal	with	partial	hepatectomy	contribute	at	a	much	higher	 proportion	 to	 the	 regeneration	 response.	 This	 is	 not	 just	 due	 to	 faster	proliferation	of	the	foetal	cells	but	also	through	induction	of	apoptosis	in	the	host	liver	cells	 (Oertel	 et	 al.	 2006).	 Enhancing	 cell	 competition	 exogenously	 is	 therefore	 an	attractive	therapeutic	goal,	which	could	be	used	to	promote	self-regeneration	or	boost	the	success	of	cell	replacement	strategies.	
Cell	 competition	 can	 have	 a	 tumour	 suppressive	 role	 in	 promoting	 tissue	 fitness.	 As	discussed,	loss	of	polarity	factors	results	in	neoplastic	overgrowth	but	polarity-defective	cells	are	losers	in	a	heterotypic	context	and	are	cleared	from	the	epithelium.	What	is	more,	overexpression	of	RasV12	or	v-Src	oncogenes	in	MDCK	cells	leads	to	cell	transformation,	which	 is	 thought	 to	be	 the	 first	 step	of	 carcinogenesis	 (Hogan	et	al.	2009;	Kajita	et	al.	2010).	Strikingly,	RasV12-	or	v-Src-transformed	cells	are	extruded	from	the	epithelium	by	
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surrounding	 wild-type	 MDCKs	 in	 a	 competitive	 ‘epithelial	 defence	 against	 cancer’	mechanism	(Ohoka	et	al.	2015).	That	said,	extrusion	of	RasV12	cells	can	be	independent	of	their	death:	basally	extruded	cells	can	survive	and	 invade	surrounding	 tissues.	 In	 fact,	additional	 factors	 like	 loss	of	E-cadherin	or	 reduced	Cdc42	activity	 can	promote	basal	extrusion	of	RasV12-transformed	cells	and	therefore	boost	their	invasive	potential	(Hogan	et	 al.	 2009).	 This	 highlights	 the	 context-dependence	 of	 cell	 competition	 as	 a	 tumour	suppressor	and	demonstrates	how	malignant	cells	may	be	able	to	evade	cell	competition	in	the	presence	of	secondary	oncogenic	mutations.	
There	 are	 also	 examples	 of	 cell	 competition	 being	 able	 to	 promote	 tumour	 formation	independently	of	secondary	mutations.	For	instance,	loss	of	APC,	a	Wnt	pathway	inhibitor,	is	highly	correlated	with	human	colon	cancers	and	also	leads	to	formation	of	intestinal	adenomas	 in	Drosophila	 (Wang	 et	 al.	 2013).	 The	 Piddini	 lab	 has	 recently	 shown	 that	adenoma	growth	in	the	Drosophila	gut	is	dependent	on	the	APC	tumour	cells	being	able	to	outcompete	the	surrounding	wild-type	tissue.	Importantly,	preventing	cell	competition	from	taking	place	by	expressing	apoptosis	inhibitors	in	the	wild-type	cells	is	sufficient	to	constrain	adenoma	growth	(Suijkerbuijk	et	al.	2016).	Similar	observations	were	made	in	
Drosophila	wing	discs,	where	co-expression	of	epidermal	growth	factor	receptor	(EGFR)	and	microRNA	miR-8	gives	rise	to	aggressive	tumours	with	super-competitor	qualities.	The	 growth	 of	 these	 tumours	 can	 be	 restricted	 by	 inhibiting	 apoptosis	 in	 the	 tissue	(Eichenlaub	et	al.	2016).	Together,	these	findings	suggest	that	removal	of	wild-type	tissue	by	apoptosis	is	not	a	by-product	of	tumour	expansion	but	is	actively	required	for	it.	
	
scribble competition in Drosophila 
Just	 like	Dlg	and	Lgl,	Scribble	 is	a	polarity	 factor	 localised	asymmetrically	 in	wild-type	epithelia.	 In	Drosophila,	 the	 Scribble	 protein	 is	 enriched	 at	 the	 cell	 cortex	 at	 septate	junctions	 (Drosophila	 homologue	 of	 mammalian	 tight	 junctions),	 which	 are	 localised	basally	to	the	adherens	junctions	(Bilder	&	Perrimon	2000).	Scribble	is	a	 large	protein	containing	several	protein-protein	interaction	domains,	many	of	which	play	a	role	in	the	establishment	and	maintenance	of	its	asymmetrical	localisation;	it	is	classified	as	a	LAP,	a	protein	 containing	 leucine-rich	 repeats	 (LRR)	 and	 PSD-95,	 ZO-1	 and	Disc	 large	 (PDZ)	domains	(reviewed	in	Humbert	et	al.	2008).	
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Homozygous	scribble	mutant	(scribble-/-)	larvae	develop	normally	due	to	maternal	stores	of	the	wild-type	Scribble	protein.	However,	once	these	supplies	are	exhausted,	scribble	mutant	 cells,	 while	 viable,	 lose	 their	 polarity	 and	 regular	 shape.	 As	 development	continues,	mutant	cells	become	multi-layered	and	have	difficulties	differentiating,	which	results	in	overproliferation	and	tumour	formation:	this	phenotype	classifies	scribble	as	a	neoplastic	 tumour	 suppressor.	 Ultimately,	 scribble	 mutant	 larvae	 cannot	 progress	through	pupariation	and	die	as	giant	larvae	(Bilder	&	Perrimon	2000).	
Importantly,	while	scribble	mutant	clones	in	Drosophila	imaginal	eye	discs	show	the	same	overgrowth	phenotype	as	homotypic	mutant	tissues,	their	growth	is	halted	through	JNK-dependent	induction	of	apoptosis	by	the	surrounding	wild-type	tissue.	By	the	time	the	larvae	reach	adulthood,	very	few	scribble-/-	cells	remain	in	the	mosaic	eye,	as	they	have	been	eliminated	through	cell	competition.	Strikingly,	outcompetition	of	scribble-/-	cells	in	a	mosaic	context	can	be	prevented	by	concomitant	expression	of	oncogenic	versions	of	genes	such	as	Ras	or	Notch,	highlighting	the	importance	of	the	tumour	microenvironment	in	cancer	progression	(Figure	I.4)	(Brumby	&	Richardson	2003;	Pagliarini	&	Xu	2003).	
It	 was	 later	 shown	 that	 Eiger,	 a	 tumour	 necrosis	 factor	 (TNF)	 superfamily	 ligand,	 is	required	for	the	JNK-dependent	elimination	of	scribble-/-	cells.	scribble	mutant	cells	show	increased	 rates	 of	 endocytosis	 specifically	when	 surrounded	by	wild-type	neighbours.	One	of	the	endosome	cargos	in	scribble	mutant	cells	is	in	fact	Eiger,	which	also	co-localises	with	 phosphorylated	 (activated)	 JNK	 staining	 in	 endosomes	 (Igaki	 et	 al.	 2009).	Endosomes	 have	 been	 previously	 described	 as	 hubs	 that	 cells	 exploit	 to	compartmentalise	and	regulate/enhance	signalling	(Miaczynska	et	al.	2004).	The	authors	therefore	propose	that	increased	endosomal	uptake	of	Eiger	in	scribble-/-	cells	results	in	enhanced	 Eiger-JNK	 signalling	 that	 is	 responsible	 for	 triggering	 their	 apoptosis,	 and	ultimately	elimination,	in	a	competition	scenario	(Igaki	et	al.	2009).	
That	said,	others	argue	that	apoptosis	of	scribble	mutant	cells	in	heterotypic	tissues	is	not	sufficient	on	its	own	to	overcome	their	overproliferation	phenotype	and	result	in	their	complete	elimination	(Chen	et	al.	2012).	The	enhanced	proliferation	of	scribble-/-	cells	is	due	to	overactivation	of	Yorkie,	a	pro-growth	transcriptional	coactivator	whose	activity	is	suppressed	by	activation	of	the	Hippo	pathway	(Doggett	et	al.	2011).	Chen	et	al.	go	on	to	 show	 that	 JNK	 signalling	 in	 scribble-/-	 cells	 suppresses	 their	 Yorkie	 activity	 during			
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Figure	 I.4:	Diagram	summarising	 the	behaviour	of	scribble-/-	 cells	 in	Drosophila	 cell	 competition	
models.	(A)	In	Drosophila	larvae,	homotypic	populations	of	scribble-/-	cells	overproliferate,	which	leads	to	
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tumour	formation	(Bilder	&	Perrimon	2000).	(B)	In	a	mixed	population	of	wild-type	and	scribble-/-	cells	in	
Drosophila	imaginal	eye	discs,	scribble	mutant	cells	are	eliminated	through	cell	competition.	scribble-/-	cells	harbouring	 oncogenic	 Ras	 or	 Notch	 mutations	 are	 no	 longer	 outcompeted	 and	 drive	 tumourigenesis	(Brumby	&	Richardson	2003;	Pagliarini	&	Xu	2003).	(C)	scribble-/-	cells	display	higher	rates	of	endocytosis	in	 the	 presence	 of	wild-type	 cells.	 This	 drives	 increased	 endosomal	 uptake	 of	 Eiger,	which	 boosts	 JNK	signalling	(Igaki	et	al.	2009).	JNK	directly	triggers	scribble-/-	cell	apoptosis,	while	simultaneously	inhibiting	pro-growth	factor	Yorkie.	Yorkie	suppression	stunts	scribble-/-	cell	proliferation	and	is	essential	for	their	elimination	(Chen	et	al.	2012).	Eiger-dependent,	non-apoptotic	JNK	signalling	is	also	required	in	the	wild-type	population,	where	it	upregulates	PVR	in	both	cell	populations.	Increased	PVR	expression	drives	the	activity	of	ELMO/Mbc,	which	promotes	 the	engulfment	of	 scribble-/-	 cells	by	 their	wild-type	neighbours	(Ohsawa	et	al.	2011).	
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competition	and	this	suppression	is	essential	 for	scribble-/-	cell	elimination	(Chen	et	al.	2012).	Oncogenes	can	also	modulate	Yorkie	activity	 in	scribble-/-	cells,	but	this	yields	a	very	different	outcome.	For	example,	combining	scribble	mutation	with	an	active	form	of	the	Ras	oncogene	(RasV12)	stops	their	outcompetition.	This	is	most	likely	because	RasV12	feeds	into	Yorkie	activation	and	both	of	these	proteins	boost	Myc	levels,	which	increases	cellular	fitness	(Brumby	&	Richardson	2003;	Pagliarini	&	Xu	2003).	
Eiger-dependent	 JNK	 signalling	 is	 also	 required	 in	 wild-type	 cells	 during	 scribble	competition.	Wild-type	cells	surrounding	scribble	mutant	clones	activate	non-apoptotic	JNK,	 which	 in	 turn	 upregulates	 the	 Drosophila	 PDGF/VEGF	 receptor	 (PVR)	 in	 both	populations.	 The	 JNK-PVR	 signalling	 then	 induces	 the	 activity	 of	 engulfment	 and	 cell	motility	(ELMO)	and	myoblast	city	(Mbc),	which	are	proteins	involved	in	the	cytoskeletal	rearrangement	during	phagocytosis.	This	results	in	the	mutant	population	being	actively	eliminated	through	engulfment	by	the	wild-type	population	(Figure	I.4).	 It	 is	currently	unknown	if	JNK	activation	in	winners	and	losers	is	part	of	the	same	pathway	(Ohsawa	et	al.	2011).	
	
Scribble in mammalian models and cancer 
There	is	only	one	homolog	of	Drosophila	scribble	in	mammals,	encoded	by	the	SCRB1	gene	(Su	 et	 al.	 2013).	 In	 Madin-Darby	 canine	 kidney	 (MDCK)	 cells,	 the	 Scribble	 protein	 is	localised	at	adherens	junctions	and	extends	more	basally	from	them	along	the	basal	and	lateral	 domains	 (Navarro	 et	 al.	 2005).	 Unlike	 in	 Drosophila,	 knockdown	 of	 scribble	(scribKD)	in	MDCKs	does	not	cause	polarity	defects	(Qin	et	al.	2005).	This	is	also	largely	consistent	with	observations	from	two-	and	three-dimensional	cultures	of	scribKD	human	mammary	epithelial	MCF10A	cells,	where	no	or	very	subtle	polarity	defects	are	reported	(Dow	et	al.	2007;	Zhan	et	al.	2008).	Also	in	contrast	to	the	Drosophila	system,	MCF10A	cells	 lacking	 scribble	 do	 not	 exhibit	 increased	 proliferation	 rates	 (Zhan	 et	 al.	 2008).	Similarly,	scribKD	MDCK	cells	do	not	form	multi-layered	structures	and	in	fact	have	slower	division	rates	than	wild-type	cells	(Qin	et	al.	2005;	Norman	et	al.	2012;	Wagstaff	et	al.	2016).	
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Despite	these	differences,	both	Drosophila	and	mammalian	Scribble	function	as	tumour		suppressors	 in	 vivo.	 Loss	 of	 scribble	 results	 in	 hyperplastic	 growth	within	 the	mouse	mammary	gland	and	prostate.	 In	mammary	epithelia,	scribble	 loss	results	 in	abnormal	epithelial	morphogenesis	and,	combined	with	hyperproliferation	caused	by	an	oncogene,	it	 can	 also	 inhibit	 apoptosis	 to	 promote	 tumorigenesis	 (Zhan	 et	 al.	 2008).	 In	 prostate	epithelia,	 loss	 of	 scribble	 promotes	 overproliferation	 through	 de-repression	 of	 the	Ras/MAPK	cascade	(Pearson	et	al.	2011).	
Mislocalisation	and	deregulation	of	Scribble	have	been	associated	with	 several	human	epithelial	cancers,	for	example	colorectal	and	breast	cancer	(Gardiol	et	al.	2006;	Navarro	et	al.	2005).	Scribble	itself	is	a	target	for	ubiquitin-mediated	degradation	during	high-risk	human	papilloma	virus	(HPV)	infection,	which	is	linked	to	a	high	percentage	of	uterine	cervical	carcinomas	(Nakagawa	&	Huibregtse	2000;	Burd	2003).	Taken	together,	these	data	support	a	tumour	suppressive	role	for	scribble	both	in	mammalian	 in	vivo	models	and	in	cancer.	
	
scribble competition in MDCK cells 
MDCK	 cells	were	 first	 isolated	 in	 1958	by	Madin	 and	Darby	 from	kidney	 tubules	 of	 a	phenotypically	normal	female	cocker	spaniel,	although	this	does	not	seem	to	have	been	published	(Dukes	et	al.	2011).	MDCKs	have	a	regular,	cobblestone	morphology	 in	vitro	and	 can	 be	 grown	 as	 flat	 epithelial	 sheets,	 which	makes	 them	 very	 amenable	 to	 live	imaging.	Clones	grow	as	tight	colonies	and	there	is	minimal	cell	mixing	between	distinct	islands	 of	 cells.	 All	 experiments	 described	 in	 this	 thesis	 have	 been	performed	 in	 two-dimensional	cultures	of	MDCKs	grown	on	either	plastic	or	glass.	One	should	bear	in	mind	that	such	2D	cultures,	while	widely	used	and	recognised	in	the	scientific	community,	have	their	 limitations:	 cells	 in	 vivo	 exist	 in	 a	 three-dimensional	 environment,	 which	 is	molecularly	and	mechanically	much	more	varied	and	complex,	so	their	behaviour	may	differ	substantially	from	observations	made	in	vitro.	
scribKD	MDCK	cells	generated	using	a	short	hairpin	RNA	(shRNA)	construct	are	viable	and	display	a	 flattened,	mesenchymal-like	morphology.	That	said,	 the	distribution	of	apical	marker	gp135	is	unaffected	 in	scribKD	MDCKs	and	their	tight	 junction	assembly	 is	only		 	
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slightly	 delayed,	 implying	 they	maintain	 apico-basal	 polarity	 at	 least	 to	 some	 degree.	MDCKs	 lacking	scribble	also	display	an	enhanced	ability	 to	migrate	 through	 filters	and	migrate	 faster,	 but	 more	 chaotically,	 than	 wild-type	 cells	 in	 two-dimensional	 wound	healing	assays	(Qin	et	al.	2005).	
Strikingly,	 juxtaposing	scribKD	and	wild-type	MDCK	cells	at	a	1	 :	10	ratio	in	a	confluent	culture	results	in	the	death	and	apical	extrusion	of	the	scribble	mutant	cells.	As	mentioned	before,	scribKD	cells	are	viable	in	homotypic	cultures	and	are	not	eliminated	if	confronted	by	other	scribKD	cells,	defining	this	phenomenon	as	cell	competition	(Figure	I.5)	(Norman	et	 al.	 2012;	 Wagstaff	 et	 al.	 2016).	 Cells	 lacking	 scribble	 undergo	 Bcl-2	 homologous	antagonist/killer	 (Bak)	 and	Bcl-2	 associated	X	protein	 (Bax)-dependent	mitochondrial	apoptosis	 that	 is	 independent	 of	 their	 extrusion.	 Unlike	 in	 Drosophila,	 scribble	competition	in	MDCKs	does	not	involve	JNK	activity	or	phagocytosis;	instead,	p38	MAPK	activates	the	apoptosis	pathway	in	scribKD	losers	(Norman	et	al.	2012).	
The	Piddini	lab	further	characterised	MDCK	scribble	competition	in	our	(Wagstaff	et	al.	2016)	publication,	which	I	describe	in	detail	below	and	in	subsequent	sections.	The	bulk	of	the	data	constituting	this	thesis	is	either	part	of	or	builds	on	the	work	within	this	paper.	
Wagstaff	et	al.	 first	demonstrated	 that	while	contact	 is	 required,	 it	 is	not	sufficient	 for	elimination	of	scribKD	cells.	Neither	conditioned	media	from	competing	scribKD	:	wild-type	cultures	added	to	scribKD	cells,	nor	media	exchanged	between	scribKD	cells	and	competing	cultures	through	a	transwell	system	is	sufficient	to	induce	loser	cell	death.	What	is	more,	only	 fully	 surrounded	 scribKD	 cells	 are	 efficiently	 eliminated;	 loser	 clones	 that	 are	 in	prolonged	contact	with	winners,	but	are	not	surrounded,	survive	for	much	longer.	
The	most	striking	difference	between	scribKD	clones	fully	surrounded	by	wild-type	cells	and	scribKD	clones	only	in	contact	with	(but	not	surrounded	by)	wild-type	cells	 is	their	density:	 the	density	of	surrounded	scribKD	clones	 is	around	4.5	times	higher	than	their	homotypic	density	and	it	is	also	higher	than	that	of	the	surrounding	wild-type	cells.	This	suggests	that	scribKD	cells	are	actively	compacted	and	their	increased	density	does	not	just	reflect	the	density	of	the	surrounding	culture.	In	fact,	compaction	of	scribKD	cells	in	the	absence	 of	 wild-type	 cells	 is	 sufficient	 to	 induce	 apoptosis	 in	 the	 loser	 population,	showing	 that	 they	 are	 hypersensitive	 to	 density.	 Taken	 together,	 scribKD	 cells	 are		 	
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Figure	I.5:	scribKD	cells	are	viable	in	homotypic	cultures	but	are	eliminated	in	the	presence	of	wild-
type	cells	via	cell	competition.	(A)	Stills	from	movies	of	a	co-culture	of	unlabelled	and	GFP-labelled	scribKD	cells.	(B)	Co-culture	of	GFP-labelled	scribKD	cells	and	unlabelled	wild-type	cells.	scribKD	cells	are	eliminated	over	the	course	of	the	movie.	
Scale	bars	=	100	μm.	Adapted	from	(Wagstaff	et	al.	2016).	
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outcompeted	through	compaction	induced	by	surrounding	winners	in	a	process	termed	mechanical	 cell	 competition,	where	 loser	 cell	 elimination	 relies	 on	mechanical	 insults	rather	than	molecular	exchange	(Wagstaff	et	al.	2016).	
Prior	 to	 initiation	 of	 competition,	 scribKD	 cells	 show	 elevated	 activity	 of	 the	 tumour	suppressor	p53.	Mechanical	stress	caused	by	compaction	is	sufficient	to	further	boost	p53	levels	in	loser	cells,	which	ultimately	results	in	their	death	and	delamination.	Consistently	with	this,	genetic	knockout	of	p53	(p53KO)	in	scribKD	cells	rescues	their	low	homeostatic	density	 and	hypersensitivity	 to	density,	 and	hence	prevents	 their	outcompetition.	The	Piddini	lab	further	showed	that	p53	in	compacted	scribKD	cells	is	activated	by	p38,	which	in	turn	lies	downstream	of	Rho-associated	protein	kinase	(ROCK)	(Wagstaff	et	al.	2016).	
Perhaps	the	most	striking	finding	emerging	from	the	work	described	in	(Wagstaff	et	al.	2016)	 is	 the	 fact	 that	 p53	 activation	 alone	 is	 sufficient	 to	 confer	 the	mechanical	 loser	status	on	cells.	Wild-type	MDCKs	were	treated	with	a	mild	dose	of	Nutlin-3	(from	here	on	referred	 to	 as	 Nutlin),	 a	 chemical	 inhibitor	 of	Mdm2,	which	 normally	 targets	 p53	 for	ubiquitin-mediated	degradation.	As	a	 consequence	of	Nutlin	 treatment,	wild-type	cells	accumulate	 sub-lethal	 levels	 of	 p53,	 which	 is	 sufficient	 to	 replicate	 flattening,	 low	homeostatic	density,	and	compaction	hypersensitivity	seen	in	scribKD	cells.	Remarkably,	confronting	wild-type	and	p53KO	MDCK	populations	in	the	presence	of	Nutlin	results	in	the	elimination	of	 the	 former	population	through	mechanical	cell	competition.	What	 is	more,	 p53-induced	 hypersensitivity	 to	 density	 and	 mechanical	 competition	 are	 also	conserved	in	mouse	tracheal	epithelial	cells.	
Nutlin	was	used	to	exacerbate	the	difference	in	p53	levels	between	the	two	populations	in	both	 the	MDCK	and	mouse	 tracheal	 system,	 as	 competition	does	not	happen	 in	 the	absence	 of	 Nutlin	 (Figure	 I.6)	 (Wagstaff	 et	 al.	 2016).	 In	 fact,	 external	 stimuli	 are	 also	necessary	 to	 induce	p53-mediated	 competition	 in	other	 systems	 (Bondar	&	Medzhitiv	2010;	 Marusyk	 et	 al.	 2010).	 This	 implies	 that	 variable	 cellular	 responses	 to	 external	insults	may	be	required	to	generate	a	sufficiently	steep	p53	imbalance	before	competition	can	occur.	
It	 is	worth	noting	that	mechanical	cell	competition	has	also	recently	been	described	in	
Drosophila.	 It	was	shown	that	 local	 tissue	crowding	 in	 the	midline	region	of	 the	pupal		  
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Figure	I.6:	p53	elevation	is	sufficient	to	induce	mechanical	cell	competition.	(A-B)	Movie	stills	of	a	co-culture	of	GFP-labelled	wild-type	cells	and	cells	lacking	p53	(p53KO)	in	the	presence	of	a	sub-lethal	dose	of	Mdm2	inhibitor,	Nutlin-3	(A),	or	the	solvent,	DMSO	(B).	Nutlin-3	treatment	elevates	p53	specifically	in	the	wild-type	cells	and	enables	their	elimination	via	mechanical	cell	competition.	
Scale	bars	=	100	μm.	Adapted	from	(Wagstaff	et	al.	2016).	
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notum	is	both	sufficient	and	necessary	to	induce	delamination.	In	accordance	with	this,	mechanical	 stress	 induced	 by	 rapidly	 growing	 Ras-transformed	 clones	 on	 their	 non-transformed	neighbours	is	sufficient	to	result	in	the	elimination	of	wild-type	tissue;	the	authors	term	this	process	‘mechanical	super-competition’	(Levayer	et	al.	2016).	
	
Scribble and E-cadherin 
‘Classical’	 cadherins	 are	 a	 subfamily	 of	 cell-cell	 adhesion	 receptors.	 Members	 include	epithelial,	neural,	 and	placental	 cadherin	 (E-,	N-,	 and	P-cadherin,	 respectively),	named	after	the	tissues	they	were	first	identified	in,	but	their	expression	is	not	restricted	to	those	tissues	(reviewed	in	Saito	et	al.	2012).	Each	classical	cadherin	molecule	is	composed	of	five	 extracellular	 cadherin	 (EC)	 domains,	 a	 single	 transmembrane	 anchor,	 and	 an	intracellular	 domain.	 The	 extracellular	 regions	 of	 cadherins	 on	 one	 cell	 recognise	 and	bind	 cadherins	 on	 neighbouring	 cells,	 predominantly	 in	 a	 homotypic	 fashion.	 The	intracellular	 domain	 is	 responsible	 for	 transducing	 extracellular	 signals	 through	mediator	 proteins	 (e.g.	 catenins)	 to	 many	 intracellular	 processes,	 including	 cell-cell	adhesion,	 cytoskeleton	 rearrangement	 during	 locomotion,	 and	 changes	 in	 gene	expression.	 Importantly	 in	 the	 context	 of	 mechanical	 cell	 competition,	 cadherin	complexes	have	also	been	shown	to	act	as	force	sensors	capable	of	triggering	intracellular	in	response	to	changes	in	intercellular	tension	(reviewed	in	Leckband	&	de	Rooij	2014).	
Because	cadherins	have	such	wide-ranging	cellular	effects	in	a	physiological	context,	it	is	not	 surprising	 that	 their	 misregulation	 has	 been	 implicated	 to	 have	 a	 role	 in	 cancer	progression.	 As	 most	 solid	 tumours	 arise	 from	 epithelial	 tissue,	 the	 link	 between	 E-cadherin	in	particular	and	cancer	has	been	the	focus	of	much	investigation.	Tumours	have	been	shown	to	often	lose	or	mislocalise	E-cadherin,	and	this	 is	associated	with	a	more	invasive/metastatic	phenotype	(reviewed	in	Jeanes	et	al.	2008).	Interestingly,	E-cadherin	expression	is	downregulated	during	the	epithelial-to-mesenchymal	transition	(EMT)	in	normal	development;	EMT	is	a	process	during	which	epithelial	cells	lose	their	apico-basal	polarity	 and	 cell-cell	 junctions	 to	 acquire	 a	 more	 motile,	 mesenchymal	 phenotype	associated	with	increased	N-cadherin	expression	(reviewed	in	Lamouille	et	al.	2014).	It	has	 therefore	 been	 suggested	 that	 aberrant	 EMT	 activation	 may	 contribute	 to	tumourigenesis.	
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In	Drosophila,	 cells	mutant	 for	scribble	 in	conjunction	with	a	 secondary	oncogenic	Ras	mutation	have	 low	E-cadherin	expression,	which	results	 in	a	more	 invasive	phenotype	(Brumby	&	Richardson	2003;	Pagliarini	&	Xu	2003).	Similarly,	loss	of	scribble	in	MDCKs	has	 been	 reported	 to	 result	 in	 an	 approximately	 threefold	 drop	 in	 the	 number	 of	homophilic	 E-cadherin	 adhesions,	 as	 assessed	 by	 the	 ability	 of	 cells	 to	 bind	 surfaces	coated	 with	 the	 extracellular	 domain	 of	 E-cadherin.	 This	 was	 shown	 to	 be	 because	Scribble	is	required	for	the	cortical	stabilisation	of	α-	and	β-catenin,	which	associate	with	the	 cytoplasmic	 tail	 of	 E-cadherin	 to	 bridge	 its	 interaction	with	 the	 cytoskeleton	 and	transduce	extracellular	signals	(Qin	et	al.	2005;	Tian	et	al.	2011).	
Despite	 the	 drop	 in	 E-cadherin	 adhesion	 numbers,	 it	 has	 been	 reported	 that	 scribKD	MDCKs	have	 the	 same	 amount	 of	 E-cadherin	 as	wild-type	 cells,	 as	 shown	by	Western	blotting	and	pull-down	of	biotinylated	surface	proteins	(Qin	et	al.	2005).	Another	group	reported	no	increase	in	E-cadherin	levels	in	scribKD	MDCKs	by	Western	blotting,	but	the	immunofluorescence	 images	 presented	 suggest	 that	 scribKD	 cells	 have	 elevated	 E-cadherin	(Norman	et	al.	2012).	In	contrast,	the	Piddini	lab	has	found	that	scribKD	MDCKs	have	elevated	total	(shown	by	Western	blot	and	immunofluorescence,	Figure	I.7A	and	B)	and	 cell	 surface	 levels	 of	 E-cadherin	 (shown	 by	 surface	 immunostaining,	 Figure	 I.7C)	(Wagstaff	et	al.	2016).	Two	of	these	publications	also	describe	E-cadherin	knockdown	(E-
cadKD)	MDCK	lines:	one	has	a	flattened,	scribKD-like	morphology	(Qin	et	al.	2005)	and	the	other	has	a	more	wild-type	morphology	(Wagstaff	et	al.	2016).	Importantly,	the	E-cadKD	MDCK	line	used	in	(Wagstaff	et	al.	2016)	was	generated	as	part	of	the	work	presented	in	(Hogan	et	al.	2009).	Hogan	et	al.	do	not	describe	any	morphological	changes	of	E-cadKD	cells	 and	 the	 micrographs	 they	 present	 imply	 that	 E-cadKD	 cells	 have	 a	 wild-type	morphology	(Hogan	et	al.	2009).	An	explanation	for	these	discrepancies	could	be	the	use	of	two	distinct	MDCK	subtypes	and	antibodies	with	different	epitopes	or	sensitivity	in	the	conflicting	reports.	
Perhaps	more	consistently,	E-cadherin	 localisation	has	been	shown	to	be	perturbed	 in	
scribKD	MDCKs.	Upon	scribble	knockdown,	E-cadherin	shifts	from	cell-cell	boundaries	to	the	basal	side	(Norman	et	al.	2012).	In	fact,	by	visualising	E-cadherin-GFP,	it	was	shown	that	 E-cadherin	 accumulates	 in	 intracellular	 vesicles	 primarily	 found	 around	 the	perinuclear	region	of	scribKD	cells	(Lohia	et	al.	2012).	One	of	the	ways	cells	regulate	E-cadherin	signalling	is	by	its	endocytosis,	followed	by	recycling	back	to	the	cell	surface	or		 	
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Figure	I.7:	E-cadherin	is	upregulated	in	scribKD	cells.	(A)	Immunofluorescence	images	showing	total	E-cadherin	levels	in	a	co-culture	of	unlabelled	wild-type	cells	and	GFP-labelled	scribKD	cells.	DAPI	is	used	to	label	the	nuclei.	(B)	Western	blot	against	E-cadherin	in	wild-type	and	scribKD	cells	in	the	presence	or	absence	of	 doxycycline	 (DOX),	 which	 induces	 scribble	 knockdown.	 β-tubulin	 was	 used	 as	 loading	 control.	 This	Western	blot	was	generated	by	me.	(C)	Immunofluorescence	images	showing	surface	E-cadherin	levels	in	a	co-culture	of	RFP-labelled	wild-type	cells	and	unlabelled	scribKD	cells.	
Scale	bars	=	50	μm.	Adapted	from	(Wagstaff	et	al.	2016).	
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lysosomal	degradation.	Loss	of	 scribble	promotes	E-cadherin	 internalisation	 in	MDCKs	through	destabilisation	of	the	E-cadherin/p120	interaction,	which	normally	maintains	E-cadherin	at	the	cell	surface.	Increased	retromer	complex	binding	in	the	absence	of	scribble	causes	 E-cadherin	 to	 be	 redirected	 from	 lysosome-bound	 endosomes	 to	 the	 Golgi	apparatus,	resulting	in	its	accumulation	in	scribKD	cells	(Lohia	et	al.	2012).	
	
Directional cell migration in scribble competition 
As	described	in	an	earlier	section,	compaction	of	scribKD	MDCKs	during	competition	is	an	active	process,	as	compacted	clones	reach	a	density	higher	than	the	surrounding	wild-type	culture.	Plating	competing	scribKD	 :	wild-type	cultures	at	 lower	densities	revealed	that	this	is	a	consequence	of	a	remarkable	migratory	behaviour	triggered	upon	contact	between	the	two	populations	(Figure	I.8A),	which	is	not	observed	in	homotypic	cultures	of	scribKD	or	wild-type	cells	(Figure	I.8B	and	Wagstaff	et	al.	2016).	Following	contact,	both	
scribKD	and	wild-type	cells	engage	in	highly	directional	collective	migration:	scribKD	cells	are	always	at	the	migrating	front	with	wild-type	cells	behind	them.	Further	analysis	of	this	 migration	 suggested	 that	 wild-type	 cells	 are	 the	 first	 to	 start	 migrating	 towards	
scribKD	cells	before	the	mutant	cells	begin	moving	away.	Both	populations	then	become	locally	compressed	at	the	contact	site,	but	it	remains	unclear	whether	this	is	due	to	wild-type	cells	‘pushing’	on	scribKD	cells	or	scribKD	cells	self-compacting	to	avoid	the	interaction.	As	migration	progresses	with	scribKD	cells	being	followed	by	wild-type	cells,	scribKD	clones	eventually	 encounter	other	wild-type	 cells,	which	 also	 start	migrating.	This	ultimately	results	 in	 scribKD	 cells	being	 corralled	 into	 tight	 clones	 for	 elimination	 (Wagstaff	 et	 al.	2016).	
Perhaps	unsurprisingly,	adhesion	molecules	including	cadherins	have	been	implicated	in	collective	 cell	 migration	 (reviewed	 in	 Theveneau	 &	 Mayor	 2012).	 Knockdown	experiments	have	shown	that	cadherins	are	to	some	extent	functionally	redundant	but	play	distinct	 roles	when	 co-expressed.	 For	 example,	when	both	P-	 and	E-cadherin	 are	present,	 P-cadherin	 is	 sensitive	 to	 the	 levels	 of	 intercellular	 force	 while	 E-cadherin	responds	to	the	rate	at	which	intercellular	force	builds	up.	In	the	absence	of	E-cadherin,	P-cadherin	can	take	over	the	mechanotransducing	properties	of	E-cadherin	(Bazellières	et	al.	2015).	 	
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Figure	I.8:	Collective,	directional	migration	is	triggered	upon	collision	between	wild-type	and	scribKD	
clones.	(A)	Movie	stills	of	a	co-culture	of	GFP-labelled	scribKD	cells	and	unlabelled	wild-type	cells.	White	dashed	lines	mark	the	initial	contact	point;	black	dashed	lines	mark	the	final	contact	point	here	and	in	(B).	(B)	Stills	from	movies	of	a	homotypic	co-culture	of	GFP-labelled	and	unlabelled	scribKD	cells.	
Scale	bars	=	100	μm.	Adapted	from	(Wagstaff	et	al.	2016).	
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Considering	 its	misregulation	 in	scribble	mutant	cells,	 the	Piddini	 lab	 investigated	 if	E-cadherin	was	involved	in	the	directional	migration	observed	during	MDCK	competition.	I	describe	the	experiments	I	did	to	help	address	this	question	in	Chapter	II.	Other	members	of	the	Piddini	lab	had	previously	used	an	E-cadherin	blocking	antibody	and	low	calcium	conditions	to	disassemble	E-cadherin-mediated	junctions	in	both	 scribKD	and	wild-type	cells,	which	abolished	the	directional	migration	(Figure	I.9A	and	B).	Lack	of	directional	migration	 prevented	 the	 active	 compaction	 of	 scribKD	 cells	 and	 this	 delayed	 their	elimination	 (Figure	 I.9C	 and	 D)	 (Wagstaff	 et	 al.	 2016).	 However,	 cultures	 with	 the	blocking	antibody	can	eventually	reach	densities	high	enough	to	induce	scribKD	cell	death.	Taken	together,	while	the	directional	migration	triggered	during	scribble	competition	is	not	 essential	 for	 scribKD	 cell	 elimination,	 it	 makes	 their	 outcompetition	 much	 more	efficient.	
The	directional	migration	triggered	during	scribble	competition	in	MDCKs	is	somewhat	similar	to	the	chase-and-run	migration	described	between	neural	crest	(NC)	and	placodal	cells	in	Xenopus	laevis	embryos.	In	this	system,	NC	cells	use	chemotaxis	to	chase	placodal	cells,	which	secrete	the	chemoattractant	Sdf1.	Following	collision,	a	contact	inhibition	of	locomotion	 response,	 mediated	 by	Wnt/planar	 cell	 polarity	 (PCP)	 and	 N-cadherin,	 is	triggered	in	both	populations.	This	results	in	a	transient	collapse	of	cell	protrusions	and	localised	 loss	 of	 focal	 adhesions.	 The	 resulting	 asymmetry	 triggers	 placodal	 cells	 to	migrate	 away	 from	NC	 cells,	 restarting	 the	 cycle	 (Theveneau	 et	 al.	 2013).	Despite	 the	similarities	shared	with	NC/placodal	cell	chase-and-run	behaviour,	directional	migration	in	MDCK	scribble	competition	does	not	rely	on	secreted	factors:	contact	between	scribKD	and	 wild-type	 cells	 is	 essential	 (Wagstaff	 et	 al.	 2016).	 This	 has	 two	 interesting	implications:	
Firstly,	 there	must	 be	 a	 recognition	 event	 triggered	 upon	 loser	 :	 winner	 contact	 that	directs	the	migration	of	winners	towards	the	loser	population	and/or	vice-versa.	Since	cell-cell	contact	is	required,	any	such	signal	is	most	likely	to	be	on	the	surface	of	either	or	both	populations.	For	example,	one	population	may	express	an	extracellular	protein	that	is	absent	or	reduced	in	the	other.	Alternatively,	the	two	populations	may	expose	different	splice	variants	of	the	same	protein	(Rhiner	et	al.	2010),	or	have	distinct	post-translational	modifications	on	a	protein	common	to	both.	Such	asymmetry	could	then	be	a	trigger	for	the	 ensuing	 directional	 migration.	 It	 is	 unlikely	 that	 transcription	 or	 translation	 are		 	
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Figure	I.9:	Functional	E-cadherin-based	junctions	are	required	for	directional	migration	between	
wild-type	and	scribKD	cells.	(A-B)	Disrupting	cell	junctions	using	an	E-cadherin	blocking	antibody	and	low	calcium	 conditions	 (B)	 prevents	 contact-induced	 migration	 compared	 with	 control	 conditions	 (A).	(C)	Compaction	of	scribKD	cells	is	significantly	reduced	in	the	presence	of	the	E-cadherin	blocking	antibody.	Error	bars	±	standard	error	of	the	mean	(SEM).	p	values	were	calculated	using	the	Kolmogorov-Smirnov	(K-S)	test	here	and	in	(D).	n	=	number	of	cells.	(D)	Elimination	of	scribKD	cells	is	delayed	in	the	presence	of	the	E-cadherin	blocking	antibody.	This	was	defined	as	the	number	of	hours	from	the	point	at	which	a	scribKD	clone	became	 fully	 surrounded	by	wild-type	 cells	 to	 the	 complete	 elimination	of	 that	 scribKD	 clone.	 n	=	number	of	clones.	
Scale	bars	=	100	μm.	Adapted	from	(Wagstaff	et	al.	2016).	
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involved,	 as	 the	onset	of	migration	happens	almost	 immediately	 after	 initial	 contact.	 I	therefore	propose	that	there	is	a	pre-existing	difference	in	the	surface	molecule	signature	of	 scribKD	 and	wild-type	 cells	 and	 that	 this	 is	 the	 trigger	 for	 the	 subsequent	 directed	migration.	
Secondly,	scribKD	cells	without	fail	migrate	away	from	wild-type	cells	and	are	intrinsically	more	motile,	suggesting	they	are	always	poised	for	migration	and	contact	from	winners	might	be	providing	 the	 symmetry	breaking	 cue	 to	 initiate	 it.	Wild-type	MDCKs	do	not	share	 this	predisposition	 to	migrate,	 as	 contact	between	 two	populations	of	wild-type	cells	does	not	result	in	either	of	the	populations	moving	away	from	the	other	(Wagstaff	et	al.	 2016).	 It	 would	 be	 important	 to	 find	 out	 which	 molecular	 pathways	 confer	 this	directional	migratory	 response	 upon	 contact	 between	wild-type	 and	 scribKD	 cells,	 and	whether	the	same	pathways	are	also	responsible	for	the	loser	status	of	scribKD	cells.	
	
Collective cell migration and leader cells 
Importantly	for	this	thesis,	scribKD	cells	during	directed	migration	are	always	observed	at	the	front	of	the	collective,	with	wild-type	cells	behind	them	(Wagstaff	et	al.	2016).	This	is	very	reminiscent	of	a	phenomenon	called	‘leader	cell	migration’,	with	scribKD	cells	acting	as	 ‘leaders’	and	wild-type	cells	acting	as	 ‘followers’.	 I	describe	 leader	cell	migration	 in	more	detail	here	and	in	subsequent	sections.	
Single	 cell	 migration	 relies	 on	 the	 establishment	 of	 a	 front-to-rear	 polarity	 axis.	Cytoskeletal	rearrangements	driven	by	the	activity	of	small	GTPases	Rac	and	Cdc42	at	the	front	of	a	migrating	cell	 lead	to	the	 formation	of	protrusions,	such	as	 lamellipodia	and	filopodia,	and	engagement	of	integrins	with	the	substrate.	As	the	lamellipodium	reaches	forward	in	the	direction	of	migration,	integrin-based	adhesions	(that	eventually	mature	into	focal	adhesions)	are	formed,	to	which	acto-myosin	cables	are	anchored.	The	activity	of	 small	 GTPase	Rho	 at	 the	 rear	 of	 the	 cell	 promotes	 acto-myosin	 contractility,	which	retracts	the	rear	end	of	the	cell.	Focal	adhesions	are	disassembled	as	the	retracting	edge	reaches	 them,	 resulting	 in	 net	 movement	 forwards	 (reviewed	 in	 Mayor	 &	 Etienne-Manneville	 2016).	 This	 type	 of	 migration	 is	 classed	 as	 mesenchymal,	 in	 contrast	 to	amoeboid	migration,	 a	 ‘crawling’	 type	 of	movement	 driven	 by	 distinct	molecular	 and	
	 33 
physical	mechanisms	 (not	 discussed	 in	 this	 thesis)	 (reviewed	 in	 Lämmermann	&	 Sixt	2009).	
Collective	cell	migration	can	be	broadly	defined	as	the	coordinated	migration	of	two	or	more	cells,	which	occurs	as	a	result	of	communication	between	them,	be	it	mechanical,	chemical,	or	physical	(reviewed	in	Theveneau	&	Linker	2017).	The	molecules	that	govern	single	cell	migration	are	also	implicated	in	collective	migration.	Importantly,	front-to-rear	polarity	is	established	at	a	‘supra-cellular’	level	(from	the	front	to	the	rear	of	the	migrating	collective	rather	than	within	an	individual	cell)	thanks	to	adhesion	and	communication	enabled	 by	 intact	 cell-cell	 junctions	 (reviewed	 in	 Khalil	 &	 Friedl	 2010).	 Collective	migration	 is	 crucial	 in	 many	 physiological	 processes,	 such	 as	 morphogenesis,	 wound	healing,	and	angiogenesis,	but	has	also	been	implicated	in	tumour	cell	migration.	Deeper	understanding	of	the	processes	underlying	this	mode	of	migration	could	therefore	form	the	 basis	 for	 therapeutic	 approaches	 promoting	 wound	 healing	 or	 preventing	 cancer	metastasis.	
The	 directionality	 and	 efficiency	 of	 collective	migration	 is	mostly	 determined	 by	 two	regions:	the	leading	and	trailing	edge.	Single	or	multiple	‘leader’	cells	are	localised	to	the	front	of	a	collectively	migrating	group,	with	‘follower’	cells	migrating	behind	them	(Figure	I.10A).	Leader	cells	are	characterised	by	a	mesenchymal-like	front	edge	and	a	rear	end	with	a	more	epithelial	identity:	this	polarisation	is	achieved	mainly	through	integrin	β1	(ITGβ1)-mediated	protrusion	formation	and	cadherin-based	junctions	with	follower	cells	at	the	rear	(reviewed	in	Khalil	&	Friedl	2010).	Leaders	are	not	always	initially	present	at	the	front	of	the	collective:	they	can	be	transported	to	the	outer	edge	of	a	colony	from	a	few	rows	behind	by	flows	within	the	collective	(Poujade	et	al.	2007).	
Canonically,	 leaders	 have	 been	 thought	 to	 sense	 the	 microenvironment,	 direct	 the	migration	 of	 the	 collective,	 generate	 traction	 forces,	 and	 proteolytically	 degrade	 the	extracellular	matrix	(ECM)	to	create	tracks	through	which	the	cells	can	migrate	(reviewed	in	Khalil	&	Friedl	2010).	This	was	challenged	by	more	recent	evidence	that	suggests	that	directionality	 is	not	 always	determined	by	 the	 cells	 at	 the	 leading	edge,	 traction	 force	generation	 and	 proteolytic	 activities	 are	 not	 necessarily	 confined	 to	 leaders,	 and	 that	protrusive	and	guidance	abilities	are	independent	of	each	other	(reviewed	in	Theveneau	&	Linker	2017).	  
	 34 
	
	
	
		
Figure	 I.10:	 Finger-like	 protrusions,	 each	 capped	 by	 a	 leader	 cell,	 emerge	 in	 MDCK	 cultures	
following	 scratching	 of	 a	 confluent	 monolayer.	 (A)	 An	 MDCK	 leader	 cell	 (highlighted	 in	 yellow)	displaying	 the	 characteristic	 flattened	morphology	 and	 an	 active	 lamellipodium	with	 the	 follower	 cells	(highlighted	 in	 blue)	 trailing	 behind	 it.	 (B)	Scratching	 of	 a	 wild-type	 MDCK	 monolayer	 results	 in	 the	emergence	of	a	finite	number	of	leader	cells,	some	of	which	are	indicated	by	the	yellow	arrows.	The	scratch-wound	area	decreases	over	time	as	cells	migrate	to	close	the	wound	gap.	
Scale	bars	=	100	μm.	
This	data	was	generated	by	me.	
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Mammalian in vitro models of leader cell migration 
In	mammalian	epithelial	in	vitro	models	of	leader	migration	(e.g.	MDCKs),	cell	monolayers	are	grown	to	confluency	before	scratching	or	releasing	a	barrier	 to	generate	space	 for	migration.	These	manipulations	trigger	the	emergence	of	a	finite	number	of	leader	cells	from	 the	colony	edges	 (Figure	 I.10B,	 leaders	are	marked	with	yellow	arrows).	Barrier	release	experiments	are	generally	accepted	 to	be	a	more	controlled	way	of	generating	leaders,	 as	 they	 avoid	 the	 formation	 of	 barriers	 of	 cell	 debris,	 release	 of	 intracellular	material	into	the	media,	and	detectable	damage	to	the	edge	cells	(Poujade	et	al.	2007).	Leader	cells	drive	the	formation	of	migration	‘fingers’	in	which	follower	cells	make	up	the	stem	and	a	 leader	 cell	 caps	 the	 tip.	 I	will	 refer	 to	 leaders	generated	by	wounding	and	barrier	release	as	‘canonical	leaders’	to	distinguish	them	from	other	types	of	leader	that	I	describe	in	this	thesis.	
While	MDCKs	dominate	the	leader	cell	migration	field,	leaders	have	also	been	described	in	other	cell	lines.	In	fact,	leaders	were	first	described	in	the	rat	liver	epithelial	line	IAR-2	and	their	formation	was	shown	to	depend	on	reduced	RhoA	activity	(Omelchenko	et	al.	2003).	 Interestingly,	 leaders	 emerging	 from	wounds	 in	monolayers	 of	 invasive	 breast	cancer	MCF-7	cells	emerge	through	a	different	mechanism.	Wounding	of	MCF-7	cultures	reduces	mechanical	 tension,	which	 triggers	 expression	of	 the	Notch	 ligand	Dll4	 at	 the	wound	 edge.	 The	 frequency	 of	 leader	 appearance	 is	 regulated	 by	 lateral	 inhibition,	whereby	cells	with	high	Dll4	inhibit	Dll4	upregulation	in	neighbouring	cells	(Riahi	et	al.	2015).	
I	will	now	focus	on	findings	established	using	MDCKs	as	a	model	for	leader	cell	migration.	
Leader	cells	are	essential	for	collective	migration	of	MDCK	cells	(Yamaguchi	et	al.	2015).	MDCK	 leaders	 are	 morphologically	 distinct	 from	 follower	 cells:	 they	 display	 a	characteristic	 half-moon	 shape,	 are	 larger	 than	 follower	 cells,	 and	 have	 active	lamellipodia	 and	 large	 focal	 adhesions	 (Poujade	 et	 al.	 2007;	Omelchenko	 et	 al.	 2003).	Leaders	have	also	been	shown	to	often	have	multiple	nuclei	and	not	to	divide	(Reffay	et	al.	 2011).	 Molecularly,	 leaders	 generated	 by	 barrier	 release	 have	 high	 levels	 of	phosphoinositide	3-kinase	(PI3K),	 ITGβ1,	and	Rac1,	whose	activities	are	 indispensable	for	leader	migration.	PI3K	and	Rac1	are	in	a	positive	feedback	loop	in	leader	cells	while	ITGβ1	regulates	Rac1	individually	(Yamaguchi	et	al.	2015).	I	will	term	PI3K,	ITGβ1,	and	
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Rac1	 ‘canonical	 leader	markers’	 and	use	 them	as	 a	 benchmark	 for	 characterisation	 of	other	types	of	leader	in	this	thesis.	It	is	also	important	to	note	that	cell	division	does	not	contribute	to	wound	closure	in	MDCK	leader	migration	(Farooqui	&	Fenteany	2005)	and	that	the	initial	speed	of	migration	depends	on	plating	density	(Rosen	&	Misfeldt	1980):	I	control	for	the	latter	in	my	experiments	by	seeding	cells	at	the	lowest	possible	density	that	still	results	in	a	confluent	monolayer.	
Other	 researchers	 have	 used	 techniques	 like	 traction	 force	 microscopy	 and	 FRET	 to	characterise	 leader	 cell	 migration	 from	 a	more	 biophysical	 perspective.	 For	 instance,	micropatterning	experiments	have	shown	that	increased	membrane	curvature	promotes	leader	formation	(Rausch	et	al.	2013).	Similarly,	particle	image	velocimetry	was	used	to	show	that	axis	alignment	of	cells	perpendicularly	to	the	wound	edge	precedes	leader	cell	appearance,	although	these	experiments	were	largely	observational	in	nature	(Reffay	et	al.	 2011).	 In	 another	 study,	 it	 was	 shown	 that	 a	 contractile	 acto-myosin	 ‘cable’	 runs	uninterrupted	along	the	outer	edge	of	the	cells	making	up	a	migratory	finger.	The	cable	is	kept	under	tension	and	its	laser	ablation	is	sufficient	to	increase	the	probability	of	a	leader	emerging,	 suggesting	 that	 the	 cable	mechanically	 inhibits	 leader	 cell	 formation	 in	 the	vicinity	of	an	existing	leader	(Reffay	et	al.	2014).	Finally,	mathematical	models	assuming	that	a	cell’s	shape	determines	its	motility,	which	leads	to	surface	instability	at	the	wound	edge,	have	successfully	recapitulated	leader	formation,	 implying	leaders	can	emerge	in	the	absence	of	biochemical	cues	(Mark	et	al.	2010).	
Despite	the	body	of	work	on	leader	cells,	there	has	so	far	been	no	evidence	to	show	that	leader	cells	are	initially	distinct	from	the	cells	around	them	(Poujade	et	al.	2007;	Petitjean	et	al.	2010;	Reffay	et	al.	2014).	Even	if	the	reduced	mechanical	tension	or	exposure	of	a	free	edge	after	wounding	provide	the	mechanical	cues	for	leader	formation,	only	a	few	cells	become	leaders	from	the	mass	of	phenotypically	homogeneous	cells,	implying	that	other	factors	are	also	at	play.	Ultimately,	it	is	not	yet	clear	how	individual	cells	are	singled	out	and	instructed	to	acquire	the	leader	cell	fate.	I	attempt	to	address	this	question	in	the	last	part	of	this	thesis.	
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Leader cell migration in wound healing and cancer 
Collective	and	leader	cell	migration	have	been	implicated	in	physiological	processes	such	as	wound	healing	but	have	also	been	shown	to	be	active	in	pathological	migration	e.g.	in	invasive	 carcinoma.	 I	 will	 discuss	 examples	 from	 both	 physiology	 and	 pathology	 to	highlight	how	findings	from	the	leader	cell	migration	field	could	be	exploited	for	potential	therapeutic	uses	in	the	future.	
The	importance	of	leader	migration	in	wound	healing	has	been	mainly	described	in	the	skin	 and	 corneal	 epithelium.	 Following	 a	 wound	 to	 the	 epithelium,	 keratinocytes	collectively	migrate	 over	 the	 wound	 bed	 to	 quickly	 close	 the	 wound	 and	 restore	 the	epithelial	 barrier.	 Proliferation	 is	 suppressed	 in	 cells	 at	 the	 leading	 edge	 so	 that	 the	integrity	of	 the	moving	sheet	 is	not	compromised	by	cells	rounding	up	during	mitosis;	meanwhile,	the	proliferation	of	follower	cells	is	boosted	to	compensate	for	cell	loss.	Just	like	canonical	leader	cells,	the	front	row	of	migrating	keratinocytes	uses	integrin-based	attachments	to	generate	traction	force	on	the	ECM	while	maintaining	cell-cell	junctions	with	the	cells	behind	them.	Additionally,	growth	factor	signalling	at	the	wound	site	(e.g.	from	stromal	fibroblasts)	helps	boost	migration	efficiency.	Importantly,	a	new	basement	membrane	 is	 deposited	 during	 keratinocyte	 migration	 and	 this	 is	 key	 for	 re-epithelisation.	Multi-layered	stratification	of	the	keratinocyte	monolayer	hours	or	days	after	wound	closure	ensures	that	an	epidermis	is	fully	reformed	(reviewed	in	Zelenka	&	Arpitha	2008	and	Friedl	&	Gilmour	2009).	
In	 vitro	 studies	 using	 MDCKs	 and	 MCF-7	 have	 directly	 demonstrated	 that	 collective	migration	driven	by	leader	cells	is	necessary	for	efficient	scratch-wound	closure	(Riahi	et	al.	2015;	Yamaguchi	et	al.	2015).	In	fact,	in	vitro	studies	were	also	particularly	useful	in	characterising	some	of	the	molecular	players	involved.	In	MDCK	wound	healing	models,	extracellular	regulated	kinase	1/2	(ERK1/2)	MAPK	activity	is	essential	for	coordinated	cell	migration	and	its	levels	are	directly	proportional	to	the	speed	of	migration.	Wounding	has	been	shown	to	generate	reactive	oxygen	species	(ROS)	and	activate	a	rapid,	transient	wave	of	ERK1/2	signalling	in	the	edge	cells.	A	second,	slower	and	more	sustained	wave	of	ERK1/2	signalling	is	then	activated,	most	likely	by	locomotion	of	individual	cells	within	the	monolayer.	 Importantly,	only	the	second	wave	 is	activated	 in	a	constraint	removal	assay,	a	completely	injury-free	barrier	release	assay,	showing	that	injury	provides	a	vital	signal	for	MDCK	migration	into	the	wound	area.	The	second	wave	is	important	for	sheet	
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movement	and	depends	on	Src	activity.	Upon	wound	closure,	ERK1/2	activity	dissipates	from	 the	 opposing	 edges	 (Matsubayashi	 et	 al.	 2004;	 Nikolic	 et	 al.	 2006).	While	 these	studies	address	collective	migration	at	the	wound	edge	and	not	leader	cell	migration	per	
se,	 leader	 cells	 are	 present	 at	MDCK	wound	 edges	 and	 I	would	 therefore	 expect	 their	migration	to	at	least	partially	rely	on	ERK1/2	activity.	
Later	 studies	 in	 keratinocytes	 showed	 that	 transforming	 growth	 factor	 β	 (TGFβ)	 lies	upstream	 of	 wound-induced	 ERK1/2	 activation.	 TGFβ	 is	 a	 secreted	 cytokine	 that	 can	signal	to	activate	a	plethora	of	intracellular	responses,	including	p38,	RhoA,	and	PI3K	that,	interestingly,	also	play	roles	in	scribble	competition	and	canonical	leader	cell	migration.	TGFβ	reduces	cell	density	at	the	leading	edge,	which	is	a	prerequisite	for	and	the	driver	of	ERK1/2	activation.	This	induces	efficient	collective	migration	towards	regions	of	lower	density	and	therefore	presumably	into	the	wound	area.	Sensing	of	cell	density	is	hence	proposed	to	be	the	way	leaders	are	defined	in	the	keratinocyte	system	(Chapnick	&	Liu	2014).	
The	processes	underlying	collective	and	leader	cell	migration	have	also	been	implicated	in	the	migration	of	cancer	cells	away	from	a	primary	tumour	during	metastasis.	Cancer	cells	 can	 adopt	 several	 types	 of	 migratory	 behaviour,	 from	 single	 cell	 migration	 to	multicellular	streaming	(reviewed	in	Friedl	et	al.	2012).	Importantly,	cancer	cells	often	migrate	as	a	collective,	at	the	front	of	which	are	leader	cells.	Leader	cells	can	emerge	from	the	tumour	itself	and	usually	have	a	mesenchymal-like	phenotype,	but	non-tumour	cells	such	as	cancer-associated	fibroblasts	(CAFs)	can	also	become	leaders	during	metastasis.	CAFs	can	provide	directional	cues	to	the	migrating	tumour	cells	and	generate	tracks	for	the	cancer	cells	to	follow	by	remodelling	the	ECM	(reviewed	in	Theveneau	&	Linker	2017).	
CAFs	 leading	 cancer	 cells	 away	 from	 a	 primary	 tumour	 in	 both	 2D	 and	 3D	migration	assays	 look	 remarkably	 like	 finger-like	 protrusions	 observed	 in	 canonical	 leader	 cell	migration.	 As	 they	 migrate,	 CAFs	 generate	 pulling	 forces	 on	 cancer	 cells	 through	mechanosensitive,	 heterotypic	 E-cadherin	 /	 N-cadherin	 adhesions.	 N-cadherin	 is	 also	important	for	the	repolarisation	of	CAFs	following	their	interaction	with	the	tumour	mass	so	that	they	migrate	away	from	it.	Taken	together,	invasive	cancer	cells	can	direct	CAF	migration	 away	 from	 the	 tumour	 mass	 and	 into	 the	 surrounding	 tissue.	 Cell-cell	adhesions	between	the	two	populations	then	result	in	CAFs	physically	pulling	cancer	cells	away	from	the	primary	tumour	to	promote	their	metastasis	(Labernadie	et	al.	2017).	
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Mechanical	 stress	 at	 tumour	 sites	 has	 also	 been	 implicated	 in	 the	 progression	 of	metastasis.	 When	 mammary	 epithelial	 cancer	 cell	 lines	 were	 subject	 to	 compression	similar	to	that	in	a	breast	tumour	microenvironment,	the	migration	of	more	invasive	lines	in	 a	 scratch-wound	 assay	 was	 enhanced.	 In	 contrast,	 compression	 suppressed	 the	migration	of	non-invasive	 lines.	More	specifically,	compression	was	shown	to	promote	the	formation	of	an	increased	number	of	 leader-like	cells	at	the	edges	of	the	scratched	invasive	cancer	cell	monolayers.	The	authors	propose	that	in	an	uncompressed	situation,	only	 a	 few	 cells	 become	 leaders	 in	 response	 to	 other	 cues	 (e.g.	 increased	membrane	curvature	at	the	edge),	but	compression	provides	pro-migratory	mechanical	cues	to	all	border	cells.	This	results	in	the	formation	of	many	more	leaders	in	a	compressed	scenario,	many	of	which	can	migrate	away	from	the	primary	tumour	(Tse	et	al.	2012).	
In	summary,	 leader	cell	migration	plays	an	important	role	 in	epithelial	wound	healing.	Leader	cells	guide	the	migration	into	the	wound	area	while	maintaining	cell-cell	contacts	that	keep	the	epithelial	barrier	intact.	On	the	flipside,	aspects	of	leader	cell	migration	can	often	 be	 exploited	 by	malignant	 cells	 to	 promote	 their	 invasion	 into	 the	 surrounding	tissue.	Cancer	cells	are	able	to	form	and	maintain	cell-cell	junctions	and	thus	migrate	as	a	collective	 following	 leader	 cells.	 Leader	 cells,	 be	 it	 CAFs	 or	 ones	 originating	 from	 the	tumour	itself,	display	properties	of	canonical	leaders	e.g.	the	ability	to	generate	traction	forces	at	the	front	while	maintaining	adhesions	at	the	rear.	Using	leader	cell	migration	models	to	understand	more	about	what	mechanisms	drive	leader-follower	migration	may	therefore	 help	 identify	 therapy	 targets	 also	 applicable	 to	 migration	 during	 cancer	metastasis.	
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Thesis objectives 
The	work	I	describe	 in	this	thesis	aims	to	broaden	our	understanding	of	three	distinct	aspects	of	cell	competition	and	leader	cell	migration	in	the	MDCK	system.	
	
(i) What roles do surface molecules play in the directional migration and mechanical 
loser status observed during scribble competition? 
It	remains	unclear	which	molecular	pathways	drive	 the	directional	migration	between	wild-type	and	scribKD	cells	during	MDCK	scribble	competition.	It	is	also	unknown	whether	the	molecular	players	 that	 drive	 contact-induced	migration	 also	play	 an	 active	 role	 in	
scribKD	cell	elimination.	This	is	an	attractive	hypothesis:	the	same	pathway	could	trigger	the	directional	migration	to	drive	loser	cell	compaction	while	simultaneously	conferring	the	density	hypersensitivity	on	losers,	leading	to	their	robust	elimination.	
The	Piddini	lab	has	recently	shown	that	the	contact	is	required	for	scribKD	cell	elimination.	Moreover,	 the	 directional	 migration	 phenotype	 is	 triggered	 almost	 immediately	 after	contact	 between	 loser	 and	winner	 clones	 (Wagstaff	 et	 al.	 2016).	 It	 is	 therefore	 highly	likely	that	the	molecules	orchestrating	the	migratory	response	reside	on	the	cell	surface	of	 either	 or	 both	 cell	 populations.	 Should	 this	 be	 the	 case,	 these	molecules	 could	 also	conceivably	transduce	‘kill’	signals	from	the	winner	cells	(or	the	environment)	to	the	loser	cells.	
Following	leads	from	exploratory	immunofluorescence	and	RNA	sequencing	experiments	done	 by	 others	 in	 the	 Piddini	 lab,	 I	 aimed	 to	 characterise	 the	 involvement	 of	 several	surface	molecules	in	the	directional	migration	triggered	between	wild-type	winners	and	
scribKD	losers.	I	also	set	out	to	test	the	role	of	these	surface	molecules	in	the	mechanical	loser	status.	
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(ii) Is the molecular cascade responsible for the density hypersensitivity of scribKD cells 
conserved in mechanical losers triggered by p53 activation alone? 
Recent	 work	 from	 the	 Piddini	 lab	 identified	 elevated	 p53	 as	 the	 underlying	 cause	 of	mechanical	loser	status	of	scribKD	cells.	In	fact,	most	scribKD	cell	phenotypes,	such	as	lower	homeostatic	density	and	hypersensitivity	to	compaction,	can	be	replicated	by	chemically	elevating	 p53	 in	 otherwise	 wild-type	 cells	 (Wagstaff	 et	 al.	 2016).	 What	 remained	unaddressed	is	whether	the	ROCK	–	P-p38	–	p53	molecular	cascade	leading	to	density	hypersensitivity	in	compacted	scribKD	cells	is	also	conserved	in	losers	induced	by	mild	p53	activation	alone.	It	remained	possible	that		scribKD	and	p53-driven	losers	activate	parallel	pathways	 in	 response	 to	 compaction	 and	 that	 these	 signalling	 events	 only	 converge	further	downstream	to	drive	the	same	outcome	in	both	types	of	mechanical	loser.	
In	the	second	part	of	this	thesis,	I	aimed	to	determine	to	what	extent	the	ROCK	–	P-p38	–	p53	molecular	cascade	was	conserved	between	scribKD-	and	p53-mediated	competition.	
	
(iii) What are the molecular drivers of the directional migration observed during MDCK 
competition? Are the same molecules involved in leader cell migration? 
The	directional	migration	preceding	compaction	and	elimination	of	scribKD	cells	had	not	been	 further	 characterised	 past	 the	 experiments	 described	 in	 (Wagstaff	 et	 al.	 2016),	which	left	several	open	questions	about	the	molecular	drivers	behind	this	phenomenon.	The	 third	 part	 of	 this	 thesis	 aimed	 to	 further	 characterise	 the	 directional	 migration	observed	during	MDCK	competition	and	pinpoint	the	signalling	pathways	involved.	
As	 I	 mentioned	 previously,	 the	 contact-induced	 collective	migration	 occurring	 during	
scribble	 competition	 is	 reminiscent	of	 canonical	 leader	 cell	migration	described	 in	 the	context	of	wound	healing.	It	is	therefore	an	interesting	possibility	that	the	same	molecular	markers	 might	 be	 involved	 in	 driving	 both	 processes.	 I	 therefore	 also	 aimed	 to	 test	whether	 any	 parallels	 can	 be	 drawn	 between	 directional	 migration	 during	 MDCK	competition	and	leader	cell	migration.	Should	this	be	the	case,	any	findings	could	be	more	significant	from	a	therapeutic	point	of	view	and	help	develop	methods	of	boosting	wound	healing	in	vivo.	
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Chapter II: E-cadherin is necessary but not sufficient for the directional 
migration observed in scribble competition and its loss does not ameliorate 
scribKD cell loser status 
	In	the	first	part	of	my	thesis	(Chapters	II	and	III),	I	investigate	the	role	of	three	candidate	molecules	(E-,	N-,	and	P-cadherin)	in	the	directional	migration	between	scribKD	and	wild-type	cells	and	in	the	mechanical	loser	status	of	scribKD	cells.	
Contact-induced	 migration	 following	 contact	 between	 scribKD	 and	 wild-type	 cells	 is	initiated	almost	immediately	after	clone	collision	(Wagstaff	et	al.	2016).	As	I	postulated	earlier,	it	is	likely	that	there	is	a	difference	in	the	surface	molecule	repertoire	of	scribKD	and	wild-type	cells	even	prior	to	initiation	of	directional	migration	or	competition.	Among	other	(not	mutually	exclusive)	possibilities,	a	pre-existing	difference	in	surface	molecules	may	be	responsible	for	loser	cell	recognition,	providing	a	directional	cue	for	winner	cell	migration,	 and	 even	 transducing	 pro-apoptotic	 signals	 from	winners	 into	 losers.	 One	candidate	 for	 this	 is	 E-cadherin,	 a	 cell	 surface	 molecule	 involved	 in	 collective	 cell	migration	 and	 mechanotransduction	 (reviewed	 in	 Theveneau	 &	 Mayor	 2012	 and	Leckband	&	de	Rooij	2014).	
Multiple	 lines	 of	 evidence	 suggest	 that	 E-cadherin	 might	 play	 a	 role	 in	 directional	migration	during	scribble	competition	in	MDCKs.	For	one,	scribKD	cells	have	elevated	levels	of	both	total	and	surface	E-cadherin	compared	to	wild-type	cells,	even	before	competition	(Figure	I.7)	(Wagstaff	et	al.	2016).	What	is	more,	the	Scribble	protein	is	directly	implicated	in	E-cadherin	regulation	(Lohia	et	al.	2012).	Disruption	of	E-cadherin	junctions	using	a	blocking	 antibody	 is	 sufficient	 to	 abolish	 contact-induced	 migration,	 as	 is	 shRNA-mediated	 knockdown	of	 E-cadherin	 in	 the	wild-type	 population	 alone	 (Wagstaff	 et	 al.	2016).	Functional	E-cadherin	junctions	and	the	presence	of	E-cadherin	in	the	wild-type	population	 are	 therefore	 necessary	 for	 contact-induced	 migration.	 This	 set	 of	experiments	however	does	not	address	the	role	of	elevated	E-cadherin	in	scribKD	cells,	as	E-cadherin	was	never	manipulated	in	this	population	alone.	I	therefore	aimed	to	test	if	E-cadherin	elevation	in	scribKD	cells	itself	was	important	in	contact-induced	migration.	
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E-cadherin,	as	well	as	other	cadherins,	has	mechanotransductive	properties:	cadherins	bear	force	and	translate	it	into	intracellular	responses	through	interaction	with	molecules	like	 α-catenin,	 whose	 function	 is	 altered	 by	 force	 (reviewed	 in	 Yap	 et	 al.	 2017).	Consistently	 with	 this,	 disruption	 of	 E-cadherin-mediated	 junctions	 with	 a	 blocking	antibody	delays	the	mechanical	outcompetition	of	scribble	mutant	cells	(Wagstaff	et	al.	2016).	I	therefore	also	aimed	to	address	the	role	of	E-cadherin	in	the	mechanical	loser	status	of	scribKD	 cells.	 It	 is	 conceivable	 that	elevated	surface	E-cadherin,	or	E-cadherin	misregulation	 due	 to	 loss	 of	 scribble,	 could	 result	 in	 aberrant	 extracellular	 signal	transduction,	which	could	ultimately	drive	loser	cells’	hypersensitivity	to	density.	The	E-cadherin	blocking	antibody	experiments	performed	in	the	Piddini	lab	suggested	that	loss	of	functional	E-cadherin	junctions	delays,	but	does	not	prevent,	scribKD	cell	elimination.	However,	 the	 possibility	 remained	 that	 excessive/aberrant	 E-cadherin-mediated	signalling	 prior	 to	 blocking	 antibody	 addition	 had	 already	 triggered	 the	 density	hypersensitivity	of	scribKD	cells	and	‘sealed’	their	fate	as	losers.	
	
Elevated E-cadherin in scribKD cells is necessary for directional migration but does not impact 
loser status 
To	test	the	role	of	E-cadherin	elevation	in	scribKD	cells,	I	generated	a	clonal,	stable	MDCK	cell	 line	 where	 both	 scribble	 and	 E-cadherin	 could	 be	 silenced	 (scribKD	 E-cadKD)	 in	 a	tetracycline	 (TET)-inducible	manner.	 I	 did	 this	 by	 generating	 a	modified	 version	 of	 a	published	silencing	vector:	I	adapted	the	antibiotic	resistance	cassette	to	allow	selection	using	 hygromycin	 and	 introduced	 a	 previously	 described	 shRNA	 against	 E-cadherin	(Hogan	et	al.	2009;	Norman	et	al.	2012).	I	then	stably	transfected	this	E-cadKD	construct	(Appendix	2A)	into	a	scribKD	cell	line.	The	knockdown	efficiency	of	E-cadherin	was	very	variable	within	 the	 hygromycin-selected	 pool,	with	most	 cells	 displaying	 negligible	 or	only	partial	knockdown,	as	determined	by	comparing	immunofluorescence	images	in	the	presence	and	absence	of	TET	(data	not	shown).	I	therefore	deemed	it	necessary	to	isolate	single	clones	from	the	stably	transfected	pool.	The	clone	I	used	in	subsequent	experiments	could	be	induced	to	silence	E-cadherin	in	scribKD	cells	down	to	levels	reminiscent	of	wild-type	MDCKs	(Figure	II.A	and	B,	yellow	dotted	line	indicates	the	boundary	between	wild-		 	
	 45 
	
	
	
Figure	II:	Elevated	E-cadherin	is	necessary	but	not	sufficient	for	the	directional	migration	observed	
in	 scribble	 competition	 and	 does	 not	 play	 a	 role	 in	 the	 mechanical	 loser	 status.	 (A)	 Directional	migration	 is	 abolished	 between	 RFP-labelled	wild-type	 cells	 and	 unlabelled	 scribKD	 cells	 expressing	 an	shRNA	against	E-cadherin	(scribKD	E-cadKD).	White	dashed	lines	mark	initial	contact	point;	black	dashed	lines	mark	final	contact	point	here	and	in	(G).	(B)	Anti-E-cadherin	immunofluorescence	at	end	of	movie	in	(A).	The	 yellow	 dashed	 line	 separates	 wild-type	 (bottom	 part)	 cells	 from	 scribKD	 E-cadKD	 cells	 (top	 part).	(C-D)	Quantification	of	single-cell	E-cadherin	intensities	from	one	representative	set	of	confocal	images	as	in	(B).	E-cadherin	levels	of	wild-type	cells	are	compared	to	scribKD	cells	(C)	or	scribKD	E-cadKD	cells	(D).	Black	bars	represent	the	median.	p	values	were	calculated	using	the	K-S	test.	AU	=	arbitrary	units.	n	=	number	of	cells.	(E)	scribKD	E-cadKD	cells	(marked	by	yellow	asterisks)	are	still	mechanical	 losers	in	co-culture	with	RFP-labelled	wild-type	cells.	Yellow	arrows	mark	cell	death	events.	(F)	Immunofluorescence	showing	total	E-cadherin	levels	in	wild-type	MDCKs	(white	dashed	line),	wild-type	cells	overexpressing	GFP-labelled	E-cadherin	(E-cadOE;	yellow	dashed	line),	and	scribKD	cells	(nuclear	GFP).	(G)	Directional	migration	does	not	occur	between	unlabelled	E-cadOE	cells	and	RFP-labelled	wild-type	cells.	(H)	E-cadOE	clones	(white	dashed	lines)	are	not	outcompeted	and	display	a	similar	response	to	increased	cell	density	as	surrounding	RFP-
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labelled	wild-type	cells.	(I)	2x	zoom	of	the	third	panel	in	(G)	showing	that	E-cadOE	cells	are	not	significantly	flatter	than	RFP-labelled	wild-type	cells.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
	
Here	and	throughout	all	figures:	
Unless	otherwise	 specified	 in	 the	 figure	 legend	or	 text,	 all	 quantifications,	 immunofluorescence	 images,	movie	 sequences,	 and	Western	 blots	 shown	 are	 from	 a	 single	 representative	 experiment	 taken	 from	 a	minimum	 of	 three	 independent	 repeats	 per	 experiment.	 For	 live	 imaging	 and	 immunofluorescence	experiments,	at	least	10	fields	of	view	were	analysed	per	condition.	
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type	and	scribKD	E-cadKD	cells),	thus	abolishing	the	E-cadherin	gradient	between	the	two	populations.	
I	did	not	observe	directed	cell	migration	in	co-cultures	of	unlabelled	scribKD	E-cadKD	and	wild-type	 cells	 labelled	 with	 nuclear	 RFP	 (Figure	 II.A,	 white	 and	 black	 dashed	 lines	indicate	 initial	 and	 final	 points	 of	 contact,	 respectively),	 suggesting	 that	 elevated	 E-cadherin	in	losers	is	required	for	this	process.	At	the	end	of	each	experiment,	I	fixed	the	co-cultures	 and	 confirmed	 by	 immunofluorescence	 that	 the	 total	 E-cadherin	 levels	 of	
scribKD	E-cadKD	clones	not	displaying	directed	migration	had	been	brought	down	to	those	of	wild-type	cells	(Figure	II.B	and	quantifications	in	C	and	D).	
Despite	the	inhibitory	effect	on	directed	migration,	E-cadherin	knockdown	did	not	rescue	
scribKD	cell	outcompetition	by	wild-type	cells	 in	higher	density	co-cultures	(Figure	II.E,	yellow	arrows	indicate	cell	death	events).	This	clearly	demonstrated	that	high	levels	of	E-cadherin	 are	 not	 responsible	 for	 scribKD	 cells’	 hypersensitivity	 to	 compaction	 and	suggested	that	E-cadherin	signalling	does	not	 feed	 into	the	ROCK	–	p38	–	p53	cascade	responsible	for	the	acute	response	of	loser	cells	to	high	density.	
Taken	 together,	 I	 have	 shown	 that	 elevated	 E-cadherin	 in	 scribKD	 cells	 is	 required	 for	directional	migration	after	confrontation	with	wild-type	cells,	but	it	does	not	contribute	to	scribKD	cells’	mechanical	loser	status.	
	
E-cadherin elevation is not sufficient for contact-induced migration or loser status 
Having	 established	 that	 elevated	 E-cadherin	 in	 scribKD	 cells	 is	 required	 for	 contact-induced	 migration	 following	 confrontation	 with	 wild-type	 cells,	 I	 next	 investigated	whether	high	levels	of	E-cadherin	alone	are	sufficient	to	trigger	this	behaviour.	Using	a	previously	published	construct	as	a	template	(Adams	et	al.	1998),	I	sub-cloned	E-cadherin	fused	 to	 GFP	 at	 its	 C	 terminus	 into	 a	 doxycycline	 (DOX)-inducible	 pTRIPZ	 RFP-NLS	lentiviral	vector.	The	main	advantage	of	using	a	lentiviral	vector	is	that	target	sequences	are	integrated	into	the	genome	and	therefore	passed	onto	daughter	cells	during	division	(Durand	&	Cimarelli	2011).	I	also	added	a	P2A	‘self-cleaving’	peptide	in	between	the	E-cadherin-GFP	and	RFP-NLS	reading	frames	so	that	both	proteins	were	expressed	at	an	equimolar	ratio	 from	the	same	promoter	(Appendix	2B)	(Kim	et	al.	2011).	Please	note	
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that	I	use	variations	of	this	DOX-mediated	overexpression	strategy	in	several	chapters	of	this	thesis.	The	overexpression	construct	is	always	inserted	into	the	pTRIPZ	vector	and	its	architecture	is	as	follows:	protein	of	interest	–	P2A	–	RFP/GFP-NLS,	plus	a	puromycin	resistance	cassette	for	antibiotic	selection.	
I	 then	 generated	 lentiviruses	 containing	 the	 E-cadherin	 overexpression	 construct	 and	used	them	to	transduce	an	otherwise	wild-type	MDCK	cell	line.	I	used	antibiotic	selection	to	generate	a	puromycin-resistant	pool,	which	I	plated	at	a	very	low	density	in	96-well	plates	to	isolate	single	clones.	I	used	immunofluorescence	in	the	presence	or	absence	of	DOX	to	select	clones	with	strong,	uniform	expression	of	E-cadherin-GFP.	The	resulting	clonal	cell	line	(E-cadOE)	overexpressed	E-cadherin-GFP	to	levels	comparable	to	or	even	surpassing	those	of	scribKD	cells	(Figure	II.F,	compare	wild-type	and	E-cadOE	cells	in	white	and	yellow	dashed	lines,	respectively,	and	scribKD	cells	with	nuclear	GFP).	
I	next	used	live	cell	imaging	to	monitor	interactions	between	clones	of	wild-type	and	E-cadOE	 cells	 and	 found	 that	 directional	migration	was	 not	 triggered	 following	 contact	between	the	two	populations.	This	showed	that	differential	levels	of	E-cadherin	are	not	sufficient	to	induce	directional	migration	(Figure	II.G).	Moreover,	E-cadOE	cells	were	not	outcompeted	 by	 their	 wild-type	 counterparts:	 at	 densities	 which	 induce	 scribKD	 cell	elimination,	 E-cadOE	 cells	 did	 not	 appear	 compacted	 and	 responded	 to	 high	 density	similarly	to	wild-type	cells	(Figure	II.H,	EcadOE	clones	are	marked	with	the	white	dashed	lines).	
I	therefore	conclude	that	elevated	E-cadherin	is	not	sufficient	to	trigger	directional	cell	migration	and	does	not	confer	the	loser	cell	status.	
	
Discussion 
The	data	I	generated	and	present	in	this	chapter	have	been	published	as	part	of	(Wagstaff	et	 al.	 2016).	Other	members	 of	 the	 Piddini	 lab	 have	 shown	 that	 directional	migration	between	scribKD	and	wild-type	cells	requires	functional	E-cadherin-based	adhesions	and	the	 presence	 of	 E-cadherin	 in	 the	 wild-type	 population.	 My	 data	 demonstrates	 that	directional	migration	 relies	 on	 scribKD	 cells	maintaining	 their	 E-cadherin	 levels	 above	those	of	wild-type:	if	the	E-cadherin	gradient	is	‘flattened’,	contact-induced	migration	no	
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longer	occurs.	However,	I	have	also	shown	that	E-cadherin	elevation	itself	is	not	sufficient	to	drive	migration,	suggesting	other	players	must	be	involved,	either	in	concert	with	or	parallel	to	E-cadherin.	
It	also	remains	unclear	whether	E-cadherin	is	part	of	a	more	complex	signal	required	by	the	 winner	 population	 to	 recognise	 and	 migrate	 directionally	 towards	 losers	 and/or	whether	it	is	required	for	a	more	mechanical	aspect	of	the	migration.	Maintenance	of	cell-cell	 contacts	 between	 leader	 and	 follower	 cells	 is	 crucial	 for	 cohesive,	 collective	 cell	migration	 and	 polarisation	 of	 the	 migrating	 group	 (reviewed	 in	 Mayor	 &	 Etienne-Manneville	2016).	This	explains	why	directional	migration	is	abolished	in	the	E-cadherin	blocking	 experiments.	 However,	 I	 have	 demonstrated	 that	 reducing	 the	 E-cadherin	 in	
scribKD	 cells	 to	 wild-type	 levels	 also	 abolishes	 directed	 migration,	 implying	 that	 E-cadherin	 does	 more	 than	 simply	 maintain	 the	 integrity	 of	 the	 collective.	 Since	overexpression	of	E-cadherin	alone	is	not	sufficient	to	trigger	contact-induced	migration,	I	 propose	 that	 elevated	 E-cadherin	 is	 part	 of	 a	more	 complex	molecular	 signature	 in	
scribKD	losers	that	is	responsible	for	their	migratory	behaviour.	
While	I	have	implied	that	surface	molecules	like	E-cadherin	may	be	playing	a	role	in	the	recognition	 event	between	 loser	 and	winner	 cells,	 this	 has	proven	difficult	 to	 address	directly.	In	the	migration	assays	I	present,	the	readout	for	a	wild-type	cell	recognising	a	
scribKD	 cell	 as	 a	 loser	 is	 directed	 migration.	 I	 therefore	 cannot	 distinguish	 whether	elevated	 E-cadherin	 in	 scribKD	 cells	 is	 necessary	 for	 their	 recognition	 as	 losers	 or	 the	directional	migration	phenotype	(or	both).	This	can	only	be	addressed	once	there	is	a	way	to	disentangle	recognition	from	contact-induced	migration	e.g.	by	tracking	a	molecular	response	within	winner	cells	that	only	occurs	upon	contact	with	losers.	
Considering	that	E-cadherin	elevation	is	necessary	but	not	sufficient	for	directional	cell	migration,	 there	are	most	 likely	other	molecules	acting	alongside	 it.	Many	of	 these	are	likely	to	be	localised	on	the	cell	surface	because	of	the	requirement	for	contact	between	
scribKD	and	wild-type	cells.	One	could	therefore	screen	for	candidates	by	comparing	the	surface	proteomes	of	the	two	populations.	A	way	to	do	this	would	be	by	using	membrane-impermeable	biotin	to	label	all	cell	surface	proteins	of	scribKD	and	wild-type	cells	grown	as	 homotypic	 cultures	 (in	 the	 absence	 of	 competition),	 purifying	 the	 proteins	 on	streptavidin	beads,	and	using	mass	spectrometry	to	identify	any	differentially	expressed	molecules	(Elia	2008).	
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That	said,	one	cannot	disregard	alternative	possibilities	that	would	not	be	detected	using	the	surface	biotinylation	approach.	For	instance,	loser	cells	might	traffic	a	molecule	to	the	membrane	in	response	to	collision,	which	triggers	winners	to	follow	them.	Trafficking	of	proteins	from	intracellular	vesicles	to	the	cell	surface	would	fall	well	within	the	timeframe	of	 contact-induced	 migration:	 for	 example,	 vesicles	 containing	 the	 GLUT4	 glucose	transporter	can	be	translocated	to	the	cell	membrane	in	response	to	insulin	in	under	15	minutes	(Lampson	et	al.	2000).	I	have	also	not	formally	tested	whether	soluble	factors	are	involved	in	directional	migration	in	scribble	competition,	but	neither	I	nor	others	in	the	Piddini	 lab	have	ever	observed	wild-type	clones	directionally	migrating	toward	scribKD	cells	prior	to	collision	(Piddini	lab,	unpublished).	The	two	populations	proliferate	in	their	individual	clones	until	they	collide,	which	is	only	when	the	directed	migration	begins.	It	is	therefore	unlikely	that	directional	migration	is	triggered	by	soluble	factors	in	the	MDCK	system.	
Lastly,	I	have	shown	that	elevated	E-cadherin	alone	does	not	induce	loser	status.	I	have	also	demonstrated	that	high	E-cadherin	in	scribKD	cells	does	not	contribute	to	their	loser	cell	status,	discounting	the	possibility	that	elevated	E-cadherin	feeds	into	the	signalling	cascade	responsible	for	scribKD	cells’	hypersensitivity	to	density.	There	must	therefore	be	other	molecular	players	bridging	the	mechanical	stress	a	scribKD	cell	experiences	and	its	acute	 response	 to	 density.	 An	 interesting	 corollary	 emerging	 from	 this	 data	 is	 that	directional	 migration	 and	 density	 hypersensitivity	 of	 loser	 cells	 seem	 to	 be	 distinct	processes.	Consistently	with	this,	others	in	the	Piddini	lab	have	shown	that	scribKD	p53KO	cells	have	elevated	E-cadherin	levels	and	exhibit	contact-induced	migration,	but	are	not	mechanical	 losers	when	 co-cultured	with	wild-type	 cells	 (Wagstaff	 et	 al.	 2016).	 I	will	revisit	this	in	Chapters	V,	VI,	and	VIII.	
It	is	worth	noting	that	cells	overexpressing	E-cadherin	are	morphologically	very	similar	to	wild-type	cells	(Figure	II.I,	compare	unlabelled	E-cadOE	cells	and	RFP-labelled	wild-type	 cells)	 and	 do	 not	 flatten	 like	 scribKD	 cells	 As	 I	 will	 discuss	 in	 later	 chapters,	 cell	flattening	is	not	sufficient	for	directional	cell	migration	but	the	two	are	closely	linked	in	the	MDCK	experimental	system.	Whether	a	cell	is	flat	is	therefore	a	good	predictor	of	its	migratory	 behaviour:	 E-cadOE	 cells	 not	 flattening	 is	 consistent	 with	 these	 cells	 not	engaging	 in	 contact-induced	 migration.	 Flattening	 is	 less	 well	 correlated	 with	hypersensitivity	 to	 cell	 density	 (see	 Chapters	 VI	 and	 VIII),	 further	 indicating	 that	
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directional	 migration	 and	 mechanical	 loser	 status	 are	 most	 likely	 driven	 by	 distinct	factors.	
	 	
	 52 
	  
	 53 
Chapter III: N-cadherin is not sufficient for directional migration or mechanical 
loser cell status, but P-cadherin may be involved in driving both 
	Having	 established	 that	 E-cadherin	 elevation	 itself	 is	 not	 sufficient	 for	 directed	 cell	migration	or	 loser	status,	 I	 investigated	two	further	candidate	molecules	that	could	be	involved	in	these	processes:	N-cadherin	and	P-cadherin.	Just	like	E-cadherin,	both	N-	and	P-cadherin	are	classical	cadherins	and	have	been	implicated	in	collective	cell	migration,	generation	and	transmission	of	mechanical	forces,	and	polarisation	of	cells	towards	the	direction	 of	 migration	 (reviewed	 in	 Plutoni	 et	 al.	 2016).	 This	 made	 them	 attractive	candidate	 molecules	 that	 could	 potentially	 be	 involved	 in	 the	 migration	 and	 density	hypersensitivity	of	scribKD	cells.	
During	EMT,	when	epithelial	cells	acquire	a	more	motile,	mesenchymal	phenotype,	loss	of	E-cadherin	is	associated	with	increased	expression	of	N-cadherin:	this	is	termed	the	‘cadherin	 switch’.	 Homotypic	 N-cadherin	 junctions	 are	 less	 robust	 than	 E-cadherin	junctions	 and	 this	 promotes	 the	 migratory	 and	 invasive	 phenotypes	 (reviewed	 in	Theveneau	 &	 Mayor	 2012).	 What	 is	 more,	 N-cadherin	 induces	 contact	 inhibition	 of	locomotion	 behaviour	 in	 cells	 undergoing	 EMT,	 resulting	 in	 their	 repolarisation	 and	migration	away	from	the	cell	mass	(Scarpa	et	al.	2015).	In	MDCK	cells,	hepatocyte	growth	factor	 (HGF)	 has	 been	 shown	 to	 induce	 ‘cadherin	 switching’	 and	promote	 an	 invasive	phenotype	 in	 3D	 collagen	matrices.	 In	 this	 system,	 N-cadherin	 has	 been	 shown	 to	 be	required	for	cohesion	within	the	migrating	collective,	as	well	as	pro-migratory	signalling.	In	contrast,	N-cadherin	cell-cell	adhesions	are	 too	weak	and/or	 transient	on	a	stiff	2D	substrate,	so	HGF-treated	MDCKs	migrate	faster	but	as	single	cells	in	2D	(Shih	&	Yamada	2012).	 I	 therefore	 had	 reason	 to	 believe	 that	 N-cadherin	 may	 be	 involved	 in	 driving	contact-induced	migration	between	scribKD	and	wild-type	cells,	with	E-cadherin	perhaps	helping	 maintain	 the	 collective	 nature	 of	 the	 migration	 on	 the	 stiff	 glass	 and	 plastic	substrates	used	to	culture	the	cells.	
N-cadherin	expression	has	been	associated	with	numerous	hallmarks	of	cancer,	including	increased	 proliferation,	 metastasis,	 an	 invasive	 phenotype,	 and	 resistance	 to	chemotherapy.	N-cadherin	expression	also	correlates	with	poor	cancer	patient	prognosis	(reviewed	in	Yan	et	al.	2015).	However,	many	tumours	classed	as	invasive	do	not	undergo	
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a	 full	 EMT	 switch	 and	 maintain	 some	 E-cadherin	 expression.	 In	 fact,	 many	 highly	aggressive	 breast	 cancers	 have	 a	 wild-type	 pattern	 of	 E-cadherin	 expression	 but	simultaneously	 express	 abnormally	 high	 levels	 of	 P-cadherin.	 Overexpression	 of	 P-cadherin,	 alongside	wild-type	E-cadherin	 levels,	 has	been	 shown	 to	promote	 invasion,	motility,	and	migration	of	MCF-7	breast	cancer	cells	(Ribeiro	et	al.	2010).	Moreover,	RNA	sequencing	experiments	comparing	transcripts	from	homotypic	cultures	of	wild-type	and	
scribKD	 cells	 showed	 that	 the	 latter	 express	 slightly	 more	 P-cadherin	 (Wagstaff	 et	 al.	2016),	 suggesting	 a	 similar	mechanism	may	 be	 involved	 in	 the	 directed	migration	 of	
scribKD	cells.	
Please	note	 that	 the	experiments	 I	describe	 in	 this	section	are	not	exhaustive	and	of	a	preliminary	nature.	I	include	them	because	they	provide	interesting	leads	to	follow	up	in	the	future.	
	
N-cadherin elevation is not sufficient for directional migration or loser status 
Consistent	with	observations	that	elevated	N-cadherin	is	correlated	with	a	more	motile,	mesenchymal	 phenotype	 (like	 that	 of	 scribKD	 cells),	 I	 found	 that	 inducing	 scribble	knockdown	with	TET	resulted	in	the	upregulation	of	N-cadherin	expression,	as	visualised	by	Western	blotting	of	whole	cell	 lysates	(Figure	III.1A).	In	fact,	scribKD	cells	expressed	more	 N-cadherin	 than	 wild-type	 MDCKs,	 as	 I	 show	 by	 immunofluorescence	 (Figure	III.1B).	This	was	very	reminiscent	of	the	E-cadherin	gradient	between	scribKD	and	wild-type	cells.	I	therefore	decided	to	test	whether	N-cadherin	upregulation	also	played	a	role	in	contact-induced	migration	and	mechanical	loser	status	in	MDCKs.	
To	address	this,	I	used	MDCK	cDNA	as	a	template	to	amplify	canine	N-cadherin	and	cloned	it	into	the	DOX-inducible	pTRIPZ	RFP-NLS	vector,	as	I	had	done	for	E-cadherin	(Appendix	2C).	I	used	the	resulting	lentiviral	construct	to	transduce	unlabelled,	wild-type	cells	and	isolated	a	single	clone	that	overexpressed	N-cadherin	(N-cadOE)	to	levels	above	those	of	
scribKD	cells	(Figure	III.1C).	Similarly	to	E-cadOE	cells,	N-cadOE	cells	retained	a	wild-type	morphology	and	did	not	flatten	(Figure	III.1D,	compare	unlabelled	N-cadOE	cells	and	GFP-labelled	wild-type	cells).	I	juxtaposed	N-cadOE	cells	with	wild-type	cells	and	showed	that	there	was	 no	 directed	 cell	 migration,	 as	 would	 be	 predicted	 by	 the	 lack	 of	 flattening		 	
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(Figure	III.1E,	first	two	panels).	At	the	end	of	each	migration	experiment,	I	also	verified	that	the	N-cadherin	levels	of	imaged	N-cadOE	cells	were	higher	than	those	of	surrounding	wild-type	 cells	 (Figure	 III.1E,	 last	 two	 panels).	 An	 N-cadherin	 gradient	 between	 two	MDCK	populations	is	therefore	not	sufficient	to	drive	contact-induced	migration.	
To	 test	 the	 involvement	of	N-cadherin	 in	 the	mechanical	 loser	 status,	 I	 co-cultured	N-cadOE	 cells	 and	 wild-type	 cells	 expressing	 nuclear	 GFP	 until	 the	 cultures	 reached	densities	at	which	scribKD	cells	would	have	been	eliminated.	Even	at	such	high	densities,	N-cadOE	cells	remained	in	the	monolayer	and	looked	non-compacted	and	healthy,	 just	like	the	surrounding	wild-type	cells	(Figure	III.1F,	N-cadOE	clones	are	labelled	in	white	dashed	 lines).	 Due	 to	 the	 heterogeneous	 nature	 of	 GFP	 expression	 in	 the	 wild-type	population,	it	was	sometimes	difficult	to	identify	the	unlabelled	N-cadOE	clones	at	the	end	of	the	experiment,	but	there	was	little	to	no	cell	death	and	no	active	clone	compaction	throughout	 the	 movies.	 I	 am	 therefore	 confident	 in	 concluding	 that	 N-cadherin	overexpression	is	not	sufficient	to	drive	the	mechanical	loser	phenotype.	
Taken	together,	I	have	shown	that	increased	N-cadherin	expression	alone	is	not	sufficient	to	drive	contact-induced	migration	or	confer	the	mechanical	loser	status	on	cells.	
	
Elevated P-cadherin levels may be necessary for contact-induced migration and loser cell 
status 
I	next	investigated	the	role	of	P-cadherin	in	directional	migration	and	mechanical	loser	status.	 The	 experiments	 described	 in	 this	 section	 are	 preliminary	 in	 nature,	 so	 any	conclusions	must	be	drawn	with	caution.	
I	used	a	cDNA	 library	 from	scribKD	 cells,	which	 transcriptionally	elevate	P-cadherin,	 to	amplify	P-cadherin	cDNA.	As	before,	 I	cloned	the	cDNA	into	the	DOX-inducible	pTRIPZ	RFP-NLS	overexpression	vector	(Appendix	2D)	and	transduced	unlabelled	wild-type	cells	with	 the	 resulting	 lentivirus.	 I	 then	 generated	 a	 pool	 population	 overexpressing	 P-cadherin	 (P-cadOE)	 using	 puromycin;	 I	 used	 this	 P-cadOE	 pool	 in	 all	 subsequent	experiments.	The	pool	nature	of	the	P-cadOE	cells	is	an	important	consideration,	as	will	become	apparent	below.	 	
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Figure	 III.1:	 N-cadherin	 is	 elevated	 in	 scribKD	 cells	 but	 is	 not	 sufficient	 to	 trigger	 directional	
migration	or	confer	the	mechanical	loser	status.	(A)	Western	blot	against	N-cadherin	in	scribKD	cells	in	the	 presence	 or	 absence	 of	 tetracycline	 (TET).	 β-tubulin	 was	 used	 as	 a	 loading	 control.	(B)	Immunofluorescence	against	N-cadherin	of	co-cultures	of	unlabelled	wild-type	cells	and	GFP-labelled	
scribKD	 cells.	 (C)	 Immunofluorescence	against	N-cadherin	of	co-cultures	of	GFP-labelled	scribKD	 cells	and	wild-type	cells	overexpressing	N-cadherin	(N-cadOE).	(D)	2x	zoom	of	second	panel	in	(E)	demonstrating	that	 N-cadOE	 cells	 (unlabelled)	 are	 not	 significantly	 flatter	 than	 wild-type	 cells	 (GFP-labelled).	(E)	Directional	migration	does	not	occur	between	GFP-labelled	wild-type	cells	and	unlabelled	N-cadOE	cells	(left	two	panels).	White	dashed	line	marks	initial	contact	point;	black	dashed	line	marks	final	contact	point.	N-cadherin	immunofluorescence	at	the	end	of	live	imaging	(right	two	panels)	confirms	elevated	N-cadherin	levels	 in	 N-cadOE	 cells.	 (F)	 Clones	 of	 unlabelled	 N-cadOE	 cells	 (white	 dashed	 lines)	 do	 not	 display	mechanical	loser	features	in	co-culture	with	GFP-labelled	wild-type	cells.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
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While	performing	single	clone	selections	of	E-cadOE	and	N-cad	OE	lines,	I	had	noticed	that	there	was	a	lot	of	variability	in	construct	expression	in	the	parent	pools,	with	some	cells	barely	expressing	any	protein	of	 interest	(data	not	shown).	Cadherins	are	 large,	multi-domain	proteins,	and	increasing	construct	size	has	been	correlated	with	lower	lentiviral	titres	(Kumar	et	al.	2001).	I	therefore	generated	clonal	populations	from	E-cadOE	and	N-cadOE	 to	 avoid	 heterogeneity	 of	 expression	 resulting	 from	 low	 titre	 lentiviruses.	Unfortunately,	 I	 did	 not	 generate	 a	 clonal	 population	 of	 P-cadOE	 cells	 due	 to	 time	constraints.	It	was	therefore	not	surprising	that	I	observed	a	mixed	response	to	DOX	in	the	 P-cadOE	 pool:	 many	 cells	 remained	 morphologically	 wild-type	 but	 some	 clones	flattened	in	a	way	similar	to	scribKD	cells	(Figure	III.2A	and	B,	blue	and	yellow	arrows,	respectively).	It	remains	to	be	confirmed	whether	cell	flattening	within	the	P-cadOE	pool	corresponds	 to	 higher	 P-cadherin	 expression,	 which	 could	 be	 established	 by	immunofluorescence.	
Interestingly,	in	co-cultures	of	P-cadOE	cells	and	wild-type	cells	expressing	nuclear	GFP,	flat	P-cadOE	cells	exhibited	directional	migration	(Figure	III.2C).	In	fact,	flat	P-cadOE	cells	also	showed	indications	of	density	hypersensitivity:	P-cadOE	cells	trapped	between	two	wild-type	clones	died,	suggesting	they	may	not	be	able	to	tolerate	high	local	cell	density	(Figure	 III.2C,	 yellow	 arrows	 indicate	 death	 events).	 Flattening	 of	 P-cadOE	 cells	 was	infrequent	 and	 the	 cells	 were	 quickly	 dispersed	 through	 activation	 of	 the	 migratory	response,	so	I	could	not	observe	whether	larger	P-cadOE	clones	were	in	fact	compacted	and	eliminated	at	higher	densities.	
Considering	 the	 incomplete	 nature	 of	 these	 experiments,	 I	 tentatively	 propose	 that	elevated	P-cadherin	is	most	likely	sufficient	to	induce	directed	migration.	High	P-cadherin	may	also	confer	lower	homeostatic	density	and	density	hypersensitivity	on	cells,	both	of	which	are	hallmarks	of	mechanical	losers.	
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Figure	III.2:	P-cadherin	overexpression	flattens	a	subpopulation	of	cells	and	may	be	sufficient	for	
directional	 migration	 and	mechanical	 loser	 status.	 (A-B)	 Movie	 stills	 of	 MDCKs	 overexpressing	 P-cadherin	in	a	DOX-inducible	manner	(P-cadOE)	in	the	absence	(A)	or	presence	(B)	of	DOX.	Flattened	cells	are	indicated	with	the	yellow	arrow;	cells	with	standard	epithelial	morphology	are	indicated	with	the	blue	arrow.	(C)	Movie	stills	of	co-cultures	of	GFP-labelled	wild-type	cells	and	unlabelled	P-cadOE	cells.	The	flat	P-cadOE	 clone	 is	 trapped	 between	 two	 wild-type	 clones	 that	 appear	 to	 corral	 it	 into	 a	 high	 density	configuration	that	it	cannot	tolerate	(death	events	are	marked	with	the	yellow	arrows).	White	dashed	lines	mark	the	initial	contact	point;	black	dashed	lines	mark	the	final	contact	point.	
Scale	bars	=	100	μm.	
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Discussion: the cadherin conundrum 
I	have	shown	that	elevated	N-cadherin	is	not	sufficient	for	either	directed	cell	migration	or	mechanical	loser	status	during	scribble	competition.	The	requirement	of	N-cadherin	in	these	processes	was	not	investigated	in	the	scope	of	this	thesis.	Addressing	this	would	require	 the	generation	of	an	N-cadherin	and	scribble	double	knockdown/knockout	cell	line.	
I	 also	provide	preliminary	 evidence	 that	 P-cadherin	upregulation	may	be	 sufficient	 to	both	 drive	 directional	 migration	 and	 confer	 the	 mechanical	 loser	 status	 on	 cells.	Interestingly,	P-cadherin	overexpression	has	been	shown	to	induce	flattening	and	a	more	motile	 phenotype	 in	 pancreatic	 ductal	 adenocarcinoma	 cells	 (Taniuchi	 et	 al.	 2005),	supporting	my	preliminary	findings.	To	further	substantiate	my	observations,	the	priority	would	 be	 to	 isolate	 a	 monoclonal	 P-cadOE	 population,	 verify	 its	 uniform	 P-cadherin	overexpression,	and	determine	whether	high	P-cadherin	correlates	with	cell	flattening.	This	would	allow	one	to	repeat	and	expand	on	my	experiments	with	a	 ‘clean’	P-cadOE	population.	If	my	conclusions	hold	true,	one	could	then	generate	P-cadherin	and	scribble	double	 knockdown/knockout	 lines	 to	 test	 the	 requirement	 of	 elevated	 P-cadherin	 in	
scribKD	cell	migration	and	mechanical	loser	status.	
Based	 on	 observations	 and	 findings	 described	 so	 far	 and	 in	 subsequent	 chapters,	 I	hypothesise	 that	cells	engaging	 in	directed	migration	activate	a	plethora	of	potentially	interlinked	factors	that	constitute	a	‘migratory	signature’.	Most	if	not	all	of	these	factors	are	 essential	 for	 directed	migration,	 but	 are	 not	 sufficient	 to	 drive	 it	 on	 their	 own.	 I	propose	 that	 E-	 and	 N-cadherin	 are	 part	 of	 this	 molecular	 signature.	 Please	 refer	 to	Chapter	VI	where	I	discuss	the	migratory	signature	in	light	of	data	I	describe	in	the	rest	of	this	thesis.	
P-cadherin	seems	to	play	a	more	instructive	role	in	the	migratory	signature,	but	I	can	only	speculate	 on	 it	 based	 on	 the	 evidence	 presented:	 P-cadherin	 may	 activate	 a	 positive	feedback	 loop	 that	 leads	 to	 the	 expression	 of	 other	 components	 of	 the	 migratory	signature,	or	 lies	upstream	of	the	whole	signature,	or	drives	migration	in	a	completely	independent	way.	While	beyond	the	scope	of	this	thesis,	there	are	several	key	questions	that	 it	 would	 be	 important	 to	 tackle.	 Does	 P-cadherin	 overexpression	 upregulate	 E-cadherin,	which	I	have	shown	is	necessary	for	the	directed	migration,	or	vice	versa?	Are	
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elevated	P-	and	N-cadherin	 in	scribKD	cells	necessary	for	contact-induced	migration?	Is	boosting	 E-,	 N-,	 or	 P-cadherin	 (alone	 or	 in	 combination)	 in	wild-type	 cells	 enough	 to	‘flatten’	the	cadherin	gradient	and	stop	migration	towards	scribKD	cells?	
The	cadherin	expression	pattern	 in	 scribKD	cells	does	not	 reflect	 the	 classical	 cadherin	switch	where	E-cadherin	expression	is	lost	in	favour	of	N-cadherin	to	drive	a	migratory	phenotype.	 scribKD	 cells	 express	 elevated	 levels	 of	 all	 three	 cadherins,	 E-,	 N-,	 and	 P-cadherin.	On	the	other	hand,	wild-type	MDCKs	express	very	low	levels	of	 junctional	N-cadherin	(Figure	III.1B	and	Shih	&	Yamada	2012),	while	E-	and	P-cadherin	are	expressed	at	a	roughly	equimolar	ratio	at	levels	higher	than	N-cadherin	(Wu	et	al.	1993).	Because	of	this,	 there	 is	a	gradient	of	all	 three	cadherins	between	scribKD	and	wild-type	cells.	The	cadherin	 gradient	 may	 therefore	 be	 part	 of	 a	 symmetry	 breaking	 cue	 to	 direct	 the	migration	of	scribKD	cells	away	from	the	wild-type	population	(or	wild-type	cells	towards	
scribKD	cells),	as	well	as	conferring	a	more	motile	phenotype	on	the	former.	In	fact,	I	have	discussed	 an	 example	where	E-	 and	P-cadherin	 co-expression	 is	 sufficient	 to	 drive	 an	invasive	phenotype	 in	breast	cancer	cells	(Ribeiro	et	al.	2010).	 In	addition,	N-cadherin	overexpression	 in	 the	 BT-20	 breast	 cancer	 cell	 line	 that	 maintains	 high	 E-cadherin	expression	is	sufficient	to	drive	a	more	motile,	invasive	phenotype	(Nieman	et	al.	1999).	A	similar	non-EMT	mechanism	could	therefore	be	responsible	for	directed	cell	migration	in	scribble	competition.	
The	role	of	cadherins	in	the	mechanical	loser	status	appears	less	convoluted,	but	I	must	first	express	a	word	of	caution.	While	my	observations	from	competition	assays	are	valid,	it	 would	 be	 advisable	 to	 formally	 test	 whether	 N-cadOE	 and	 E-cadOE	 cells	 are	 not	mechanical	losers	and	that	P-cadOE	cells	are.	This	could	be	done	by	compacting	the	cells	in	the	absence	of	competition	using	a	 ‘stretcher	assay’,	where	cells	are	plated	either	at	confluence	or	at	a	low	density	on	a	stretched	PDMS	membrane.	The	membrane	stretch	is	then	released,	mechanically	compacting	the	confluent	cells	(experimental	condition),	but	not	significantly	affecting	the	cells	at	lower	density	(control	condition)	(Eisenhoffer	et	al.	2012;	Wagstaff	et	al.	2016).	A	density-dependent	increase	in	cleaved	caspase-3	staining	above	wild-type	 levels	 indicates	 a	 hypersensitivity	 to	 density	 that	 is	 characteristic	 of	mechanical	losers.	That	said,	overexpression	of	neither	N-	nor	E-cadherin	resulted	in	cell	flattening,	 another	 feature	of	mechanical	 losers.	As	 I	have	discussed,	 scribKD	cells	 (and	potentially	P-cadOE	cells)	have	a	lower	homeostatic	density,	which	contributes	to	their	mechanical	 loser	 status.	Based	on	 this,	 I	would	 therefore	predict	 that	E-cadOE	and	N-
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cadOE	cells	are	not	hypersensitive	to	density,	even	in	a	stretcher	assay,	but	that	P-cadOE	cells	may	be.	
The	 molecular	 details	 of	 how	 P-cadherin	 may	 be	 conferring	 density	 hypersensitivity	should	 only	 be	 investigated	 if	 my	 preliminary	 findings	 can	 be	 confirmed	 using	 a	monoclonal	P-cadOE	population	 in	 the	 stretcher	assay.	One	way	 to	 shortlist	 candidate	molecules	would	be	to	compare	targets	regulated	either	only	by	P-cadherin	activity	(and	not	E-	or	N-cadherin)	or	those	affected	by	P-cadherin	in	a	uniquely	identifiable	way	(e.g.	P-cadherin	 engagement	 results	 in	 the	 phosphorylation	 of	 a	 target	 at	 a	 site	 that	 is	 not	phosphorylated	as	a	result	of	E-	or	N-cadherin	activity).	It	should	be	possible	to	achieve	this	by	using	mass	spectrometry	to	compare	the	proteomes	of	MDCKs	lines	individually	silenced/knocked-out	for	E-,	N-,	and	P-cadherin.	
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Chapter IV: p53-mediated competition shares molecular features of scribble 
competition 
	In	the	second	part	of	my	thesis	(Chapter	IV),	I	test	whether	the	signalling	cascade	leading	to	 scribKD	 cell	 elimination	 upon	 compaction	 is	 also	 conserved	 in	 mechanical	 losers	generated	through	p53	activation	alone.	
In	 the	scribble	competition	system,	 losers	have	elevated	p53	even	prior	 to	 the	start	of	competition.	 Compaction-mediated	 ROCK	 activation	 triggers	 phosphorylation	 of	 the	stress	kinase	p38	at	T180	and	Y182	(P-p38),	which	boosts	p53	 levels	 further	still	and	ultimately	leads	to	scribKD	cell	death	through	induction	of	apoptosis.	Importantly,	a	p53	imbalance	 between	 losers	 (high	 p53)	 and	winners	 (low	 p53)	 is	 sufficient	 to	 replicate	mechanical	cell	competition.	Experimentally,	this	is	done	by	mildly	elevating	p53	in	wild-type	cells	using	sub-lethal	doses	of	Nutlin	and	juxtaposing	them	with	p53KO	cells,	which	are	unresponsive	to	Nutlin	and	maintain	minimal	p53	levels	(Wagstaff	et	al.	2016).	
It	 is	 clear	 that	 sub-lethal	 Nutlin	 treatment	 of	 wild-type	 cells	 replicates	 most	 of	 the	phenotypic	 features	 of	 scribKD	 mechanical	 losers:	 Nutlin-treated	 cells	 flatten,	 their	homeostatic	density	 is	 lowered,	and	 they	display	density	hypersensitivity.	However,	 it	remained	 unaddressed	 whether	 the	 molecular	 cascade	 leading	 to	 loser	 cell	outcompetition	was	conserved	between	 the	 two	mechanical	 competition	systems.	 It	 is	important	 to	establish	how	similar	 scribKD-	and	p53-mediated	 competition	models	 are	because	 p53-mediated	 competition	 is,	 arguably,	 more	 broadly	 relevant	 from	 both	 a	physiological	and	a	clinical	perspective.	For	 instance,	mechanical	cell	competition	may	lead	to	the	elimination	of	cells	with	activated	p53	as	a	result	of	injury	or	other	cellular	stress	in	vivo:	exogenously	boosting	competition	could	therefore	promote	tissue	fitness	following	 damage.	 Moreover,	 cells	 lacking	 functional	 p53	 (p53KO)	 are	 insensitive	 to	mechanical	competition,	suggesting	p53	loss	in	cancer	is	permissive	for	tumourigenesis,	as	 potentially	 malignant	 cells	 escape	 elimination.	 In	 this	 case,	 reactivating	 signalling	pathways	responsible	for	the	mechanical	loser	status	in	p53KO	cells,	and	hence	bypassing	the	requirement	for	p53,	could	offer	a	potential	therapeutic	approach.	
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I	 therefore	 investigated	 if	 key	 findings	 from	 the	 scribble	 competition	 system	 are	 also	conserved	in	p53-mediated	competition.	If	they	are,	I	would	argue	that	future	work	on	characterising	 mechanical	 cell	 competition	 should	 mostly	 focus	 on	 the	 p53-mediated	system,	as	it	is	free	of	any	competition-independent	effects	of	scribble	knockdown.	That	said,	p53	itself	is	a	master	regulator	of	many	cellular	processes	and	may	therefore	confer	its	own	set	of	competition-independent	phenotypes,	so	any	conclusions	should	still	be	drawn	with	appropriate	caution.	
	
The ROCK – p38 – p53 signalling pathway is activated in p53-mediated mechanical losers 
To	determine	whether	the	ROCK	–	p38	–	p53	signalling	cascade	is	conserved	in	p53-based	competition,	 I	 quantified	 the	 nuclear	 p53	 signal	 intensity	 of	 each	 cell	 within	 a	 pure	population	of	wild-type	cells	treated	with	a	sub-lethal	dose	of	Nutlin,	where	the	cells	could	reach	 their	 low	homeostatic	density	 (Figure	 IV.A).	 I	 compared	 these	p53	 intensities	 to	those	recorded	for	wild-type	clones	in	a	competing	co-culture:	p53KO	cells	versus	wild-type	 in	 the	 presence	 of	 the	 same	 dose	 of	 Nutlin	 as	 homotypic	 cultures.	 I	 found	 that	competing	 wild-type	 cells	 appeared	more	 compacted	 than	 in	 a	monoculture	 and	 had	significantly	elevated	levels	of	p53	(Figure	IV.B	and	C).	This	indicated	that	the	initial	p53	elevation	as	a	 result	of	Nutlin	 treatment	 is	 further	boosted	 in	 response	 to	compaction	during	competition.	
In	the	scribble	competition	system,	phosphorylation	(activation)	of	p38	lies	upstream	of	compaction-dependent	p53	elevation	(Wagstaff	et	al.	2016).	I	therefore	used	an	antibody	against	phosphorylated	p38	to	compare	the	nuclear	P-p38	intensities	of	Nutlin-treated	homotypic	 wild-type	 cultures	 and	 compacted	 wild-type	 cells	 in	 a	 p53-mediated	competition	scenario.	 I	 found	that	P-p38	 levels	were	significantly	higher	 in	compacted	wild-type	 cells	 during	 competition	 (Figure	 IV.D-F).	 While	 these	 experiments	 do	 not	demonstrate	that	phosphorylation	of	p38	is	upstream	of	p53	activation,	Nutlin-treated	wild-type	cells	exhibit	compaction-dependent	elevation	of	both	p53	and	P-p38,	mirroring	the	 scribble	 competition	 system.	 I	 therefore	 propose	 that	 it	 is	 highly	 likely	 that	 the	directional	P-p38	->	p53	interaction	is	also	conserved	in	the	Nutlin	competition	system.	
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Figure	 IV:	 The	 molecular	 hallmarks	 of	 scribble	 competition	 are	 conserved	 in	 p53-mediated	
competition.	(A-B)	Immunofluorescence	images	(sum	projections	in	z)	showing	p53	levels	of	wild-type	cells	treated	with	a	sub-lethal	dose	of	Nutlin-3	in	a	monoculture	(A)	and	in	a	competing	co-culture	with	
p53KO	cells	(B).	The	GFP-labelled	WT	clone	is	outlined	by	the	white	dashed	line	here	and	in	(E),	(G),	(H),	and	(K).	(C)	Quantification	of	single-cell	nuclear	p53	intensities	from	a	single	representative	experiment	as	in	(A-B).	Here	and	in	(F)	and	(I):	black	bars	represent	the	median,	p	values	were	calculated	using	the	K-S	test,	and	n	=	number	of	nuclei.	(D-F)	Same	as	(A-C)	but	for	phosphorylated	p38	(P-p38)	levels.	(G-H)	P-p38	levels	in	wild-type	cells	under	competing	conditions	(G)	are	higher	than	in	competing	co-cultures	treated	with	ROCK	inhibitor	Y27632	(H).	 (I)	Quantification	of	single-cell	nuclear	P-p38	 intensities	 from	a	single	representative	experiment	as	in	(G-H).	(J-K)	Single	immunofluorescence	section	showing	phosphorylated	
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MYPT1	(pMYPT1)	levels	of	Nutlin-3-treated	wild-type	cells	grown	as	a	monoculture	(J)	and	in	competing	conditions	(K).	
Scale	bars	=	50	μm.	
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To	 test	whether	ROCK	 is	 activated	 in	 compacted	wild-type	 cells	 during	 p53-mediated	competition	 and,	 if	 so,	 lies	 upstream	 of	 P-p38,	 I	 used	 a	 chemical	 inhibitor	 of	 ROCK	(Y27632).	 I	 treated	 competing	 co-cultures	 of	 wild-type	 and	 p53KO	 cells	 with	 ROCK	inhibitor	or	 the	 solvent	 (DMSO)	and	measured	 the	nuclear	P-p38	 signal	of	 compacted	wild-type	 cells.	 I	 found	 that	 compaction-induced	 elevation	 of	 nuclear	 P-p38	 was	significantly	 reduced	 upon	 ROCK	 inhibitor	 treatment	 (Figure	 IV.G-I).	 Moreover,	 I	immunostained	compacted	wild-type	losers	during	Nutlin	competition	against	Thr853-phosphorylated	myosin	phosphatase	target	subunit	1	(pMYPT1),	a	regulatory	subunit	of	myosin	phosphatase	phosphorylated	by	ROCK	specifically	at	this	residue	(Khromov	et	al.	2009;	Qiao	et	al.	2014).	pMYPT1	levels	therefore	provide	an	indirect	but	specific	readout	of	ROCK	activity:	I	showed	that	compacted	wild-type	losers	have	elevated	pMYPT1,	and	hence	more	ROCK	activity,	compared	to	the	surrounding	p53KO	winners	(Figure	IV.J-K).	
Taken	 together,	 these	 findings	 indicate	 that	 p53-mediated	 competition	 in	MDCK	 cells	shares	 the	 key	molecular	 hallmarks	 of	 scribble	 competition.	 Upon	 confrontation	 with	
p53KO	winners,	ROCK	activity	is	detectably	boosted	in	Nutlin-generated	losers,	as	are	the	downstream	signalling	components	P-p38	and	p53.	
	
Discussion 
The	data	I	describe	in	this	chapter	strongly	support	the	hypothesis	that	the	ROCK	–	p38	–	p53	pathway	responsible	for	the	acute	response	of	mechanical	losers	upon	compaction	is	conserved	between	scribKD-	and	Nutlin-induced	competition.	 I	have	shown	that	Nutlin-treated	wild-type	cells	elevate	nuclear	p53	and	P-p38	following	compaction	in	competing	cultures.	I	have	also	shown	that	ROCK	activity	is	increased	in	compacted	Nutlin-generated	losers	 and	 is	 required	 for	 and	 likely	 upstream	 of	 p38	 phosphorylation.	 If	 these	 key	milestones	are	conserved	 in	the	Nutlin-based	competition	system,	 I	believe	 it	 is	highly	likely	that	so	is	the	rest	of	the	cascade	described	in	the	scribKD-mediated	system.	Namely,	that	elevated	P-p38	results	 in	 increased	p53	and	 that	compaction	 itself	 is	 sufficient	 to	increase	ROCK,	P-p38,	and	p53.	
What	my	experiments	do	not	formally	demonstrate	is	the	connection	between	P-p38	and	p53	 or	 its	 directionality.	 This	 could	 be	 addressed	 by	measuring	 nuclear	 p53	 levels	 of		 	
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Nutlin-treated	wild-type	cells	following	compaction	and	p38	inhibitor	treatment	or	the	introduction	of	the	catalytically	inactive	p38K53N	allele	(Wang	et	al.	1998).	Following	this,	it	would	be	worthwhile	testing	that	compaction	itself	is	responsible	for	elevation	of	ROCK,	P-p38,	 and	 p53	 in	 Nutlin-generated	 losers	 by	 compacting	 the	 cells	 in	 the	 absence	 of	competition	using	the	stretcher	system.	Considering	the	vast	similarities	between	scribKD-	and	 Nutlin-mediated	 losers,	 I	 suggest	 that	 the	 whole	 compaction-activated	 signalling	cascade	is	likely	conserved	in	the	latter.	
It	is	interesting	to	note	that	increased	ROCK	activity	(and	the	resultant	MYPT	inactivation)	in	 loser	 cells	may	 also	 have	 a	more	 direct,	mechanical	 effect	 on	 competition.	 Broadly	speaking,	 ROCK	 promotes	 cellular	 contractility	 (reviewed	 in	 Amano	 et	 al.	 2010).	Increased	ROCK	signalling	in	response	to	p53	activation	could	therefore	mean	that	loser	cells	 contribute	 to	 their	 own	 elimination	 by	 ‘self-compacting’.	 The	 forces	 generated	during	 this	 ‘self-compaction’	 may	 be	 interpreted	 by	 a	 loser	 cell	 as	 surrounding	 cells	pushing	 inwards	 on	 its	 membrane	 in	 a	 crowded	 tissue.	 This	 could	 help	 explain	 why	mechanical	losers	have	such	an	acute	response	to	seemingly	normal	cell	densities:	loser	cells	may	perceive	densities	to	be	higher	than	they	are.	
Further	 research	 should	 focus	 on	 understanding	 how	 mechanical	 compaction	 is	translated	into	ROCK	activation	and	how	p53	confers	density	hypersensitivity.	It	would	also	be	of	great	interest	to	test	whether	elevated	p53	is	also	responsible	for	mechanical	cell	competition	in	vivo.	It	is	easy	to	envisage	how	imbalances	in	p53	expression	might	occur	in	tissues	e.g.	as	a	result	of	stress,	injury,	or	mutation	in	a	subset	of	cells.	If	changes	in	 p53	 expression	 are	 sufficient	 to	 determine	whether	 a	 cell	 is	 eliminated	 or	 gains	 a	competitive	 advantage	 also	 in	 vivo,	 manipulation	 of	 this	 process	 may	 be	 of	 great	therapeutic	relevance.	In	theory,	p53-mediated	competition	could	be	boosted	to	promote	endogenous	 clearance	 of	 damaged	 cells,	 or	 reactivated	 in	 malignant	 cells	 escaping	mechanical	elimination.	
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Chapter V: p53 drives leader cell migration 
	In	the	third	and	final	part	of	my	thesis	(Chapters	V	to	VIII),	I	 investigate	the	molecular	mechanisms	underlying	the	directional	migration	between	scribKD	and	wild-type	cells.	I	draw	molecular	parallels	between	migration	occurring	during	competition	and	leader	cell	migration	in	wound	healing.	I	also	re-discuss	data	from	Chapters	II	and	III	regarding	the	determinants	of	contact-induced	migration	in	light	of	these	new	findings.	
While	live	imaging	untreated,	sub-confluent	cultures	of	wild-type	MDCKs,	Laura	Wagstaff	in	the	Piddini	lab	noticed	the	spontaneous	emergence	of	cells	with	a	distinctive,	flattened	morphology	(Figure	V.1A,	yellow	arrows).	Laura	noticed	that	these	flattened	cells	were	more	motile	than	the	surrounding	wild-type	cells	with	standard,	epithelial	morphology,	but	their	movement	lacked	directionality.	Following	contact	between	these	flat	cells	and	cells	with	classical,	epithelial	morphology,	the	flat	cells’	migration	acquired	directionality.	These	flat	cells	would	then	lead	the	collective	migration	of	the	entire	colony	(Figure	V.1A)	in	 a	 behaviour	 reminiscent	 of	 contact-induced	 migration	 previously	 described	 for	interactions	between	scribKD	and	wild-type	cells	(Figure	I.8A).	In	fact,	the	supra-cellular	finger-like	structures	formed	as	migration	progressed,	with	the	leader	cell	at	the	tip	and	other	cells	following	it,	were	also	remarkably	similar	to	leader	cell	migration	in	a	wound	healing	context	(Poujade	et	al.	2007).	As	discussed,	little	is	known	about	the	mechanisms	that	allow	leader	cells	to	emerge	from	a	seemingly	homotypic	culture.	Considering	how	leader-like	these	flat	cells	were,	I	hypothesised	that	characterising	them	could	offer	an	orthogonal	strategy	to	study	not	only	directed	migration	in	scribble	competition,	but	also	wound-induced	 leader	 cell	 migration,	 which	 would	 make	 any	 findings	 more	therapeutically	relevant.	
	
Spontaneous leaders in MDCK cultures have elevated p53 
I	 first	 asked	 how	 pervasive	 the	migration	 of	 spontaneously	 emerging	 flat	 cells	was.	 I	plated	untreated,	wild-type	cells	and	imaged	them	over	several	days.	When	I	analysed	the	behaviour	of	112	 spontaneously	emerging	 flat	 cells,	 I	 found	 that	 around	90%	of	 them		 	
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showed	leader	behaviour	(Figures	V.1A	and	B).	I	will	refer	to	these	cells	as	‘spontaneous	leaders’,	as	they	emerge	in	the	absence	of	external	stimuli	like	wounding.	Laura	Wagstaff	also	noticed	that	spontaneous	leaders	often	had	two	or	even	more	nuclei:	I	confirmed	this	observation	by	live	imaging	wild-type	cells	expressing	nuclear	GFP.	Spontaneous	leaders	did	in	fact	tend	to	have	multiple	nuclei	(Figure	V.1C),	although	this	was	not	always	the	case.	 The	 ‘tetraploidy	 checkpoint’	 triggered	 upon	 cytokinesis	 failure	 and	 subsequent	binucleation	 has	 been	 shown	 to	 induce	 cell	 cycle	 arrest	 in	 a	 p53-dependent	 manner	(Andreassen	et	al.	2001),	so	I	next	tested	whether	spontaneous	leaders	continue	dividing	after	they	emerge.	During	the	timeframe	of	my	movies	(≥48	hours),	almost	all	(97.5%)	of	the	89	spontaneous	leaders	I	analysed	did	not	divide,	while	the	surrounding	cells	with	standard	epithelial	morphology	did	(Figure	V.1D).	This	implied	that	spontaneous	leaders	might	activate	p53	signalling.	
To	assess	the	p53	status	of	spontaneous	leaders,	I	seeded	wild-type	MDCKs	in	optically	clear,	 gridded	 cell	 culture	 dishes	 that	 allowed	 me	 to	 identify	 and	 track	 spontaneous	leaders	during	live	imaging	and	locate	them	again	on	a	confocal	microscope	after	fixation	and	staining.	Following	anti-p53	immunofluorescence,	I	quantified	the	nuclear	p53	signal	intensity	of	spontaneous	leaders	and	showed	that	they	tend	to	have	higher	nuclear	p53	levels	than	neighbouring	non-leader	cells	(Figure	V.1E	and	F).	I	next	asked	if	p53	activity	played	an	active	role	in	driving	the	migration	of	leader	cells.	
	
p53 activation is sufficient and necessary for leader cell migration 
Considering	that	spontaneous	leaders	elevate	p53,	I	asked	whether	p53	activation	itself	is	 sufficient	 to	 generate	 leader	 cells.	 I	 did	 this	by	 establishing	an	assay	 to	 irreversibly	activate	p53	 in	one	cell	population	and	confront	 it	with	another	untreated,	genetically	similar	population.	More	specifically,	I	used	mitomycin	C	(MMC)	to	induce	DNA	damage	in	a	wild-type	population	expressing	nuclear	GFP;	MMC	crosslinks	complementary	DNA	strands,	so	the	damage	is	irreversible	(Tomasz	1995).	I	then	seeded	the	MMC-treated	cells	in	tissue	culture	dishes	containing	unlabelled,	wild-type	cells	seeded	a	day	earlier	(Figure	V.2A).	 This	 approach	 both	 prevented	 MMC	 carryover	 and	 generated	 larger	 clones	 of	untreated	 cells	 to	 better	 visualise	 any	 leader-follower	 behaviour.	 As	 expected,	 DNA		 	
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Figure	V.1:	Flat	cells	spontaneously	emerging	from	untreated	wild-type	MDCK	cultures	show	leader	
behaviour,	are	often	binucleated,	and	have	higher	p53	levels	than	surrounding	cells	with	standard	
epithelial	morphology.	(A)	Time-lapse	movie	stills	of	untreated	wild-type	MDCK	cultures	in	which	a	cell	with	 flattened	 morphology	 (yellow	 arrow)	 has	 spontaneously	 emerged	 and	 displays	 leader	 behaviour	following	contact	with	neighbouring	cells.	I	term	such	cells	‘spontaneous	leaders’.	Here	and	in	(C)	and	(E):	white	 dashed	 lines	 mark	 the	 initial	 contact	 point;	 black	 dashed	 lines	 mark	 the	 final	 contact	 point.	(B)	Quantification	of	the	frequency	at	which	cells	with	flattened	morphology	act	as	leaders.	Here	and	in	(D):	n	=	number	of	cells	pooled	from	three	independent	repeats;	error	bars	±	SEM.	(C)	Time-course	movie	stills	of	a	binucleated	spontaneous	leader	emerging	from	a	wild-type	MDCK	population	that	expresses	nuclear	GFP.	(D)	Quantification	of	the	number	of	spontaneous	leaders	that	did	not	divide	during	the	course	of	movie	acquisition.	(E)	Movie	stills	(first	 three	panels)	 following	the	migration	of	a	spontaneous	 leader	(yellow	arrows).	 Fourth	 panel	 shows	 the	 confocal	 image	 of	 that	 same	 spontaneous	 leader	 following	 p53	immunostaining.	 (F)	Quantification	 of	 single-cell	 nuclear	 p53	 intensities	 of	 spontaneous	 leaders	 versus	surrounding	non-leaders.	n	=	number	of	cells.	A	sample	size	of	at	least	212	leaders	would	be	required	to	perform	statistical	analysis.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
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damage	triggered	stabilisation	of	p53	specifically	in	the	MMC-treated	population	(Figure	V.2B)	(reviewed	in	Mirzayans	et	al.	2012).	
I	was	careful	to	select	a	dose	of	MMC	that	would	activate	p53	to	sub-lethal	levels.	At	a	dose	of	7.5	μg/ml	MMC,	MDCK	cells	arrested	their	division	and	took	on	a	flattened	morphology,	but	remained	viable	for	the	duration	of	the	experiment	(Figure	V.2C	and	D).	MMC-treated	cells	also	became	slightly	more	motile	than	untreated	cells	but	their	migration	was	not	directional	(Figure	V.2D,	yellow	and	blue	dashed	lines	indicate	the	trajectories	followed	by	two	cells	during	the	experiment).	The	flattening	was	particularly	intriguing,	as	scribKD	cells	 and	 spontaneous	 leaders	 are	both	also	 flat,	 intrinsically	more	motile,	 and	exhibit	leader-like	 directional	 migration	 following	 collision	 with	 cells	 of	 classical,	 epithelial	morphology.	 Canonical	 leaders	 have	 also	 been	 reported	 to	 have	 lost	 their	 classical	epithelial	morphology	and	be	much	larger	and	flatter	than	follower	cells	(Poujade	et	al.	2007).	These	observations	drew	me	 to	hypothesise	 that	 cell	 flattening	 is	potentially	 a	prerequisite	for	leader	fate;	I	will	further	discuss	this	in	Chapter	VIII.	
Strikingly,	when	I	co-cultured	MMC-treated	wild-type	cells	expressing	nuclear	GFP	with	unlabelled,	untreated	wild-type	cells,	the	MMC-treated	cells	acted	as	leaders	and	guided	the	migration	of	untreated	follower	cells	(Figure	V.2E).	I	did	not	observe	any	directional	migration	 following	 collisions	 between	 two	 untreated	 populations	 (Figure	 V.2F).	Unpublished	work	in	the	Piddini	lab	also	showed	that	p53	elevation	following	sub-lethal	Nutlin	 treatment	 of	 wild-type	 cells	 was	 sufficient	 to	 trigger	 a	 leader	 phenotype	 after	confrontation	 with	 p53KO	 cells.	 Together,	 this	 suggested	 that	 p53	 elevation	 alone	 is	sufficient	to	trigger	the	leader	cell	phenotype.	
I	next	asked	if	p53	activation	was	necessary	for	the	leader	phenotype.	I	treated	a	p53KO	population	with	MMC	and	found	that	a	significantly	lower	proportion	of	cells	behaved	as	leaders:	 following	 MMC	 treatment,	 only	 ~20%	 of	 p53KO	 cells	 behaved	 as	 leaders,	compared	to	~80%	of	wild-type	cells	(Figure	V.2G	and	H).	This	trend	can	be	visualised	in	the	cell	tracking	analysis	performed	by	Medhavi	Vishwakarma	in	the	Piddini	lab	(Figure	V.2I-K).	This	suggested	that	p53	activity	is	required	for	the	bulk	of	leader	cell	migration,	Interestingly,	 MMC-treated	 p53KO	 cells	 still	 flattened	 but	 did	 not	 become	 leaders,	suggesting	flattening	is	not	sufficient	for	the	leader	phenotype.	
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Figure	V.2:	p53	activation	is	both	necessary	and	sufficient	for	leader	cell	behaviour.	(A)	Schematic	illustrating	 the	 experimental	 design	 to	 test	whether	 p53	 is	 sufficient	 for	 leader	 cell	 fate,	 shown	 in	 (E).	(B)	Confocal	images	of	a	co-culture	of	unlabelled	wild-type	cells	and	mitomycin	C	(MMC)-treated	wild-type	
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cells	expressing	nuclear	GFP	immunostained	against	p53.	(C-D)	MMC	treatment	(D)	induces	cell	cycle	arrest	and	flattening	in	GFP-labelled	wild-type	cells,	compared	to	untreated	control	cells	(C).	MMC-treated	cells	are	also	more	mobile:	the	yellow	and	blue	dashed	lines	in	(D)	indicate	trajectories	of	two	cells	during	the	experiment.	The	insets	are	2x	zooms	of	the	two	cell	populations	at	80	hours	to	demonstrate	cell	flattening	in	 the	MMC-treated	 condition.	 (E-F)	Movie	 stills	 of	 co-cultures	 of	 unlabelled	wild-type	 cells	 and	MMC-treated	(E)	or	untreated	(F)	wild-type	cells	labelled	with	nuclear	GFP.	Leader	behaviour	only	occurs	if	one	of	the	populations	has	been	MMC-treated.	Here	and	in	(G):	white	dashed	lines	mark	the	initial	contact	point;	black	dashed	lines	mark	the	final	contact	point.	(G)	Movie	stills	from	co-cultures	of	unlabelled	wild-type	cells	and	MMC-treated	p53KO	cells	expressing	nuclear	GFP.	(H)	Quantification	showing	the	percentage	of	MMC-treated	wild-type	or	p53KO	cells	acting	as	leaders	when	confronted	with	untreated	wild-type	cells.	p	values	 were	 calculated	 using	 the	 K-S	 test.	 Error	 bars	 ±	 SEM.	 n	 =	 number	 of	 cells	 pooled	 from	 three	independent	repeats.	(I-J)	Coordinates	of	pairs	of	untreated	wild-type	and	MMC-treated	wild-type	cells	(I)	or	untreated	wild-type	and	MMC-treated	p53KO	cells	(J)	plotted	over	time	after	they	first	establish	contact	at	point	0,0.	(K)	Coordinates	of	untreated	wild-type	cells	 in	two	scenarios:	where	they	are	contacted	by	MMC-treated	wild-type	cells	(grey	shades)	or	MMC-treated	p53KO	 cells	 (green	shades).	Untreated	wild-type	cells	migrate	much	further	following	interaction	with	an	MMC-treated	wild-type	leader.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
The	quantifications	in	(I-K)	were	performed	by	Medhavi	Vishwakarma	in	the	Piddini	lab.	
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Taken	together,	I	have	shown	that	p53	activation	is	both	sufficient	and	necessary	to	confer	the	leader	cell	fate	on	most	leader	cells.	
	
Canonical leader cell markers are upregulated in spontaneous, scribKD-, and p53-driven 
leaders 
Leader	cells	induced	by	scratching	or	barrier	release	are	the	gold	standard	in	the	leader	cell	 migration	 field.	 These	 canonical	 leaders	 have	 been	 reported	 to	 be	 frequently	binucleated,	 have	 an	 increased	 surface	 area,	 and	 divide	 more	 slowly	 compared	 to	surrounding	cells	with	standard	epithelial	morphology	(Poujade	et	al.	2007;	Reffay	et	al.	2011).	 All	 these	 features	 are	 shared	 by	 spontaneous	 leaders,	while	 scribKD	 and	MMC-treated	cells	only	exhibit	the	latter	two.	These	similarities	led	me	to	hypothesise	that	the	p53	elevation	present	in	spontaneous	leaders,	scribKD	cells,	and	MMC-generated	leaders	may	 induce	 leader	cell	behaviour	using	 the	same	 factors	required	 for	 the	migration	of	scratch-	 or	 barrier	 release-induced	 leaders.	Molecularly,	 leaders	 generated	 by	 barrier	release	 upregulate	 Rac1,	 ITGβ1,	 and	 PI3K	 and	 require	 their	 activities	 to	 drive	 cell	migration	 (Yamaguchi	 et	 al.	 2015).	 I	 therefore	 tested	whether	 these	 canonical	 leader	markers	were	also	upregulated	and	required	in	spontaneous	leaders	and	those	induced	by	scribble	loss	and	p53	activation.	
I	 used	optically	 clear,	 gridded	dishes	 and	 immunofluorescence	 to	 show	 that	PI3K	and	ITGβ1	were	both	upregulated	in	spontaneous	leaders	(Figure	V.3A-D).	Interestingly,	I	also	showed	that	scribKD	cells	expressed	higher	levels	of	PI3K	and	ITGβ1	than	their	wild-type	neighbours	(Figure	V.3E-G),	as	did	MMC-generated	leaders	(Figure	V.4A-C).	Consistently	with	 this,	 when	 I	 treated	 actively	 migrating	 p53-driven	 leaders	 with	 PI3K	 or	 Rac1	inhibitors,	their	migration	stalled	(Figure	V.4D-F).	This	strongly	suggested	that	p53	lies	upstream	of	PI3K	and	ITGβ1	activation	and	that	migration	of	p53-driven	leaders	relies	on	the	 activity	 of	 PI3K	 and	 Rac1.	 I	 therefore	 propose	 that	 elevation	 of	 these	markers	 in	spontaneous	leaders	is	a	consequence	of	their	elevated	p53	levels.	
scribKD	 upregulate	 canonical	 leader	 markers	 PI3K	 and	 ITGβ1,	 display	 a	 flattened	morphology	similar	 to	spontaneous	 leaders,	and	engage	 in	directional	migration	when	confronted	by	wild-type	cells.	I	therefore	suggest	that,	during	contact-induced	migration,		 	
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Figure	 V.3:	 Spontaneous	 and	 scribKD	 leaders	 have	 elevated	 canonical	 leader	 cell	 markers.	(A-B)	Movie	stills	(first	three	panels)	following	the	migration	of	a	spontaneous	leader	(yellow	arrow).	White	dashed	lines	mark	the	initial	contact	point;	black	dashed	lines	mark	the	final	contact	point.	The	first	panel	in	 (B)	 shows	 a	 confocal	 image	 (maximum	 projection	 in	 z)	 of	 the	 same	 spontaneous	 leader	 following	immunostaining	against	phosphoinositide	3-kinase	(PI3K).	The	second	panel	in	(B)	is	a	2x	zoom	of	a	single	z	slice	taken	from	the	stack	in	the	first	panel	to	better	show	PI3K	localisation.	(C-D)	Same	as	(A-B)	but	for	integrin	β1	(ITGβ1).	 (E-F)	Confocal	 images	of	co-cultures	of	unlabelled	wild-type	cells	and	GFP-labelled	
scribKD	cells	immunostained	against	PI3K	(E)	and	ITGβ1	(F).	(G)	2x	zoom	of	a	single	z	slice	taken	from	the	leftmost	image	in	(F)	to	better	show	ITGβ1	localisation.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
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scribKD	 cells	 can	 be	 classified	 as	 leaders	 and	 wild-type	 cells	 as	 followers.	 As	 with	spontaneous	leaders,	p53	may	also	drive	PI3K	and	ITGβ1	expression	in	scribKD	leaders,	but	the	situation	is	less	clear-cut	because	scribKD	p53KO	cells	exhibit	directional	migration	(Wagstaff	et	al.	2016).	In	other	words,	scribKD	p53KO	cells	can	still	become	leaders	without	functional	p53.	I	will	discuss	this	in	Chapters	VI	and	VIII	in	light	of	experiments	I	describe	there:	I	propose	that	scribKD	p53KO	cells	activate	a	pathway	parallel	to	p53	to	drive	their	migration.	
Altogether,	I	have	shown	that	spontaneously	occurring	flattened	cells,	scribKD	cells,	and	MMC-treated	cells	all	display	the	molecular	hallmarks	of	canonical	leaders	and	engage	in	leader	cell	migration.	I	also	propose	that	elevated	p53	in	leaders	lies	upstream	of	PI3K	and	ITGβ1	upregulation.	
	
Discussion 
I	 have	 characterised	 spontaneously	 occurring	 leaders	 in	 untreated,	 wild-type	 MDCK	cultures	 and	 shown	 that	 they	have	 elevated	p53	 levels.	 I	 then	demonstrated	 that	 p53	activation	is	both	sufficient	and	necessary	for	leader	cell	migration,	suggesting	that	p53	may	 be	 a	 universal	 driver	 of	 leader	 cell	migration	 in	MDCKs.	 I	 have	 also	 shown	 that	spontaneous,	scribKD-,	and	MMC-mediated	leaders	all	upregulate	both	p53	and	canonical	leader	 cell	 markers	 PI3K	 and	 ITGβ1.	 p53	 may	 lie	 upstream	 of	 canonical	 leader	 cell	markers,	but	 this	needs	 to	be	 further	verified	by	 immunostaining	MMC-treated	p53KO	cells	against	PI3K	and	ITGβ1,	for	example.	
p53	activation	using	MMC	mimics	many	hallmarks	of	canonical	 leaders:	 flattening,	cell	cycle	 arrest,	migratory	 phenotype,	 and	 expression	 of	 specific	molecular	markers.	 It	 is	therefore	likely	that	p53	elevation	may	also	be	instrumental	in	the	migration	of	canonical	leaders	during	wound	healing;	I	will	test	this	hypothesis	in	Chapter	VII.	Should	this	be	the	case,	it	could	molecularly	explain	how	only	some	cells	are	singled	out	to	become	leaders	from	a	phenotypically	homogeneous	wound	edge.	
The	most	striking	feature	that	spontaneous,	scribKD-,	and	MMC-mediated	leaders	have	in	common	is	that	they	have	significantly	higher	p53	levels	than	follower	cells.	Importantly,		 	
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Figure	V.4:	MMC-driven	leaders	have	elevated	canonical	leader	markers,	whose	function	they	rely	
on	for	their	migration.	(A-B)	Confocal	images	of	co-cultures	of	unlabelled	wild-type	cells	and	MMC-treated	wild-type	cells	expressing	nuclear	GFP	immunostained	against	PI3K	(A)	and	ITGβ1	(B).	(C)	2x	zoom	of	a	single	z	slice	taken	from	the	leftmost	image	in	(B)	to	better	show	ITGβ1	localisation.	(D-F)	Movie	stills	from	co-cultures	of	unlabelled	wild-type	cells	and	MMC-treated	wild-type	cells	labelled	with	GFP.	White	dashed	lines	mark	the	initial	contact	point;	yellow	dashed	lines	mark	the	contact	point	at	which	treatments	were	added;	 black	 dashed	 lines	mark	 the	 final	 contact	 point.	 The	 addition	 of	 DMSO	 (D)	 does	 not	 affect	 the	migration	of	MMC	leaders,	but	acute	chemical	inhibition	of	PI3K	(E)	or	Rac1	(F)	stalls	leader	cell	migration.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
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MDCKs	with	high	p53	in	homotypic	cultures	(e.g.	MMC-treated	cells)	are	more	motile	than	wild-type	cells,	but	their	migration	is	random.	It	is	only	upon	contact	with	a	population	with	lower	p53	that	their	migration	becomes	directional,	heading	away	from	the	collision	site.	It	is	possible	that	p53	elevation	induces	cytoskeletal	changes	resulting	in	cells	being	‘poised’	for	migration	but	an	imbalance	in	p53	activity	is	further	required	to	provide	a	symmetry	breaking	cue	to	initiate	leader	cell	behaviour.	
These	observations	may	be	considered	difficult	to	reconcile	with	the	canonical	role	of	p53	as	 a	 tumour	 suppressor,	 as	 it	 has	 been	widely	 reported	 that	 wild-type	 p53	 has	 anti-metastatic	 properties.	 For	 example,	 p53	 promotes	 cell-cell	 adhesion	 by	 boosting	 E-cadherin	 expression	 and	 suppresses	 motility	 via	 inhibition	 of	 focal	 adhesion	 kinase	(reviewed	 in	 Powell	 et	 al.	 2014).	 Conversely,	 loss	 of	 p53	 has	 been	 associated	 with	increased	 migration	 in	 mouse	 embryonic	 fibroblasts,	 while	 tumours	 produced	 by	experimental	p53	inactivation	are	particularly	invasive	(reviewed	in	Roger	et	al.	2006).	That	 said,	 tumours	 in	p53KO	mice	 are	often	not	 invasive	 and	 tend	not	 to	metastasise,	suggesting	that	loss	of	p53	is	not	sufficient	to	drive	the	migration	of	malignant	cells.	In	fact,	 there	 is	 increasing	 evidence	 to	 suggest	 that	 dominant	 negative,	 gain-of-function	mutations	 in	p53	are	primarily	responsible	 for	 its	role	 in	the	context	of	migration	and	metastasis	 in	cancer.	Mutant	variants	of	p53	are	thought	to	exert	 their	effects	 through	binding	and	activating	non-p53	promoters	and	potentially	modifying	the	function	of	other	p53	family	proteins	(reviewed	in	Powell	et	al.	2014).	
Despite	 this	 apparent	 contradiction,	pro-migratory	effects	of	wild-type	p53	have	been	described	 in	 other	 contexts,	which	 are	 potentially	more	 relevant	 to	MDCK	 leader	 cell	migration	than	cancer	models.	For	example,	human	pulmonary	fibroblasts	become	more	proliferative	and	migratory	following	silicone	dioxide	treatment.	Ablation	of	p53	activity	inhibits	migration	in	a	scratch-wound	assay	in	the	presence	of	silicone	dioxide	(Wang	et	al.	2015).	Similarly,	p53	protein	and	mRNA	levels	are	boosted	at	the	migrating	edges	of	mouse	skin	wounds,	both	in	keratinocytes	and	in	the	recruited	inflammatory	cells.	The	role	 of	 p53	 in	 this	 model	 was	 only	 investigated	 in	 the	 context	 of	 apoptosis	 of	 the	inflammatory	cells	beneath	the	leading	edge	of	the	migrating	epithelium,	rather	than	in	the	migration	itself	(Kane	&	Greenhalgh	2000),	but	it	remains	plausible	that	p53	at	the	wound	edge	may	also	be	contributing	to	the	migration	in	this	system.	
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Ultimately,	it	would	be	important	to	recapitulate	the	instructive	role	of	wild-type	p53	in	migration	 in	 a	 system	other	 than	MDCKs.	 Firstly,	 conservation	of	 a	mechanism	across	multiple	 model	 systems	 would	 give	 more	 significance	 to	 the	 research,	 as	 it	 remains	possible	that	my	observations	are	a	phenomenon	restricted	to	a	single	cell	line.	Secondly,	as	the	ultimate	goal	is	to	use	any	findings	in	a	clinical	setting,	it	would	be	important	to	be	able	to	validate	them	in	an	in	vitro	or	ex	vivo	human	cell	system.	Lastly,	there	are	far	more	tools	available	 for	non-canine	systems	(e.g.	commercial	antibodies	and	verified	shRNA	sequences)	that	could	make	further	research	quicker	and	more	efficient.	
In	 fact,	 our	 lab	 has	 recently	 started	 a	 collaboration	 with	 Stephane	 Gross	 (Aston	University)	 to	 investigate	 whether	 p53-driven	 migration	 may	 be	 conserved	 during	placental	implantation.	Preliminary	results	suggest	that	there	may	be	an	enrichment	of	p53	(and	its	effector	p21)	in	the	cells	at	the	tip	of	the	implantation	structures	in	human	trophoblast	 sections	 (unpublished	 data).	 This	would	 be	 an	 interesting	 observation	 to	follow	 up,	 as	 it	 could	 be	 a	 great	 model	 for	 non-pathological,	 physiologically	 relevant	migration.	
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Chapter VI: The p53 effector p21 is the key driver of leader cell migration 
	Having	 shown	 that	 p53	 drives	 leader	 cell	migration,	 I	 next	wanted	 to	 find	 out	which	downstream	 p53	 targets	 are	 involved	 in	 this	 process.	 The	major	 clue	 came	 from	 the	observation	that	both	spontaneous	and	MMC-driven	leaders	are	cell	cycle	arrested	and	
scribKD	cells	divide	at	a	reduced	rate	(Wagstaff	et	al.	2016).	One	of	the	main	transcriptional	targets	 of	 p53	 involved	 in	 cell	 cycle	 arrest	 is	 Cyclin-Dependent	 Kinase	 Inhibitor	 1A	(CDKN1A),	 also	 known	 as	 p21WAF1/Cip1	 (from	 here	 on	 referred	 to	 as	 p21)	 (Dulić	 et	 al.	1994).	RNA	sequencing	experiments	have	previously	 shown	 that	 the	p21	 transcript	 is	more	 highly	 expressed	 in	 scribKD	 cells	 than	 in	wild-type	 cells	 (Wagstaff	 et	 al.	 2016).	 I	therefore	decided	to	investigate	the	involvement	of	p21	in	leader	cell	migration.	
	
p21 is sufficient for leader cell migration but not mechanical loser status 
Using	the	same	approach	as	for	p53,	I	tracked	the	migration	of	spontaneous	leaders	using	live	imaging	and	then	fixed	the	samples	for	immunostaining.	Using	a	polyclonal	anti-p21	antibody,	I	showed	that	spontaneous	leaders	have	higher	levels	of	p21	than	surrounding	non-leader	cells	(Figure	VI.1A	and	B).	It	is	worth	noting	that	the	p21	antibody	and/or	the	expression	pattern	of	p21	gives	much	more	binary	readouts	than	the	p53	antibody.	
I	next	asked	if	elevated	p21	is	instructive	of	leader	cell	fate.	To	address	this,	I	constructed	a	lentiviral	vector	from	which	the	concomitant	expression	of	p21	and	nuclear	RFP	could	be	driven	by	the	addition	of	DOX	(in	a	similar	way	to	the	construct	I	used	to	overexpress	E-cadherin	in	Chapter	II,	see	Appendix	2E).	I	transduced	wild-type	cells	with	the	resulting	lentivirus	and	generated	a	monoclonal	cell	 line	strongly	and	uniformly	overexpressing	p21	in	a	DOX-inducible	manner	(p21OE;	Figure	VI.1C	and	D).	As	expected,	p21OE	cells	displayed	cell	cycle	arrest	specifically	in	the	presence	of	DOX	and,	remarkably,	adopted	a	flat	leader-like	morphology	(Figure	VI.1E	and	F).	p21OE	cells	in	homotypic	cultures	were	also	slightly	more	migratory	than	wild-type	cells,	similarly	to	scribKD	and	MMC-treated	cells	(Figure	VI.1F,	yellow	arrows	indicate	the	position	of	the	same	cell	at	the	start	and	end	of	the	experiment).	 	
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Figure	VI.1:	p53	target	p21	is	both	necessary	and	sufficient	to	drive	leader	cell	migration	but	does	
not	confer	mechanical	loser	status.	(A)	Movie	stills	(first	two	panels)	of	a	migrating	spontaneous	leader	(yellow	 arrows).	 Last	 two	panels	 show	 confocal	 images	 of	 the	 same	 spontaneous	 leader	 following	 p21	immunostaining.	Here	and	in	(G):	white	dashed	lines	mark	the	initial	contact	point;	black	dashed	lines	mark	
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the	 final	 contact	 point.	 (B)	 Quantification	 of	 single-cell	 nuclear	 p21	 intensities	 of	 spontaneous	 leaders	versus	surrounding	non-leaders.	n	=	number	of	cells.	A	sample	size	of	at	least	47	leaders	would	be	required	to	perform	statistical	 analysis.	 (C-D)	Confocal	 images	of	 co-cultures	of	GFP-labelled	wild-type	 cells	 and	unlabelled	cells	overexpressing	p21	(p21OE)	in	a	DOX-inducible	manner.	Immunostaining	against	p21	in	the	absence	(C)	or	presence	(D)	of	DOX	shows	strong,	DOX-dependent	induction	of	p21	expression	in	p21OE	cells.	(E-F)	p21	overexpression	induces	cell	cycle	arrest	and	flattening	of	p21OE	cells	(F),	compared	to	DOX-free	conditions	(E).	p21OE	cells	are	also	more	motile:	yellow	arrows	in	(F)	indicate	the	position	of	the	same	cell	at	the	beginning	and	end	of	the	experiment.	(G)	Movie	stills	from	co-cultures	of	GFP-labelled	wild-type	cells	and	unlabelled	p21OE	cells.	(H-I)	Coordinates	of	pairs	of	untreated	wild-type	and	MMC-treated	wild-type	cells	(H)	or	untreated	wild-type	and	MMC-treated	p21KO	cells	(I)	plotted	over	time	after	they	 first	establish	contact	at	point	0,0.	(J)	Coordinates	of	untreated	wild-type	cells	in	two	scenarios:	where	they	are	contacted	 by	 MMC-treated	 wild-type	 cells	 (grey	 shades)	 or	 MMC-treated	 p21KO	 cells	 (green	 shades).	Untreated	 wild-type	 cells	 migrate	 much	 further	 following	 interaction	 with	 an	 MMC-treated	 wild-type	leader.	(K)	Unlabelled	p21OE	clones	(white	dashed	line)	are	compacted	but	not	eliminated	by	surrounding	GFP-labelled	wild-type	cells.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
The	quantifications	in	(H-J)	were	performed	by	Medhavi	Vishwakarma	in	the	Piddini	lab.	
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When	I	co-cultured	p21OE	cells	with	wild-type	cells	expressing	nuclear	GFP,	I	found	that	the	 p21OE	 population	 became	 leaders	 and	 led	 the	 migration	 of	 wild-type	 followers	(Figure	VI.1G).	This	observation	is	corroborated	by	the	cell	tracking	analysis	performed	by	 Medhavi	 Vishwakarma	 in	 the	 Piddini	 lab	 (Figure	 VI.1H-J).	 The	 leader/follower	migration	 resulted	 in	 the	 compaction	 of	 p21OE	 clones	 by	 wild-type	 neighbours	 to	densities	at	which	scribKD	cells	would	be	eliminated.	Unexpectedly,	p21OE	were	often	not	outcompeted	 (Figure	VI.1K),	 suggesting	 that	 p53-mediated	density	 hypersensitivity	 of	losers	is	not	driven	through	p21.	This	demonstrated	that	p21	activation	is	sufficient	to	drive	leader	cell	migration	but	does	not	confer	the	mechanical	loser	status.	It	would	be	important	to	verify	whether	p21OE	cells	are	indeed	not	mechanical	losers	using	stretcher	experiments	where	cells	can	be	compacted	in	the	absence	of	competition.	If	compaction	is	insufficient	to	elevate	the	p53	in	p21OE	cells,	then	this	could	explain	why	they	are	not	eliminated	during	competition.	
I	 next	 wanted	 to	 establish	 whether	 p21	 activity	 was	 also	 necessary	 for	 the	 leader	phenotype.	
	
Construction of the p21KO MDCK cell line 
In	 order	 to	 test	 the	 requirement	 of	 p21	 in	 leader	 cell	 migration,	 I	 constructed	 a	 p21	knockout	 (p21KO)	 cell	 line	using	CRISPR/Cas9	 technology.	 I	designed	 two	short	guide	RNA	(sgRNA)	target	sequences	targeting	the	5’	end	of	exon	2	of	canine	CDKN1A,	which	is	the	first	translated	exon	(Figure	VI.2A).	I	cloned	these	target	sequences	individually	into	a	 previously	 published	 vector	 encoding	 the	 Cas9	 D10A	 ‘nickase’	 variant	 of	 the	 Cas9	nuclease	 derived	 from	 Streptococcus	 pyogenes	 and	 the	 sgRNA	 scaffold	 (Appendix	 2J)	(Wyman	et	al.	2013).	Thanks	to	the	nickase	mutation,	only	a	single	DNA	strand	is	cleaved	at	each	of	the	positions	in	the	genomic	DNA	specified	by	the	sgRNA,	which	results	in	a	staggered	double-stranded	break	(DSB).	The	advantage	of	 the	nickase	system	over	the	wild-type	Cas9,	which	creates	DSBs	directly,	is	that	generates	fewer	off-target	hits.	Error-prone	DNA	 repair	mechanisms	activated	 in	 response	 to	DSBs	 can	occasionally	 lead	 to	insertions	and/or	deletions	of	base	pairs	at	the	targeted	locus.	This	ultimately	disrupts	the	coding	region	of	the	target	protein	and	creates	a	non-functional	allele	(reviewed	in	Sander	&	Joung	2014).	 	
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Figure	VI.2:	Construction	and	verification	of	the	p21KO	MDCK	lines.	(A)	Target	region	for	CRISPR/Cas9	mutagenesis	in	exon	2	of	canine	CDKN1A	(p21).	sgRNA1	and	sgRNA2	indicate	the	target	sequences	used	to	guide	a	pair	of	Cas9	nickase	enzymes.	PAM	=	protospacer	adjacent	motif.	(B)	Agarose	gel	containing	the	PCR	products	from	a	reaction	amplifying	a	~800bp	region	around	the	CDKN1A	locus	from	the	genomic	DNA	of	clones	B5	(heterozygous	mutant,	leftmost	panel),	E9	(pseudo-homozygous	mutant	with	only	one	CDKN1A	allele,	middle	 panel),	 and	G5	 (homozygous	mutant	with	 two	 different	mutant	 alleles,	 rightmost	 panel).	(C)	Schematic	representation	of	the	sequencing	analysis	of	the	three	mutant	clones.	(D)	Confocal	images	of	homotypic	cultures	of	wild-type	cells	(leftmost	panel),	or	p21KO	clones	E9	(middle	panel)	and	G5	(rightmost	panel)	treated	with	a	mild	dose	of	Nutlin-3	and	stained	against	p21.	
Scale	bars	=	50	μm.	
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Normally,	Nutlin	treatment	activates	p53	and	hence	its	transcriptional	targets,	including	the	cell	cycle	inhibitor	p21.	By	definition,	p21KO	cells	lack	functional	p21,	so	they	should	not	be	growth-inhibited	in	the	presence	of	Nutlin.	I	followed	this	logic	to	enrich	for	a	pool	of	MDCKs	 lacking	 functional	 p21	 by	 culturing	 cells	 transfected	with	 the	 Cas9	 nickase	vectors	for	six	days	at	a	moderate	dose	of	Nutlin.	I	split	the	surviving	cells	at	a	low	density	to	isolate	single	clones.	I	then	pre-screened	the	clones	using	p21	immunofluorescence	in	the	presence	and	absence	of	Nutlin	(data	not	shown)	and	chose	the	following	for	further	characterisation:	two	clones	that	did	not	show	Nutlin-induced	p21	elevation	(E9	and	G5)	and	one	that	expressed	p21	as	a	negative	control	for	p21	knockout	(B5).	
To	 verify	whether	 I	 had	 generated	 true	p21KO	 clones,	 I	 used	PCR	 to	 amplify	 a	 region	containing	exon	2	of	CDKN1A	 (just	under	800	bp)	 from	the	genomic	DNA	of	 the	 three	clones.	Visualisation	of	 the	PCR	products	on	an	agarose	gel	 showed	 that	 the	 ‘negative’	control	B5	clone	had	two	bands:	one	of	the	expected	size,	and	one	around	100	bp	larger	(Figure	VI.2B,	leftmost	panel).	This	implied	that	only	one	of	the	p21	alleles	was	truly	wild-type	 and	 the	 other	 most	 likely	 contained	 an	 insertion.	 Clone	 B5	 was	 therefore	 a	heterozygous	p21KO	clone	and	was	still	able	to	drive	p21	expression	(data	not	shown).	In	contrast,	clone	E9	only	had	one	band,	much	larger	than	the	predicted	size	for	a	wild-type	band	(Figure	VI.2B,	middle	panel).	Clone	G5	had	two	bands:	one	at	the	800	bp	mark,	and	one	slightly	smaller	than	that	(Figure	VI.2B,	rightmost	panel).	The	minute	size	difference	between	the	larger	G5	band	(800	bp)	and	the	wild-type	band	(just	under	800	bp)	implied	that	there	might	have	been	a	small	insertion	in	that	allele	of	clone	G5.	In	fact,	sequencing	revealed	this	was	exactly	the	case.	Clone	G5	returned	two	sequences:	one	with	a	28	bp	deletion	and	one	with	a	mixture	of	deletions	and	insertions	but	a	net	size	increase;	both	of	these	mutations	generated	frameshifts	at	the	p21	locus.	Clone	B5	gave	two	sequences:	one	wild-type	and	one	with	a	95	bp	insertion,	as	I	predicted	from	the	PCR.	Clone	E9	only	had	one	sequence	with	a	large	insertion	and	a	small	deletion,	implying	it	had	completely	lost	 the	 other	 allele	 or	 potentially	 duplicated	 the	 mutated	 one.	 These	 results	 are	summarised	in	Figure	VI.2C.	
Having	established	that	clones	E9	and	G5	were	disrupted	at	both	p21	loci	by	sequencing,	I	formally	tested	their	loss	of	functional	p21	by	immunofluorescence	in	the	presence	of	Nutlin.	Rather	than	using	the	heterozygous	p21KO	clone	B5	as	a	control,	I	reverted	to	wild-		  
	 87 
	
		
Figure	VI.3:	p21	activity	is	necessary	for	leader	migration	and	lies	upstream	of	canonical	leader	cell	
markers,	E-cadherin,	and	N-cadherin.	(A-B)	Stills	from	movies	of	GFP-labelled	wild-type	cells	co-cultured	with	unlabelled,	MMC-treated	wild-type	(A)	or	p21	knockout	(p21KO)	cells	(B).	White	dashed	lines	mark	the	 initial	contact	point;	black	dashed	 lines	mark	the	 final	contact	point.	(C)	Quantification	showing	the	percentage	of	MMC-treated	wild-type	or	p21KO	 cells	 acting	as	 leaders	when	confronted	with	untreated	wild-type	 cells.	 n	 =	 number	 of	 cells.	 p	 values	 were	 calculated	 using	 the	 K-S	 test.	 Error	 bars	 ±	 SEM.	(D-G)	Unlabelled	p21OE	cells	display	higher	levels	of	PI3K	(D),	ITGβ1	(E),	E-cadherin	(F),	and	N-cadherin	(G)	than	GFP-labelled	wild-type	cells.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
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type	cells	as	the	benchmark	for	p21	activity.	In	agreement	with	the	sequencing	analysis,	I	found	 that	both	p21KO	 clones	E9	and	G5	 showed	minimal	p21	activity	 in	 response	 to	Nutlin	(Figure	VI.2D).	
	
p21 is necessary for leader migration and lies upstream of canonical leader markers, 
E-cadherin, and N-cadherin 
Having	confirmed	that	I	had	generated	two	functional	p21KO	clones,	I	next	asked	whether	p21	is	necessary	for	leader	cell	behaviour.	As	discussed	earlier,	MMC	treatment	of	wild-type	cells	 is	 sufficient	 to	drive	 leader	migration	when	confronted	with	 their	untreated	counterparts	(Figure	VI.3A).	Strikingly,	MMC-treated	p21KO	cells	behaved	as	leaders	less	often	but	still	displayed	a	rather	flat,	leader-like	morphology	(Figure	VI.3B	and	C).	Taken	together,	 the	data	 I	describe	 in	Chapter	V	and	here	suggest	 that	p53	drives	 leader	cell	migration	through	activation	of	its	transcriptional	target	p21.	
I	have	previously	shown	that	p53-driven	leaders	activate	canonical	leader	cell	markers	PI3K	 and	 ITGβ1,	 implying	 that	 they	 lie	 downstream	 of	 p53.	 I	 therefore	 tested	where	canonical	 leader	 marker	 expression	 lies	 with	 respect	 to	 p21	 activation.	 Using	immunofluorescence,	 I	 showed	 that	 p21	 overexpression	 alone	 may	 be	 sufficient	 to	upregulate	 both	 PI3K	 and	 ITGβ1	 (Figure	 VI.3D	 and	 E).	 Interestingly,	 p21OE	 cells	 also	tended	to	display	higher	levels	of	E-	and	N-cadherin,	markers	upregulated	in	scribKD	cells,	which	also	display	leader	behaviour	(Figure	VI.3F	and	G).	scribKD	cells	have	high	p21	levels	(Wagstaff	et	al.	2016),	which	would	imply	that	PI3K,	ITGβ1,	E-cadherin,	and	N-cadherin	are	expressed	downstream	of	p21	also	in	scribKD	leaders.	That	said,	this	hypothesis	would	need	to	be	formally	tested	using	a	scribKD	p21KO	line.	
Taken	together,	these	experiments	suggest	that	leaders	upregulate	multiple	markers	as	part	of	a	‘leader	cell	signature’	and	that	these	markers	are	activated	downstream	of	p53	signalling	via	p21.	
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Discussion: the leader cell signature 
So	far,	I	have	described	four	types	of	MDCK	leaders:	scribKD	cells,	spontaneous	leaders,	MMC-induced	leaders,	and	p21OE	cells.	The	expression	pattern	of	and	requirement	for	published	 and	 novel	 leader	 cell	markers	 in	 these	 four	 types	 of	 leaders	 and	 canonical	leaders	is	summarised	in	Table	1.	Because	of	the	morphological	and	molecular	similarities	between	 all	 described	 types	 of	 MDCK	 leaders,	 I	 suggest	 that	 one	 may	 be	 able	 to	extrapolate	findings	from	one	type	of	leader	to	others.	For	example,	it	is	possible	that	the	E-cadherin	gradient	 is	 also	 required	 for	 the	migration	of	 spontaneous	and	p53-driven	leaders,	not	just	scribKD	cells.	It	would	be	interesting	to	experimentally	verify	this	in	the	future.	
	
	
Leader	marker	
E-cadherin	 N-cadherin	 P-cadherin	 PI3K	 ITGβ1	 Rac1	
Type	of	leader	 ↑ Req.	 ↑	 Req.	 ↑	 Req.	 ↑	 Req.	 ↑	 Req.	 ↑	 Req.	Canonical	barrier	release	 	 	 	 	 	 	 ✓	 ✓	 ✓	 ✓	 ✓	 ✓	
scribKD	 ✓	 ✓*	 ✓*	 	 ✓	 	 ✓*	 	 ✓*	 	 	 	Spontaneous	 	 	 	 	 	 	 ✓*	 	 ✓*	 	 	 	p53-mediated	 	 	 	 	 	 	 ✓*	 	 ✓*	 	 	 ✓*	p21OE	 ✓*	 	 ✓*	 	 	 	 ✓*	 	 ✓*	 	 	 	
Table	1:	Molecular	markers	upregulated	 in	different	 types	of	MDCK	 leader,	based	on	 (Yamaguchi	et	al.	2015),	(Wagstaff	et	al.	2016),	and	data	presented	in	this	thesis.	P-cadherin	is	included	for	completeness	but	its	involvement	requires	further	testing.	
“↑”	indicates	whether	a	given	marker	is	upregulated;	“Req.”	indicates	whether	a	given	marker	is	required	for	leader	migration.	Asterisks	(*)	indicate	experiments	I	have	done	myself	and	present	in	this	thesis;	blank	spaces	indicate	that	that	combination	has	not	been	tested	yet.	
	Taking	 together	 observations	 from	 all	 investigated	 types	 of	 leaders,	 I	 propose	 the	existence	of	a	multi-component	leader	cell	signature	shared	by	all	leaders	in	the	MDCK	system.	 The	 leader	 signature	 includes,	 but	 is	 not	 necessarily	 limited	 to,	 elevated	
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expression	of	PI3K,	ITGβ1,	Rac1,	E-cadherin,	and	N-cadherin.	Neither	E-	nor	N-cadherin	are	sufficient	to	drive	leader	migration	on	their	own	and	appear	to	be	activated	alongside	PI3K	and	ITGβ1	(as	demonstrated	in	scribKD	cells).	Moreover,	PI3K	and	ITGβ1	have	been	shown	to	regulate	Rac1	in	the	context	of	leader	migration	independently	of	each	other	(Yamaguchi	et	al.	2015).	 I	 therefore	suggest	 that	 leader	signature	components	may	be	acting	 in	 parallel	 pathways	 and	 that	 their	 concerted	 activities	 are	 required	 for	 the	coordinated,	directed	migration	of	leader	cells,	even	though	the	evidence	for	this	is	still	incomplete	(Table	2).		
Molecularly,	the	leader	signature	is	likely	promoting	cytoskeletal	changes	predisposing	cells	for	migration	or	actively	participating	in	it,	and	may	be	responsible	for	leader	cell	flattening.	The	boosted	expression	of	multiple	intracellular	and	extracellular	molecules	may	also	be	responsible	 for	generating	asymmetry	cues	 that	can	be	sensed	by	 leaders	and/or	 followers	 to	 promote	 the	 directionality	 of	 leader	 cell	 migration.	 It	 would	 be	interesting	 to	 determine	 whether	 there	 is	 any	 interplay	 between	 the	 signature	components	and	what	processes	lies	downstream	of	each	of	them.	
	
Molecule	 Necessary	for	leader	migration		
Sufficient	for	
leader	migration	
PI3K	 Yes	 [not	tested]	
ITGβ1	 Yes	 [not	tested]	
Rac1	 Yes	 [not	tested]	
E-cadherin	 Yes*	 No*	
N-cadherin	 [not	tested]	 No*	P-cadherin	 [not	tested]	 Yes*	p53	 Yes*	 Yes*	p21	 Yes*	 Yes*	
Table	 2:	 The	 requirement	 for	 different	 molecules	 in	 the	 migration	 of	 MDCK	 leaders,	 based	 on	 data	extrapolated	from	(Yamaguchi	et	al.	2015),	(Wagstaff	et	al.	2016),	and	this	thesis.	Proposed	leader	signature	molecules	are	italicised.	
Asterisks	(*)	indicate	experiments	I	have	done	myself	and	present	in	this	thesis.	
	The	 data	 I	 present	 here	 and	 in	 Chapter	 V	 suggests	 that	 p53	 drives	MDCK	 leader	 cell	migration	 through	 its	 transcriptional	 target	 p21.	 Increased	 p21	 activity	 leads	 to	
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expression	of	the	leader	signature,	implying	that	p53/p21	activity	lies	upstream	of	leader	cell	marker	expression.	Interestingly,	density	hypersensitivity	of	mechanical	losers	does	not	 seem	 to	be	mediated	by	p21,	 suggesting	 it	 is	 part	 of	 a	 separate,	 p21-independent	pathway	downstream	of	p53.	This	is	particularly	interesting,	as	it	could	explain	how	cells	with	elevated	p53	may	be	eliminated	by	mechanical	competition	in	non-migratory	tissues	like	homeostatic	adult	epithelia.	
I	have	shown	that	p53	activation	is	both	sufficient	and	necessary	for	leader	cell	behaviour,	but	an	important	exception	to	this	are	scribKD	p53KO	cells,	which	are	not	mechanical	losers	but	 still	 act	 as	 leaders	 (Wagstaff	 et	 al.	 2016).	 To	 reconcile	 these	 data,	 I	 propose	 the	following.	Loss	of	scribble	affects	multiple	pathways,	one	of	which	is	p53,	responsible	for	
scribKD	 cells’	 hypersensitivity	 to	 density	 and,	 through	 p21,	 for	 their	 leader	 behaviour.	
scribKD	p53KO	cells	have	little	p21	activity	but	maintain	high	expression	of	E-cadherin,	a	leader	 signature	marker	 (Wagstaff	 et	 al.	 2016).	While	 I	 have	 not	 tested	 this,	 I	 would	hypothesise	 that	 scribKD	p53KO	 cells	 also	express	high	 levels	of	other	 leader	 signature	markers	e.g.	PI3K	and	N-cadherin.	This	would	imply	that	loss	of	scribble	simultaneously	feeds	 into	 a	 pathway	 parallel	 to	 or	 downstream	 of	 p21	 to	 drive	 leader	 signature	expression,	or	that	scribKD	p53KO	cells	have	a	p53-	and	p21-independent	way	of	activating	those	markers.	As	I	will	discuss	in	Chapter	VIII,	one	possibility	is	that	scribKD	p53KO	cells	activate	other	 cell	 cycle	 inhibitors	 (e.g.	p16)	 that	 lie	upstream	of	 the	 leader	 signature,	parallel	to	p21.	
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Chapter VII: p53 and p21 activity drive migration of leader cells during wound 
healing, many of which become mechanical losers and are eliminated at 
wound closure 
	In	Chapters	V	and	VI,	I	established	that	increased	p53/p21	activity	is	both	sufficient	and	necessary	for	leader	cell	migration.	I	also	demonstrated	that	p53-	and	p21-driven	leaders	share	 the	 same	 molecular	 mechanisms	 as	 canonical	 leaders.	 I	 therefore	 next	 asked	whether	 p53	 and	 p21	may	 also	 play	 an	 instructive	 role	 in	 the	migration	 of	 canonical	leaders,	 both	during	 scratching	 and	barrier	 release.	 This	was	 an	 attractive	hypothesis	because	it	could	potentially	explain	how	only	some	cells	are	singled	to	become	leaders	from	a	superficially	homogeneous	environment	at	wound	edges.	What	is	more,	a	better	understanding	of	the	factors	that	drive	cell	migration	during	wound	healing	could	help	identify	future	treatments	to	accelerate	wound	closure	in	vivo.	
	
Scratch-induced and barrier release leaders elevate p53 and p21 
Historically,	leader	cell	migration	has	been	studied	using	one	of	two	assays:	scratching	of	a	lawn	of	cells	or	releasing	a	barrier	from	around	a	confluent	monolayer.	Both	of	these	manipulations	 are	 used	 to	 generate	 space	 for	 migration	 to	 proceed	 into,	 as	 physical	damage	 is	 not	 required	 to	 trigger	 leader	migration.	 Barrier	 release	 is	 generally	more	accepted,	as	it	minimises	the	damage	element	at	the	colony	edge	(Poujade	et	al.	2007),	but	 I	 expected	 scratching	may	 be	more	 relevant	 from	 a	 physiological	 wound	 healing	perspective.	 I	 therefore	 set	 out	 to	 assess	 the	 p53/p21	 status	 of	 canonical	 leaders	generated	using	both	methods.	
Using	a	P1000	pipette	tip,	I	generated	scratch-wounds	in	confluent	monolayers	of	wild-type	MDCKs.	I	followed	the	emergence	and	migration	of	leaders	using	live	imaging,	and	then	fixed	the	samples	for	immunofluorescence.	I	found	that	both	p53	(Figure	VII.1A	and	B)	and	p21	(Figure	VII.1C	and	D)	tended	to	be	upregulated	in	scratch-generated	leaders,	although	this	could	not	be	statistically	tested	for	significance	due	to	an	insufficient	sample		 	
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Figure	VII.1:	p53	and	p21	are	elevated	in	MDCK	leaders	generated	by	scratching	and	barrier	release.	(A)	Movie	stills	following	a	scratch-wound	to	a	confluent	wild-type	MDCK	monolayer	(first	three	panels)	show	emergence	of	leader	cells	(an	example	one	is	indicated	using	the	yellow	arrows).	The	last	panel	shows	a	confocal	image	of	that	same	leader	cell	after	p53	immunostaining.	(B)	Quantification	of	single-cell	nuclear	p53	 intensities	 in	 scratch-induced	 leaders	 versus	 non-leaders.	Here	 and	 in	 (D),	 (G),	 and	 (I):	 black	 bars	represent	the	median;	n	=	number	of	cells.	(C)	Movie	stills	following	a	scratch-wound	to	a	confluent	wild-type	MDCK	monolayer	 (first	 two	panels).	 Last	 two	panels	 are	 confocal	 images	 of	 that	 same	 leader	 cell	(yellow	 arrows)	 after	 p21	 immunostaining.	 (D)	 Quantification	 of	 single-cell	 nuclear	 p21	 intensities	 of	scratch-induced	leaders	versus	surrounding	non-leaders.	(E)	Schematic	of	the	barrier	release	experiment	shown	in	(F)	and	(H).	(F)	Movie	stills	(first	two	panels)	following	the	migration	of	leaders	generated	by	barrier	release.	The	last	panel	shows	a	confocal	image	of	those	same	leaders	following	p53	immunostaining.	(G)	 Quantification	 of	 single-cell	 nuclear	 p53	 intensities	 of	 barrier	 release-induced	 leaders	 versus	
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surrounding	non-leaders.	(H)	Movie	stills	(first	two	panels)	following	the	migration	of	a	leader	generated	by	 barrier	 release.	 Last	 two	 panels	 show	 confocal	 images	 of	 that	 same	 leader	 following	 p21	immunostaining.	(I)	Quantification	of	single-cell	nuclear	p21	intensities	of	barrier	release-induced	leaders	versus	surrounding	non-leaders.	
A	sample	size	of	at	least	1200,	942,	867,	and	1057	leaders	would	be	required	to	perform	statistical	analysis	in	(B),	(D),	(G),	and	(I),	respectively.	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
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size	of	leaders.	Next	I	plated	two	pools	of	wild-type	cells	into	a	twin-chambered	silicone	mould	with	a	barrier	separating	the	two	populations	(schematic	in	Figure	VII.1E).	When	the	 cells	 reached	 confluence,	 I	 removed	 the	 barrier	 and	 followed	 the	 migration	 of	subsequently	formed	leaders.	Upon	fixation	and	immunostaining,	I	showed	that	leaders	generated	by	barrier	release	also	indicated	a	slight	increase	in	both	p53	(Figure	VII.1F	and	G)	and	p21	(Figure	VII.1H	and	I).	
Taken	together,	I	demonstrated	that	p53	and	p21	are	activated	in	leaders	generated	by	scratching	 and	 barrier	 release,	 suggesting	 their	 involvement	 in	 canonical	 leader	 cell	migration.	
	
p53 activity drives migration at the wound edge 
I	next	tested	whether	the	p53/p21	pathway	plays	an	active	role	in	leader	cell	migration	during	wound	healing.	 I	hypothesised	that	 inhibiting	 the	pathway	should	decrease	 the	speed	of	wound	healing,	as	fewer	leaders	would	be	formed	and	thus	make	wound	closure	less	 efficient.	 Conversely,	 activating	 p53	 in	 cells	 at	 the	 wound	 edge	 should	 boost	 the	number	of	leaders	and	hence	also	increase	wound	closure	rates.	
I	had	initially	performed	wound	healing	assays	with	p53KO	cells,	which	developed	finger-like	protrusions	and	closed	the	wound	comparably	to	wild-type	cells	(data	not	shown).	I	hypothesised	that	the	p53KO	line	may	have	acquired	background	mutations	due	to	its	compromised	 tumour	 suppressor	 activity	 and	 was	 therefore	 able	 to	 overcome	 the	requirement	for	p53	in	leader	migration.	To	avoid	any	such	genetic	background	effects,	I	chose	to	 inhibit	 the	p53	pathway	more	acutely	and	use	a	dominant	negative	peptide,	GSE-22.	
The	 GSE-22	 peptide	 is	 derived	 from	 full	 length	 p53	 and	 has	 been	 reported	 to	 have	 a	dominant	negative	effect	on	p53	function:	GSE-22	stabilises	p53	but	the	latter	is	rendered	functionally	 inactive	 (Ossovskaya	 et	 al.	 1996).	 The	 original	 construct	was	made	 up	 of	amino	acids	312-391	from	rat	p53.	I	amplified	the	sequence	encoding	the	homologous	canine	amino	acids	(302-381)	from	a	cDNA	library	obtained	from	scribKD	MDCKs,	which	express	p53	at	high	levels.	In	accordance	with	the	original	publication,	I	cloned	an	adaptor	with	 three	 start	 ATG	 codons	 in	 front	 of	 the	 GSE-22	 coding	 sequence	 and	 a	 fragment	
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containing	 three	 stop	 codons	 behind	 it	 to	 account	 for	 all	 three	 reading	 frames.	 I	 then	introduced	this	into	a	DOX-inducible	lentivirus	expressing	GFP-NLS	in	tandem	with	GSE-22	(Appendix	2F).	I	transduced	wild-type	cells	with	the	GSE-22	lentivirus	and	selected	an	antibiotic-resistant	pool.	
While	I	could	not	verify	GSE-22	expression	directly	due	to	loss	of	the	anti-p53	antibody	epitope,	 I	 could	detect	quite	uniform	 levels	of	GFP-NLS	 in	 the	antibiotic-selected	pool,	which	was	a	proxy	 for	GSE-22	expression	 (Figure	VII.2A	and	B).	Remarkably,	 scratch-wounds	 of	 cells	 expressing	 GSE-22	 closed	 at	 a	 significantly	 slower	 rate	 than	 control	scratches	in	the	absence	of	DOX,	as	quantified	(Figure	VII.2C-E).	This	suggests	that	p53	activity	is	essential	for	efficient	wound	closure	in	MDCKs.	That	said,	it	would	be	important	to	additionally	use	an	indirect	readout	for	p53	activity	to	confirm	whether	increased	GSE-22	expression	 translates	 into	 impaired	p53	 signalling	by,	 for	 example,	 comparing	p21	levels	of	Nutlin-treated	cultures	in	the	presence	and	absence	of	GSE-22.	
To	 complement	 this	 finding,	 I	 next	 sought	 to	 specifically	 activate	 p53	 at	 the	 edge	 of	scratch-wounds.	The	localisation	of	p53	activity	just	to	the	edge	cells	was	crucial,	as	I	have	previously	shown	p53	activity	is	only	elevated	in	leader	cells,	while	followers	have	low	p53,	and	that	this	imbalance	in	p53	expression	is	crucial	for	leader	migration.	I	used	a	405	nm	laser	to	induce	sub-lethal	DNA	damage	exclusively	in	the	front	row	of	cells	of	a	scratch-wound	(Figure	VII.2F).	 I	used	 immunostaining	against	𝛾H2AX,	a	 form	of	histone	H2AX	specifically	phosphorylated	in	response	to	DSBs	(Kuo	&	Yang	2008),	to	verify	that	DNA	damage	was	indeed	generated	in	response	to	UV	treatment	(Figure	VII.2G).	It	remains	to	be	 formally	demonstrated	whether	p53	 is	 elevated	 in	 the	 irradiated	 cells	 under	 these	experimental	conditions,	which	could	be	assessed	by	anti-p53	immunofluorescence.	
Importantly,	 I	 only	 irradiated	 the	 top	half	 of	 one	 side	of	 a	 scratch-wound	and	not	 the	bottom	half.	I	then	compared	the	migration	speeds	of	the	irradiated	and	non-irradiated	halves	 within	 the	 same	 wound:	 this	 helped	 control	 for	 other	 factors	 that	 may	 have	influenced	the	migration	speed	e.g.	cell	density	or	soluble	factors	leaking	into	the	media	from	damaged	cells.	Using	this	technique,	I	showed	that	laser-mediated	p53	activation	in	cells	at	the	wound	edge	resulted	in	significantly	faster	migration	and	wound	closure	rates	than	those	observed	for	untreated	edges	(Figure	VII.2H-J).	
	 	
	 98 
	
		
Figure	 VII.2:	 p53	 activity	 drives	 leader	 cell	 migration	 during	 wound	 healing.	 (A-B)	 Homotypic	cultures	of	wild-type	cells	overexpressing	GSE-22,	a	dominant	negative	p53	peptide,	and	nuclear	GFP	in	a	DOX-inducible	 manner.	 (C-E)	 Movie	 stills	 of	 uninduced	 wild-type	 cultures	 (C)	 or	 cultures	 induced	 to	overexpress	the	GSE-22	peptide	(D)	following	a	scratch-wound.	The	fields	were	chosen	to	be	representative	of	the	median	front	migration	speeds	of	each	population,	quantified	in	(E).	Here	and	in	(H)	and	(I):	white	dashed	lines	mark	the	wound	edge	at	the	beginning	of	the	experiment;	black	dashed	lines	mark	the	wound	edge	at	the	end	of	the	experiment.	Here	and	in	(J):	black	bars	represent	the	median;	p	values	were	calculated	using	the	K-S	test;	n	=	number	of	fields.	(F)	Schematic	illustrating	the	experimental	design	to	test	whether	p53	activation	through	UV	irradiation	is	sufficient	to	accelerate	wound	healing,	shown	in	(H-I).	(G)	The	first	panel	 is	 a	 confocal	 image	 of	 a	 scratch-wound	 edge	 generated	 in	 a	 Hoechst-treated	 wild-type	 MDCK	monolayer	prior	UV	irradiation	of	the	left	half	of	the	edge	cells;	the	UV	target	region	is	marked	using	the	green	line.	The	last	two	panels	are	confocal	images	of	a	𝛾H2AX	immunostaining	of	the	same	scratch	area	
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approximately	2	hours	post	UV	treatment.	 (H-J)	Movie	stills	of	non-irradiated	wild-type	cultures	(H)	or	wild-type	 cultures	 treated	with	 a	 sub-lethal	 dose	 of	 UV	 (I)	 following	 a	 scratch-wound.	 The	 fields	were	chosen	to	be	representative	of	the	median	front	migration	speeds	of	each	population,	quantified	in	(J).	
Scale	bars	=	100	μm	for	movie	sequences	and	50	μm	for	immunofluorescence	images.	
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Taken	together,	I	have	shown	that	p53	activity	is	likely	both	necessary	and	sufficient	to	drive	efficient	wound	closure	in	the	MDCK	scratch-wound	model.	
	
Spontaneous and scratch-induced leaders are mechanical losers due to increased p53 
activity 
As	I	have	discussed	previously,	elevated	p53	levels	confer	the	mechanical	loser	status	on	cells.	 Considering	 that	 wound-generated	 leaders	 have	 elevated	 p53	 signalling,	 I	 next	investigated	what	happens	to	leader	cells	upon	wound	closure.	I	 imaged	the	closure	of	wild-type	MDCK	scratch-wounds	and	found	that	many	leaders	are	eliminated	when	the	two	wound	edges	meet	(Figure	VII.3A,	yellow	and	blue	arrows).	In	fact,	almost	40%	of	scratch-induced	 leaders	were	 eliminated	 at	wound	 closure,	 compared	 to	under	2%	of	non-leader	cells	present	at	the	wound	edge	at	the	same	cell	density	(Figure	VII.3B).	
Moreover,	when	I	followed	the	fate	of	spontaneous	leaders	that	had	been	surrounded	by	neighbours	with	standard	epithelial	morphology,	I	found	that	around	70%	of	the	former	were	 eliminated	 (Figure	 VII.3C	 and	 D).	 The	 binucleation	 frequently	 observed	 in	spontaneous	leaders	implies	that	they	maintain	high	p53	throughout	their	lifetime,	which	is	consistent	with	their	elimination	at	a	higher	frequency	than	scratch-induced	leaders.	I	suggest	that	p53	levels	in	wound-mediated	leaders	are	lower	and/or	less	‘terminal’	than	those	 of	 spontaneous	 leaders,	 which	 explains	 why	 fewer	 scratch-induced	 leaders	 are	eliminated.	
Taken	together,	 I	show	that	while	elevated	p53	signalling	drives	the	migration	of	both	wound-generated	and	spontaneous	leaders,	it	also	turns	them	into	mechanical	losers.	At	higher	 densities	 achieved	 through	 corralling	 by	 surrounding	 cells	 or	 wound	 closure,	sustained	high	p53	activity	results	 in	leaders’	hypersensitivity	to	cell	density	and	their	consequent	elimination.	
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Figure	 VII.3:	 Wound-generated	 and	 spontaneous	 leaders	 are	 often	 eliminated	 at	 higher	 cell	
densities.	(A)	Movie	stills	following	the	closure	of	a	wild-type	scratch-wound.	Leaders	indicated	in	yellow	and	blue	arrows	are	being	eliminated.	(B)	Quantification	of	the	number	of	leader	cells	that	are	eliminated	at	wound	closure,	compared	to	non-leader	cells	present	at	the	wound	edge.	The	comparison	was	made	at	cell	densities	where	leaders	tend	to	get	eliminated.	Here	and	in	(D):	n	=	number	of	cells	pooled	from	three	independent	repeats;	error	bars	±	SEM.	(C)	Movie	stills	following	the	migration	of	a	spontaneous	leader	(yellow	arrow)	that	is	eliminated	once	the	local	cell	density	increases.	(D)	Quantification	of	the	number	of	spontaneous	leaders	that	are	eliminated	when	surrounded	by	wild-type	neighbours.	
Scale	bars	=	100	μm.	
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Construction of a fluorescent p21 reporter 
An	important	question	raised	by	my	finding	that	~40%	of	wound-generated	leaders	are	eliminated	by	mechanical	cell	competition	concerns	the	fate	of	the	other	~60%.	I	propose	the	 two	 following	 hypotheses	 to	 explain	 why	 some	 scratch-induced	 leaders	 are	 not	eliminated.	Either	p53	elevation	in	non-eliminated	leaders	may	only	reach	a	 level	high	enough	 to	 trigger	 their	migration	via	p21	activation,	 but	 too	 low	 for	mechanical	 loser	status.	Alternatively,	p53-inducing	damage	sustained	by	these	leaders	during	wounding	may	 be	 repaired	 by	 the	 time	 the	 wound	 closes,	 lowering	 their	 p53	 back	 to	 levels	insufficient	for	density	hypersensitivity.	
One	way	to	correlate	the	p53	status	of	leader	cells	with	their	fate	would	be	to	use	a	live	reporter	 for	 p53	 activity.	 Rather	 than	 using	 a	 labelled	 version	 of	 p53,	 I	 modified	 a	previously	published	reporter	for	p21	activity	(Paek	et	al.	2016).	This	was	because	of	the	binary	nature	of	p21	expression,	which	I	had	noticed	myself	and	was	also	described	in	(Paek	et	al.	2016):	their	p21	sensor	has	very	little	background	fluorescence	and	is	capable	of	 responding	 quickly	 to	 stimuli	 with	 a	 very	 bright	 signal.	 The	 original	 p21	 sensor	consisted	of	destabilised	CFP-NLS	driven	by	the	human	p21	promoter;	I	used	the	same	principle	to	clone	a	GFP-NLS	version	of	the	p21	reporter	(Appendix	2G),	which	was	more	compatible	with	the	live	imaging	set	up	in	the	Piddini	lab	(Figure	VII.4A).	
I	 transfected	 the	 GFP-NLS	 p21	 reporter	 construct	 into	 wild-type	 MDCK	 cells.	 After	generating	 an	 antibiotic-resistant	 pool,	 I	 used	 immunofluorescence	 to	 identify	 three	clones	with	very	 low	background	signal	 that	 responded	 to	Nutlin	 treatment	by	strong	induction	of	nuclear	GFP,	as	assessed	by	confocal	microscopy	(Figure	VII.4B-D).	
Unfortunately,	due	to	time	constraints,	I	did	not	have	the	chance	use	these	p21	reporter	clones	 in	 an	 experimental	 setting.	 The	 next	 step	 would	 be	 to	 verify	 whether	 the	fluorescence	 produced	 in	 response	 to	 Nutlin	 treatment	 (and	 hence	 p53	 activation)	 is	bright	enough	for	the	live	imaging	set	up	in	the	Piddini	lab.	Following	this,	it	should	be	possible	 to	 visualise	 the	 emergence	 of	 GFP-positive	 leaders	 and	 correlate	 their	 GFP	intensities	with	their	 fate	at	wound	closure.	Considering	that	GFP	expression	 is	driven	directly	by	the	p53-responsive	p21	promoter,	it	might	be	possible	to	determine	whether	the	threshold	of	p53	activity	that	triggers	leader	migration	is	lower	than	that	conferring		  
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Figure	VII.4:	Construction	and	testing	of	the	p21	GFP	reporter	lines.	(A)	Schematic	representation	of	the	architecture	of	the	p21	reporter	construct.	NLS	=	nuclear	localisation	sequence.	PEST	=	destabilisation	sequence	rich	in	proline	(P),	glutamate	(E),	serine	(S),	and	threonine	(T).	(B-D)	Confocal	images	of	three	candidate	p21	reporter	clones	in	the	absence	(left	two	panels)	and	presence	(right	two	panels)	of	a	mild	dose	of	Nutlin-3.	Nutlin-3	addition	induces	a	reduction	in	cell	density	and	expression	of	GFP-NLS,	driven	by	the	p21	promoter.	
Scale	bars	=	50	μm.	
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mechanical	 loser	 status:	 if	 this	were	 true,	 eliminated	 leaders	would	 have	 consistently	brighter	GFP	signal	than	their	non-eliminated	counterparts.	Alternatively,	the	GFP	signal	might	spike	early	in	the	wound	healing	process	and	then	fall	back	down,	as	some	leaders	reduce	their	p53	activity	through	induction	of	repair	mechanisms.	
In	summary,	I	have	generated	and	verified	three	p21	reporter	clones	that	could	be	used	as	a	proxy	 to	measure	p53	activity	of	 leader	cells	during	 live	 imaging.	This	could	help	address	questions	regarding	the	p53	status	of	non-eliminated	leaders.	
	
Discussion 
I	have	shown	that	leaders	generated	by	barrier	release	and	scratching	have	elevated	p53	and	p21.	I	further	demonstrated	that	the	speed	at	which	an	MDCK	wound	front	migrates	is	 directly	 dependent	 on	p53	 activity,	 implying	 that	 p53	 is	 crucial	 for	 efficient	wound	healing.	Lastly,	 I	presented	evidence	to	suggest	that	elevated	p53	signalling	in	scratch-induced	 and	 spontaneous	 leaders	 results	 in	 their	 hypersensitivity	 to	 density	 and,	ultimately,	their	elimination.	
It	is	important	to	note	that	the	migration	speed	of	scratch-wound	fronts	was	measured	by	manually	drawing	freehand	lines	outlining	the	wound	edge	at	the	first	and	final	time	points.	If	any	wound	edges	were	not	parallel	to	the	y	axis,	the	images	were	adequately	rotated.	 The	median	 x	 position	 for	 each	 line	 was	 recorded	 to	 calculate	 the	median	 x	displacement	in	μm,	which	was	then	divided	by	the	duration	of	the	experiment	in	hours	to	generate	a	speed	value	in	μm/h.	An	important	consideration	of	this	approach	is	that	it	masks	the	individual	speeds	at	which	the	cells	in	the	front	are	migrating	by	assigning	a	single	speed	value	to	the	whole	front	within	a	field	of	view.	Calculating	the	rate	of	wound	area	shrinkage,	for	example,	could	have	provided	a	more	accurate	representation	of	the	speed	of	wound	closure.	Similarly,	one	could	have	calculated	the	rate	of	increase	in	the	area	 between	 the	 initial	 and	 final	 wound	 front	 positions	 to	 give	 a	 measure	 of	 front	advancement.	All	of	these	approaches	would	have	also	benefitted	from	stitching	together	fields	of	view	to	create	one	continuous	image	of	the	whole	wound,	rather	than	individually	analysing	subsections	of	it.	
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The	p53/p21	upregulation	observed	in	leaders	generated	by	barrier	release	or	scratching	can	be	explained	by	one	of	two	not	mutually	exclusive	theories:	wound-induced	damage	either	triggers	a	stress	response	that	elevates	p53/p21,	or	simply	exposes	cells	with	pre-existing	high	levels	of	p53/p21.	While	it	has	been	reported	that	barrier	release	does	little	damage	to	cells	in	contact	with	the	barrier	walls	(Poujade	et	al.	2007),	it	is	possible	that	cells	can	sense	minute	mechanical	distortions	and	translate	them	into	an	elevated	p53	response	 even	 if	 no	 gross	 damage	 can	 be	 detected	 through	 experimental	 means.	 In	support	of	 the	pre-existing	 leader	 theory,	 it	has	been	reported	that	 leader	cells	do	not	always	emerge	from	the	first	row	of	cells	(Poujade	et	al.	2007).	As	I	have	shown	in	the	case	of	spontaneous	 leaders,	cells	with	elevated	p53/p21	levels	occur	naturally	within	wild-type	populations	and	are	viable	at	lower	densities.	It	is	therefore	conceivable	that	wounding	 simply	 provides	 the	 space	 for	 the	 migration	 of	 pre-existing	 spontaneous	leaders	present	in	the	first	few	rows	of	cells.	
One	of	the	tools	that	could	be	used	to	distinguish	between	these	two	possibilities	are	the	MDCK	p21	reporter	lines	that	I	generated	to	indirectly	measure	p53	activity.	It	should	be	possible	to	use	live	imaging	techniques	to	test	whether	and	how	often	cells	with	elevated	GFP	levels	pre-wounding	become	leaders,	or	whether	wounding	generates	cells	with	high	GFP	signal	that	then	become	leaders.	In	fact,	I	expect	these	cell	lines	will	also	help	answer	other	 important	 questions:	 is	 there	 a	 threshold	 of	 p53	 activity	 that	 drives	 leader	migration,	but	 results	 in	 leader	elimination	 if	 exceeded?	Does	 the	p53	activity	of	non-eliminated	leaders	fall	back	down	to	 ‘normal’	 levels	prior	to	wound	closure	or	do	they	never	reach	levels	high	enough	for	elimination?	Do	all	cells	with	high	p21	and	space	to	migrate	into	become	leaders?	Do	all	leaders	show	elevated	p53/p21	activity?	
Although	 useful,	 the	 p21	 reporter	 line	 has	 an	 important	 limitation.	 While	 p21	transcription	is	mainly	regulated	by	p53	(reviewed	in	Sullivan	et	al.	2017),	p21	can	also	be	activated	in	p53-independent	ways	(reviewed	in	Karimian	et	al.	2016).	For	example,	TGFβ	can	activate	p21	transcription	through	elements	in	its	promoter	distinct	from	the	p53	response	elements	(Datto	et	al.	1995).	In	MDCK	leader	cell	migration,	I	suggest	that	p21	is	mainly	activated	through	a	p53-dependent	pathway:	p21	activation	is	necessary	for	 leader	 cell	 migration,	 but	 MMC-treated	 p53KO	 cells	 do	 not	 behave	 as	 leaders,	suggesting	 the	 presence	 of	 p53	 is	 required	 for	 p21	 activation.	 However,	 I	 have	 also	established	in	this	thesis	that	the	role	of	p53	in	mechanical	loser	status	is	separate	from		
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its	 p21-dependent	 role	 in	 leader	 migration.	 One	 should	 therefore	 be	 cautious	 when	making	conclusions	about	p53	activity	in	the	mechanical	loser	status	based	solely	on	the	p21	reporter.	
Taken	 together,	 I	 suggest	 a	model	where	 damage	 during	wounding	 induces	 p53/p21	activity	 in	several	cells	at	 the	scratch	edge	or	exposes	cells	with	pre-existing	p53/p21	elevation.	Elevation	of	the	p53	pathway	drives	the	leader	cell	phenotype	through	p21	and	promotes	migration.	The	free	space	in	the	wound	bed	and	the	discontinuity	of	high	to	low	p53/p21	between	 leaders	and	 followers	both	contribute	symmetry	breaking	cues	 that	drive	migration	into	the	wound	gap.	The	imbalance	of	p53/p21	activity	may	be	especially	important	to	give	directionality	to	the	migration	of	leaders	not	immediately	at	the	wound	edge.	 Importantly,	 sustained	 high	 p53	 ensures	 elimination	 of	 cells	 with	 irreparable	damage	through	mechanical	cell	competition	once	the	wound	is	sealed.	All	in	all,	p53/p21	activity	 drives	 leader	 cell	 migration	 into	 the	 wound	 gap	 to	 promote	 efficient	 wound	healing	and	ensures	the	elimination	of	cells	damaged	beyond	repair	from	the	epithelium	(Figure	VII.5).	
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Figure	 VII.5:	 Schematic	 diagram	 summarising	 the	 role	 of	 p53/p21	 in	 wound	 healing.	 Cells	 with	elevated	p53/p21	activity	emerge	as	a	 consequence	of	damage	during	wounding	or	because	 scratching	opens	 up	 space	 for	 the	migration	 of	 cells	with	 pre-existing	 p53/p21	 elevation	 (the	 latter	 option	 is	 not	portrayed).	Increased	p53/p21	activity	drives	the	migratory	phenotype,	while	the	imbalance	of	p53/p21	activity	between	leaders	and	followers	helps	direct	leaders	into	the	wound	gap.	Upon	wound	closure,	the	local	cell	density	 increases	and	 leaders	with	persisting	p53	elevation	are	eliminated	via	mechanical	cell	competition.	
Adapted	from	images	commissioned	by	Eugenia	Piddini	from	Veronique	Juvin	of	SciArtWork.	
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Chapter VIII: Cell cycle inhibitors may be the universal drivers of leader cell 
migration 
	Cell	cycle	arrest	is	a	common	feature	of	many	types	of	MDCK	leader:	canonical	leaders,	spontaneous	leaders,	MMC-treated	cells,	and	p21OE	cells.	That	said,	cell	cycle	arrest	is	not	a	prerequisite	for	leader	cell	fate,	as	scribKD	cells	and	Nutlin-treated	cells	are	both	leaders	but	continue	dividing,	if	at	a	slower	rate	than	untreated	wild-type	cells.	Importantly,	slow	division	 implies	 that	 scribKD-	 and	 Nutlin-mediated	 leaders	 maintain	 some	 cell	 cycle	inhibitor	activity	and,	in	fact,	p21	(and	potentially	other	cell	cycle	inhibitors)	is	expressed	in	both	types	of	leader	(Wagstaff	et	al.	2016	and	Figure	VI.2D,	respectively).	I	therefore	decided	to	investigate	whether	elevated	cell	cycle	inhibitor	activity	could	be	a	common	factor	that	induces	leader	migration.	
The	activity	of	cyclin/cyclin-dependent	kinase	(CDK)	complexes	is	crucial	for	cell	cycle	progression.	One	way	in	which	CDKs	are	regulated	is	by	interaction	with	CDK	inhibitors	(CKIs).	CKIs	have	been	classified	into	two	families,	INK4	and	Cip/Kip,	each	of	which	have	different	specificities	and	mechanisms	of	CDK	inhibition.	p21WAF1/Cip1	and	p27Kip1	(from	here	on	referred	to	as	p27)	are	part	of	the	Cip/Kip	CKI	family	and	share	a	common	N-terminal	motif	responsible	for	binding	to	cyclin/CDK	complexes,	but	they	also	have	their	own	distinct	functions.	For	example,	p21	has	been	shown	to	inhibit	DNA	replication	by	binding	 to	 a	 DNA	 polymerase	 processivity	 factor,	 proliferating	 cell	 nuclear	 antigen	(PCNA).	In	contrast,	p27	does	not	bind	PCNA	but	has	been	reported	to	interact	with	and	inhibit	 a	 helicase	 subunit	 at	 the	 replication	 fork	 to	 stall	DNA	 replication	 (reviewed	 in	Besson	et	al.	2008).	
p16INK4A	(from	here	on	referred	to	as	p16)	is	part	of	the	INK4	CKI	family	and	therefore	evolutionarily	distinct	from	p21	and	p27	(reviewed	in	Besson	et	al.	2008).	p16	specifically	inhibits	 CDK4	 and	 CDK6	 but	 can	 also	 stop	 cell	 cycle	 progression	 in	 CDK-independent	ways,	just	like	p21	and	p27.	For	instance,	p16	has	been	shown	to	inhibit	phosphorylation	of	a	subunit	of	RNA	polymerase	II,	which	contributes	to	cell	cycle	arrest	(reviewed	in	Li	et	al.	2012).	
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While	 p21	 is	 a	 direct	 transcriptional	 target	 of	 p53,	 this	 has	 not	 been	 shown	 for	 the	structurally	 related	 p27	 (Zhang	 et	 al.	 2005).	 There	 is	 also	 little	 evidence	 for	 the	relationship	between	p53	and	p16:	so	far,	it	has	only	been	reported	that	p53	is	necessary	but	not	sufficient	for	the	repression	of	p16	(Leong	et	al.	2009).	I	would	therefore	argue	that	both	the	regulation	and	the	downstream	targets	of	 the	 three	CKIs	 in	question	are	quite	distinct.	Consequently,	I	used	manipulation	of	p27	and	p16	to	achieve	two	largely	independent	ways	of	cell	cycle	arrest	(alongside	p21	overexpression	discussed	in	Chapter	VI)	to	test	the	requirement	for	cell	cycle	inhibition	in	leader	cell	migration.	
	
Cell cycle inhibitors p27 and p16 are elevated in various types of MDCK leaders 
I	first	wanted	to	know	if	p27	and	p16	are	expressed	and/or	upregulated	in	MDCK	leader	cells,	as	this	could	indicate	their	potential	involvement	in	the	leader	status.	Interestingly,	nuclear	p27	tended	to	be	higher	in	spontaneous	leaders	than	in	wild-type	follower	cells	(Figure	 VIII.1A	 and	 B),	 but	 the	 statistical	 power	 was	 not	 sufficient	 to	 be	 completely	conclusive.	I	only	took	nuclear	signal	 into	consideration,	as	that	is	where	the	CDKs	are	localised	 and	 can	 be	 inhibited	 by	 p27.	Moreover,	 I	 noticed	 that	 nuclear	 p16	was	 also	elevated	in	spontaneous	leaders	(Figure	VIII.1C),	but	this	was	just	a	preliminary	finding,	as	 I	only	performed	this	 immunostaining	once.	Further	pilot	experiments	also	showed	that	nuclear	p27	appeared	to	be	increased	in	scratch-induced	leaders	(Figure	VIII.D)	and	in	 leaders	 generated	 by	 p21	 overexpression	 (Figure	 VIII.E),	 but	 this	 needs	 further	confirmation.	
Assuming	these	observations	can	be	reproduced,	both	p27	and	p16	appear	elevated	in	different	types	of	leader	cell	and	might	therefore	be	contributing	to	the	leader	phenotype.	
	
p27 and p16 independently drive leader cell migration but are not responsible for 
mechanical loser status 
In	 order	 to	 test	 whether	 p27	 and/or	 p16	 have	 an	 instructive	 role	 in	 leader	 status,	 I	generated	 two	 DOX-inducible,	 lentiviral	 overexpression	 constructs:	 canine	 p27	 and		 	
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Figure	VIII.1:	CDK	inhibitors	p27	and	p16	are	elevated	in	different	types	of	MDCK	leader.	(A)	Nuclear	p27	is	elevated	in	spontaneous	leaders	emerging	from	wild-type	cultures.	(B)	Quantification	of	single-cell	nuclear	p27	intensities	in	spontaneous	leaders	versus	surrounding	non-leaders.	Black	bars	represent	the	median.	n	=	number	of	cells.	A	sample	size	of	at	least	138	leaders	would	be	required	to	perform	statistical	analysis.	 (C)	 Confocal	 images	 following	 immunostaining	 against	 p16	 on	 spontaneous	 leaders.	 (D)	 p27	immunostaining	on	 leaders	generated	by	scratching	of	a	wild-type	MDCK	monolayer.	 (E)	Co-cultures	of	GFP-labelled	wild-type	cells	and	unlabelled	p21OE	cells	following	immunostaining	against	p27.	
Scale	bars	=	50	μm.	
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human	 p16,	 each	 expressed	 in	 tandem	 with	 nuclear	 RFP	 (Appendix	 2H	 and	 I,	respectively).	 I	 used	 human	 p16	 because	 it	 was	 available	 in	 a	 plasmid	 backbone	 and	therefore	easier	to	amplify	by	PCR.	This	was	justified,	as	there	is	83%	sequence	identity	between	human	and	canine	p16	(Altschul	et	al.	1997).	I	individually	transduced	wild-type	MDCKs	with	the	lentiviral	p27	and	p16	constructs	and	used	antibiotic	selection	to	make	pool	populations	overexpressing	p27	(p27OE)	or	p16	(p16OE).	Remarkably,	both	p27OE	and	p16OE	cells	 flattened	 in	 the	presence	of	DOX	(Figure	VIII.2A-D),	much	 like	p21OE	cells	and	a	subpopulation	of	P-cadOE	cells.	It	is	worth	noting	that	the	p27OE	and	p16OE	pools	 flattened	 much	 more	 uniformly	 than	 the	 P-cadOE	 pool,	 most	 likely	 due	 to	 the	smaller	 size	 of	 the	 constructs	 and	 hence	 more	 efficient	 packaging	 into	 the	 lentiviral	particles	(Kumar	et	al.	2001).	
Strikingly,	when	I	co-cultured	wild-type	cells	expressing	nuclear	GFP	with	p27OE,	I	found	that	 p27OE	 cells	 displayed	 leader	 behaviour	 (Figure	 VIII.2E).	 Similarly,	 p16OE	 cells	juxtaposed	by	wild-type	cells	also	behaved	as	leaders	(Figure	VIII.2F).	I	could	also	show	that	neither	p27OE	(Figure	VIII.2G)	nor	p16OE	clones	(Figure	VIII.2H)	were	eliminated	at	higher	cell	densities	 in	competing	cultures,	but	this	should	be	confirmed	in	a	stretcher	assay.	Taken	together,	I	show	that	elevation	of	p27	or	p16	(just	like	p21)	is	sufficient	for	leader	cell	behaviour	but	not	mechanical	loser	status.	
	
Chemical cell cycle inhibition may be sufficient for leader cell fate 
p21,	p27,	and	p16	have	all	been	shown	to	have	functions	outside	their	role	as	CKIs.	For	example,	p21	and	p27	can	inhibit	the	Rho/ROCK/LIMK/cofilin	signalling	pathway,	which	normally	stabilises	actin	filaments	and	maintains	stress	fibres	(reviewed	in	Besson	et	al.	2008).	I	therefore	wanted	to	test	whether	p21,	p27,	and	p16	induce	leader	fate	through	activation	of	their	CDK	inhibitory	role	or	another	function	that,	for	instance,	affects	the	cytoskeleton	directly.	
To	 address	 this,	 I	 performed	pilot	 experiments	using	 a	 chemical	 inhibitor	 of	 CDK1	on	actively	 migrating	 leaders	 generated	 by	 scratching	 wild-type	 MDCK	 monolayers.	 As	expected,	 cells	 treated	 with	 CDK1	 inhibitor	 stopped	 proliferating	 and,	 interestingly,	acquired	a	more	flattened	morphology	than	their	untreated	counterparts	(Figure	VIII.3A).		 	
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Figure	 VIII.2:	 Overexpression	 of	 CDK	 inhibitors	 p27	 and	 p16	 is	 sufficient	 to	 drive	 the	 leader	
phenotype	but	does	not	confer	the	mechanical	 loser	status.	 (A-D)	Homotypic	cultures	of	unlabelled	cells	overexpressing	p27	(p27OE)	(A-B)	or	p16	(p16OE)	(C-D)	in	a	DOX-inducible	manner.	Overexpression	
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of	either	p27	or	p16	induces	cell	cycle	arrest	and	flattening	(B,	D),	compared	to	DOX-free	conditions	(A,	C).	The	insets	are	2x	zooms	of	the	cell	populations	at	32	hours	to	better	demonstrate	cell	flattening	in	the	+DOX	conditions.	(E-F)	Movie	stills	from	co-cultures	of	GFP-labelled	wild-type	cells	and	p27OE	(E)	or	p16OE	(F)	cells.	White	dashed	 lines	mark	the	 initial	contact	point;	black	dashed	 lines	mark	the	 final	contact	point.	(G-H)	Neither	p27OE	(G)	nor	p16OE	(H)	clones	(marked	in	white	dashed	lines)	are	eliminated	at	higher	densities	when	surrounded	by	GFP-labelled	wild-type	cells.		
Scale	bars	=	100	μm.	
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Strikingly,	 acute	CDK1	 inhibition	was	 sufficient	 to	 halt	 leader	 cell	migration	 following	scratching	(Figure	VIII.3B	and	C).	Based	on	these	observations,	I	hypothesised	that	CDK1	inhibition	caused	follower	cells	to	become	more	leader-like	and	the	asymmetry	between	leaders	 and	 followers	was	 lost.	 This	meant	 that	 leader	 cell	migration	 could	 no	 longer	proceed	directionally	 into	 the	wound	gap.	This	 suggests	 that	 the	 free	 space	generated	after	scratching	is	not	sufficient	to	drive	efficient,	directional	leader	migration	across	the	wound	bed:	a	molecular	imbalance	between	leaders	and	followers	is	also	required.	
These	experiments	strongly	suggest	that	CDK1	inhibition	is	sufficient	to	confer	the	leader	cell	 fate.	 The	 next	 step	 would	 be	 to	 irreversibly	 inhibit	 CDK1	 in	 one	 population	 and	confront	 it	 with	 wild-type	 cells	 to	 test	 if	 the	 CDK1-deficient	 population	 becomes	migratory.	It	is	also	important	to	note	that	because	of	the	preliminary	nature	of	these	data,	I	cannot	exclude	the	possibility	that	chemical	CDK1	inhibition	activates	one	of	the	known	drivers	of	leader	migration	e.g.	p21.	It	is	possible	that	acutely	activating	p21	in	all	cells	within	a	scratch-wound	would	have	a	similar	effect	of	the	leader	cell	migration	as	CDK1	inhibition:	wound	closure	would	stall	because	of	loss	of	asymmetry	between	leaders	and	followers.	Without	further	investigation,	I	cannot	conclusively	say	that	CDK1	inhibition	confers	the	leader	cell	status	independently	of	other	leader	cell	drivers.	
My	 preliminary	 experiments	 imply	 that	 cell	 cycle	 inhibition	 itself	 is	 sufficient	 for	 the	leader	cell	status.	If	this	can	be	confirmed,	I	would	like	to	investigate	if	there	is	common	pathway	activated	downstream	of	cell	cycle	arrest	factors	that	drives	expression	of	the	leader	signature.	
	
Discussion 
The	 data	 I	 present	 in	 this	 chapter	 supports	 the	 role	 of	 cell	 cycle	 inhibition	 being	 a	universal	driver	of	leader	cell	fate	in	MDCK	cells.	p27	and	p16	are	elevated	in	many	types	of	MDCK	leader	and	independently	overexpressing	them	is	sufficient	to	trigger	leader	cell	migration.	What	is	more,	chemical	CDK1	inhibition	stalls	the	migration	of	scratch-induced	leaders	by	(potentially)	eradicating	the	asymmetry	between	leaders	and	followers	that	is	necessary	for	the	directional	progression	of	leaders	across	the	wound	gap.	 	
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Figure	VIII.3:	Chemical	CDK1	inhibition	is	sufficient	to	stall	leader	cell	migration	following	a	scratch-
wound	to	an	MDCK	monolayer.	(A)	CDK1	inhibition	using	RO-3306	(right	panel)	results	in	cell	cycle	arrest	and	flattening,	compared	to	the	solvent-only	condition	(left	panel).	(B-C)	Addition	of	the	CDK1	to	actively	migrating	scratch-induced	leaders	results	in	their	stalling.	The	yellow	asterisks	indicate	the	positions	of	two	leaders	when	treatments	were	added	at	the	beginning	of	the	experiment.	
Scale	bars	=	100	μm.	
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Considering	 these	 observations	 and	 that	 p21OE	 cells	 are	 also	 leaders,	 it	 is	 likely	 that	mediators	of	 cell	 cycle	 inhibition	activate	 a	 common	set	of	 targets	 responsible	 for	 the	leader	cell	phenotype.	If	chemical	CDK1	inhibition	can	be	shown	to	be	independent	of	p21,	p27,	and	p16	and	confer	the	leader	cell	fate	in	co-culture	assays,	this	would	demonstrate	that	 the	 cell	 cycle	 inhibitory	 role	 of	 the	 three	CKIs	 tested	 is	 the	 driving	 factor	 behind	leader	cell	fate,	rather	than	any	of	their	alternative	roles	(e.g.	direct	modification	of	the	cytoskeleton).	I	therefore	propose	that	p21,	p27,	and	p16	all	likely	lie	upstream	of	leader	signature	expression	and	thus	leader	cell	 fate.	Alternatively,	p27	and	p16	may	activate	distinct	factors,	which	are	responsible	for	the	increased	motility	and	other	cytoskeletal	changes	 permissive	 to	 leader	 status	 in	 parallel	 to	 those	 downstream	 of	 p21.	 Testing	whether	 p27OE	 and	 p16OE	 cells	 express	 leader	 cell	 markers	 would	 help	 distinguish	between	these	hypotheses.	
In	light	of	the	findings	and	hypotheses	discussed	in	this	chapter,	I	would	like	to	re-discuss	several	aspects	of	leader	cell	migration	and	the	mechanical	loser	status:	
	
(i) scribKD p53KO cells and the leader signature 
Firstly,	 p53/p21	activity	 is	 necessary	 for	 leader	 cell	migration	but	 scribKD	 p53KO	 cells	behave	as	leaders	despite	having	no	p53	or	p21	activity.	In	Chapter	VI,	I	suggested	that	
scribKD	p53KO	cells	may	be	activating	a	p53-	and	p21-independent	pathway	upstream	of	the	leader	cell	signature	that	this	induces	their	leader	behaviour.	While	I	have	not	tested	whether	p27OE	and	p16OE	cells	express	leader	cell	markers	like	PI3K	and	E-cadherin,	I	would	expect	that	they	do,	based	on	their	flattened	morphology	and	leader	behaviour.	If	so,	activation	of	other	CKIs	like	p27	and	p16	may	be	driving	scribKD	p53KO	cell	migration;	this	could	be	tested	by	immunostaining	of	scribKD	p53KO	cultures	against	p27	and	p16.	
That	said,	scribKD	p53KO	cells	are	an	exception,	as	I	have	shown	in	Chapter	V	that	the	bulk	of	leader	cell	migration	is	p53-dependent	(~80%,	Figure	V.2H).	I	therefore	propose	that	the	MDCK	leader	cell	phenotype	is,	in	majority	of	cases,	a	consequence	of	p53-dependent	p21	activation.	In	the	absence	of	p53,	p53-independent	activation	of	other	CKIs	like	p27	and	 p16	 may	 be	 responsible	 for	 leader	 migration	 and	 feed	 into	 leader	 signature	expression.	To	test	this	hypothesis,	one	could	for	example	use	the	p21	reporter	cell	line	I	generated	 to	 ask	what	 percentage	 of	 scratch-induced	 leaders	 have	 elevated	 p21,	 and	
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whether	any	that	do	not	upregulate	p21	elevate	p27	and/or	p16	instead.	It	would	also	be	important	to	find	out	what	factors	lie	upstream	of	p27	and	p16	activation	and	whether	there	is	any	interplay	between	them,	as	p27	expression	in	p21OE	cells	would	suggest.	It	also	remains	unknown	how	CKIs	mediate	leader	cell	signature	expression.	
	
(ii) Flattening 
Secondly,	I	have	shown	that	flattening	is	a	common	feature	of	most	leaders:	scribKD	cells,	P-cadOE	cells,	 spontaneous	 leaders,	MMC-generated	 leaders,	p21OE	cells,	p27OE	cells,	and	p16OE	 cells.	Wound-induced	 leaders	 have	 also	 been	described	 as	 having	 a	 larger	surface	area	(Poujade	et	al.	2007).	This	implies	that	cell	flattening	may	be	a	prerequisite	for	leader	behaviour.	I	have	however	shown	that	MMC-treated	p53KO	and	p21KO	cells	are	flat	but	do	not	behave	as	leaders.	I	would	therefore	argue	that	flattening	may	be	necessary	but	is	not	sufficient	for	leader	cell	fate;	this	hypothesis	would	need	testing	experimentally.	Micropatterning	 could	 be	 used	 to	 prevent	 cell	 flattening	 upon,	 for	 example,	 p21	overexpression.	 It	 would	 however	 be	 difficult	 to	 test	 if	 cells	manipulated	 in	 this	way	became	leaders	because	generating	space	for	migration	would	also	allow	flattening.	To	test	whether	flattening	is	sufficient	for	the	leader	phenotype,	one	could	use	an	established	method	to	induce	cell	flattening	(e.g.	trapping	cells	between	glass	and	a	sheet	of	agar	and	then	wicking	away	some	of	the	media	to	lower	the	agar	sheet)	and	ask	whether	this	is	sufficient	for	expression	of	leader	signature	markers	(Westendorf	et	al.	2010).	
	
(iii) Leader cell migration and mechanical loser status 
Thirdly,	p21OE,	p27OE,	and	p16OE	cells	are	all	leaders	in	co-culture	with	wild-type	cells	but	they	are	not	eliminated	as	cell	density	increases,	suggesting	they	are	not	mechanical	losers.	Mechanical	 losers	have	 three	defining	 features	 in	 the	MDCK	system:	 flattening,	lower	homeostatic	density,	and	hypersensitivity	to	density	(Wagstaff	et	al.	2016).	While	overexpression	of	p21,	p27,	or	p16	is	correlated	with	cell	flattening	and	therefore	a	lower	homeostatic	 density,	 it	 does	 not	 appear	 to	 be	 sufficient	 for	 cells’	 hypersensitivity	 to	density.	 If	 these	 observations	 are	 confirmed	 using	 stretcher	 experiments,	 and	immunoblotting	of	p21OE,	p27OE,	and	p16OE	cells	shows	that	p53	is	indeed	inactive,	it	
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would	argue	that	p53	elevation	confers	density	hypersensitivity	independently	of	leader	cell	 migration.	 It	 remains	 unknown	what	 factors	 downstream	 of	 p53	 are	 involved	 in	conferring	density	hypersensitivity.	This	could	be	investigated	using	chemical	inhibitors	of	known	downstream	p53	effectors	to	pinpoint	which	of	its	signalling	branches	may	play	a	part.	
	
(iv) Senescence and wound healing 
Many	 of	 the	 MDCK	 leaders	 described	 in	 this	 thesis	 share	 many	 features	 with	 cells	undergoing	senescence.	Senescence	can	be	 triggered	by	cellular	damage	(e.g.	 telomere	loss,	ROS,	oncogene	activation)	and	some	developmental	processes	(e.g.	polyploidy,	cell	fusion).	 Senescence	 plays	 a	 role	 in	 physiological	 processes	 that	 promote	 clearance	 of	damaged	 or	 ageing	 cells	 and	 boost	 tissue	 regeneration,	 as	 well	 as	 in	 the	 removal	 of	transient	developmental	structures	and	pre-malignant	cells.	However,	senescent	cells	can	accumulate	after	persistent	damage,	or	due	to	ageing	that	compromises	their	clearance,	and	this	can	have	detrimental	effects	on	the	tissue	(reviewed	in	Muñoz-Espín	&	Serrano	2014).	
Senescent	cells	are	cell	cycle	arrested	and	can	be	characterised	by	several	molecular	and	morphological	 markers,	 although	 they	 do	 not	 always	 display	 all	 of	 these	 features.	Senescent	cells	 in	vitro	can	be	multinucleated,	 tend	to	be	 flat,	and	have	 large	vacuoles,	although	in	vivo	their	morphology	is	determined	by	their	host	tissue.	They	have	also	been	shown	to	express	a	multitude	of	tumour	suppressors	and	cell	cycle	inhibitors,	including	p53,	 p21,	 p16,	 and	 p27.	 Increased	 lysosomal	 activity	 in	 senescent	 cells	 allows	 for	detection	 of	 arguably	 the	most	 common	 senescence	marker,	 senescence-associated	 β-galactosidase	 (SAβGAL).	 Additionally,	 senescent	 cells	 secrete	 extracellular	 proteins	 as	part	of	a	senescence-associated	secretory	phenotype	(SASP),	which	acts	in	an	autocrine	and	paracrine	manner	to	reinforce	and	promote	senescence	(reviewed	in	Muñoz-Espín	&	Serrano	 2014).	 The	 SASP	 is	 also	 responsible	 for	 attracting	 immune	 cells,	 which	 clear	senescent	cells	from	tissues	(reviewed	in	Lujambio	2016).	
Many	 senescent	 cells	 are	 not	 migratory	 and	 it	 has	 been	 hypothesised	 that	 ECM	degradation	by	SASP	components	may	impair	wound	healing	(reviewed	in	Burton	2009).		 	
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More	recently,	however,	it	was	demonstrated	the	presence	of	senescent	fibroblasts	and	endothelial	cells	accelerates	wound	repair	in	mouse	models.	This	depends	on	PDGF-AA	secretion	that	promotes	wound	contraction,	rather	than	migration	(Demaria	et	al.	2015).	Interestingly,	senescent	cells	can	also	be	detected	at	invasive	borders	in	papilliary	thyroid	carcinoma	 samples;	 the	 invasive	 area	 is	 also	 characterised	 by	 increased	 E-cadherin	expression.	Senescent	cells	in	the	thyroid	were	shown	to	attract	cancer	cells	and	promote	their	survival	through	a	chemokine	gradient,	which	hence	promotes	cancer	invasion	(Kim	et	 al.	 2017).	 Similarly	 to	 MDCK	 leaders,	 senescent	 cells	 can	 therefore	 play	 a	 role	 in	migration	and	wound	healing,	although	this	is	mediated	by	soluble	factors	and	does	not	appear	to	require	cell	contact.	
Clearly,	 MDCK	 leaders	 are	 very	 similar	 to	 senescent	 cells,	 both	 morphologically	 and	molecularly.	It	would	be	of	great	importance	to	determine	whether	MDCK	leaders	also	express	SAβGAL,	 the	hallmark	of	most	senescent	cells.	On	 the	other	hand,	 I	would	not	expect	leaders	to	secrete	many	SASP	components,	as	I	have	never	observed	a	propagation	of	 the	 leader	phenotype	 to	 follower	 cells,	 as	might	 be	 expected	 if	 soluble	 senescence-promoting	factors	were	present.	This	should	however	be	tested	experimentally.	If	MDCK	leaders	are	shown	to	be	senescent,	findings	from	one	system	could	be	translated	into	the	other.	 For	 example,	 p53-mediated	 mechanical	 competition	 may	 have	 a	 role	 in	 the	elimination	of	senescent	cells	from	tissues	in	vivo	in	the	absence	of	an	immune	response.	
	
(v) Quantifications 
It	 is	 important	 to	 point	 out	 that	 all	 cell	 migration	 within	 this	 thesis	 was	 assessed	qualitatively	by	analysing	movie	sequences	from	at	least	three	independent	repeats	with	at	least	10	fields	per	experiment.	While	I	took	great	care	to	minimise	bias	and	subjectivity	in	 my	 analyses,	 my	 conclusions	 could	 be	 further	 strengthened	 by	 performing	 new	quantifications	and	improving	on	the	ones	presented.	
Firstly,	 it	 would	 be	 advisable	 to	 quantify	 whether	 two	 populations	 are	 engaging	 in	collective,	directional	migration.	One	way	to	do	this	would	be	to	track	the	paths	taken	by	cells	 in	each	population	over	time	and	overlay	them.	The	migration	of	each	population	before	 and	 after	 leader/follower	 collision	 should	 be	 tracked:	 migration	 would		 	
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presumably	 be	 random	 prior	 to	 collision	 and	 more	 coordinated	 afterwards.	 If	 one	population	 could	 be	 shown	 to	 start	 migrating	 directionally	 first,	 one	 could	 also	demonstrate	which,	if	either,	population	was	leading	the	migration.	Quantifications	like	these	were	done	by	Medhavi	Vishwakarma	for	some	of	my	data	(Figure	V.2I-K	and	Figure	VI.1H-J)	and	it	would	be	prudent	to	do	them	for	all	other	migration	data	presented.	
Secondly,	several	of	my	quantifications	have	a	large	imbalance	in	the	numbers	of	leader	and	follower	cells	analysed	because	the	two	populations	exist	at	very	different	numbers	in	 the	 culture	 (e.g.	 Figure	 VII.1B).	 As	 discussed	 earlier,	 this	 poses	 a	 problem	 for	 the	statistical	 analysis	 and	 prevents	 one	 from	 determining	 whether	 there	 is	 a	 significant	difference	between	the	two	samples.	One	way	to	balance	out	the	numbers	of	leaders	and	followers	would	be	to	only	count	non-leader	cells	at	the	wound	edge	as	followers,	rather	than	all	the	non-leader	cells	in	the	field	of	view.	Naturally,	the	minimum	sample	size	of	leaders	required	for	this	new	follower	sample	size	would	still	have	to	be	calculated	before	any	statistical	tests	could	be	performed.	
Thirdly,	it	would	be	useful	to	establish	a	non-biased	way	for	identifying	leaders	in	wound	healing	 assays.	 For	 example,	 one	 could	 use	 pre-defined	 criteria	 to	 establish	 what	constitutes	a	finger-like	protrusion,	such	as	a	minimum	length	and	diameter.	One	could	then	define	a	pre-specified	number	of	cells	at	the	tip	of	a	finger-like	protrusions	as	leaders.	These	leaders	could	be	compared	to	followers	defined	as	cells	at	the	edge	of	the	trough	between	 fingers.	This	 approach	would	also	help	balance	out	 the	 leader	vs.	 non-leader	numbers,	so	that	quantifications	could	be	analysed	statistically.	
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Chapter IX: Conclusions and perspectives 
	In	 this	 thesis,	 I	 further	 characterised	 three	 aspects	 of	 cell	 competition	 in	MDCK	 cells.	Firstly,	I	investigated	the	roles	of	E-,	N-,	and	P-cadherin	in	the	directed	migration	triggered	following	 encounters	 between	 wild-type	 and	 scribKD	 cells;	 I	 later	 demonstrated	 this	migration	is	most	likely	a	manifestation	of	leader	behaviour.	I	also	briefly	probed	the	roles	of	classical	cadherins	in	the	mechanical	loser	status.	Secondly,	I	showed	that	the	signalling	pathway	responsible	for	the	acute	response	of	compacted	scribKD	cells	is	also	conserved	in	 p53-mediated	 competition.	 This	 is	 especially	 significant,	 because	 findings	 from	 the	
scribble	competition	system	can	now	be	more	easily	translated	to	other	situations	where	discontinuities	 in	p53	expression	are	present,	 some	of	which	are	of	prime	 therapeutic	interest	 (e.g.	 tumourigenesis).	Thirdly,	 I	 further	characterised	the	molecular	drivers	of	leader	cell	migration	and	showed	that	p53/p21	elevation	is	the	key	driver	of	the	leader	cell	phenotype.	This	is	the	first	time	(to	my	knowledge)	that	activation	of	a	single	pathway	was	shown	to	result	in	the	formation	of	leader	cells.	I	propose	that	the	p53/p21	imbalance	drives	the	migratory	phenotype,	provides	a	symmetry	breaking	cue	for	efficient	migration	across	the	wound	bed,	and	results	in	the	elimination	of	cells	with	sustained	damage	at	wound	closure.	My	findings	also	provide	an	explanation	as	to	how	only	some	cells	are	singled	out	to	become	leaders.	Lastly,	I	explored	the	possibility	that	cell	cycle	arrest	may	be	the	common	trigger	of	leader	fate,	which	could	constitute	an	alternative	pathway	for	the	clearance	of	senescent-like	cells	in	vivo.	
Please	refer	to	Figure	IX	for	a	model	integrating	the	findings	I	describe	in	this	thesis.	
	
Cadherins in loser recognition and leader migration 
scribKD	 cells	 display	 a	migratory	 phenotype	when	 confronted	with	wild-type	 cells	 and	express	 a	 range	 of	 markers	 also	 present	 in	 other	 types	 of	 MDCK	 leader.	 I	 therefore	propose	that	scribKD	cell	migration	is	in	fact	another	manifestation	of	leader	migration	and	that	findings	in	the	scribble	system	are	applicable	to	MDCK	leader	migration	as	a	whole.		 	
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Figure	IX:	Model	summarising	the	molecular	interactions	governing	leader	cell	migration	in	MDCKs.	p53	activation	as	a	result	of	wound-induced	damage,	scribble	knockdown,	or	Nutlin	treatment	(‘mild	p53	activation’)	leads	to	increased	p21	activity.	p21	drives	expression	of	a	number	of	markers	comprising	the	leader	cell	signature	(highlighted	in	magenta)	through	a	currently	uncharacterised	mechanism.	The	leader	signature	 is	 required	 for	 the	 leader	 cell	 fate	 downstream	of	 p21	 activation;	 the	 list	 of	 leader	 signature	components	is	not	necessarily	exhaustive.	Elevated	p53	simultaneously	confers	the	mechanical	loser	status	independently	of	p21	activity.	
I	 represent	 conclusions	 and	 implications	 from	 pilot	 experiments	 using	 dashed	 lines	 to	 indicate	 more	tentative	 connections	 that	 require	 further	 testing.	 Firstly,	 loss	 of	 scribble	 may	 feed	 into	 both	 p53/p21	activation,	as	well	as	a	parallel	pathway	like	p27	or	p16,	which	would	explain	how	scribKD	p53KO	maintain	the	leader	phenotype.	Secondly,	P-cadherin	overexpression	may	be	sufficient	for	both	leader	cell	fate	and	mechanical	loser	status:	how	this	links	into	what	is	already	known	about	both	processes	still	needs	to	be	established.	 Thirdly,	 cell	 cycle	 inhibition	 through	 expression	 of	 CDK	 inhibitors	 other	 than	 p21	 appears	sufficient	for	the	leader	fate,	but	it	remains	unclear	if	this	depends	on	leader	signature	components.	
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In	the	first	part	of	my	thesis,	I	investigated	the	role	of	E-,	N-,	and	P-cadherin	as	potential	candidates	driving	scribKD	cell	recognition	and	their	directed	migration	away	from	winner	cells.	
E-,	N-,	and	P-cadherin	are	all	elevated	in	scribKD	cells	and	I	showed	that	at	least	E-cadherin	is	necessary	for	their	migration	following	contact	with	wild-type	cells.	Neither	E-	nor	N-cadherin	elevation	is	sufficient	to	drive	leader	migration.	Preliminary	experiments	with	P-cadherin	suggested	it	may	play	a	more	active	role	in	leader	migration,	but	this	needs	further	confirmation.	I	propose	that	E-	and	N-cadherin	are	part	of	the	leader	cell	signature	downstream	of	p21,	the	components	of	which	work	together	to	enable	leader	migration.	It	remains	to	be	determined	what	role	each	of	the	leader	signature	factors	plays,	whether	there	 is	 any	 interaction	 between	 them,	 and	 how	 increased	 p21	 activity	 leads	 to	 their	upregulation.	
It	was	not	possible	to	determine	whether	the	three	cadherins	are	part	of	a	winner/loser	recognition	 event,	 as	 the	 assay	 readout	 was	 ambiguous:	 no	 migration	 following	 E-cadherin	 knockdown	 in	 scribKD	 cells	 could	 simply	 mean	 that	 the	 cells	 have	 lost	 the	cytoskeletal	 changes	permissive	 for	migration	or	are	 incapable	of	generating	 forces	 to	migrate,	rather	than	evading	recognition	by	followers.	Combined	with	the	available	RNA	sequencing	 data	 highlighting	 the	 difference	 between	 the	 transcriptomes	 of	 MDCK	winners	and	 losers	(Wagstaff	et	al.	2016),	a	screen	for	surface	molecules	differentially	expressed	 between	 loser	 and	 winner	 cells	 would	 shortlist	 more	 candidates	 for	recognition	molecules.	However,	the	difficulty	remains	in	defining	a	recognition	event.	If	the	molecular	 change	 that	 happens	 in	winner	 cells	 upon	 loser	 cell	 recognition	 can	 be	pinpointed,	one	could	test	which	molecule(s)	on	the	surface	of	losers	is/are	sufficient	to	trigger	it.	These	experiments	could	ultimately	define	what	differences	winner	cells	can	sense	in	loser	cells	(or	vice	versa)	that	triggers	the	cascade	of	events	leading	to	loser	cell	elimination	in	a	mammalian	system.	
	
p53-mediated competition 
In	the	second	part	of	my	thesis,	I	demonstrated	that	the	ROCK	–	P-p38	–	p53	signalling	pathway	 activated	during	 compaction	of	 scribKD	 cells	 is	 also	 conserved	 in	 competition		 	
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induced	 by	mild	 p53	 elevation.	 This	 allows	 for	 findings	 from	 the	 scribble	 mechanical	competition	 system	 to	 be	 extrapolated	 into	 contexts	 where	 only	 a	 p53	 imbalance	 is	present.	 For	 example,	 does	 p53	 loss	 during	 tumourigenesis	 enable	 cells	 to	 stop	responding	to	mechanical	cues	and	evade	elimination?	Conversely,	are	damaged/less	fit	cells	removed	in	vivo	by	mechanical	cell	competition	if	they	display	chronic	p53	elevation	below	levels	that	directly	induce	their	apoptosis	and,	if	so,	how	prevalent	is	this?	If	p53-mediated	mechanical	cell	competition	proves	to	be	relevant	in	in	vivo	systems,	one	could	envisage	that	it	could	become	a	therapeutic	target.	For	instance,	ectopic	reactivation	of	p53	 selectively	 in	 cells	 harbouring	 p53	mutations	 could	 enable	 their	 clearance	 by	 an	intrinsic	mechanical	cell	competition	mechanism	and	restore	epithelial	health.	
The	mechanism	of	ROCK	activation	by	compaction,	as	well	as	the	downstream	effectors	of	p53	responsible	for	density	hypersensitivity	also	remain	to	be	determined.	The	more	is	unveiled	about	the	factors	governing	mechanical	cell	competition,	the	more	directed	any	future	therapies	targeting	it	can	be.	
	
Leader cell migration in wound healing 
The	most	significant	findings	described	in	this	thesis	concern	the	role	of	leader	cells	in	MDCK	wound	 healing,	 described	 in	 the	 third	 part	 of	my	 thesis.	 I	 propose	 that	 p53	 is	activated	in	some	cells	at	the	wound	edge	as	a	result	of	cellular	damage,	or	that	the	wound	gap	opens	up	space	 for	 the	migration	of	cells	with	pre-existing	p53	elevation:	 the	p21	reporter	 line	 that	 I	 generated	 may	 help	 distinguish	 between	 these	 two	 possibilities.	Increased	p53	activity	drives	expression	of	p21,	which	is	both	sufficient	and	necessary	to	drive	 leader	 cell	migration	 across	 the	wound	 bed.	 In	 fact,	 I	 suggest	 that	 the	 p53/p21	imbalance	 between	 leader	 and	 follower	 cells	 actively	 contributes	 to	 directing	 cell	migration	into	the	wound	area	by	providing	a	symmetry	breaking	cue.	
p21	lies	upstream	of	the	leader	cell	signature	(E-cadherin,	N-cadherin,	PI3K,	ITGβ1,	and	Rac1),	which	is	necessary	for	leader	migration.	Other	CKIs	like	p27	and	p16	may	also	lie	upstream	of	these	signature	markers	and	contribute	to	the	leader	status	alongside	p21.	Members	of	the	leader	signature	are	highly	expressed	in	all	types	of	MDCK	leader	tested.	Most	 signature	 components	 are	 necessary	 for	 leader	migration	 but	 are	 not	 sufficient,		 	
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suggesting	they	work	in	concert	to	drive	the	migratory	phenotype	of	leaders.	It	remains	unclear	how	expression	of	the	leader	signature	contributes	to	the	leader	phenotype	e.g.	does	 it	 confer	 a	 more	 motile	 phenotype	 on	 cells?	 Does	 it	 drive	 formation	 of	 cell-cell	contacts	necessary	for	follower	migration?	Does	it	enable	faster	cell	repolarisation	upon	detection	 of	 symmetry	 breaking	 cues	 in	 a	 mechanism	 akin	 to	 contact	 inhibition	 of	locomotion?	Moreover,	 I	cannot	discount	the	possibility	that	there	are	members	of	the	leader	signature	that	have	not	yet	been	identified.	One	example	may	be	P-cadherin,	which	is	upregulated	in	scribKD	cells	and	may	drive	 leader	cell	migration	either	as	part	of	 the	leader	signature	or	independently	from	it,	but	this	needs	further	investigation.	
I	 show	 that	 increased	 p53/p21	 activity	 is	 sufficient	 to	 drive	 leader	 cell	 migration	 in	MDCKs.	This	is	a	key	finding	in	the	leader	cell	migration	field,	as	it	is	the	first	time	leader	cells	have	been	generated	‘on	demand’	through	activation	of	a	single	pathway.	In	fact,	p53	pathway	activation	could	also	explain	the	upregulation	of	Notch	ligand	Dll4	demonstrated	to	play	a	role	in	MCF-7	leader	formation:	p53	has	been	shown	to	directly	regulate	Dll4	expression	in	cancer	cell	lines,	including	MCF-7	cells	(Yao	&	Sherif	2016).	What	is	more,	I	show	 that	 activation	of	 cell	 cycle	 inhibitors	 is	 likely	 the	universal	 driver	of	 the	 leader	status.	Stochastic	or	damage-induced	CKI	activation	may	therefore	explain	how	only	some	cells	are	singled	out	to	acquire	the	leader	fate	over	others.	
Interestingly,	my	findings	shed	a	new	light	on	a	previously	described	experiment	where	the	acto-myosin	cable	 lining	 the	border	of	 finger-like	protrusions	was	cut	with	a	 laser	(Reffay	et	al.	2014).	This	manipulation	frequently	generates	a	new	leader	at	the	cut	site,	which	 the	 authors	 claim	 is	 a	 result	 of	mechanical	 de-inhibition	 of	 leader	 formation.	 I	would	 argue	 that	 the	 laser	 simultaneously	 induces	 cellular	 damage	 and	 activates	 a	p53/p21	response,	which	promotes	leader	emergence.	In	fact,	other	factors	implicated	in	the	 formation	 of	 leaders	 (e.g.	 increased	membrane	 curvature)	may	 also	 contribute	 by	feeding	 into	 p53	 activation	 through	 a	 yet-unidentified	 mechanism.	 Alternatively,	 p53	activation	may	pre-determine	a	cell’s	response	to	an	external	cue	and	make	it	respond	like	a	leader	when	cells	with	lower	p53	might	not.	
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Mechanical loser status 
It	has	previously	been	 shown	 that	p53	elevation	 converts	 cells	 into	mechanical	 losers	(Wagstaff	 et	 al.	 2016).	 I	 have	 demonstrated	 situations	 where	 leader	 migration	 is	uncoupled	 from	 mechanical	 loser	 status	 (p21OE,	 p27OE,	 and	 p16OE	 cells),	 strongly	suggesting	that	p53	elevation	confers	the	mechanical	loser	status	on	cells	independently	of	 leader	 cell	 behaviour.	 Spontaneous	 leaders	 with	 ‘terminal’	 p53	 upregulation	 are	eliminated	at	a	higher	frequency	than	scratch-induced	leaders.	I	therefore	suggest	that	mid-level	p53	activity	results	in	p21	activation	and	leader	behaviour,	but	p53	elevation	above	this	level	also	additionally	triggers	factors	responsible	for	density	hypersensitivity.	This	would	make	sense	from	an	organismal	point	of	view,	as	only	cells	with	irreparable	damage	would	be	destined	for	elimination.	If	this	theory	were	true,	it	should	be	possible	to	isolate	cells	that	are	mechanical	losers	but	do	not	act	as	leaders.	
During	 wound	 healing,	 I	 propose	 that	 persistent	 p53	 elevation	 in	 migrating	 leaders	results	in	their	elimination	at	wound	closure	when	the	cell	density	increases.	Meanwhile,	any	cells	that	do	not	reach	as	high	p53	levels	or	reduce	them	by	repairing	the	damage	by	the	time	the	wound	shuts	are	deemed	healthy	enough	to	remain	in	the	epithelium.	Taken	together,	this	model	places	p53	as	a	key	player	in	MDCK	scratch-wound	healing:	p53	is	the	driver	of	the	directional	migration	that	seals	the	gap	and	also	ensures	the	elimination	of	cells	damaged	beyond	repair.	While	migration	has	been	implicated	in	wound	healing	in	mammalian	corneal	epithelia	and	rat	skin	(reviewed	in	Li	et	al.	2013),	wound	healing	in	
vivo	 is	 a	 very	 complex	 process	 additionally	 involving	 the	 immune	 response,	 a	 3D	environment,	soluble	factors,	cell	proliferation,	and	many	other	variables	(reviewed	in	de	Oliveira	 Gonzalez	 et	 al.	 2016).	 p53/p21	 activity	 may	 therefore	 contribute	 to	 wound	healing	in	vivo,	but	it	is	unlikely	it	is	the	sole	driver	of	the	process.	
p53-mediated	density	hypersensitivity	is	conserved	in	an	ex	vivo	mouse	tracheal	model	(Wagstaff	et	al.	2016),	but	due	to	the	nature	of	the	experimental	set-up,	it	could	not	be	determined	whether	p53	elevation	also	triggered	a	leader-like	migratory	phenotype.	It	hence	remains	unclear	if	there	is	a	role	for	p53/p21-driven	leader	migration	in	systems	other	 than	MDCK	cells.	 It	 is	 therefore	 imperative	 that	 findings	are	 translated	 from	the	MDCK	 system	 into	 other	 mammalian	 models,	 especially	 if	 they	 are	 to	 form	 the	foundations	for	future	therapeutic	approaches.	
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Chapter X: Materials and methods 
	
Antibodies and drugs 
For	immunofluorescence,	the	following	antibodies	were	used:	
Epitope	 Species	 Dilution	
Catalogue	
number	
Supplier	Alexa	Fluor	conjugated	secondary	antibodies	 various	 1:1,000	 various	 Thermo	Fisher	Scientific	DAPI	 N/A	 1	µg/ml	in	water	 D3571	 Thermo	Fisher	Scientific	E-cadherin	 mouse	 1:600	 rr1	 DSHB	ITGb1	 rat	 1:200	 AIIB2	 DSHB	N-cadherin	(13A9)	 mouse	 1:200	 14215	 Cell	Signalling	Technology	p-MYPT1	(Thr	853)	 goat	 1:50	 sc-17432	 Santa	Cruz	Biotechnology	P-p38	MAPK	(T180/Y182)	 rabbit	 1:50	 9215	 Cell	Signalling	Technology	p16	 rabbit	 1:5,000	 10883	 Proteintech	Europe	p21	 rabbit	 1:200	 sc-397	 Santa	Cruz	Biotechnology	p27	 mouse	 1:200	 610241	 BD	Biosciences	p53	 rabbit	 1:750	 9382	 Cell	Signalling	Technology	PI3K	 mouse	 1:200	 610045	 BD	Biosciences	𝛾H2AX	(Ser	139)	 rabbit	 1:200	 9718	 Cell	Signalling	Technology		
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For	Western	blotting,	the	following	antibodies	were	used:	
Epitope	 Species	 Dilution	
Catalogue	
number	
Supplier	E-cadherin	 mouse	 1:1,000	 rr1	 DSHB	HRP	conjugated	secondary	antibodies	 various	 1:3,000	 various	 BioRad	N-cadherin	(13A9)	 mouse	 1:1,000	 14215	 Cell	Signalling	Technology	p21	 rabbit	 1:500	 sc-397	 Santa	Cruz	Biotechnology	p53	 rabbit	 1:1,000	 9382	 Cell	Signalling	Technology	β-tubulin	 rabbit	 1:50,000	 ab6046	 Abcam		
Treatments	used:	
Treatment	
Final	
concentration	
Solvent	 Supplier	Blasticidin	 5	μg/ml	 water	 Sigma	CDK1	inhibitor	RO-3306	 10	µM	 DMSO	 Calbiochem	Doxycycline	(DOX)	 1	µg/ml	 water	 Merck	Hoechst	33342	 3	µg/ml	 water	 Thermo	Fisher	Scientific	Hygromycin	B	 75	μg/ml	 water	 Thermo	Fisher	Scientific	Mitomycin	C	(MMC)	 7.5	µg/ml	 water	 Merck	Nutlin-3	 as	specified	in	text	 DMSO	 Cambridge	Bioscience	PI3K	inhibitor	LY294002	 10	µM	 DMSO	 Merck	Puromycin	(puro)	 0.65	µg/ml	 water	 Merck	Rac1	inhibitor	Z62954982	 100	µM	 DMSO	 Merck	ROCK	inhibitor	Y27632	 30	µM	 DMSO	 Sigma	Tetracycline	(TET)	 5	µg/ml	 water	 Sigma		 	
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Cell culture – MDCK cells 
Wild-type	 MDCK	 and	 MDCK-pTR	 scribble	 shRNA	 (scribKD)	 cells	 were	 provided	 by	Yasuyuki	Fujita	(Norman	et	al.	2012).	MDCK	cells	were	maintained	in	Dulbecco’s	Modified	Eagle	media	(DMEM,	Thermo	Fisher	Scientific)	supplemented	with	10%	TET-free	foetal	bovine	serum	(FBS)	in	a	humidified	incubator	at	37°C	/	5%	CO2.	Unless	stated	otherwise,	MDCK	culture	media	was	not	supplemented	with	any	antibiotics.	Cells	were	cultured	at	sub-confluence	and	split	twice	a	week	at	ratios	varying	between	1:8	and	1:15,	depending	on	 growth	 rates.	 Passaging	 was	 performed	 as	 follows:	 cells	 were	 washed	 once	 in	phosphate	buffered	saline	(PBS)	and	then	once	in	0.05%	trypsin-EDTA	(Thermo	Fisher	Scientific).	 Fresh	 0.05%	 trypsin-EDTA	 was	 then	 added	 and	 the	 culture	 dishes	 were	incubated	 for	 10-15	min	 at	 37°C	 /	 5%	 CO2	 until	 all	 cells	 had	 detached.	 At	 least	 two	volumes	of	DMEM	+	10%	FBS	were	then	used	to	quench	the	trypsin	and	the	suspension	centrifuged	at	200	rcf	for	3.5	min.	Cell	pellets	were	resuspended	in	fresh	DMEM	+	10%	FBS	(with	appropriate	antibiotics,	if	required)	and	plated	into	fresh	cell	culture	dishes.	
scribKD	 cells	 were	maintained	 in	media	 supplemented	 with	 800	 μl/ml	 G418	 (Thermo	Fisher	 Scientific)	 and	 5	μg/ml	 blasticidin	 (Sigma);	 media	 for	 scribKD	 GFP-NLS	 cells	additionally	contained	0.65	μg/ml	puromycin	(Sigma).	
Wild-type	clones	expressing	either	nuclear	GFP	or	RFP	were	generated	by	my	colleagues	in	the	Piddini	lab	using	a	modified	pGIPZ-turboGFP-Puro	(Thermo	Scientific)	plasmid,	in	which	turbo-GFP	was	replaced	with	either	turbo	GFP-NLS	or	turbo	RFP-NLS	(Wagstaff	et	al.	 2016).	 The	 MDCK	 p53KO	 lines	 were	 generated	 by	 others	 in	 the	 Piddini	 lab	 using	CRISPR/Cas9	technology	(Wagstaff	et	al.	2016).	
	
MDCK transfection 
On	 day	 1,	 80,000	MDCK	 cells	 per	 well	 were	 seeded	 in	 a	 6-well	 plate.	 On	 day	 2,	 two	solutions	were	prepared	as	follows:	
Solution	 1:	 250	 μl	 Opti-MEM	 (Thermo	 Fisher	 Scientific)	 +	 10	 μl	 Lipofectamine	 2000	(Thermo	Fisher	Scientific)	
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Solution	2:	250	μl	Opti-MEM	+	4	μg	of	plasmid	DNA	
Solution	1	was	incubated	at	RT	for	5	min.	Solution	2	was	then	pipetted	into	Solution	1,	the	tube	tapped	to	mix,	and	incubated	at	RT	for	20	min.	The	media	on	the	cells	was	changed	to	2	ml	of	fresh	DMEM	+	10%	FBS.	The	transfection	mix	was	then	added	drop-wise	to	the	cells	and	incubated	at	37°C	/	5%	CO2	for	6	hours	before	the	media	was	changed	to	fresh	DMEM	+	10%	FBS.	The	media	was	changed	again	on	the	morning	of	day	3.	If	required,	antibiotic	selection	was	begun	on	day	4	and	continued	until	no	cells	were	left	in	the	non-transfected	well.	
	
Cell culture – HEK293T cells 
HEK293T	cells	were	maintained	in	DMEM	supplemented	with	10%	FBS	in	a	humidified	incubator	at	37°C	/	5%	CO2.	Cells	were	cultured	at	sub-confluence	and	split	twice	a	week	at	 a	 ratio	 of	 around	 1:10.	 Passaging	 was	 performed	 as	 follows:	 HEK293T	 cells	 were	washed	once	in	PBS,	then	0.05%	trypsin-EDTA	was	added	and	the	culture	dishes	were	incubated	for	1-3	min	at	37°C	/	5%	CO2	until	all	cells	had	detached.	At	least	two	volumes	of	DMEM	+	10%	FBS	were	then	used	to	quench	the	trypsin	and	the	suspension	centrifuged	at	200	rcf	for	3.5	min.	Cell	pellets	were	resuspended	in	fresh	DMEM	+	10%	FBS	and	plated	into	fresh	cell	culture	dishes.	
	
Lentivirus production 
On	day	1,	2	x	106	HEK293T	cells	were	seeded	in	a	10	cm	dish.	On	day	2,	the	following	solution	was	made	up:	
600	 μl	 Opti-MEM	 +	 2	 μg	 psPAX2	 +	 2	 μg	 pMD2G	 +	 3	 μg	 of	 transfer	 vector	 of	 choice	(pTRIPZ/pGIPZ	backbone	–	second	generation	vectors)	
The	DNA	mix	was	then	supplemented	with	20	μl	FuGENE	HD	(Promega),	the	tube	tapped	to	mix,	and	incubated	at	RT	for	15	min.	The	media	on	the	cells	was	changed	to	8	ml	of	fresh	DMEM	+	10%	FBS.	The	transfection	mix	was	then	added	drop-wise	to	the	cells	and		
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the	plates	incubated	at	37°C	/	5%	CO2	overnight.	The	media	was	changed	on	the	morning	of	 day	 3	 to	 fresh	DMEM	+	10%	FBS.	 Lentiviruses	were	 harvested	 on	 days	 4	 and	5	 as	follows:	 the	HEK293T	media	was	 collected	 and	 centrifuged	 at	 200	 rcf	 for	 5	min.	 The	supernatant	 was	 filtered	 through	 a	 0.45	 μm	 filter,	 aliquoted	 into	 cryovials,	 and	 used	immediately	or	frozen	at	-80°C.	
	
Lentiviral transduction 
On	day	1,	80,000	MDCK	cells	per	well	were	seeded	in	a	6-well	plate.	On	day	2,	lentiviral	aliquots	were	thawed	on	ice.	The	media	on	the	cells	was	then	replaced	with	pure	lentiviral	suspension	or	just	DMEM	+	10%	FBS	in	the	negative	control	well.	On	the	morning	of	day	3	(approximately	24	hours	later),	the	media	was	changed	to	fresh	DMEM	+	10%	FBS.	If	required,	antibiotic	selection	was	begun	on	day	4	and	continued	until	no	cells	were	left	in	the	non-transduced	well.	
	
Freezing cells 
To	 generate	 frozen	 cell	 stocks,	 cells	 were	 passaged	 as	 normal.	 The	 cell	 pellet	 was	resuspended	 in	a	 solution	of	90%	FBS	and	10%	DMSO	 to	make	a	 cell	 suspension	at	 a	concentration	of	106	cells	per	ml.	1	ml	aliquots	of	 this	suspension	were	 then	 frozen	 in	cryovials	placed	in	a	Styrofoam	rack	at	-80°C.	A	minimum	of	24	hours	later,	vials	were	moved	into	liquid	nitrogen	for	long-term	storage.	
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MDCK cell lines generated as part of this work 
Name	 Description	
Associated	
fluorophore	
Antibiotic(s)	
in	media	
scribKD	E-cadKD	
TET/DOX-inducible	knockdown	of	Scribble	and	E-cadherin	 N/A	 G418*,	blasticidin,	hygromycin	E-cadOE	 DOX-inducible	overexpression	of	E-cadherin	 RFP-NLS	 Puromycin	N-cadOE	 DOX-inducible	overexpression	of	N-cadherin	 RFP-NLS	 Puromycin	P-cadOE	(pool)	 DOX-inducible	overexpression	of	P-cadherin	 RFP-NLS	 Puromycin	p21OE	 DOX-inducible	overexpression	of	p21	 RFP-NLS	 Puromycin	
p21KO	
CRISPR/Cas9-mediated	knockout	of	p21	 N/A	 None	
p21	reporter	 Destabilised	GFP-NLS	expression	controlled	by	the	p21	promoter	to	report	p21	activity	 GFP-NLS	 G418*	
GSE-22	(pool)	 DOX-inducible	overexpression	of	dominant	negative	p53	peptide,	GSE-22	 GFP-NLS	 Puromycin	p27OE	(pool)	 DOX-inducible	overexpression	of	p27	 RFP-NLS	 Puromycin	p16OE	(pool)	 DOX-inducible	overexpression	of	p16	 RFP-NLS	 Puromycin		
Antibiotic	 concentrations	 used:	 5	μg/ml	 blasticidin,	 75	μg/ml	 hygromycin,	 0.65	 μg/ml	puromycin.	
*	 Cells	 with	 scribKD	 in	 their	 genetic	 background	 were	 cultured	 in	 media	 containing	800	μg/ml	G418;	400	μg/ml	G418	was	used	in	all	other	cases.	
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Generation of the scribKD E-cadKD construct and cell line 
To	knockdown	E-cadherin	expression	in	MDCK	scribble	shRNA	cells	(scribKD	E-cadKD),	 I	modified	a	plasmid	provided	by	Yasuyuki	Fujita,	pSUPERIOR.neo+gfp	E-cadherin	shRNA	(Hogan	et	al.	2009),	which	that	already	contained	an	shRNA	against	canine	E-cadherin.	I	excised	the	neomycin/G418	antibiotic	resistance	cassette	and	used	In-Fusion	to	replace	it	with	a	hygromycin	resistance	cassette	amplified	from	pCMV-LacI	(Agilent	Genomics).	This	created	pSUPERIOR.hygro+gfp	E-cadherin	shRNA,	which	I	transfected	into	recipient	
scribKD	 cells	 and	 selected	 for	 positive	 double	 knockdown	 clones	 using	 hygromycin	 B	(75	μg/ml).	 The	 knockdown	 efficiencies	 of	 Scribble	 and	 E-cadherin	 were	 verified	 by	Western	blotting	and	immunofluorescence,	respectively.	
	
Generation of the E-cadherin, N-cadherin, P-cadherin, p27, and p16 overexpression 
constructs and cell lines 
I	 amplified	 the	 E-cadherin-GFP	 sequence	 from	 a	 plasmid	 provided	 by	 James	 Norman	(Adams	 et	 al.	 1998).	 For	 N-	 and	 P-cadherin,	 the	 respective	 cDNA	 sequences	 were	amplified	 from	a	 cDNA	 library	obtained	 from	MDCK	 scribble	 shRNA	cells	 treated	with	tetracycline	to	induce	scribble	knockdown,	as	these	cells	have	elevated	levels	of	both	N-	and	P-cadherin	(Piddini	lab,	unpublished	and	Wagstaff	et	al.	2016).	I	amplified	p27	cDNA	from	the	same	canine	cDNA	library.	 I	amplified	human	p16	 from	pLenti	CMV	p16	Neo	(w111-1)	 (Addgene	 #22260);	 I	 modified	 the	 forward	 primer	 to	 reintroduce	 eight	 N-terminal	 amino	 acids	 that	were	missing	 from	 the	 p16	 construct	 in	 the	 plasmid	when	compared	 to	 the	 full-length	 human	 p16	 sequence	 (transcript	 ENST00000304494.9,	Ensembl).	
I	designed	 the	reverse	primers	used	 for	amplification	such	 that	 they	contained	a	 ‘self-cleaving’	P2A	peptide	sequence	(Kim	et	al.	2011).	Using	In-Fusion	cloning,	I	individually	introduced	 the	 three	 cadherin,	 p27,	 and	 p16	 cDNAs	 into	 pTRIPZ-RFP-NLS-Puro,	 a	lentiviral	backbone	where	protein	expression	was	induced	by	addition	of	doxycycline.	
The	final	constructs	were	as	follows:	
pTRIPZ	E-cadherin-GFP-P2A-RFP-NLS	=	EcadOE	cell	line	
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pTRIPZ	N-cadherin-P2A-RFP-NLS	=	NcadOE	cell	line	
pTRIPZ	P-cadherin-P2A-RFP-NLS	=	PcadOE	cell	line	
pTRIPZ	p27-P2A-RFP-NLS	=	p27OE	cell	line	
pTRIPZ	p16-P2A-RFP-NLS	=	p16OE	cell	line	
These	 constructs	 express	 E-cadherin-GFP/N-cadherin/P-cadherin/p27/p16	 and	 RFP-NLS	as	a	single	transcript	in	a	doxycycline-inducible	manner.	I	then	generated	lentiviruses	from	 the	 final	 constructs	and	used	 them	to	 (individually)	 transduce	wild-type	MDCKs.	Selection	following	infection	was	carried	out	with	puromycin	(0.65	μg/ml).	I	then	plated	the	E-cadOE	and	N-cadOE	pools	at	one	cell	per	well	in	96-well	plates	to	generate	single	clones;	I	verified	the	expression	levels	of	the	relevant	cadherins	by	immunofluorescence.	The	P-cadOE,	p27OE,	and	p16OE	antibiotic-selected	pools	were	used	as	pool	populations.	
	
Generation of the p21KO construct and clones 
I	 generated	 MDCK	 p21KO	 clones	 G5	 and	 E9	 using	 Cas9	 D10A	 CRISPR	 technology.	 I	manually	 designed	 the	 sgRNA	 target	 sequences	 against	 canine	 CDKN1A	 following	published	methods	 (Ran	et	al.	2013).	 I	made	sure	 that	 the	 two	 target	 sequences	were	≤20nt	 apart	 and	 that	 their	 respective	 PAM	 sequences	were	 pointing	 away	 from	 each	other.	I	used	the	following	target	sequences	in	exon	2	of	CDKN1A:	
5’-CGGCAAGCCTTGCTGCCATG(AGG)-3’	
5’-TGGACAGCGAGCAGCTGCGC(CGG)-3’	
I	cloned	the	target	sequences	individually	into	PX461	vectors	(Appendix	2J)	containing	the	Cas9	D10A	nickase	enzyme	and	the	sgRNA	scaffold	(Ran	et	al.	2013),	as	described	in	the	‘Molecular	Biology’	section	of	this	work,	and	co-transfected	2	µg	of	each	plasmid	into	wild-type	MDCK	cells.	I	treated	the	transfected	cells	with	11	µM	Nutlin	for	6	days	to	enrich	for	p21KO	cells,	as	these	would	not	be	growth-inhibited	as	a	result	of	Nutlin-mediated	p53	(and	hence	p21)	elevation.	I	then	plated	the	pool	at	one	cell	per	well	in	96-well	plates;	I	
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expanded	the	resulting	clones	and	verified	them	by	immunofluorescence	in	the	presence	or	absence	of	Nutlin	and	sequencing.	
	
Generation of the p21OE construct and cell line 
To	 overexpress	 p21,	 I	 amplified	 the	 p21	 cDNA	 a	 cDNA	 library	 obtained	 from	 MDCK	
scribble	shRNA	cells	treated	with	tetracycline	to	induce	scribble	knockdown,	as	these	cells	have	been	shown	to	express	high	levels	of	p21	(Wagstaff	et	al.	2016).	I	used	In-Fusion	to	introduce	 the	 resulting	 PCR	product	 into	 doxycycline-inducible	 pTRIPZ-RFP-NLS-Puro	with	a	P2A	peptide	bridging	the	two	proteins	to	make	pTRIPZ-p21-P2A-RFP-NLS.	I	then	made	lentiviruses	from	the	final	construct	and	transduced	wild-type	MDCK	cells.	I	then	selected	positive	clones	using	0.65	µg/ml	puromycin,	and	plated	the	pool	out	at	one	cell	per	well	in	96-well	plates	to	isolate	single	clones	that	I	verified	by	immunofluorescence.	
	
Generation of the p21 reporter construct and clones 
To	generate	a	cell	line	reporting	p21	activity	through	the	dynamics	of	GFP-NLS,	I	modified	a	reporter	for	p21	activity	described	in	(Paek	et	al.	2016).	The	original	reporter	contained	a	 destabilised	 version	 of	 CFP-NLS	 whose	 expression	 was	 driven	 by	 the	 human	 p21	promoter.	 I	 first	 excised	 the	CMV	promoter,	 CMV	enhancer,	 and	 eGFP	 from	pcDNA3.3	d2eGFP	 (Addgene	 #26821)	 using	 MluI	 and	 HindIII	 (this	 left	 behind	 the	 PEST	destabilisation	 signal	 in	 the	 backbone).	 Meanwhile,	 I	 amplified	 turbo	 GFP-NLS	 from	pTRIPZ	 GFP-NLS-Puro	 and	 used	 In-Fusion	 to	 insert	 it	 into	 MluI/HindIII-digested	pcDNA3.3	 d2eGFP.	 This	 generated	 a	 vector	 containing	 a	 destabilised	 version	 of	 turbo	GFP-NLS,	pcDNA3.3	d2turbo	GFP-NLS.	I	then	amplified	the	p21	promoter	from	a	modified	version	of	the	original	reporter,	p273,	supplied	by	Andrew	Paek.	Finally,	I	used	In-Fusion	to	add	the	p21	promoter	into	MluI-digested	pcDNA3.3	d2turbo	GFP-NLS.	
The	final	construct	contained	a	destabilised	version	of	turbo	GFP-NLS	whose	expression	is	driven	by	the	human	p21	promoter.	I	transfected	this	construct	into	wild-type	MDCKs	and	selected	for	stably	transfected	cells	using	G418	(400	μg/ml).	From	the	pool,	I	isolated	
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three	clones	that	had	very	low	background	signal	and	responded	to	Nutlin	treatment	by	strong	induction	of	nuclear	GFP,	as	assessed	by	confocal	microscopy.	
	
Generation of the GSE-22 construct and cell line 
The	dominant	negative	GSE-22	peptide	was	first	described	for	the	rat	in	(Ossovskaya	et	al.	 1996).	 To	 overexpress	 the	 dominant	 negative	 GSE-22	 peptide	 in	 MDCK	 cells,	 I	amplified	the	sequence	encoding	amino	acids	302-381	of	canine	p53	(homologous	to	the	original	rat	sequence)	from	the	MDCK	cDNA	library	used	in	p21OE	cloning	above.	I	used	a	forward	primer	carrying	an	adaptor	with	three	start	ATG	codons	and	a	reverse	primer	containing	three	stop	codons	to	account	for	all	three	reading	frames,	as	was	done	in	the	original	 publication.	 I	 used	 In-Fusion	 to	 introduce	 the	 resulting	 PCR	 product	 into	doxycycline-inducible	 pTRIPZ-GFP-NLS-Puro	 with	 a	 P2A	 peptide	 bridging	 the	 two	proteins	to	make	pTRIPZ-GSE-22-P2A-GFP-NLS.	I	then	generated	lentiviruses	with	this	construct	and	tranduced	wild-type	MDCK	cells.	 I	selected	positive	transformants	using	0.65	µg/ml	puromycin	to	generate	a	pool	population.	
	
Competition and directed migration assays using the ‘fences’ system 
Cell	competition	and	directed	migration	assays	were	carried	out	in	24	well	plates	using	‘fences’	(Aix	Scientifics,	http://www.aix-scientifics.co.uk/en/fences.html).	‘Fences’	allow	two	 different	 cell	 populations	 to	 be	 seeded	 on	 either	 side	 of	 a	 silicone	 barrier,	 thus	allowing	 for	 an	 internal	 control	 for	 any	 treatments	 and/or	 immunostainings.	 Control,	pure	 cultures	 were	 plated	 on	 the	 inside	 of	 the	 ‘fence’;	 competition	 co-cultures	 were	seeded	on	the	outside	of	the	‘fence’.	To	distinguish	the	two	cell	populations,	one	cell	line	was	always	labelled	with	a	fluorescent	nuclear	marker,	GFP-NLS	or	RFP-NLS.	
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Cell	numbers	were	as	follows:	
Experiment	 Inside	 Outside	Competition	 1000	loser	cells	 800	loser	cells	:	7200	winner	cells	Directed	migration	 1000	loser	cells	 400	loser	cells	:	3600	winner	cells	Nutlin	competition	 1000	WT	GFP-NLS	 900	WT	GFP-NLS	:	1900	p53KO	
‘Fences’	were	removed	~5	hours	after	plating	for	all	experiments.	For	most	competition	and	directed	migration	experiments,	the	culture	medium	was	replaced	at	this	point	with	media	 containing	 TET	 or	 DOX,	 and	 replaced	 again	 20	 hours	 later.	 For	 Nutlin-induced	competition,	the	culture	medium	was	replaced	with	fresh	DMEM	+	10%	FBS	after	‘fence’	removal;	Nutlin/DMSO	was	only	 added	~30	h	 after	 ‘fence’	 removal.	 Live	 imaging	was	started	2–4	h	after	the	last	media	change	and	was	continued	for	at	least	3	days	with	media	changes	every	2	days.	
	
Gridded dishes for scribKD E-cadKD directed migration assays 
6,250	cells	were	plated	per	gridded	tissue	culture	plate	(μ-Dish	35	mm	Grid-500,	Ibidi).	This	 allowed	 for	 live	 imaging	 of	 specific	 clones	 that	 could	 be	 located	 again	 for	immunofluorescence	analysis.	Co-cultures	were	plated	at	a	ratio	of	1:10	loser	 :	winner	and	imaged	every	2-4	hours	using	the	Nikon	BioStation	CT	system.	Cells	at	the	end	of	live	imaging	 were	 fixed	 in	 4%	 PFA	 in	 PBS	 for	 10	 min	 at	 RT	 and	 processed	 using	 the	immunofluorescence	protocol	described	below.	
	
Mitomycin C (MMC) assays 
On	day	1,	2,500	untreated	wild-type	MDCK	cells	(labelled	with	GFP-NLS	or	unlabelled,	as	appropriate)	were	seeded	per	well	in	24-well	plates;	5,000	of	that	same	population	was	also	plated	in	a	separate	well	as	a	pure	population.	On	day	2,	a	second	population	of	MDCK	cells	was	trypsinised,	and	1	x	106	of	these	were	incubated	in	suspension	in	5	ml	complete	media	containing	7.5	µg/ml	MMC	for	1	hour	at	37°C	/	5%	CO2.	The	cells	were	then	washed	at	least	three	times	in	complete	media	(spinning	down	the	cells	after	each	wash)	to	reduce	
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MMC	 carryover.	 5,000	 MMC-treated	 cells	 (or	 2,500	 untreated	 cells	 for	 the	 negative	control)	were	then	plated	on	top	of	the	2,500	untreated	cells;	10,000	MMC-treated	cells	(or	5,000	untreated	cells	for	the	negative	control)	were	also	plated	as	a	pure	population	in	an	otherwise	empty	well.	Live	imaging	was	begun	on	day	3	and	continued	for	at	least	2	days;	samples	were	imaged	every	2	hours.	
It	is	worth	noting	that	I	tested	MMC	concentrations	ranging	from	1	to	50	µg/ml	(data	not	shown).	 Many	 cells	 in	 ≤5	µg/ml	 MMC	 did	 not	 display	 cell	 cycle	 arrest,	 while	concentrations	above	10	µg/ml	MMC	resulted	in	rapid	cell	death.	I	chose	7.5	µg/ml	MMC,	as	all	cells	stopped	dividing	at	this	MMC	concentration,	but	still	survived	for	many	days,	which	enabled	assays	to	be	run.	
	
Spontaneous leader assays 
5,000	wild-type	MDCK	cells	were	seeded	in	a	24-well	plate	or,	if	immunofluorescence	was	to	be	performed	at	end	of	live	imaging,	in	a	gridded	tissue	culture	plate	(µ-Dish	35	mm	Grid-500,	 ibidi).	 Approximately	 48	 hours	 later,	 cells	 with	 the	 flattened	 spontaneous	leader	morphology	were	manually	selected	on	the	Nikon	BioStation	CT	and	imaged	every	2	hours.	Where	applicable,	cells	at	the	end	of	live	imaging	were	fixed	in	4%	PFA	in	PBS	for	10	min	at	RT	and	processed	using	the	immunofluorescence	protocol	described	below.	
	
Wound healing and barrier release assays 
27,000-33,000	wild-type	MDCK	cells	were	seeded	in	the	middle	of	a	‘fence’	placed	in	a	24-well	plate	or	straight	into	a	well	of	a	96-well	plate	(no	‘fence’).	If	immunofluorescence	was	to	 be	 performed	 after	 live	 imaging,	 optically	 clear	 plates	 (µ-Plate	 24	 well,	 ibidi	 or	CellCarrier-96,	PerkinElmer)	were	used.	The	‘fence’	was	removed	approximately	5	hours	after	seeding	and	the	culture	medium	changed	to	fresh	DMEM	+	10%	FBS	(supplemented	with	DOX	for	experiments	with	the	GSE-22	line).	Approximately	20	hours	later,	a	P1000	pipette	 tip	 was	 used	 to	 generate	 a	 scratch-wound	 through	 the	 middle	 of	 the	 now-confluent	monolayer	and	the	culture	medium	changed.	Imaging	of	the	wound	edge	was	started	approximately	1	hour	after	scratching	and	imaged	every	1-2	hours.	 	
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UV irradiation experiments 
On	day	1,	25,000-30,000	wild-type	cells	per	well	were	plated	in	an	optically	clear	96-well	plate	(CellCarrier-96,	PerkinElmer).	The	cells	were	left	to	adhere	overnight.	On	day	2,	a	scratch-wound	was	generated	through	the	middle	of	each	well	in	the	96-well	plate	using	a	P1000	tip	and	returned	to	the	37°C	/	5%	CO2	incubator	for	approximately	30	min.	Cells	were	then	treated	in	the	incubator	with	3	µg/ml	Hoechst	diluted	in	complete	media	for	10	min.	The	cells	were	washed	three	times	in	complete	media.	UV	irradiation	along	the	top	 half	 of	 the	 wound	 edge	 was	 performed	 using	 a	 20´	 air	 objective	 on	 a	 Leica	 SP8	confocal	microscope,	which	was	 set	 up	 to	 keep	 the	 samples	 at	 37°C	 /	 5%	CO2	during	imaging;	the	bottom	half	of	the	wound	was	not	irradiated.	UV	treatment	settings	used:	30	frames	 at	 100%	 405	 nm	 laser	 with	 the	 FRAP	 booster	 on.	 The	 samples	 were	 then	imaged	using	 the	BioStation	CT	 every	hour	 for	 at	 least	 24	hours.	 For	𝛾H2AX	 staining,	samples	were	fixed	and	processed	using	the	phospho-antibody	protocol	described	below	2-4	hours	after	UV	irradiation.	
	
Immunofluorescence 
Depending	on	the	assay,	cells	were	cultured	on	glass	coverslips	or	optically	clear	tissue	culture	dishes.	Cells	were	fixed	in	4%	PFA	(Electron	Microscopy	Sciences)	in	PBS	for	10	min	at	RT,	quenched	for	10	min	at	RT	in	50	mM	in	NH4Cl	in	PBS,	and	permeabilised	for	10	min	at	RT	in	0.1%	Triton	X-100	in	PBS.	Samples	were	blocked	for	at	least	30	min	in	2%	BSA,	 2%	 FBS	 in	 PBS	 at	 RT.	 Both	 primary	 and	 secondary	 antibodies	 were	 diluted	 in	blocking	 solution	 diluted	 1	 :	 1	with	 PBS.	 Primary	 antibody	 incubations	were	 either	 a	minimum	 of	 1	 hour	 at	 RT	 or	 overnight	 at	 4°C.	 Following	 4	 x	 5	 min	 washes	 in	 PBS,	secondary	antibodies	were	 incubated	 for	1	hour	at	RT,	 then	washed	4	x	5	min	 in	PBS.	Coverslips	were	mounted	in	FluorSave	(Merck).	Optically	clear	dishes	were	either	flooded	with	FluorSave	and	sealed	with	a	coverslip	or	imaged	directly	in	the	last	PBS	wash.	For	immunostaining	against	phosphorylated	proteins,	fixing	solution	was	supplemented	with	PhosSTOP	(1	tablet	per	10ml,	Sigma),	all	PBS	solutions	were	substituted	with	TBS,	and	blocking	solution	was	substituted	with	5%	BSA	in	TBS.	
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Imaging and image analysis 
Imaging	 of	 fixed	 samples	 was	 primarily	 done	 at	 RT	 on	 Leica	 SP5	 or	 SP8	 confocal	microscopes	using	a	40´	oil	objective.	The	PerkinElmer	Opera	LX	system	with	a	20´	water	objective	and	the	Yokogawa	Electric	Corporation	CellVoyager	7000	system	with	a	20´	air	objective	were	also	used	for	high-throughput	screening	of	clonal	cell	lines.	UV	irradiation	experiments	were	done	on	a	Leica	SP8	confocal	microscope	set	up	to	keep	the	samples	at	37°C	/	5%	CO2	during	imaging.	All	live	imaging	was	done	on	a	Nikon	BioStation	CT	system	at	37°C	/	5%	CO2	using	10´	or	4´	 air	objectives	with	an	 imaging	 frequency	every	1-4	hours	(indicated	in	movie	time	stamps);	media	was	changed	every	2–3	days.	
Unless	stated	otherwise	in	the	figure	legends,	all	confocal	images	are	displayed	as	sum	projections	in	z.	
E-cadherin	 staining	 intensities	 were	 measured	 using	 Fiji	 (Schindelin	 et	 al.	 2012).	Individual	 cells	 were	 selected	 manually	 on	 an	 average	 z	 stack	 projection	 and	 their	integrated	densities	values	were	recorded	and	plotted.	
Mean	intensities	of	nuclear	p53,	P-p38,	and	p21	were	measured	using	DAPI	as	a	mask	to	segment	 the	 nuclear	 volumes	 in	 Volocity	 (PerkinElmer).	 This	 script	 was	 written	 by	Richard	Butler	from	the	Imaging	Facility	at	the	Gurdon	Institute,	University	of	Cambridge.	
The	migration	speed	of	scratch-wound	fronts	was	measured	in	Fiji	by	manually	drawing	freehand	lines	outlining	the	wound	edge	at	the	first	and	final	time	points.	If	any	wound	edges	were	not	parallel	to	the	y	axis,	the	images	were	adequately	rotated.	The	median	x	position	for	each	line	was	recorded	to	calculate	the	median	x	displacement	in	μm,	which	was	then	divided	by	the	duration	of	the	experiment	in	hours	to	generate	a	speed	value	in	μm/h.	
Statistical	analysis	was	performed	using	Prism	7	(GraphPad).	All	p	values	were	obtained	using	the	Kolmogorov-Smirnov	(K-S)	test.	
Prism	7	was	used	to	plot	all	graphs.	Brightness	and	contrast	adjustments	were	made	in	Fiji.	Figures	were	made	using	Adobe	Illustrator	CS6.	
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Statistical analysis 
Every	experimental	condition	and	treatment	was	carried	out	alongside	an	untreated	or	solvent-only	(e.g.	DMSO)	control.	Unless	otherwise	specified	in	the	figure	legend	or	text,	all	 quantifications,	 immunofluorescence	 images,	 movie	 sequences,	 and	Western	 blots	shown	 are	 from	 a	 single	 representative	 experiment	 taken	 from	 a	 minimum	 of	 three	independent	 repeats	 per	 experiment.	 For	 live	 imaging	 and	 immunofluorescence	experiments,	at	least	10	fields	of	view	were	analysed	per	condition.	
When	 analysing	 the	 migration	 of	 MMC-treated	 p53KO	 and	 p21KO	 cells	 (and	 their	respective	controls),	 the	experiments	were	randomised	by	another	lab	member	before	being	analysed	blind	by	me.	
Where	 indicated	 in	 the	 text	 and	 figure	 legends,	 some	 quantifications	 could	 not	 have	statistical	 tests	 performed	 due	 to	 uneven	 sample	 sizes.	 In	 these	 instances,	 I	 used	 the	means	and	standard	deviations	of	the	two	populations	to	calculate	the	minimum	sample	size	required	to	be	conclusive	about	saying	there	is	a	significant	difference	between	them	(Chow	et	al.	2008).	
	
Western blotting 
To	lyse	cell	samples,	1%	SDS	diluted	in	PBS	was	added	to	the	culture	dish	and	the	cells	scraped	with	the	wide	end	of	a	P1000	tip.	Lysates	were	incubated	at	100°C	for	5	min	and	then	passed	through	a	25G	needle	ten	times	to	shear	the	DNA.	Lysates	were	then	frozen	at	-20°C,	thawed	and	the	DNA	shearing	process	repeated.	The	freezing-shearing	process	was	repeated	once	more	such	that	each	lysate	had	been	passed	through	a	needle	a	total	of	30	times.	Samples	were	made	up	with	10-20	µg	of	protein,	3	µl	dithiothreitol	(DTT),	7.5	
µl	4×	SDS	loading	dye	(Invitrogen),	and	topped	up	to	30	µl	with	PBS.	Samples	were	then	separated	 on	 a	 4-12%	Bis-Tris	 gradient	 gel	 (Invitrogen)	 in	MOPS	 SDS	 running	 buffer	(Invitrogen)	at	175V	for	approximately	1	hour.	Proteins	were	then	transferred	from	the	gel	onto	a	methanol-activated	PVDF	membrane	(Anachem)	using	a	semi-dry	blotter	(Bio-Rad)	at	13V	for	45-60	min.	Membranes	were	blocked	with	5%	skimmed	milk	diluted	in	0.05%	Tween-20	in	PBS	(PBST)	for	1	hour	at	RT,	incubated	in	primary	antibodies	(in	2%		 	
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skimmed	milk	in	PBST)	overnight	at	4°C,	washed	in	PBST,	and	incubated	in	secondary	HRP-conjugated	antibodies	diluted	in	2%	skimmed	milk	in	PBST	for	1	hour	at	RT.	After	washes	in	PBST,	membranes	were	developed	using	ECL	(GE	Healthcare)	and	radiographic	film.	
	
Molecular biology 
I	 designed	 all	 cloning	 strategies	 and	 primers	 in	 SnapGene	 (GSL	 Biotech)	 and	 cDNA	sequences	obtained	using	the	Ensembl	genome	browser	(Zerbino	et	al.	2018).	I	also	used	SnapGene	 to	 analyse	 sequencing	 data	 and	 draw	 the	 plasmid	 maps	 presented	 in	Appendix	2.	
All	 forward	 primers	 used	 to	 amplify	mammalian	 coding	 regions	 contained	 the	 Kozak	consensus	sequence	GCCACC	just	upstream	of	the	first	ATG	codon.	
The	pTRIPZ-RFP-NLS-Puro	and	pTRIPZ-GFP-NLS-Puro	plasmids	were	generated	by	Silvia	Vivarelli,	a	colleague	in	the	Piddini	lab,	by	modifying	the	commercially	available	pTRIPZ-turboGFP-Puro	(Thermo	Scientific).	
	
(vi) cDNA library preparation 
The	RNA	 template	was	 prepared	by	 colleagues	 in	 the	 Piddini	 lab	 from	MDCK	 scribble	shRNA	cells	treated	with	tetracycline	to	induce	scribble	knockdown.	I	then	used	this	RNA	to	make	 an	MDCK	 cDNA	 library	 using	 Superscript	 III	 Reverse	 Transcriptase	 (Thermo	Fisher	Scientific)	according	to	the	manufacturer’s	instructions.	I	used	the	resulting	cDNA	library	for	further	cloning,	as	described	in	the	relevant	sections.	
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(vii) PCR amplification 
PCR	 amplification	 of	 desired	 genes	 was	 performed	 using	 Phusion	 High-Fidelity	 DNA	Polymerase	(New	England	Biolabs)	and	construct-specific	DNA	oligonucleotides	(Sigma)	in	the	following	reaction	mix:	
Component	
Volume	per	50	µl	
reaction	(µl)	5´	Phusion	GC	buffer	 10	dNTPs	(10	mM	each)	 1	Forward	primer	(10	μM)	 2.5	Reverse	primer	(10	μM)	 2.5	Template:	cDNA	(100	ng)	or	plasmid	(<30	ng)	 1	DMSO	 2.5	Phusion	enzyme	 0.5	ddH2O	 30	
If	needed,	the	above	reaction	mix	was	optimised	by	changing	to	5´	Phusion	HF	buffer,	varying	 the	 DMSO	 concentration	 (0-5%	 final	 concentration),	 or	 screening	 a	 range	 of	annealing	temperatures.	
The	PCR	reaction	mix	was	then	cycled	in	a	thermocycler	under	the	following	conditions:	
Stage	 Temperature	 Duration	Initial	denaturation	 98°C	 30	sec	Denaturation	 98°C	 10	sec	 30	cycles	Annealing	 Primer-specific	Tm	 10	sec	Extension	 72°C	 30	sec	per	kb	of	expected	product	Final	extension	 72°C	 7	min	Hold	 15°C	 ∞	
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Presence	and	size	of	expected	PCR	products	were	verified	by	agarose	gel	electrophoresis	(1%	w/v	 agarose	 in	 1×	 TAE	 buffer).	 Bands	 of	 interest	were	 cut	 out	 from	 the	 gel	 and	purified	using	a	QIAquick	Gel	Extraction	Kit	(Qiagen).	
	
(viii) Restriction digestion 
Plasmid	backbones	were	linearised	by	restriction	digestion	overnight	at	37°C	to	minimise	the	amount	of	uncut	plasmid.	The	whole	reaction	was	then	run	on	an	agarose	gel	and	the	bands	of	interest	cut	out	and	purified	using	a	QIAquick	Gel	Extraction	Kit	(Qiagen).	
	
(ix) sgRNA target sequence cloning for CRISPR strategies 
The	PX461	backbone,	encoding	Cas9	D10A	(‘nickase’)	and	GFP,	was	linearised	overnight	using	BbsI/BpiI.	The	whole	reaction	was	run	on	an	agarose	gel;	the	band	was	cut	out	and	purified	using	a	QIAquick	Gel	Extraction	Kit	(Qiagen).	
Two	DNA	oligos	per	sgRNA	target	sequence	were	designed	such	that,	once	annealed,	they	formed	 a	 fragment	 with	 sticky	 ends	 compatible	 with	 the	 BbsI/BpiI-linearised	 PX461	backbone:	
	
5’	 CACCG	–	NNNNNNNNNNNNNNNNNNNN	 	 	 3’	top	(guide	sequence)	
3’	 											C	–	NNNNNNNNNNNNNNNNNNNN	–	CAAA		 5’	bottom	
	
The	following	reaction	was	set	up	to	first	phosphorylate	their	5’	ends	of	the	DNA	oligos	and	then	anneal	them:	
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Component	
Volume	per	10	µl	
reaction	(µl)	Oligo	1	(100	μM)	 1	Oligo	2	(100	μM)	 1	10´	T4	polynucleotide	kinase	(PNK)	buffer	 1	T4	PNK	 1	ddH2O	 6	
The	reaction	was	placed	in	a	thermocycler	with	the	following	programme:	30	min	at	37°C	to	allow	the	T4	PNK	to	work,	followed	by	gradient	from	95°C	to	25°C	dropping	5°C	every	minute	to	enable	oligo	annealing.	
The	following	ligation	mix	was	then	set	up:	
Component	
Volume	per	20	µl	
reaction	(µl)	50	ng	BbsI/BpiI	digested	PX461	backbone	 x	Annealed	oligos	(1:200	dilution	in	ddH2O)	 1	10´	T4	ligase	buffer	 1	T4	ligase	 1	ddH2O	 make	up	to	20	
The	ligation	reaction	was	incubated	for	approximately	1	hour	at	RT.	2	μl	of	the	reaction	mix	was	then	transformed	into	20	μl	of	chemically	competent	Stbl3	E.	coli.	
	
(x) In-Fusion cloning 
The	 In-Fusion	 HD	 Cloning	 Kit	 (Clontech)	 was	 used	 for	 all	 cloning,	 unless	 specified,	according	to	the	manufacturer’s	instructions.	I	designed	In-Fusion	primers	such	that	they	had	a	20	nt	overlap	with	the	 linearised	vector	(rather	than	the	suggested	minimum	of	15	nt).	
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(xi) Bacterial transformation and culture 
To	 amplify	 plasmid	 DNA,	 an	 appropriate	 volume	 of	 In-Fusion	 reaction	 mix,	 ligation	reaction	mix,	or	purified	plasmid	was	transformed	into	chemically	competent	E.	coli	cells.	For	In-Fusion	reactions,	Stellar	cells	were	used;	for	large	plasmids	like	pTRIPZ	or	PX461,	Stbl3	cells	were	used	to	prevent	recombination	events;	for	any	other	purposes,	TOP10	cells	were	used.	The	DNA	was	incubated	with	20-50	μl	of	cells	for	20	min	on	ice.	Cells	were	then	heat	shocked	at	42°C	for	42	sec,	followed	by	2	min	on	ice.	1	ml	of	LB	broth	was	then	added	 to	 the	 transformation	 mix	 and	 the	 samples	 incubated	 in	 a	 ThermoMixer	(Eppendorf)	for	1	hour	at	37°C	with	shaking.	100	μl	of	the	cell	suspension	was	then	plated	on	an	LB	agar	plate	containing	appropriate	antibiotics	(100	μg/ml	ampicillin	or	50	μg/ml	kanamycin).	The	remainder	of	the	solution	was	pelleted	(16,000	rcf,	30	sec),	most	of	the	supernatant	tipped	out	such	that	the	pellet	could	be	resuspended	in	approximately	100	μl	of	 liquid,	and	spread	on	another	LB	plate	containing	antibiotics.	This	produced	 two	plates	per	transformation,	one	with	approximately	10%	of	the	cells	and	the	other	with	the	remaining	~90%.	Plates	were	incubated	at	37°C	for	16-20	hours.	
Plasmids	 were	 recovered	 from	 an	 overnight	 culture	 in	 2	 ml	 LB	 broth	 containing	appropriate	antibiotics	(100	μg/ml	ampicillin	or	50	μg/ml	kanamycin)	using	a	QIAGEN	Plasmid	Mini	Kit	 (Qiagen).	 If	 larger	quantities	of	plasmid	were	required,	 the	overnight	culture	was	scaled	up	to	50-100	ml	and	a	QIAGEN	Plasmid	Midi	Kit	(Qiagen)	was	used	for	plasmid	recovery.	Plasmids	were	eluted	in	ddH2O	and	the	DNA	concentration	measured	using	a	NanoDrop	spectrophotometer	(Thermo	Fisher	Scientific).	
	
(xii) Verification by ‘diagnostic digest’ and sequencing 
Correct	fragment	insertion	was	verified	by	performing	a	‘diagnostic	digest’:	a	small-scale	restriction	 digestion	 (≤5	 μl	 of	 the	 recovered	 plasmid)	 followed	 by	 agarose	 gel	electrophoresis.	Clones	with	correct	digestion	patterns	were	diluted	to	50	ng/μl	in	15	μl	and	sent	for	sequencing	(Eurofins	Genomics)	with	plasmid-specific	primers	at	10	μM.	
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List of abbreviations 
	°C	 	 	 	 Degrees	Celsius	APC	 	 	 	 Adenomatous	polyposis	coli	AU	 	 	 	 Arbitrary	units	Bak	 	 	 	 Bcl-2	homologous	antagonist/killer	Bax	 	 	 	 Bcl-2	associated	X	protein	BNPs	 	 	 	 Bone	morphogenetic	proteins	bp	 	 	 	 Base	pair(s)	BSA	 	 	 	 Bovine	serum	albumin	CAFs	 	 	 	 Cancer-associated	fibroblasts	CDK	 	 	 	 Cyclin/cyclin-dependent	kinase	CDKN1A	 	 	 Cyclin-Dependent	Kinase	Inhibitor	1A,	p21WAF1/Cip1,	p21	cDNA	 	 	 	 Complementary	DNA	CFP	 	 	 	 Cyan	fluorescent	protein	CKI	 	 	 	 Cyclin/cyclin-dependent	kinase	inhibitor	cm	 	 	 	 Centimetre(s)	CO2	 	 	 	 Carbon	dioxide	DAPI	 	 	 	 4′,6-diamidino-2-phenylindole	ddH2O		 	 	 Double-distilled	water	Dlg	 	 	 	 Discs	large	DMEM		 	 	 Dulbecco’s	Modified	Eagle	media	DMSO	 	 	 	 Dimethyl	sulphoxide	DNA	 	 	 	 Deoxyribonucleic	acid	dNTPs		 	 	 Deoxyribonucleotide	triphosphates	DOX	 	 	 	 Doxycycline	
Drosophila	 	 	 Drosophila	melanogaster	DSB	 	 	 	 Double-strand	break	DTT	 	 	 	 Dithiothreitol	E-cad/E-cadherin	 	 Epithelial	cadherin	
E-cadKD	 	 	 E-cadherin	knockdown	
E.	coli	 	 	 	 Escherichia	coli	
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EC	domain	 	 	 Extracellular	cadherin	domains	ECM	 	 	 	 Extracellular	matrix	EDTA	 	 	 	 Ethylenediaminetetraacetic	acid	EGFR	 	 	 	 Epidermal	growth	factor	receptor	ELMO	 	 	 	 Engulfment	and	cell	motility	EMT	 	 	 	 Epithelial	to	mesenchymal	transition	ERK1/2	 	 	 Extracellular	regulated	kinase	1/2	FBS	 	 	 	 Foetal	bovine	serum	GEF	 	 	 	 Guanosine	exchange	factor	GFP	 	 	 	 Green	fluorescent	protein	h/hrs	 	 	 	 Hour(s)	HEK-293T	cells	 Human	embryonic	kidney	cells	293	transformed	with	the	SV40	large	T	antigen	HGF	 Hepatocyte	growth	factor	Hoechst	 	 	 Hoechst	33342	HRP	 	 	 	 Horseradish	peroxidase	ITGb1	 	 	 	 Integrin	β1	JAK/STAT	 Janus	kinase	/	signal	transducer	and	activator	of	transcription	JNK	 	 	 	 c-Jun	N-terminal	kinase	K-S	test	 	 	 Kolmogorov–Smirnov	test	KO	 	 	 	 Knockout	LAP	protein	 	 	 LRR	and	PDZ	domains	protein	LB	 	 	 	 Lysogeny	broth	Lgl	 	 	 	 Lethal	giant	larvae	LRR	 	 	 	 Leucine-rich	repeats	MAPK	 	 	 	 Mitogen-activated	protein	kinase	Mbc	 	 	 	 Myoblast	city	MDCK	cells	 	 	 Madin-Darby	canine	kidney	cells	Mdm2		 	 	 Mouse	double	minute	2	min	 	 	 	 Minute(s)	ml	 	 	 	 Millilitre(s)	mm	 	 	 	 Millimetre(s)	mM	 	 	 	 Millimolar	
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MMC	 	 	 	 Mitomycin	C	MOPS	 	 	 	 3-(N-morpholino)propanesulphonic	acid	mRNA		 	 	 Messenger	ribonucleic	acid	N-cad/N-cadherin	 	 Neural	cadherin	NC	 	 	 	 Neural	crest	NF-ĸB	 nuclear	factor	kappa-light-chain-enhancer	of	activated	B	cells	ng	 	 	 	 Nanogram(s)	NLS	 	 	 	 Nuclear	localisation	sequence	nt	 	 	 	 Nucleotide(s)	OE	 	 	 	 Overexpression	oligo	 	 	 	 DNA	oligonucleotide	P-cad/P-cadherin	 	 Placental	cadherin	p16	 	 	 	 p16INK4A	p21	 	 	 	 p21WAF1/Cip1	
p21KO		 	 	 p21	knockout	p27	 	 	 	 p27Kip1	P2A	 	 	 	 Porcine	teschovirus-1	2A	
p53KO		 	 	 p53	knockout	PAM	 	 	 	 Protospacer	adjacent	motif	PBS	 	 	 	 Phosphate	buffered	saline	PBST	 	 	 	 Phosphate	buffered	saline	+	0.05%	Tween-20	PCNA	 	 	 	 Proliferating	cell	nuclear	antigen	PCP	 	 	 	 Planar	cell	polarity	PCR	 	 	 	 Polymerase	chain	reaction	PDGF	 	 	 	 Platelet-derived	growth	factor	PDMS	 	 	 	 Polydimethylsiloxane	PDZ	 	 	 	 PSD-95,	ZO-1	and	Disc	large	PEST	 Peptide	sequence	rich	in	proline	(P),	glutamate	(E),	serine	(S),	and	threonine	(T)	PFA	 	 	 	 Paraformaldehyde	PI3K	 	 	 	 Phosphoinositide	3-kinase	pMYPT1	 	 	 Phosphorylated	myosin	phosphatase	target	subunit	1	PNK	 	 	 	 Polynucleotide	kinase	
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Puro	 	 	 	 Puromycin	PVDF	 	 	 	 Polyvinylidene	difluoride	PVR	 	 	 	 PDGF/VEGF	receptor	rcf	 	 	 	 Relative	centrifugal	force	RFP	 	 	 	 Red	fluorescent	protein	RNA	 	 	 	 Ribonucleic	acid	ROCK	 	 	 	 Rho-associated	protein	kinase	ROS	 	 	 	 Reactive	oxygen	species	RT	 	 	 	 Room	temperature	SAβGAL	 	 	 Senescence-associated	β-galactosidase	
scribble-/-	 	 	 scribble	knockout	(in	Drosophila)	
scribKD		 	 	 scribble	knockdown	(in	mammalian	systems)	SDS	 	 	 	 Sodium	dodecyl	sulphate	sec	 	 	 	 Second(s)	SEM	 	 	 	 Standard	error	of	the	mean	sgRNA		 	 	 Short	guide	RNA	shRNA		 	 	 Short	hairpin	RNA	SV40	 	 	 	 Simian	virus	40	TAE	buffer	 	 	 Tris-acetate-EDTA	buffer	TBS	 	 	 	 Tris	buffered	saline	TET	 	 	 	 Tetracycline	TGFβ	 	 	 	 Transforming	growth	factor	β	Tm	 	 	 	 Melting	temperature	TNF	 	 	 	 Tumour	necrosis	factor	Tris	 	 	 	 Tris(hydroxymethyl)aminomethane	TRR	 	 	 	 Toll-related	receptor	UV	 	 	 	 Ultraviolet	V	 	 	 	 Volt(s)	VEGF	 	 	 	 Vascular	endothelial	growth	factor	WT	 	 	 	 Wild-type	µg	 	 	 	 Microgram(s)	µl	 	 	 	 Microlitre(s)	µM	 	 	 	 Micromolar		  
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Mechanical cell competition kills cells via induction
of lethal p53 levels
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Cell competition is a quality control mechanism that eliminates unfit cells. How cells compete
is poorly understood, but it is generally accepted that molecular exchange between cells
signals elimination of unfit cells. Here we report an orthogonal mechanism of cell
competition, whereby cells compete through mechanical insults. We show that MDCK cells
silenced for the polarity gene scribble (scribKD) are hypersensitive to compaction, that
interaction with wild-type cells causes their compaction and that crowding is sufficient for
scribKD cell elimination. Importantly, we show that elevation of the tumour suppressor p53 is
necessary and sufficient for crowding hypersensitivity. Compaction, via activation of
Rho-associated kinase (ROCK) and the stress kinase p38, leads to further p53 elevation,
causing cell death. Thus, in addition to molecules, cells use mechanical means to compete.
Given the involvement of p53, compaction hypersensitivity may be widespread among
damaged cells and offers an additional route to eliminate unfit cells.
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Cell competition is a remarkable phenomenon, conservedfrom arthropods to mammals, that causes the eliminationof relatively less fit cells from tissues, helping to maintain
overall tissue health1–10. Despite important advances11–16, the
mechanisms that lead to the elimination of unfit cells are still little
understood and it is unclear whether one or multiple pathways
lead to cell killing17–22.
It has recently been reported that Madin–Darby canine kidney
(MDCK) epithelial cells silenced for the polarity gene scribble
(scribKD cells) are eliminated in the presence of wild-type MDCK
cells23, while they are viable on their own23. However, the
mechanisms by which scribKD cells are killed by wild-type cells
are largely unknown. We therefore took advantage of this recent
observation to investigate the mechanisms of cell competition.
Here we show that scribKD cells are out-competed by wild-type
cells through mechanical insults rather than molecular exchange.
We find that scribKD cells are hypersensitive to compaction and
that this is due to elevation of baseline p53 levels, which is both
necessary and sufficient to induce hypersensitivity to crowding
and confer a mechanical loser status. We further show that on
contact with wild-type cells, scribKD cells become compacted into
a high-density arrangement and that compaction is not only
required but also sufficient to eliminate scribKD cells. We also
delineate the mechano-transduction cascade that leads to scribKD
cell death. Specifically, we show that scribKD cells’ compaction
causes activation of the Rho-associated kinase (ROCK), which in
turn activates p38 leading to further p53 elevation and cell death.
Overall, this work demonstrates that mechanical forces can be
responsible for the elimination of cells during cell competition
and that p53 levels play a key role both in instructing the
mechanical loser status and in the execution of mechanical cell
competition.
Results
Compaction of scribKD cells induces mechanical competition. It
has previously been shown that scribKD MDCK cells are elimi-
nated when co-cultured with wild-type MDCK cells through cell
death and delamination (see ref. 23 and Supplementary Fig. 1a
and Supplementary Movie 1, left), while monocultures of scribKD
cells are viable (see ref. 23 and Supplementary Fig. 1b and
Supplementary Movie 1, right). To investigate the mechanisms of
scribKD-mediated cell competition, we first asked whether it is
mediated by soluble factors, as in other cases of in vitro cell
competition6,24. Growth rate (doubling time) profiles showed that
scribKD cells in pure cultures divide, albeit at a reduced rate, to
reach a steadily maintained number (Supplementary Fig. 1d),
whereas under competing conditions, their numbers collapse
following initial growth (Fig. 1a). Interestingly, we found that the
growth rate of scribKD cells is not affected by conditioned
medium from competing cultures (Fig. 1b and Supplementary
Fig. 1c). Similarly, in transwell systems that allow exchange of
solutes but prevent cell contact, scribKD cells grown together with
co-cultures of competing (wild-type/scribKD) cells grew
comparably to scribKD cells grown with other scribKD cells
(Fig. 1c and Supplementary Fig. 1c). This indicated that soluble
factors are not sufficient to induce cell competition and that cell
contact is required. We hypothesized that cell contact enables
molecular interactions essential for cell competition, as observed
by others11,12. However, to our surprise, we found that sustained
contact with wild-type cells is not sufficient for elimination of
scribKD cells (Fig. 1d, black arrow and Supplementary Movie 2)
and that scribKD clones are efficiently eliminated only when fully
surrounded by wild-type cells (Fig. 1d, white arrow and
Supplementary Movie 2). This suggested that a type of
exchange other than molecular signalling (which would be
enabled by contact) may be needed, and prompted us to look
for differences between scribKD clones that were surrounded and
peripheral clones that were simply contacted.
One striking feature of surrounded clones, which is not shared
by peripheral clones, is that they reach a dramatically higher cell
density than confluent scribKD pure cultures (Fig. 1e–g and
Supplementary Fig. 1e). scribKD cells acquire a flattened
morphology upon gene silencing23,25, which at confluence
results in a much lower (B1/3) final density compared with
wild-type cells (Fig. 1e–g). However, scribKD clones surrounded
by wild-type cells do not flatten and reach a density that isB4.5-
fold higher than that of pure scribKD cultures (Fig. 1e–g).
Furthermore, competing scribKD cells are taller than when grown
in single cultures (Fig. 1h–j). Together, this indicates that as a
result of their interaction with wild-type cells, scribKD cells
become more compacted than in their default state and this
correlates with and precedes their elimination.
We next asked whether cell compaction plays a role in scribKD
cell elimination, by assessing its effect on scribKD cells in complete
absence of wild-type cells. To that end, we used micropatterns to
form scribKD microcultures of a defined, homogenous density and
size (+¼ 800mm, ref. 26). When plated at high density, control
cells that had not undergone scribble silencing (without
tetracycline, "TET) continued to grow until they reached a
maximal density of 61±4 cells per 10,000 mm2, which they
maintained homeostatically (Fig. 1k,l and Supplementary Movie
3, left), as previously shown27,28. Remarkably, scribKD cultures
(þTET) instead saw their numbers and densities drop
(Fig. 1m,n, dark green and Supplementary Movie 3, right), due
to a combination of increased cell death and extrusion, the same
two events that lead to the elimination of scribKD cells during cell
competition (Supplementary Movie 1, left and ref. 23). Notably,
scribKD cells seeded at a lower density maintained that initial
density (Fig. 1n, light green) indicating that the drop in cell
number observed at higher density is not a general response of
scribKD cells to plating. This suggested that scribKD cells are
hypersensitive to compaction. To test this directly, we seeded
confluent monolayers of control ("TET) or scribKD (þTET)
cells on stretched polydimethylsiloxane (PDMS) substrates, which
we then released to induce cell compression27. Control cultures
showed no increase in apoptosis upon compression (Fig. 1o–q).
The scribKD cells, however, displayed a 3-fold increase in
apoptosis over their uncompressed baseline cell death, which
was already higher than control (Fig. 1p,q). Altogether, these
experiments show that scribKD cells display hypersensitivity to
cell density and cannot sustain levels of crowding normally
reached by wild-type cells. They further indicate that compaction
of scribKD cells into higher cell densities, like those imposed on
them by wild-type cells during competition, is sufficient to induce
cell death. This suggests that wild-type cells eliminate scribKD cells
through crowding-induced compaction. We name this new mode
of selective elimination of one cell population by another due to
differential sensitivity to crowding ‘mechanical cell competition’,
to contrast it with forms of cell competition that rely on
molecular exchange.
Corralling promotes but is not needed for scribKD elimination.
As shown in Fig. 1f,g, in subconfluent competing cultures, the
density of scribKD cells surpasses that of surrounding wild-type
cells. This indicates that their acquired density does not simply
reflect the density of the mixed culture, but is the result of
an active process. To understand how scribKD cells become
compacted during competition, we plated cells at low density and
observed what happens when wild-type and scribKD clones first
come into contact. Strikingly, we saw that, on contact, both
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scribKD and wild-type cells engage in collective cell migration
(Fig. 2a and Supplementary Movie 4). This behaviour was specific
to wild-type/scribKD encounters, as it was not observed upon
homotypic encounters of either cell population (Fig. 2b and
Supplementary Movie 5). Interestingly, this migration was highly
directional with scribKD cells always at the migrating front and,
conversely, wild-type cells always at the back. We next
characterized this migratory behaviour and assessed its con-
tribution to cell compaction and elimination. First, we repeated
the above experiment using a fluorescent nuclear label in each
population to facilitate cell tracking (Fig. 2c). Kymograph analysis
showed rapid activation of collective cell migration at the time of
contact between wild-type and scribKD cells, with both popula-
tions moving synchronously (Fig. 2d, top and Fig. 2e). By
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contrast, similar kymographs of homotypic collisions did not
show significant cell displacement (Fig. 2d, centre and bottom;
and Fig. 2e). To further characterize the features of this collective
cell migration, we carried out single-cell tracking of both cell
populations before and after contact. The analysis of individual
cell trajectories shows that single-cell movement is faster and
more persistent for both wild-type and scribKD cells upon
heterotypic collision (Fig. 2f and Supplementary Fig. 2a–d). We
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then looked more closely at the dynamic interplay between wild-
type and scribKD cells at the onset of migration. Interestingly,
analysis of cell shape at the interface between the two populations
revealed that both wild-type and scribKD cells become elongated
at the site of contact (Fig. 2g,h), indicating that they are under
anisotropic stress. Moreover, the cells in both populations move
in the direction of their short axis (Fig. 2i), suggesting that they
could be locally compressed. This could be the result of wild-type
cells beginning migration and locally ‘piling up’ against the
scribKD cells. In agreement with this, particle image velocimetry
(PIV) and single-cell tracking revealed that wild-type cells begin
migrating towards scribKD cells on average B2 h before the
scribKD cells start migrating away (Fig. 2j,k and Supplementary
Movie 6). Together, the chronology of these events and the local
cellular deformations suggest that cells might engage in a beha-
viour similar to the ‘chase and run’ migration reported for other
cell types29. These experiments do not distinguish whether
scribKD cells are pushed by wild-type cells or, conversely, whether
scribKD cells self-compact to avoid closer interaction wild-type
cells. However, it is clear that as migration progresses, scribKD
cells become corralled by wild-type cells and are compacted and
eliminated (Supplementary Movie 7), indicating that this
behaviour may facilitate compaction and outcompetition of
scribKD cells.
To directly test the relevance of directional cell migration in the
elimination of scribKD cells, we next sought to disrupt this
behaviour. Adhesion molecules play an important role in
collective cell migration30 and have also been implicated in
‘chase and run’ among mesenchymal cells29. In addition, scribble
downregulation has previously been shown to induce intracellular
accumulation of E-cadherin23,31 and we found that it causes an
increase of both total and cell surface E-cadherin levels
(Supplementary Fig. 2e–g). We therefore reasoned that
targeting E-cadherin-mediated adhesion might disrupt
directional migration between the wild-type and scribKD cells.
We undertook two separate approaches and found that either
blocking E-cadherin function in both populations, through a
combination of low calcium and addition of a blocking antibody
(Fig. 2l–o and Supplementary Movie 8), or silencing E-cadherin
only in wild-type cells (E-cadKD (ref. 32); Fig. 2p) was sufficient to
inhibit directional migration. Interestingly, disruption of
E-cadherin inhibited active cell compaction (Fig. 2l,m,
Supplementary Movie 8 and quantification in Fig. 2n) and
resulted in delayed elimination of scribKD cells (Fig. 2l,m,
Supplementary Movie 8 and quantification in Fig. 2o).
However, it did not rescue the scribKD cells from cell
competition, since they were eventually eliminated as the
culture became progressively more crowded due to proliferation
(Fig. 2l,m and Supplementary Movie 8).
Having established that E-cadherin-mediated adhesion is
involved in contact-induced migration between wild-type and
scribKD cells, we next asked whether the upregulation of
E-cadherin observed in scribKD cells (Supplementary Fig. 2e–g)
plays a role in this directional cell movement. We therefore
generated an inducible double scribKD E-cadherin knockdown cell
line (scribKD E-cadKD) and specifically selected clones that
displayed partial silencing, enough to bring E-cadherin down to
wild-type levels (Fig. 2q, right panel and Supplementary Fig. 2h,i).
Indeed, partial downregulation of E-cadherin inhibited contact-
induced migration, suggesting that high E-cadherin levels in the
scribKD cells are required for this process (Fig. 2q and
Supplementary Movie 9). As expected, these clones were still
outcompeted by wild-type cells (Supplementary Fig. 2j). In
contrast, we found that E-cadherin upregulation alone is not
sufficient to cause contact-induced migration, as cells over-
expressing E-cadherin at levels comparable to those of scribKD
cells (Supplementary Fig. 2k) did not engage in directional cell
migration with wild-type cells upon contact (Supplementary
Fig. 2l). Altogether, we conclude that directional cell migration,
by enabling corralling and active compaction of scribKD cells,
promotes but is not required for mechanical cell competition, and
that E-cadherin is necessary for corralling and active compaction
but it does not impact on loser cell status.
p53 is activated in scribKD cells before cell competition. Key to
the outcompetition of scribKD cells is their hypersensitivity to
compaction (Fig. 1k–q). To identify genes and pathways involved
in this behaviour, we carried out transcriptional profiling of
scribKD cells (scribKD þTET) and compared it with the tran-
scriptomes of control MDCK cells (scribKD "TET) and,
importantly, of an isolate of scribKD cells that is resistant to cell
competition (scribRES). Despite maintaining scribble gene
knockdown (Supplementary Fig. 3a), the scribRES cells do not
display elevated E-cadherin (Supplementary Fig. 3b), do not
engage in contact-induced migration with wild-type cells
(Supplementary Fig. 3c) and are not outcompeted in cell
competition assays (Supplementary Fig. 3d and Supplementary
Movie 10). Notwithstanding these fundamental differences, we
observed that the scribKD transcriptome is still substantially closer
to scribRES (with 523 differentially expressed genes) than to
control (scribKD "TET) cells (with 1,645 differentially expressed
genes; Fig. 3a, left and Supplementary Data 1 and 2). This allowed
us to rule out all genes that are differentially expressed in scribKD
versus wild-type cells but are similarly expressed between scribKD
and scribRES, as these are clearly not sufficient to induce cell
competition. Instead, we focused on the small intersection of 306
genes that are differentially expressed between wild-type and
scribKD cells but are also different between scribKD and scribRES
cells (Fig. 3a and Supplementary Data 3).
Gene Ontology term enrichment analysis highlighted p53
signalling as the top functionally enriched pathway (Fig. 3a,
middle). A number of known p53 target genes were moderately
upregulated in scribKD cells, suggesting p53 activation (Fig. 3a,
right). Consistent with this, we found that p21 (a known p53
target33 and the most highly upregulated p53 target in our gene
list; Fig. 3a) is specifically upregulated upon scribble knockdown
in scribKD cells (Fig. 3b, Supplementary Fig. 3e and
Supplementary Fig. 4d,e) but not in scribRES cells (Fig. 3b) and
that p53 levels are higher in scribKD cells than in wild-type cells
(Fig. 3c,d and Supplementary Fig. 3f), confirming pathway
activation. Thus, scribKD cells have high baseline p53 activity
and this correlates with their loser status.
p53 is further elevated in scribKD cells by compaction. Next we
asked whether cell competition affects p53 activity. Interestingly,
we found that in competing conditions, p53 levels in scribKD cells
increase above their already elevated baseline level, in a way that
correlates with the degree of cell compaction (Fig. 3c–e; r¼ 0.56
by non-parametric Spearman correlation). This suggested that
compaction increases p53 levels or, conversely, that higher p53
levels enable compaction. To distinguish between these two
possibilities, we looked at how compression alone affects p53,
using deformable PDMS substrates as before (Fig. 1o–q).
Importantly, we found that compression alone causes an increase
in p53 levels (Fig. 3f,g), as seen during competition. This indicates
that cell competition induces further p53 activation in the scribKD
cells via compaction-induced mechanical stress.
Given that p53 is upregulated during cell competition, we next
sought to ask whether it contributes to this process. Therefore we
mutated p53 in scribKD cells by CRISPR-mediated mutagenesis
(scribKD p53" /" cells, Supplementary Fig. 4a,b). The scribKD
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p53" /" cells failed to upregulate p21 following ultraviolet
irradiation (Supplementary Fig. 4b) or scribble knockdown
(Supplementary Fig. 4c–e), confirming functional p53 inactiva-
tion. Strikingly, we found that p53 inactivation in scribKD
p53" /" cells was sufficient to partially rescue their low
homeostatic cell density (Fig. 3h) and their hypersensitivity to
compaction (Fig. 3i). Remarkably, genetic (using scribKD p53" /"
cells) or chemical (using the inhibitor Pifithrin-a) inhibition of
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scribKD p53" /" cells. (i) Quantification of cell death (cleaved Caspase-3) for scribKD cells versus scribKD p53" /" cells on PDMS substrate þ /"
compression; black bars¼mean; data from three biological replicates across two independent experiments. (j) Stills from time-lapse movies of WT and
GFP-labelled scribKD p53" /" co-cultures, see corresponding Supplementary Movie 11; n¼ cell number in e and g or n¼ number of imaged fields of cells in
h and i. a.u.¼ arbitrary units, here and throughout all the figures. *Po0.05, ***Po0.0005 by KS test.
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p53 in scribKD cells was also sufficient to prevent their
outcompetition (Fig. 3j and Supplementary Movie 11;
Supplementary Fig. 4f). Furthermore, scribKD p53" /" cells
maintained high E-cadherin levels (Supplementary Fig. 4g) and still
displayed contact-induced migration (Supplementary Fig. 4h),
demonstrating again that corralling is not sufficient for competition.
Altogether, we conclude that high baseline p53 activity in scribKD
cells is associated with their loser status and is required for them to
acquire a low homeostatic cell density and hypersensitivity to
compaction, two key features of the mechanical loser status.
Interestingly, though it has long been established that
scribble" /" cells are eliminated by cell competition in Droso-
phila34,35, when we tested whether this might happen via
mechanical insults in wing imaginal discs we found that, unlike
in MDCK cells, scribble" /" wing disc cells did not upregulate
E-cadherin (Supplementary Fig. 5a,b) and their outcompetition
was not rescued by p53 inhibition (Supplementary Fig. 5c). It is
possible that scribble" /" cells are not eliminated by mechanical
cell competition in Drosophila or that the function of Scribble or
p53 may not be conserved in this process. Alternatively and
perhaps more likely, mechanical cell competition may be
redundant with other mechanisms of cell competition that have
been described to target scribble" /" cells in that system36,37.
ROCK activates p38 leading to p53 elevation and cell death.
We next wondered how mechanical stress might lead to p53
activation. A potential candidate was p38 signalling, as it is
required for scribKD cell competition23, is known to promote p53
activity38–40 and has also been involved in the response to
mechanical stress41. Consistent with an involvement of p38, we
found that compression alone causes an increase in active
phosphorylated (T180/Y182) p38 (ref. 38; P-p38) in scribKD cells
(Fig. 4a,b) and that chemical inhibition of this pathway partially
rescues both the homeostatic density of scribKD cells (Fig. 4c) and
their compaction hypersensitivity (Fig. 4d). Moreover, the
upregulation of p53 in competing scribKDcells was reduced by
p38 inhibition (Fig. 4e). We conclude that in scribKD cells,
compression induces p53 via activation of p38.
We next asked how compression of scribKD cells causes p38
activation. We monitored cytoskeletal changes induced by
compression and found that both cortical Actin (by phalloidin
staining) and active phosphorylated-myosin (P-Myosin) are
upregulated in compacted scribKD cells during competition
(Fig. 4f,g). Since the cytoskeletal regulator ROCK42 is one of
the main kinases responsible for Myosin phosphorylation, this
suggested that ROCK might be activated. Indeed P-Myosin
upregulation was reduced in the presence of a ROCK inhibitor
(Supplementary Fig. 6a,b) and the ROCK target phospho-MYPT1
(ref. 43; p-MYPT1) was also elevated in compacted scribKD cells
(Fig. 4h), indicating that ROCK is activated in compacted scribKD
cells. This was potentially relevant because ROCK has been
shown to phosphorylate p38 (ref. 44). Thus, to ask whether
ROCK is upstream of p38 activation, we compressed pure
cultures of scribKD cells in the presence or absence of a ROCK
inhibitor and looked at P-p38 levels. ROCK inhibition led to a
partial reduction of P-p38 levels, thus placing ROCK upstream of
p38 signalling (Fig. 4i,j). In addition, ROCK inhibition was
sufficient to partially rescue the homeostatic density of scribKD
cells (Fig. 4k) and compression-induced cell death (Fig. 4l).
Importantly, inhibition of ROCK was also sufficient to prevent
the out-competition of scribKD cells, with no appreciable cell
death observed even though cells were compacted far beyond
standard competition densities (Fig. 4m and Supplementary
Movie 12). Altogether, these experiments indicate that
mechanical cell competition is caused by compaction-induced
ROCK activation, which activates p38, leading to p53 elevation
and cell death. Interestingly, ROCK has also been implicated in
apical extrusion of dying or crowded MDCK cells45,46. However,
in the case of Scribble competition, ROCK has a different
function, as it is involved in p53 activation and cell death. In
addition, while in that context ROCK was activated by S1P2 and
Piezo signalling45,46, inhibition of these pathways had no effect
on Scribble cell competition (Supplementary Fig. 7a,b), suggesting
a distinct upstream activation mechanism.
p53 activation turns wild-type cells into mechanical losers.
Finally, we decided to address how scribble knockdown earmarks
cells as losers. Our data indicated that a loser cell status is not an
obligate outcome of scribble silencing, as we could isolate scribKD
cells that are competition resistant (scribRES cells; Supplementary
Fig. 3d). Instead, our data showed that p53 is necessary for com-
petition and that mild p53 elevation is required for scribKD cells to
acquire key features of the mechanical loser status (Fig. 3h,i). This
prompted us to investigate whether p53 might actually be sufficient
to induce the mechanical loser status and cell competition.
Nutlin-3, a chemical inhibitor of the E3 ubiquitin ligase MDM2
(Mouse Double Minute 2 (ref. 47)), activates p53 in a dose-
dependent manner. This allowed us to establish conditions to
induce mild p53 activation in wild-type MDCK cells. Strikingly,
low-level p53 activation was sufficient to induce cell flattening
(Fig. 5a) and to lower the homeostatic density of wild-type cells
(Fig. 5b). Remarkably, Nutlin-3 treatment was also sufficient to
induce compaction hypersensitivity (Fig. 5c). Thus, mild p53
activation is sufficient to induce in wild-type cells all the features
that we observed in scribKD cells that are hallmarks of their
mechanical loser status. Therefore, we next asked whether differ-
ential p53 levels are sufficient to induce mechanical cell competi-
tion. To test this, we generated a p53 knockout cell line (p53" /" ),
which we then co-cultured with wild-type cells. Not surprisingly,
simply mixing wild-type and p53" /" cells was not sufficient to
induce competition (Supplementary Fig. 8a). Strikingly however,
mild p53 activation in wild-type cells, by Nutlin-3 addition at
sublethal doses, caused the elimination of these cells specifically in
the co-culture, but not when they were cultured alone (Fig. 5d,
Supplementary Fig. 8b and Supplementary Movie 13). Importantly,
p53-induced cell competition was indistinguishable from scribble
cell competition, as it resulted in loser cell compaction (Fig. 5e) and
only caused elimination when cells were compacted by p53" /"
cells (Fig. 5d). Overall, these results demonstrate that mild eleva-
tion of p53 is sufficient to phenocopy Scribble cell competition and
induce both hypersensitivity to cell crowding and the mechanical
loser status in otherwise wild-type cells.
To demonstrate the existence of p53-mediated mechanical cell
competition beyond the MDCK experimental paradigm, we
turned to primary cultures of epithelial cells, specifically to mouse
tracheal epithelial cells (MTECs), and looked for evidence of this
process. Under normal conditions, confluent MTEC monolayers
show little proliferation or change in cell density (Fig. 5f,g,
compare first and second time points, and Supplementary Movie
14, left, before Nutlin-3 addition). Interestingly however, when we
induced mild elevation of p53 (by Nutlin-3 treatment) in these
cultures, we found that this results in a 26% average reduction in
cell density, accompanied by cell extrusion, suggesting acquired
hypersensitivity to crowding (Fig. 5f,g, compare before and after
Nutlin-3 addition, and Supplementary Movie 14, left, after
Nutlin-3 addition). To test whether differential levels of p53
could induce cell competition in MTECs, we mixed Tomato-
labelled wild-type MTECs (MTEC Tomato; from Rosa26R-
nTomato-nGFP mice48) either with unlabelled wild-type
MTECs or with unlabelled p53 null MTECs (MTEC p53" /" ;
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from p53 null mice). Before Nutlin-3 addition, the proportion of
wild-type (Tomato) MTECs in the monolayer did not change for
several days when co-cultured with either p53" /" cells or more
wild-type cells (Fig. 5f–i, first two time points, and Supplementary
Movie 14, before Nutlin-3 addition). However and strikingly,
Nutlin-3 addition induced robust cell competition specifically in
wild-type/p53" /" MTEC co-cultures, causing the number of
wild-type cells to plummet within 6 days to B17% of their
starting number, with pronounced cell death and fragmentation
(Fig. 5h,i and Supplementary Movie 14, right). Thus, mild p53
elevation is sufficient to induce crowding hypersensitivity and
mechanical cell competition in MTEC cultures.
Discussion
In summary, our work demonstrates that in addition to molecular
signals, cells use mechanical means to compete (see model in
Fig. 5j,k), a concept that had previously only been speculated about
and proposed on theoretical grounds19,49. We show that
hypersensitivity to crowding provides an additional route to the
loser cell status, leading to mechanical cell competition and the
elimination of loser cells. One interesting prediction of our findings is
that they suggest that competition could take place between
genetically identical cells if they are endowed with differential
sensitivity to mechanical stress or if they reside in tissues with varying
mechanical properties50,51, a hypothesis that should be investigated.
In addition, given the involvement of p53, a general sensor of cell
stress, we suggest that mechanical cell competition may be
widespread among the damaged cells. Moreover, future work
should also examine the implications of our findings on the
behaviour of cancer cells. Since p53 is one of the most commonly
mutated genes in cancer52, our findings suggest that its loss could
enable neoplastic cells (scribble is a tumour-suppressor gene53,54) to
evade mechanical cell competition. Identifying the physiological
contexts where mechanical cell competition plays a role may help
better understand tissue biology and potentially cancer formation.
Note added in proof: Evidence of mechanical competition in
Drosophila was reported just prior to acceptance of this work55.
Methods
Antibodies and materials. For immunofluorescence we used:
Rabbit anti-p53 antibody (1:750, Cell Signaling Technology #9382), rabbit anti-
p21 antibody (1:200, Santa Cruz sc-397). In functional tests, both antibodies show
an increase in staining intensity þ ultraviolet-C treatment and a reduction or
complete absence of staining in scribKD p53" /" and p53" /" cells (Supplementary
Fig. 4b). In addition, the anti-p21 antibody is documented to cross-react in canine.
Mouse anti-E-cadherin antibody (1:600 total stain or 1:200 surface stain56), rabbit
anti-E-cadherin antibody (1:500 total stain or 1:50 surface stain57), both
documented to cross-react in canine. Rabbit anti-P-p38 MAPK (T180/Y182)
antibody (1:50, Cell Signaling Technology #9215) was used as in Norman et al.23
Rabbit anti-P-Myosin light chain (phospho S20) antibody (1:100, Abcam ab2480),
predicted to cross-react with all mammals. Goat p-MYPT1 (Thr 853) (1:50, Santa
Cruz sc-17432) antibody, documented to cross-react in canine. Rabbit anti-cleaved
Caspase-3 antibody (1:200, Cell Signaling Technology #9661s), predicted to cross-
react in canine based on 100% sequence homology. DAPI (1 mgml" 1 Invitrogen);
Alexa Fluor conjugated secondary antibodies (1:1,000, Invitrogen); Alexa Fluor-568
and Alexa Fluor-647 conjugated phalloidin (1:40, Invitrogen).
For western blotting we used:
Rabbit anti-p53 antibody (1:1000, Cell Signaling Technology #9382), rabbit
anti-p21 antibody (1:500, Santa Cruz sc-397). Goat anti-Scribble antibody (1:500,
Santa Cruz sc-11048), functional tests show a decrease in signal intensity in scribKD
cells þTET and it is documented to cross-react in canine (Supplementary Fig. 3a).
Mouse anti-E-cadherin antibody (1:1,000; (ref. 56)), rabbit anti-b-tubulin antibody
(1:50,000, Abcam ab6046), HRP conjugated secondary antibodies (1:3,000, Bio-
Rad) and IRDye infrared fluorescent dyes (1:10,000, LI-COR).
Inhibitors and treatments were used at the following concentrations: Pifithrin-a
(Sigma) 10mM, p38 inhibitor SB202190 (Calbiochem) 10mM, ROCK inhibitor Y27632
(Sigma) 30mM, Piezo inhibitor gadolinium III chloride (Sigma) 100mM, S1P2 inhibitor
JTE013 (Tocris Bioscience) 10mM, tetracycline (Sigma) 5mgml" 1 (except for
pre-treating scribKD cells for RNA-seq analysis where it was used at 10mgml" 1),
doxycycline (Sigma) 1mgml" 1, Nutlin-3 (Cayman Chemicals) was added as specified.
Cell culture and plasmids. The cell lines used in this publication are not listed in
the database of misidentified cell lines maintained by ICLAC. MDCK cell lines
were authenticated in our laboratory by RNA sequencing, which confirmed their
canine origin. All cell lines used in this publication have been tested in our
laboratory and were found to be negative for mycoplasma infection (EZ PCR
Mycoplasma Test Kit, Geneflow).
Wild-type MDCK, MDCK-pTR E-cadherin shRNA (EcadKD)32 and MDCK-
pTR scribble shRNA (scribKD) cells23 were a kind gift from Yasuyuki Fujita. Wild-
type and E-cadKD MCDK cells were cultured in DMEM (21885; Invitrogen)
supplemented with 10% fetal bovine serum (FBS, Invitrogen) in a humidified
incubator at 37 !C with 5% CO2. The scribKD cells were cultured as described for
wild-type cells with the addition of blasticidin 50 mgml" 1 (Sigma) and G418
800 mgml" 1 (Invitrogen) to the culture media. To establish MDCK cell lines that
stably express a nuclear green fluorescent protein (GFP) or red fluorescent protein
(RFP) marker, we used a modified pGIPZ-turboGFP-Puro (Thermo Scientific)
plasmid where we replaced turbo-GFP with either GFP-NLS or RFP-NLS. Selection
following infection was carried out with puromycin (0.65 mgml" 1, Sigma).
Resistant scribKD MDCK cells (scribRES) were generated by culturing MDCK-
pTR scribble shRNA cells in 5 mgml" 1 tetracycline for 20 days. The resulting final
population was expanded in the absence of tetracycline and tested for efficient
Scribble knockdown by western blotting.
The MDCK p53" /" and scribKD p53" /" cells were generated using Cas9
D10A CRISPR technology. sgRNAs against canine TP53 were manually designed
following published guidelines58
(p53_CRISPR#1_Fw: 50-GCAGAAGTGGCTGGCATCCT-30 , p53_CRISPR#2_Fw:
50-CCCTGGACCGGCCCCCTCC-30).
sgRNAs were individually cloned into the PX461 vector58 and the pair was
co-transfected into recipient cells. Pools of both p53" /" and scribKD p53" /" cells
were generated by functional selection with Nutlin-3 (20–30 mM) for 5–7 days and
either used immediately or expanded from single cells. p53 knockout was verified
by functional tests.
To knock down E-cadherin expression in MDCK scribble shRNA cells (scribKD
E-cadKD), the recipient cells were stably transfected with a modified version
(pSUPERIOR.hygroþ gfp E-cadherin shRNA) of a plasmid provided by Yasuyuki
Fujita (pSUPERIOR.neoþ gfp E-cadherin shRNA32). Selection was carried out
with Hygromycin B (75 mgml" 1, Invitrogen). To overexpress E-cadherin in wild-
type MDCK cells, the E-cadherin-GFP cDNA59 was introduced into a modified
pTRIPZ-turboRFP-Puro plasmid (Thermo Scientific) in which turboRFP was
replaced by RFP-NLS (pTRIPZ-RFP-NLS-Puro). The cells infected with the
pTRIPZ ECAD-GFP-P2A-RFP-NLS construct express doxycycline-inducible
E-cadherin-GFP and RFP-NLS as a single transcript. Selection following infection
was carried out with puromycin (0.65 mgml" 1, Sigma).
Primary mouse tracheal epithelial cells (MTECs) were obtained from
5-month-old animals from 26R-Tomato (Gt(ROSA)26Sortm1(CAG-tdTomato*,-
EGFP*)Ees) and p53-null (Trp53tm1tyj) strains, both of C57BL/6 background, using
a protocol adapted from published methods60. Tracheas were dissected from the
larynx to the bronchial main branches and collected in ice-cold DMEM:F12
(11330-32; Invitrogen) supplemented with a solution of 100 units ml" 1 penicillin
and 100 mgml" 1 streptomycin (Invitrogen). The muscle, vascular tissue and
glands were then removed and the trachea cut into three to four rings. Each
fragment was washed in phosphate-buffered saline (PBS) and then incubated in
Dispase (BD Biosciences) at 7.5 Caseinolytic Units in PBS (total volume 450 ml
per trachea) for 25min at room temperature (RT). Tracheal fragments were then
transferred into ice-cold DMEM:F12 and the sheets of epithelial tissue were
peeled off. The epithelial sheets and medium were transferred to an ice-cold
1.5ml tube, and pelleted twice at 500 g for 3min with a PBS wash in between. The
pellets were resuspended in 0.05% TE (Invitrogen) supplemented with 5mM
EDTA for 30min at 37 !C. Five hundred microlitres of DMEM:F12 supplemented
with 5% FBS was added to stop the reaction. The cells were pelleted (500 g,
3 min), resuspended in MTEC/Plus media and plated on collagen-coated
(50 mgml" 1 rat tail collagen I (BD Biosciences)/0.02M acetic acid) 24-well tissue
culture inserts (BD Falcon) in MTEC/Plus media at approximately 5$ 104 cells
per insert. The MTEC cells were cultured in MTEC/Plus media consisting of:
DMEM:F12 basal media supplemented with a solution of 100 units ml" 1
penicillin and 100 mgml" 1 streptomycin, 10 mgml" 1 insulin (Invitrogen),
5.5 mgml" 1 transferrin (Invitrogen), 6.7 mgml" 1 selenium (Invitrogen),
0.1 mgml" 1 cholera toxin (Sigma), 25 ngml" 1 epidermal growth factor
(R&D Systems), 30 mgml" 1 bovine pituitary extract (Invitrogen), 5% FBS,
15mM HEPES and 0.01 mM freshly added retinoic acid (Sigma) in a humidified
incubator at 37 !C with 5% CO2.
Conditioned media and transwell assays. For competition-conditioned medium
experiments, media were conditioned for 48 h by cultures of GFP-labelled scribKD
and wild-type cells with (competition condition) or without (mock condition)
tetracycline. Recipient GFP-labelled scribKD cells were pre-treated with tetracycline
for 24 h and 10,000 cells per well were seeded into 24-well plates with 1ml of
conditioned medium. For transwell assays, GFP-labelled scribKD cells (10,000 per
well) were seeded at the bottom of a 24-well plate. Co-cultures at a ratio of 1:10
(GFP-labelled scribKD: wild-type or GFP-labelled scribKD: scribKD) were plated onto
a transwell insert (3.0 mm pore size-polyester membrane, Corning) at 1,500 cells
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per insert). All scribKD and GFP-labelled scribKD cells were pre-treated for 24 h with
tetracycline before plating.
Fences system. Where applicable, immunofluorescence of cell competition was
carried out in a 24-well plate using ‘fences’ (Aix Scientifics, http://www.aix-scien-
tifics.co.uk/en/fences.html). The system allows two different populations of cells to
be seeded on either side of a silicone barrier, thus allowing experimental and
control conditions to be cultured, treated, imaged and (where applicable) stained
within the same well/coverslip.
Cell competition and contact-induced migration assays. Cell competition
assays on MDCK cells were carried out in 24-well plate fences. Control cultures
were plated in the centre of the fence (1,000 cells per fence) at a ratio of 1:10 GFP-
labelled scribKD: scribKD. Competition cultures were seeded on the outside of the
barrier (8,000 cells per fence) at a ratio of 1:10, scribKD: wild-type cells. The fences
were removed approximately 5 h after plating and the culture medium was replaced
with or without addition of tetracycline. Twenty hours later, the culture medium
was replaced with phenol red-free DMEM (þ 10% FBS and 1% L-glutamine,
Invitrogen) with or without tetracycline. Where specified, the chemical inhibitors
were also added at this point, except for the ROCK, Piezo and S1P2 inhibitors,
which were added after an additional 24 h. Live imaging was started 2–4 h after the
final media change and was continued for at least 50 h with regular media changes
every 2–3 days.
For cell migration assays, the cells were seeded as for competition assays, except
that they were plated at a lower density (1,000 cells in the centre of the fence,
2,000–5,000 cells in the outer chamber) and imaged more frequently (every 10min
to every 2 h). Alternatively, where specified, cells for competition or migration
assays were plated on gridded tissue culture plates (m-Dish 35mm Grid-500, Ibidi)
at 6,250 cells per plate. This allowed us to find specific clones of cells for
immunofluorescence analysis after live imaging had finished. Co-cultures, unless
otherwise specified, were plated at a ratio of 1:10 (scribKD: wild-type).
The MTEC cells were plated in collagen-coated tissue culture inserts and
allowed to grow for approximately 2 weeks until they reached homeostatic density
before commencing experiments. In control cultures, wild-type (unlabelled) cells
were plated with wild-type Rosa26R-Tomato (nuclear red) cells (MTEC Tomato)48
cells at a 2:1 ratio. In competition cultures, unlabelled p53-null cells
(MTEC p53" /" ) and wild-type Rosa26R-Tomato cells (MTEC Tomato) were
plated at a 2:1 ratio. Nutlin-3 was added at 17.5 mM on day 3 of live imaging. The
medium was changed every 2 days.
Homeostatic cell density assays. These assays were carried out in 96-well plates.
GFP-labelled scribKD and scribKD p53" /" cells (8,000–12,000 cells per plate) were
pre-treated with tetracycline for 12 h before plating where applicable, in the
presence or absence of inhibitors. Where applicable, Nutlin-3 was added 24 h after
plating. The whole well was then imaged and the individual images were stitched
together for further analysis to obtain data on total cell number and density. The
plates were imaged every 6 h and cell culture medium and drug treatments were
changed every 2 days.
Micropattern assays. For assays in micropatterns, GFP-labelled scribKD cells with
or without tetracycline pre-treatment (72 h) were plated onto circular adhesive
patterns (+ 800mm) within a PEG cell-repellent surface26,61. The cells were
flushed with culture medium 5 h after plating and the medium was replaced with
phenol red-free DMEM (þ 10% FBS and 1% L-glutamine, Invitrogen) with or
without tetracycline. Cell culture medium and drug treatments were changed every
2 days.
PDMS-based cell compression assays. The GFP-labelled scribKD cells were
plated onto a stretched flexible silicone substrate (Gel pak PF-60-X4, 150 mm
thickness, Teltek), held in a custom-made chamber (GREM; http://www.jove.com/
video/51193/stretching-micropatterned-cells-on-a-pdms-membrane). Before plat-
ing, the clamped membranes were coated with 25 mgml" 1 fibronectin/PBS
(Sigma) for 1 h at 37 !C. The membranes were stretched precisely by 2 cm, which
provided a 57% stretch over the resting length (unless otherwise specified).
A PDMS rectangular chamber, with two compartments (6.6$ 13mm each) was
attached to the membrane with Baysilone paste (GE Bayer). Two densities (low and
high) of tetracycline pre-treated or Nutlin-3 pre-treated (48 h) GFP-labelled
scribKD cells were plated, one in each compartment. High-density cells were plated
between 75,000 and 120,000 cells per compartment, forming a confluent mono-
layer; low-density cells were plated at 25,000–35,000 cells per compartment. The
cells were allowed to adhere for 24 h and then the membrane was released to
induce compression. The cells were fixed in 4% PFA/PBS (3 h after release for p53
staining, 1.5 h for P-p38 staining and 5 h for cleaved Caspase-3 staining) and
processed for immunofluorescence. As per design, low- and high-density cells were
stained and imaged from the same stretcher avoiding sample-to-sample variability.
The p38 inhibitor was added one day before plating; the ROCK inhibitor was
added 1 h before releasing the membrane.
E-cadherin-blocking experiments. To block E-cadherin-dependent junctions,
20 h after the addition of tetracycline, the cells were incubated in 10mM EDTA/
PBS for 5min, followed by a 20min incubation in calcium-free DMEM (Invitro-
gen). The cells were then cultured in calcium-free DMEM (þ 10% FBS and 1%
L-glutamine, Invitrogen), supplemented with an anti-E-cadherin-blocking antibody
(1:200; ref. 57). Live-image analysis was started 2–4 h after the final media change
and continued for at least 50 h.
Immunofluorescence. For immunofluorescence, the cells were cultured on glass
coverslips or on gridded dishes (m-Dish 35mm Grid-500, Ibidi). The cells were
fixed for 10min in 4% PFA/PBS, quenched for 10min in 50mM NH4Cl/PBS and
then permeabilized for 10min with 0.1% Triton X-100/PBS. The cells were blocked
in 2% BSA, 2% FBS/PBS for 30min. Primary and secondary antibodies were
diluted in blocking solution diluted 1:1 in PBS. The primary antibodies were
incubated for a minimum of 1 h at RT, followed by washes in PBS; secondary
antibodies were incubated for a minimum of 30min at RT followed by washes in
PBS. Coverslips were mounted with FluorSave (Millipore). For immunostaining
against phosphorylated proteins, fixing solution was supplemented with PhosSTOP
(1 tablet per 10ml, Sigma), all PBS solutions were substituted with TBS, and
blocking solution was substituted with 5% BSA/TBS. For surface immunostaining,
the cells were washed in ice-cold phenol red-free DMEM (Gibco) and incubated
with primary antibody diluted in ice-cold phenol red-free DMEM at 4 !C for
45min. The cells were then washed in ice-cold PBS before fixation at RT in 4%
PFA/PBS for 10min. Secondary antibody staining was then carried out as outlined
previously.
Western blotting. The cells were lysed in 1% SDS/PBS and 10–20 mg of protein
was separated on a 4–12% gradient gel (Invitrogen) and transferred onto PVDF
membrane for standard ECL blots (Anachem) or Immobilon FL PVDF for LI-COR
blots (Millipore, 0.45 mm pore size). The membranes were blocked with 5% Marvel/
0.05% Tween-20/PBS (PBST) for 1 h at RT, incubated in primary antibodies (in 2%
Marvel/PBST) overnight at 4 !C, washed in PBST and incubated in secondary
HRP-conjugated antibodies for ECL blots or Infrared fluorescent dyes (IRDye-
800CW and IRDye-680RD) for LI-COR blots, diluted in 2% Marvel/PBST for 1 h
at RT. After washes in PBST, the membranes were developed using standard ECL
(GE Healthcare) or scanned with a LI-COR Odyssey CLx near-infrared fluores-
cence imaging system. Quantifications for LI-COR blots were carried out using
Image studio lite (http://www.licor.com/bio/products/software/image_studio_lite/
?gclid=COWG_Yze98MCFYvpwgodfR8Adg), using Actin to normalize the
samples for loading. For original full blots, see Supplementary Fig. 9.
RNA-seq and differential expression analysis. RNA-seq libraries were prepared
with the TrueSeq RNA sample preparation V2 kit (Illumina) according to the
manufacturer’s instructions, and sequenced on an Illumina HiSeq 2000 instrument
in single-read mode at 36 or 40 base length. The resulting fastq files were filtered
for low-quality reads (oQ20) and low-quality bases were trimmed from the ends
of the reads (oQ20).
Genome-based RNA-seq mapping was carried out using Canis lupus familiaris
3.1 (NCBI/Dog Sequencing Consortium) as a reference genome. Transcript
sequences were assigned to genome using BLAT62. The resulting mappings were
filtered by a mismatch threshold (2%), as well as requiring 90% of the transcript to
match the genome and all exons to match a single chromosome. This resulted in
21,571 transcripts mapping to the genome. This mapping was used as a junction
file for Tophat 2 (ref. 63), which was used to map the RNA-seq reads to the
genome. To provide gene names, transcript sequences were downloaded from the
NCBI RefSeq database in March 2013 (24,538 sequences). Orthologues were found
against the Mus musculus proteome (downloaded in January 2013—NCBI RefSeq)
using Inparanoid64. The sequences were further annotated using InterProScan65 to
provide both InterPro Domains and Panther ontology terms66. For differential
expression, read counts were generated by quantifying overlaps with transcript
locations. These were then used to generate RPKMs. Comparisons were made
between pairs of conditions, each with at least four replicates. For a transcript to be
included, counts per million had to be above 10 for all samples in at least one
condition and within 2-fold between replicates. Differentially expressed transcripts
were then called using EdgeR67. Hits were selected applying the following
thresholds: P40.05 log FC (fold change) 40.5. Gene Ontology terms over-
represented among these lists were found using David Bioinformatics Resources68,
in particular, KEGG pathway analysis.
Experiments in Drosophila wing discs. Flies were raised on a standard fly food
containing yeast at 25 !C. The larvae were collected at wandering third instar stage.
Clones in wing discs were induced either with en-FLP (Supplementary Fig. 5a,b)
or with hs-FLP (with a 10-min heat-shock at 37 !C, 48–72 h before dissection;
Supplementary Fig. 5c). For immunofluorescence, late third instar larvae were
dissected in PBS followed by fixation in 4% formaldehyde/PBS solution for 20min,
permeabilization in 0.25% Triton X-100 PBS for 20min and blocking in 4% FBS/
PBS for 30min. The primary and secondary antibodies were diluted in blocking
solution. The primary antibodies were incubated overnight at 4 !C, followed by
washes in 0.25% Triton X-100/PBS; secondary antibodies were incubated for a
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minimum of 1 h at RT followed by washes in 0.25% Triton X-100/PBS. The wing
discs were mounted in Vectashield (Vector Laboratories) and imaged on Leica SP5
or SP8 confocal microscopes. Optical sections were acquired with 0.8mm steps.
The images were processed in ImageJ and Photoshop. Genotypes: Supplementary
Fig. 5a,b en-flp, Act4STOP4Gal4, UAS-GFP/þ ; UAS-Scrib-RNAi,
Supplementary Fig. 5c (left) hs-FLP, tub-Gal4, UAS-GFP/þ ; þ /þ , FRT82, tub-
Gal80/ FRT82, scrib2 and Supplementary Fig. 5c (right) hs-FLP, tub-Gal4, UAS-
GFP/þ ; UAS-p53DN/þ , FRT82, tub-Gal80/ FRT82, scrib2. Antibodies used:
anti-Scribble (1:2000, from Chris Doe lab), anti-E-Cadherin (DSHB DCAD2,
1:200). Both the antibodies were raised against Drosophila antigens and have been
previously used in Drosophila.
Imaging and image analysis. Quantifications shown in the figures are from a
single representative experiment of a minimum of three independent repeats per
experiment, unless otherwise specified in the figure legend.
Fixed samples were imaged with a Leica SP5 or SP8 confocal microscope. For
live imaging, the cells (kept at 37 !C and 5% CO2) were imaged using a Nikon
BioStation CT with a $ 10 air objective with imaging frequency between every
10min and every 6 h (as indicated in the movie time stamps), with media changes
every 2–3 days. For each live imaging experiment, at least five fields were imaged by
time lapse and analysed. Movie sequences or individual field time points that lost
focus during the experiment were discarded from further analysis, as this precluded
accurate cell counting.
For Fig. 1a–c and Supplementary Fig. 1d, quantifications of cell number
over time were carried out using the open-source image analysis software Cell
Profiler (http://www.cellprofiler.org/), using the nuclear GFP signal to segment
cells.
To measure cell density in competition assays, the number of nuclei was
manually counted using DAPI and/or nuclear GFP and divided by surface area, as
calculated in Fiji (http://fiji.sc/Fiji; Fig. 1g and 2n, Fig. 5e, Supplementary Fig. 1e).
For Fig. 1k–n, cell number over time was quantified with the open-source image
analysis software Icy69, using Icy Protocols. The nuclei were detected using the
wavelet-based spot detection plugins. Areas with cysts, where nuclei were not
visible due to overexposure or because they were out of focus, and areas without
cells were excluded from both cell counting and from area measurements on a
frame by frame basis. For Fig. 3h, Fig. 4c,k and Fig. 5b, entire wells of a 96-well
plate were imaged by tiling. Individual images were then stitched and processed as
above.
Cell height (mm, Fig. 1h–j) was measured from apical to basal membranes using
the open image analysis software Fiji.
Cell death in compression assays was quantified as the number of activated
caspase-3 positive death events (Fig. 1o–q, Fig. 3i, Fig. 4d,l and Fig. 5c) divided by
total number of DAPI-positive nuclei.
Kymographs were generated by first registering the hyperstack containing the
different channels (bright-field, RFP and GFP) to remove any global motion or
drift over time of the cells (Fig. 2d). The position of the centroid for each nucleus at
each time point was extracted and the RFP and GFP channels were then projected
on the same mean direction of motion by re-slicing the stacks and then projecting
the maximum intensity of the centroid. For the control kymographs (GFP-labelled
scribKD: scribKD; RFP-labelled WT: WT), this was done only using the bright-field
channel and one fluorescent channel.
The directionality index of migrating cells (D¼Euclidean distance/total
distance, Supplementary Fig. 2b,d) was calculated after manual tracking of
individual cell nuclei (440 cells and 45 movies per condition) with the aid of
ImageJ (http://imagej.nih.gov/ij/). Data analysis was performed with Matlab
(MathWorks Inc.).
Analysis of cell shape and migratory features (Fig. 2g–k). The aspect ratio,
which is defined as the ratio of the long axis to the short axis of cells, was measured
from three independent movies by manually fitting the best fit ellipses to single
cells. To plot the distribution of angles between the cell’s long axis and the cell’s
direction of motion, we determined for each cell the orientation of the cell’s long
axis and calculated its angular deviation with respect to the cell’s direction of
motion (data were binned at 40! interval), by manual tracking. To measure the
displacement of wild-type and scribKD cells, we carried out PIV analysis, using a
custom algorithm based on the MatPIV software package for MATLAB, and
measured the displacement of individual cells within the first row of contact.
Trajectories across different movies were adjusted so that the first time point where
both populations formed a broad interface and moved concertedly was set at
t¼ 5 h. Distance is the projected distance along the axis that joins both cell
populations.
In Figs 3c–e and 4e, local density was measured for each cell by taking the sum
of the Gaussian-weighted distances to all other cells within 50 mm using a Gaussian
function with s¼ 20.
Nuclear p53 (Fig. 3f,g), nuclear phospho-p38 (Fig. 4a,b,i,j) and nuclear p21
(Supplementary Fig. 4d) mean intensity was measured using Volocity (http://
www.perkinelmer.co.uk/pages/020/cellularimaging/products/volocity.xhtml), using
DAPI as a mask to segment the nuclei.
For Fig. 5f–I, quantifications of cell number over time were carried out
in ImageJ (http://imagej.nih.gov/ij/), using the nuclear Tomato signal to
segment cells.
In Supplementary Fig. 2h–i, E-cadherin staining intensity was measured using
Fiji. The individual cells were manually selected on an average z stack projection
and their integrated density values were recorded.
Statistical analysis. No statistical methods were used to predetermine sample
size. Every experimental condition and treatment was carried out alongside a
complete control set of experiments or no treatment control. The sample size was
chosen to see a statistical difference between data sets. In the few instances where
no difference was observed, sample size was at least as big as in conditions that had
shown a difference. The experiments were not randomized and there was no
blinding during experiments or analysis, as samples were marked. We carried out a
minimum of independent three repeats for each experiment, unless otherwise
specified in the figure legend.
The t-Test was used in Supplementary Fig. 1e and Supplementary Fig. 2b,d,
where data were normally distributed and with equal variance. The Wicoxon rank-
sum test was used in Supplementary Fig. 3f. Non-parametric Spearman correlation
was used in Fig. 3e. Otherwise, the non-parametric KS test was used for all the
statistical tests, removing the requirement for normally distributed data and equal
variance. Throughout: *Po0.05, **Po0.005, ***Po0.0005.
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Abstract 
Upon wounding, epithelial cells migrate across the wound to close the gap. Leader cells at the 
front of migrating sheets drive this migratory process. However, how leader cells emerge from a 
seemingly homogeneous cell population is not fully understood. Here, by characterizing leaders 
emerging from MDCK monolayers, we identify the activity of the stress sensor p53 as the 
instructive signal for leader behaviour. p53 is necessary and sufficient to instruct leader cell fate 
and it does so by activating a single target gene, the cell cycle inhibitor p21WAF1/Cip1. On wound 
closure, leader cells maintaining high p53 are eliminated by cell competition to preserve tissue 
health. Overall, our data indicate that injury itself instructs the emergence of leader cells by 
damage-induced p53 activation. 
 
 
 
 
 
 
 
 
 
One Sentence Summary 
 
Cell damage drives wound closure by inducing the activity of p53 and p21WAF1/Cip1 in leader cells, 
which drive cell migration.  
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Main Text 
Epithelial cells are normally non-migratory. However, when the integrity of an epithelial 
monolayer is compromised by injury or wounding, epithelial cells extend and migrate over the 
exposed area to seal the open space quickly (1-3). This process is driven by leader cells, which 
are located at the edge of the migrating front and guide the collective migration of epithelial 
sheets (3-5). Collective cell migration in wound closure has been actively studied to understand 
the cellular interactions and the biophysics underpinning wound closure (1, 4-7) and to identify 
the features of leader cells that allow them to orchestrate this process (3, 8-10). Several groups 
have shown that leader cells are morphologically distinct from followers and have different 
cytoskeletal properties (3, 10-13). 
Despite their distinctive characteristics, leader cells originate from the same epithelial cells as 
follower cells, begging the question of how they emerge. It is currently unknown how cells are 
singled out and instructed to become leaders from a seemingly homogeneous population of 
epithelial cells. Studies have proposed that geometrical cues at the wound edge itself may induce 
asymmetry and that this may be sufficient to instruct the leader cell fate (9, 14-16). However, 
only a few cells at the wound edge become leaders suggesting that additional factors - cell 
intrinsic or cell extrinsic - are required.  
MDCK kidney epithelial cells have been used extensively as a model to investigate leader cells 
and the mechanisms of wound closure, as they are a versatile system where wound healing can be 
studied by mechanically scratching epithelial cell monolayers or by releasing confluent 
monolayers from physical barriers. While imaging growing colonies of wild-type MDCK cells, 
we observed the spontaneous emergence of cells with a distinctive flattened morphology (Fig. 
1A, yellow arrow). These flat cells often became migratory upon contact with colonies composed 
of cells with standard epithelial morphology, leading the entire colony with them in a behavior 
reminiscent of leader cell migration at wound sites (Fig. 1A and B and Movie 1). As these cells 
appear spontaneously in the absence of wounds, we termed them ‘spontaneous leaders’. Given 
their leader-like behavior, we thought that characterizing these cells might offer an orthogonal 
strategy to identify the mechanisms that allow leader cells to emerge. 
Leader cells have been reported to have increased surface area, frequent binucleation, and lower 
division rates compared to normal epithelial cells (3, 17). Interestingly, spontaneous leaders 
shared these same features, as they often did not divide during the entire span of our movies (> 
48 hours) and tended to be binucleated (fig. S1A and B). We therefore asked if binucleation was 
sufficient to induce the leader status. Treating MDCK cells with the myosin inhibitor blebbistatin 
(18) prevents cytokinesis while still allowing karyokinesis to proceed (19). To facilitate the 
identification of blebbistatin-induced binucleated cells (BBCs) through visualization of their 
nuclei, we treated cells expressing nuclear GFP with blebbistatin and co-cultured these with 
untreated, unlabeled wild-type cells. Notably, the resulting BBCs were morphologically similar 
to spontaneous leaders and behaved as leaders themselves (fig. S1C and Movie 2). 
The ‘tetraploidy checkpoint’ triggered upon cytokinesis failure has been shown to induce cell 
cycle arrest in a p53-dependent manner (20). p53 levels were indeed elevated in BBCs (fig. S1D), 
so we asked what the p53 status of spontaneous leaders was. Live imaging on optically clear 
gridded cell culture dishes allowed us to identify and track spontaneous leaders (Fig. 1C, first 
three panels) and locate them again following fixation. Immunostaining against p53 revealed that 
spontaneous leaders have significantly higher nuclear p53 levels than neighboring non-leader 
cells (Fig. 1C, rightmost panel and D). 
We next asked if elevated nuclear p53 is instructive for leader cell fate. We treated wild-type 
MDCK cells expressing nuclear GFP with mitomycin C (MMC), an irreversible DNA damaging 
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agent (21), to permanently stabilize p53 (fig. S1E). After extensive washes to prevent MMC 
carryover, we co-seeded MMC-treated, GFP-labelled cells with untreated, unlabeled wild-type 
cells (Fig. 1E). Strikingly, MMC treatment was sufficient to trigger the leader phenotype and to 
induce the formation of migrating ‘fingers’ of untreated follower cells led by MMC-treated cells 
(Fig. 1F, fig. S1F, and Movie 3), suggesting that p53 elevation is sufficient to trigger the leader 
phenotype. 
Cytokinesis failure and MMC treatment arrest cell division, due to the high levels of p53 (22, 23). 
To ask whether cell cycle arrest was necessary for spontaneous leader fate, we sought conditions 
that allowed us to elevate p53 without inducing cell cycle arrest. Nutlin-3 is an Mdm2 inhibitor 
that stabilizes p53 in a dose-dependent manner (24). This allowed us to use concentrations that 
cause p53 elevation at levels that reduce, but do not arrest, cell cycle progression (fig. S1G and 
H), as we have done previously (25). We co-cultured GFP-labelled wild-type cells with p53 
knockout (p53KO) cells (25) in the presence of Nutlin-3, which created a discontinuity in p53 
activity between the two populations. Under these conditions, p53 activation was still sufficient 
to confer a leader phenotype (Fig. 1G, fig. S1I, and Movie 4), indicating that cell cycle arrest is 
not required for cells to become leaders. Altogether, these experiments indicate that p53 elevation 
is sufficient to instruct the leader cell fate. 
To test whether p53 is also necessary for leader cell migration, we generated two independent 
p53KO clones expressing nuclear GFP (p53KO C6 and C14). Sequencing of the p53 locus 
showed that both alleles were disrupted (Fig. 1H) and no p53 protein was detected upon 
induction of binucleation (fig. S1J-L). We then treated p53KO cells with MMC to test if they 
acquired leader behavior. Notably, MMC-treated p53KO cells behaved as leaders in just under 
20% of cases, whereas MMC-treated wild-type cells acted as leaders in 80% of cases (Fig. 1I and 
J, and Movie 5). Indeed, cell tracks from representative movies showed that MMC-treated cells, 
if wild-type, migrate alongside wild-type cells upon contact (Fig. 1K) and cover long distances 
(Fig. 1M, gray tracks), as leader-follower pairs. However, this is not observed if the MMC-
treated cells are p53KO (Fig. 1L and Fig. 1M, green tracks). Functional ablation of p53 was also 
sufficient to reduce drastically the incidence of leader behavior in BBCs (fig. S1M and N). Taken 
together, these data demonstrate that p53 is both necessary and sufficient to induce leader cell 
behavior in MDCK cells. 
We next wondered which factors downstream of p53 were responsible for the leader phenotype. 
Considering that spontaneous leaders, BBCs, and MMC-treated cells are cell cycle arrested, and 
that Nutlin-3 treated leaders divide less frequently than untreated controls, we hypothesized that 
effectors of p53 involved in cell cycle arrest might be involved. One of the main p53 target genes 
involved in cell cycle arrest is Cyclin-Dependent Kinase Inhibitor 1A (CDKN1A), also known as 
p21WAF1/Cip1 (from here on referred to as p21) (26). Nuclear p21 was indeed upregulated in 
spontaneous leaders (Fig. 2A and B). To ask whether p21 was involved in leader cell behavior, 
we generated a clonal MDCK cell line overexpressing p21 (p21OE) in a doxycycline (DOX)-
inducible manner. Overexpression of p21 resulted in cell cycle arrest, as expected, but also 
caused cells to flatten and take on a leader-like morphology (fig. S2A and B). Strikingly, when 
p21OE cells were co-cultured with wild-type cells, they behaved as leaders upon contact with 
wild-type cells (Fig. 2C and Movie 6), indicating that p21 overexpression is sufficient for leader 
cell behavior. 
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Fig. 1. p53 instructs leader cell behavior. (A) Movie stills of wild-type MDCK cultures shows spontaneously 
emerging flattened cells (yellow arrow displaying leader behavior. (B) Frequency at which cells with flattened 
morphology act as leaders. (C) Movie stills (first three panels) showing the migration of a spontaneous leader 
(yellow arrows). Fourth panel shows p53 immunostaining of the field indicated (dotted lines). (D) Quantification of 
single-cell nuclear p53 intensity of spontaneous leaders and surrounding non-leaders. (E) Experimental design for 
co-culture of untreated and MMC-treated cells (F). (F) Movie stills of co-cultures of wild-type cells expressing 
nuclear GFP and treated with MMC and unlabeled wild-type cells. (G) Movie stills of co-cultures of unlabeled 
p53KO cells and wild-type cells expressing nuclear GFP, treated with Nutlin-3. (H) Schematic representation of the 
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canine p53 exon 4 sequence, targeted for CRISPR/Cas9-mediated mutagenesis. Gene disruptions in p53KO clones 6 
and 14 (C6 and C14, respectively) are as indicated. (I) Movie stills from co-cultures of unlabeled wild-type cells and 
MMC-treated p53KO cells expressing nuclear GFP. (J) Percentage of MMC-treated wild-type or p53KO cells acting 
as leaders. (K-L) Cell tracks of pairs of untreated wild-type and MMC-treated wild-type cells (K) or untreated wild-
type and MMC-treated p53KO cells (L); 0,0 coordinate indicates time of contact. (M) Cell tracks of wild-type cells 
upon contact by MMC-treated wild-type (gray) or p53KO cells (green).  
 
Black bars = median in (D); n = number of cells in (B), (D), and (J). Data from one representative repeat of three 
biological replicates in (D), or pooled from three biological replicates in (B) and (J). Error bars = ±SEM in (B) and 
(J). 
 
Here and throughout all figures: 
White dashed line = initial contact point; black dashed line = final contact point. Scale bars 100μm (movie 
sequences) and 50μm (confocal images). P values obtained using the K-S test. DAPI = 4′,6-diamidino-2-
phenylindole. 
 
We next wanted to ask whether p21 is also necessary for leader fate. Using CRISPR/Cas9 
technology, we generated two p21 knockout clones (p21KO E9 and G5); bi-allelic disruption of 
the p21 loci was verified by sequencing (Fig. 2D) and loss of functional p21 protein was 
confirmed by p21 immunofluorescence in the presence of Nutlin-3 (fig. S2C). Importantly, 
p21KO cells treated with MMC were substantially less likely to behave as leaders (Fig. 2E and F, 
fig. S2D, and Movie 7), demonstrating that p21 is necessary for the leader cell fate. Indeed, cell 
tracks from representative movies showed that p21KO MMC-treated cells do not migrate 
alongside wild-type cells upon contact (Fig. 2H) and do not cover long distances (Fig. 2I, green 
tracks) as leader-follower pairs, unlike control wild-type MMC-treated cells (Fig. 2G and Fig. 2I, 
gray tracks). Taken together, this demonstrates that p53 activation drives the spontaneous leader 
cell phenotype in MDCK cells by upregulating p21. 
Having identified p53/p21 as a new pathway driving leader cell migration, we next asked whether 
this pathway induces leader cell behavior using the same factors required in leaders induced by 
wounding or barrier release. Wound-induced leaders upregulate Rac1, integrin β1 (ITGβ1), and 
phosphoinositide 3-kinase (PI3K) and require their activities to drive cell migration (12). We 
therefore tested whether these genes were also upregulated and required in spontaneous leaders 
and in p53/p21-induced leaders. Spontaneous leaders indeed showed upregulation of both PI3K 
and ITGβ1 compared to followers (fig. S3A and B). This was specifically due to p53 activation, 
as leaders generated by MMC treatment also showed high levels of both PI3K and ITGβ1 
compared to neighboring untreated, wild-type followers (Fig. 3A and B). In addition, leaders 
induced by p21 overexpression alone showed PI3K and ITGβ1 upregulation (Fig. 3C and D). 
Furthermore, chemical inhibition of PI3K and Rac1 stalled the progress of actively migrating 
MMC-generated leaders (Fig. 3E-G and Movie 8), indicating that these pathways are also 
essential for p53/p21-mediated leader cell migration. Altogether, these results indicate that PI3K 
and ITGβ1 activation are downstream of p53 and p21 and that spontaneous leaders use the same 
mechanisms as wound induced leaders to drive collective cell migration.  
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Fig. 2 p21 drives leader cell migration. (A) Movie stills (first two panels) of a migrating spontaneous leader 
(yellow arrows). Last two panels show confocal images of the same spontaneous leader following p21 
immunostaining. (B) Quantification of single-cell nuclear p21 intensity of spontaneous leaders and surrounding non-
leaders. (C) Movie stills from co-cultures of wild-type cells expressing nuclear GFP and unlabeled cells inducibly 
overexpressing p21 (p21OE). (D)Schematic representation of the canine p21 exon 2 sequence, which was targeted 
for CRISPR/Cas9-mediated mutagenesis. Gene disruption in p21KO clones E9 and G5 are as indicated. (E) Movie 
stills of wild-type cells expressing nuclear GFP co-cultured with MMC-treated unlabeled p21KO cells. (F) 
Percentage of MMC-treated wild-type or p21KO cells acting as leaders. (G-H) Coordinates of pairs of untreated 
wild-type and MMC-treated wild-type cells (G) or untreated wild-type and MMC-treated p21KO cells (H) plotted 
over time after they first establish contact at point 0,0. (I) Cell tracks of pairs of untreated wild-type and MMC-
treated wild-type cells (G) or untreated wild-type and MMC-treated p21KO cells (H); 0,0 coordinate indicates time 
of contact. (I) Cell tracks of wild-type cells upon contact by MMC-treated wild-type (gray) or p21KO cells (green).  
 
Black bars = median in B; n = number of cells in (B) and (F). Data from one representative repeat of three biological 
replicates in (B), or pooled from three biological replicates in (F). Error bars = ±SEM in (F).
 
Since p53/p21-induced leaders share the same molecular mechanisms as wound-induced leaders 
to drive migration, we wondered whether p53 and p21 might also play a role in the migration of 
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wound-generated leaders. Strikingly, we found that leader cells emerging from scratched 
epithelial monolayers show high levels of both p53 (Fig. 4A and B) and p21 (Fig. 4 C and D). 
Importantly, leaders induced by barrier release (fig. S4A) also showed elevated levels of p53 (fig. 
S4B and C) and p21 (fig. S4D and E). This suggested that the p53/p21 pathway might be a 
general driver of leader cell migration in MDCK cells. We next sought to demonstrate that this 
pathway plays an active role during MDCK wound healing. We reasoned that, if that were true, 
then inhibiting p53 should slow down the speed of wound healing, whereas activating p53 should 
accelerate wound closure. Thus, we generated MDCK cells that inducibly express the canine 
version of the p53 peptide inhibitor GSE-22 (27). Notably, inhibiting p53 function was sufficient 
to reduce the migration speed of scratched monolayers (Fig. 4E-G). Next, we used laser-induced 
DNA damage (28) to elevate p53 at sub-lethal doses in specific regions of interest at the wound 
edge. Following epithelial scratching, we exposed only the first row of cells at the edge of the 
migrating front to laser-induced DNA damage (Fig. 4H and fig. S4F). Remarkably, inducing p53 
in edge cells was sufficient to accelerate both cell migration and wound closure (Fig. 4I-K and 
Movie 9). Altogether, these data demonstrate that p53 and its target gene p21 are the signals 
activated at damaged wounds that instruct leader cell fate. 
We next investigated what happens to leader cells once the wound is closed. Our interest was 
sparked by our recent observation that p53 elevation in MDCK cells causes mechanical cell 
competition: cells with high p53 acquire hypersensitivity to cell crowding and behave as 
mechanical losers, undergoing cell extrusion and apoptosis when compacted by cells with low 
p53 (25). Since the data in Fig. 4A and B indicate that high p53 is a hallmark of scratch-induced 
leaders, we wondered whether these might be eliminated upon wound closure, when they are 
compacted by follower cells. Remarkably, both spontaneous leaders (fig. S4G and H) and 
wound-induced leaders (Fig. 4L and M, and Movie 10) were extruded at high rates upon 
compaction. This indicates that leader cells behave as mechanical losers and are removed from 
repaired epithelial sheets if they still display high p53 elevation at the time of wound closure. 
Understanding how leader cells emerge in damaged epithelia is important to understand the 
process driving wound healing and to identify interventions that could accelerate and improve 
wound repair. Our work identifies p53 as a key cell determinant that is both necessary and 
sufficient to instruct leader cell fate. As we show, p53 induces the transcriptional activation of 
p21, which in turn is sufficient to induce PI3K and ITGβ1 (Fig. 4N and O), both of which are 
required for leader cell migration (12). p53 is a general stress sensor and its activation constitutes 
a signaling node where multiple types of cellular damage converge. Here we show that cells with 
pre-existing damage may behave as leaders if exposed at the colony edge, as we observe in the 
case of spontaneous leaders. Notably, p53 can be activated by mechanical damage (29). We 
therefore suggest that, in the case of epithelial wounding, injury itself causes the emergence of 
leader cells by mechanically inducing p53 elevation. Our findings show that p53 orchestrates 
wound closure by playing multiple key roles (Fig. 4N and O). Firstly, it detects wounding 
through mechanical stress. Secondly, by juxtaposition of cells with high (leaders) and low 
(followers) p53, it provides the symmetry breaking that drives directional cell migration across 
the wound. Lastly and equally importantly, it induces leader cell clearance at wound closure, as 
injured leader cells with persistent p53 are eliminated as mechanical losers, providing a means to 
eliminate injured cells and fully reinstate epithelial health. 
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Fig. 3. The function of canonical leader cell markers is preserved in p53- and p21-driven leaders. (A-B) 
Confocal images of co-cultures of unlabeled wild-type cells and MMC-treated wild-type cells expressing nuclear 
GFP immunostained against phosphoinositide 3-kinase (PI3K; A) and integrin β1 (ITGβ1; B). (C-D) Confocal 
images of co-cultures of wild-type cells expressing nuclear GFP and unlabeled p21OE cells immunostained against 
(PI3K; C) and (ITGβ1; D). (E-G) Movie stills of co-cultures of unlabeled wild-type cells and MMC-treated wild-
type cells expressing nuclear GFP. Following 22 hours DMSO (E) or PI3K inhibitor LY294002 (F), or Rac1 
inhibitor Z62954982 (G) were added and the migration was followed for another 16 hours. White dashed line = 
initial contact point; yellow dashed line = contact point at addition of inhibitor; black dashed line = final contact 
point. 
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Fig. 4. p53 drives leader cell migration and leader cell outcompetition during wound healing. (A) Movie stills 
show emergence of leader cells (yellow arrow) following a scratch-wound to a MDCK monolayer (first three 
panels). Last panel shows p53 immunostaining of the field indicated (dotted lines) (B) Quantification of single-cell 
nuclear p53 intensity of scratch-induced leaders and surrounding non-leaders. (C) Movie stills wild-type MDCK 
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monolayer following a scratch (first two panels). Last two panels shows p21 immunostaining of the field indicated 
(dotted lines); yellow arrow points at leaders. (D) Quantification of single-cell nuclear p21 intensity of scratch-
induced leaders and surrounding non-leaders. (E-F) Representative movie stills of control cultures (E) or cultures 
induced to overexpress GSE-22 (F). (G) Speed of migrating front from movies as in (E) and as in (F). (H) 
Experimental design to induce localized p53 activation at the edge of migrating wounds. (I-J) Movie stills of non-
irradiated (I) or irradiated (J) wild-type cultures following a scratch-wound. (K) Speed of migrating front from 
movies as in (I) and as in (J). (L) Movie stills following the closure of a wild-type scratch-wound. Leaders (yellow 
and blue arrows) are eliminated. (M) Quantification of the frequency of leader cells eliminated at wound closure, 
compared to non-leader cells present at the wound edge. (N-O) Diagrams summarizing the function of p53/p21 in 
wound healing. 
 
Black bars = median in (B), (D), (G), and (K); n = number of cells in (B), (D), and (M); n = number of fields in (G) 
and (K). Data from one representative repeat of three biological replicates in (B), (D), (G), and (K), or pooled from 
three biological replicates in (M). Error bars = ±SEM in (M). 
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Materials and Methods 
 
Antibodies and drugs 
 
For immunofluorescence we used: rabbit anti-p53 (1:750, 9382, Cell Signalling Technology), rabbit anti-p21 (1:200, 
sc-397, Santa Cruz Biotechnology), rat anti-ITGb1 (1:200, AIIB2, DSHB), mouse anti-PI3K (1:200, 610045, BD 
Biosciences), rabbit anti-𝛾H2AX (Ser 139) (1:200, 9718, Cell Signalling Technology), Alexa Fluor conjugated 
antibodies (1:1,000; ThermoFisher Scientific). 
 
Treatments used: Rac1 inhibitor Z62954982 (100 µM in DMSO, 553512, Merck), PI3K inhibitor LY294002 (10 µM 
in DMSO, L9908, Merck), Nutlin-3 (concentration as specified in DMSO, CAY10004372, Cambridge Bioscience), 
mitomycin C (7.5 µg/ml in water, M4287, Merck), doxycycline (1 µg/ml in water, D9891, Merck), puromycin (0.65 
µg/ml in water, P9620, Merck), Hoechst 33342 (3 µg/ml in water, H3570, Thermo Fisher Scientific), DAPI (1 µg/ml 
in water, D3571, Thermo Fisher Scientific). 
 
Cell culture and plasmids 
 
MDCK cells were maintained in DMEM (21885, Thermo Fisher Scientific) supplemented with 10% foetal bovine 
serum (FBS; P30-3305, FBS Standard, South America, PAN Biotech) in a humidified incubator at 37°C and 5% 
CO2. The origin of the MDCK wild-type and MDCK wild-type GFP-NLS cells has been previously described in 
Wagstaff et al. 2016. 
 
MDCK p53KO GFP-NLS clones 6 and 14 were constructed by infecting the MDCK p53KO pool (Wagstaff et al. 
2016) with lentiviral construct pGIPZ-turboGFP-NLS-Puro (Wagstaff et al. 2016). Selection post infection was 
carried out in 0.65 µg/ml puromycin. The resulting GFP-NLS labelled pool was then plated at one cell per well in 
96-well plates; the clones were expanded and verified by immunofluorescence, sequencing, and Western blotting. 
 
MDCK p21KO clones G5 and E9 were generated using Cas9 D10A CRISPR technology. sgRNAs against canine 
CDKN1A were designed manually following published methods (Ran et al. 2013). Target sequences used: 5’-
CGGCAAGCCTTGCTGCCATG(AGG)-3’ and 5’-TGGACAGCGAGCAGCTGCGC(CGG)-3’. sgRNAs were 
cloned individually into PX461 vectors (Ran et al. 2013) and co-transfected as a pair into wild-type MDCK cells 
using Lipofectamine 2000 (Thermo Fisher Scientific). The transfected cells were treated with 11 µM Nutlin-3 for 6 
days to enrich for non-growth-inhibited p21KO cells. The pool was then plated at one cell per well in 96-well plates; 
the resulting clones were expanded and verified by immunofluorescence and sequencing. 
 
To overexpress p21, p21 cDNA was amplified from a cDNA library obtained from MDCK scribble shRNA cells 
treated with tetracycline to induce scribble knockdown, as these cells have been shown to express high levels of p21 
(Wagstaff et al. 2016). The resulting PCR product was introduced into doxycycline-inducible pTRIPZ-RFP-NLS-
Puro (Wagstaff et al. 2016) with a P2A peptide bridging the two proteins to make pTRIPZ-p21-P2A-RFP-NLS-Puro. 
MDCK wild-type cells were infected with the final construct, selected using 0.65 µg/ml puromycin, and then plated 
out in 96-well plates to isolate single clones that were verified by immunofluorescence. 
 
The dominant negative GSE-22 peptide was first described for the rat in Ossovskaya et al. 1996. To overexpress the 
dominant negative GSE-22 peptide in MDCK cells, amino acids 302-381 of canine p53 (homologous to the original 
rat sequence) were amplified from the MDCK cDNA library used in p21 cloning above; a forward primer carrying 
an adaptor with three start ATG codons and a reverse primer containing three stop codons were used to account for 
all three reading frames, as was done in the original publication. The resulting PCR product was introduced into 
doxycycline-inducible pTRIPZ-GFP-NLS-Puro with a P2A peptide bridging the two proteins to make pTRIPZ-GSE-
22-P2A-GFP-NLS-Puro. MDCK wild-type cells were infected with the final construct, selected using 0.65 µg/ml 
puromycin to generate a pool population. 
 
Mitomycin C (MMC) assays 
 
On day 1, 2,500 untreated wild-type MDCK cells (labelled with GFP-NLS or unlabeled, as appropriate) were seeded 
per well in 24-well plates. On day 2, a second population of MDCK cells was trypsinized, and 1x106 of these were 
incubated in suspension in 5 ml complete media containing 7.5 µg/ml MMC for 1 hour at 37°C and 5% CO2. The 
cells were then washed at least three times in complete media (spinning down the cells after each wash) to reduce 
MMC carryover, and then 5,000 MMC-treated cells were plated on top of the untreated population. Live imaging 
was begun on day 3; samples were imaged every 2 hours. 
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Spontaneous leader assays 
 
5,000 wild-type MDCK cells were seeded in a 24-well plate or, if immunofluorescence was to be performed at end 
of live imaging, in a gridded tissue culture plate (µ-Dish 35 mm Grid-500, 81166, ibidi). Approximately 48 hours 
later, cells with the spontaneous leader morphology were manually selected on the Nikon BioStation CT and imaged 
every 2 hours. Where applicable, cells at the end of live imaging were fixed in 4% PFA (15713-S, Electron 
Microscopy Sciences) in PBS for 10 min at RT. 
 
Wound healing and barrier release assays 
 
27,000-33,000 wild-type MDCK cells were seeded in the middle of a ‘fence’ (Aix Scientifics, http://www.aix-
scientifics.co.uk/en/fences.html) placed in a 24-well plate or straight into a well of a 96-well plate (no ‘fence’). If 
immunofluorescence was to be performed after live imaging, we used optically clear plates (µ-Plate 24 well, 82406, 
ibidi or CellCarrier-96, 6005550, PerkinElmer). The ‘fence’ was removed approximately 5 hours after seeding and 
the culture medium changed. Approximately 20 hours later, a P1000 pipette tip was used to generate a scratch-
wound through the middle of the now-confluent monolayer and the culture medium changed. Imaging of the wound 
edge was started approximately 1 hour after scratching and imaged every 1-2 hours. 
 
UV irradiation experiments 
 
On day 1, 25,000-30,000 wild-type cells per well were plated in an optically clear 96-well plate (CellCarrier-96, 
6005550, PerkinElmer). The cells were left to adhere overnight. On day 2, a scratch-wound was generated through 
the middle of each well in the 96-well plate using a P1000 tip and returned to the 37°C / 5% CO2 incubator for 
approximately 30 min. Cells were then treated in the incubator with 3 µg/ml Hoechst 33342 diluted in complete 
media for 10 min. The cells were then washed three times in complete media. UV irradiation along the top half of the 
wound edge was performed using a 20´ air objective on a Leica SP8 confocal microscope, which was set up to keep 
the samples at 37°C / 5% CO2 during imaging; the bottom half of the wound was not irradiated. UV treatment 
settings used: 30 frames at 100% 405 nm laser with the FRAP booster on. The samples were then imaged using the 
BioStation CT every hour for at least 24 hours. For 𝛾H2AX staining, samples were fixed and processed 2-4 hours 
after UV irradiation. 
 
Blebbistatin-induced binucleated cell (BBC) generation 
 
On day 1, 5,000 unlabeled wild-type MDCK cells were plated per gridded dish (µ-Dish 35 mm Grid-500, 81166, 
ibidi). Also on day 1, 12,000 GFP-NLS labelled WT MDCK cells were incubated with 37.5 µM blebbistatin in 
DMSO (B0560, Merck) in a 12-well plate. 16 hours later, on day 2, the cells were washed three times in PBS and left 
to recover for 4 hours in complete media. The cells were then harvested by trypsinization and large clumps removed 
using a 20 µm filter (04-0042-2315, CellTrics). Half of the recovered cells were plated per gridded dish. Imaging 
was started on day 3; cells were imaged every 2-4 hours. 
 
Immunofluorescence 
 
Depending on the assay, cells were cultured on glass coverslips or optically clear tissue culture dishes. Cells were 
fixed in 4% PFA (15713-S, Electron Microscopy Sciences) in PBS for 10 min at RT, quenched for 10 min at RT in 
50 mM in NH4Cl in PBS, and permeabilized for 10 min at RT in 0.1% Triton X-100 in PBS. Samples were blocked 
for at least 30 min in 2% bovine serum albumin (BSA; A2153, Sigma), 2% FBS in PBS at RT. Both primary and 
secondary antibodies were diluted in blocking solution diluted 1:1 with PBS. Primary antibody incubations were 
either a minimum of 1 hour at RT or overnight at 4°C. Following 4 x 5 min washes in PBS, secondary antibodies 
were incubated for 1 hour at RT, then washed 4 x 5 min in PBS. Coverslips were mounted in FluorSave (345789, 
Merck). Optically clear dishes were either flooded with FluorSave and sealed with a coverslip or imaged directly in 
the last PBS wash. For immunostaining against phosphorylated proteins, fixing solution was supplemented with 
PhosSTOP (1 tablet per 10ml, Sigma), all PBS-based solutions were substituted with TBS, and blocking solution 
was substituted with 5% BSA in TBS. 
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Imaging and image analysis 
 
Imaging of fixed samples was done at RT on Leica SP5 or SP8 confocal microscopes using a 40´ oil objective or on 
the PerkinElmer Opera LX system using a 20´ water objective. UV irradiation experiments were done on a Leica 
SP8 confocal microscope set up to keep the samples at 37°C / 5% CO2 during imaging. All live imaging was done on 
a Nikon BioStation CT system at 37°C / 5% CO2 using 10´ or 4´ air objectives with an imaging frequency every 1-4 
hours (indicated in movie time stamps); media was changed every 2–3 days. 
 
Mean intensities of nuclear p53 and p21 were measured using DAPI as a mask to segment the nuclear volumes in 
Volocity (PerkinElmer). 
 
Cell tracking was done by marking coordinates of cell nuclei over time using MtrackJ plugin in ImageJ. Cells from 
an untreated / MMC-treated pair were tracked starting from 8 hours (four time points) before, until 12 hours (six time 
points) after contact between the two was established, thereby making coordinate 0,0 a point when the two cells 
meet. Coordinates of cell tracks were analyzed in Microsoft Excel. 
 
The migration speed of scratch-wound fronts was measured in FIJI by manually drawing freehand lines outlining the 
wound edge at the first and final time points. If any wound edges were not parallel to the y axis, the images were 
adequately rotated. The median x position for each line was recorded to calculate the median x displacement in 
pixels, which was then divided by the duration of the experiment in hours to generate a speed value in pixels/h. 
 
All graphs were plotted using GraphPad Prism. Figures were made using Adobe Illustrator CS6. 
 
Statistical analysis 
 
All statistical analysis was performed using GraphPad Prism. All p values were obtained using the Kolmogorov-
Smirnov (K-S) test. 
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Supplementary Figures 
 
 
 
 
 
Fig. S1. Blebbistatin-induced binucleated cells (BBCs) behave as leaders and this behavior is driven by p53. 
(A) Time-course movie stills of a binucleated spontaneous leader emerging from a wild-type MDCK population that 
expresses nuclear GFP. (B) Quantification of the number of spontaneous leaders that did not divide during the course 
of movie acquisition. (C) BBCs, which had been generated from a population of wild-type cells expressing nuclear 
GFP, display leader behavior in the presence of unlabeled wild-type cells. (D) Confocal images of BBCs following 
p53 immunostaining show that they have elevated p53 levels compared to their mononucleated neighbors. (E) 
Confocal images of a co-culture of unlabeled wild-type cells and mitomycin C (MMC)-treated wild-type cells 
expressing nuclear GFP immunostained against p53. (F) Movie stills from co-cultures of unlabeled wild-type 
MDCKs and wild-type cells expressing nuclear GFP. There is no leader behavior if neither of the populations have 
been treated with MMC; control panels for Fig. 1F. (G-H) Wild-type cells expressing nuclear GFP still divide when 
treated with sub-lethal doses of Nutlin-3 (G), albeit at a slower rate than cells treated with the DMSO vector alone 
(H). (I) Movie stills from co-cultures of unlabeled p53KO MDCKs and wild-type cells expressing nuclear GFP in the 
presence of DMSO. There is no leader behavior in the absence of Nutlin-3; control panels for Fig. 1G. (J-L) 
Confocal images of p53 immunostaining of co-cultures of unlabeled wild-type cells and BBCs generated from cells 
expressing nuclear GFP, the latter being either wild-type (J) or p53 knockout clones 6 (K) and 14 (L) (p53KO C6 and 
C14, respectively). (M) Movie stills from a co-culture of unlabeled wild-type cells and BBCs generated from p53KO 
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cells expressing nuclear GFP. (N) Quantification of the frequency of leader cell behavior of wild-type and p53KO 
BBCs in the presence of an untreated wild-type population. 
 
n = number of cells in (B), (G), (H), and (N). Data pooled from three biological replicates in (B) and (N). Error bars 
= ±SEM in (B) and (N). 
 
Here and throughout all figures: 
White dashed line = initial contact point; black dashed line = final contact point. Scale bars 100μm (movie 
sequences) and 50μm (confocal images). P values obtained using the K-S test. 
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Fig. S2. Generation of cells overexpressing p21 and p21 knockout MDCKs. (A-B) A clonal cell line that 
overexpressed canine p21 (p21OE) in a doxycycline (DOX)-inducible manner was generated. Without DOX addition 
(A) the cells displayed normal MDCK morphology; upon addition of DOX (B) the cells stopped dividing and 
flattened. (C) Confocal images of p21 immunostaining after 24 hours of Nutlin-3 treatment of wild-type or p21KO 
clones E9 and G5. (D) Movie stills of co-cultures of MMC-treated unlabeled wild-type cells and untreated wild-type 
cells expressing nuclear GFP. Control panels for Fig. 2E. 
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Fig. S3. Spontaneous leaders display elevation of canonical leader cell markers. (A-B) Movie stills (first three 
panels) following the migration of two spontaneous leaders (yellow arrows). Fourth panel shows confocal images of 
those same spontaneous leaders following immunostaining against phosphoinositide 3-kinase (PI3K) in (A) and 
integrin β1 (ITGβ1) in (B). 
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Fig. S4. Leaders generated by barrier release also display p53/p21 elevation; UV treatment that increases the 
speed of migration during wound healing also elevates DNA damage marker 𝛾H2AX; spontaneous leaders are 
mechanical losers. (A) Schematic of the barrier release experiment shown in (B). (B) Movie stills (first two panels) 
following the migration of leaders generated by barrier release. Last panel shows a confocal image of those same 
spontaneous leaders following p53 immunostaining. (C) Quantification of single-cell nuclear p53 intensity of barrier 
release-induced leaders versus surrounding non-leaders. (D) Movie stills (first two panels) following the migration of 
leaders generated by barrier release. Last two panels show confocal images of those same spontaneous leaders 
following p21 immunostaining. (E) Quantification of single-cell nuclear p21 intensity of barrier release-induced 
leaders versus surrounding non-leaders. (F) The first panel is a confocal image of a scratch-wound edge generated in 
a Hoechst-treated wild-type MDCK monolayer prior UV irradiation of the left half of the edge cells; the UV target 
region is marked using the green line. The last two panels are confocal images of a 𝛾H2AX immunostaining of the 
same scratch area approximately 2 hours post UV treatment. (G) Movie stills following the migration of a 
spontaneous leader (yellow arrow) that is eliminated once the local cell density increases. (H) Quantification of the 
number of spontaneous leaders that are eliminated when surrounded by wild-type neighbors. 
 
Black bars = median in (C) and (E); n = number of cells in (C), (E), and (H). Data from one representative repeat of 
three biological replicates, (C) and (E), or pooled from three biological replicates, (H). Error bars = ±SEM in (H). 
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Movie Legends 
 
Throughout all movies, the initial contact point is marked using a magenta asterisk. 
 
1. A spontaneous leader emerging from a wild-type MDCK culture. (Fig. 1A) 
2. A blebbistatin-induced binucleated cell (BBC) expressing nuclear GFP displays leader 
behavior following contact with untreated, unlabeled wild-type cells. (Fig. S1C) 
3. MMC-treated wild-type cells expressing nuclear GFP become leaders when confronted 
with untreated, unlabeled wild-type cells (left movie). Untreated cells do not display 
leader behavior (right movie). (Fig. 1F and Fig. S1F) 
4. In the presence of sub-lethal doses of Nutlin-3 (left movie), wild-type cells expressing 
nuclear GFP show leader behavior following contact with unlabeled cells lacking p53 
(p53KO). There is no leader behavior in the absence of Nutlin-3 (right movie). (Fig. 1G 
and Fig. S1I) 
5. Loss of p53 prevents leader behavior of MMC-treated cells expressing nuclear GFP 
following contact with untreated, unlabeled wild-type cells. (Fig 1I) 
6. Unlabeled cells overexpressing p21 (p21OE) show leader behavior following contact with 
wild-type cells expressing nuclear GFP. (Fig. 2C) 
7. MMC-treated, unlabeled wild-type cells become leaders when confronted with untreated 
wild-type cells expressing nuclear GFP (right movie) but knockout of p21 (p21KO) 
prevents this (left movie). (Fig. 2E and Fig. S2D) 
8. MMC-treated cells expressing nuclear GFP show leader behavior following contact with 
untreated, unlabeled wild-type cells. This migration is stalled upon the addition of PI3K 
and Rac1 inhibitors (middle and right movies, respectively) but continues in the presence 
of the DMSO vector (left movie). Please note that the drug treatments are added at time = 
0 hours, when the text appears in the top right corner of each movie. (Fig. 3E-G) 
9. UV irradiation of cells at the wound edge (right movie) accelerates the speed of front 
migration, compared to a non-irradiated edge (left movie). The white line denotes initial 
front position; the black line denotes final front position. (Fig. 4I-K) 
10. Scratch-induced leaders (cyan and magenta arrows) are often eliminated upon wound 
closure. (Fig. 4L) 
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Appendix 2: Plasmid maps 
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